0001213900-19-023283.txt : 20191114 0001213900-19-023283.hdr.sgml : 20191114 20191114061117 ACCESSION NUMBER: 0001213900-19-023283 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 69 CONFORMED PERIOD OF REPORT: 20190930 FILED AS OF DATE: 20191114 DATE AS OF CHANGE: 20191114 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SenesTech, Inc. CENTRAL INDEX KEY: 0001680378 STANDARD INDUSTRIAL CLASSIFICATION: AGRICULTURE CHEMICALS [2870] IRS NUMBER: 202079805 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-37941 FILM NUMBER: 191216182 BUSINESS ADDRESS: STREET 1: 3140 N. CADEN COURT STREET 2: SUITE 1 CITY: FLAGSTAFF STATE: AZ ZIP: 86004 BUSINESS PHONE: (928) 779 - 4143 MAIL ADDRESS: STREET 1: 3140 N. CADEN COURT STREET 2: SUITE 1 CITY: FLAGSTAFF STATE: AZ ZIP: 86004 10-Q 1 f10q0919_senestechinc.htm QUARTERLY REPORT

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

  

FORM 10-Q

  

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended September 30, 2019

 

OR

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from                      to                     

 

Commission File Number: 001-37941

  

SENESTECH, INC. 

(Exact name of registrant as specified in its charter)

  

Delaware   20-2079805

(State or other jurisdiction of
incorporation or organization)

 

(I.R.S. Employer
Identification No.)

     
3140 N. Caden Court, Suite 1
Flagstaff, AZ
  86004
(Address of principal executive offices)   (Zip Code)

 

(928) 779-4143

(Registrant’s telephone number, including area code)

 

 

(Former name, former address and former fiscal year, if changed since last report)

 

Securities registered pursuant to Section 12(b) of the Securities Exchange Act of 1934:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which
registered
Common Stock, $0.001 par value   SNES   The NASDAQ Stock Market LLC
(NASDAQ Capital Market)

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  ☒   No  ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    Yes   ☒   No  ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer     Accelerated filer  
Non-accelerated filer     Smaller reporting company  
Emerging growth company          

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☒    

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes  ☐    No  ☒

  

The number of shares of common stock outstanding as of November 14, 2019: 28,288,596

  

 

 

 

 

SENESTECH, INC.

FORM 10-Q

For the Quarterly Period Ended September 30, 2019

 

TABLE OF CONTENTS

 

    Page
  PART I. FINANCIAL INFORMATION 1
Item 1 Financial Statements 1
Item 2 Management’s Discussion and Analysis of Financial Condition and Results of Operations 19
Item 3 Quantitative and Qualitative Disclosures About Market Risk 30
Item 4 Controls and Procedures 30
  PART II. OTHER INFORMATION 31
Item 1 Legal Proceedings 31
Item 1A Risk Factors 31
Item 2 Unregistered Sales of Equity Securities and Use of Proceeds 31
Item 3 Defaults Upon Senior Securities 31
Item 4 Mine Safety Disclosures 31

  

i

 

 

PART I. FINANCIAL INFORMATION

 

Item 1. Financial Statements

 

SENESTECH, INC.

CONDENSED BALANCE SHEETS

(In thousands, except shares and per share data)

 

   September 30,   December 31, 
   2019   2018 
   (Unaudited)     
ASSETS        
         
Current assets:        
Cash  $3,945   $4,920 
Accounts receivable   155    139 
Prepaid expenses   304    342 
Inventory   1,285    1,261 
Deposits   6    9 
Total current assets   5,695    6,671 
           
Right to use asset-operating leases   29    - 
Property and equipment, net   830    1,083 
Total assets  $6,554   $7,754 
           
LIABILITIES AND STOCKHOLDERS’ EQUITY          
           
Current liabilities:          
Short-term debt  $129   $219 
Accounts payable   291    173 
Accrued expenses   785    771 
Total current liabilities   1,205    1,163 
           
Long-term debt, net   167    261 
Operating lease liability   29    - 
Common stock warrant liability   -    - 
Deferred rent   5    16 
Total liabilities   1,406    1,440 
           
Commitments and contingencies (See note 12)   -    - 
           
Stockholders’ equity:          
Common stock, $0.001 par value, 100,000,000 shares authorized, 28,288,285 and 23,471,999 shares issued and outstanding at September 30, 2019 and December 31, 2018, respectively   28    24 
Additional paid-in capital   98,196    92,128 
Accumulated deficit   (93,076)   (85,838)
Total stockholders’ equity   5,148    6,314 
           
Total liabilities and stockholders’ equity  $6,554   $7,754 

 

See accompanying notes to financial statements.

 

1

 

 

SENESTECH, INC.

CONDENSED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS

(In thousands, except shares and per share data)

(Unaudited)

 

   For the Three Months   For the Nine Months 
   Ended September 30,   Ended September 30, 
   2019   2018   2019   2018 
                 
Revenue:                
Sales  $36   $105   $79   $160 
Cost of sales   25    114    58    153 
Gross profit (loss)   11    (9)   21    7 
                     
Operating expenses:                    
Research and development   432    476    1,359    1,746 
Selling, general and administrative   2,173    2,013    5,908    7,506 
Total operating expenses   2,605    2,489    7,267    9,252 
                     
Net operating loss   (2,594)   (2,498)   (7,246)   (9,245)
                     
Other income (expense):                    
Interest income   19    1    45    8 
Interest expense   (10)   (16)   (34)   (60)
Other income (expense)   -    13    (3)   19 
Total other income (expense)   9    (2)   8    (33)
                     
Net loss and comprehensive loss   (2,585)   (2,500)   (7,238)   (9,278)
Deemed dividend-warrant price protection adjustment   -    333    -    333 
Net loss attributable to common shareholders  $(2,585)  $(2,833)  $(7,238)  $(9,611)
                     
                     
Weighted average common shares outstanding - basic and fully diluted   27,891,501    20,862,216    25,336,837    18,036,982 
                     
Net loss per common share - basic and fully diluted  $(0.09)  $(0.14)  $(0.29)  $(0.53)

 

See accompanying notes to financial statements.

 

2

 

 

SENESTECH, INC.

STATEMENT OF CHANGES IN STOCKHOLDERS’ EQUITY (DEFICIT)

(In thousands, except shares and per share data)

(Unaudited)

 

For The Three Months Ended September 30, 2018 and 2019

 

           Additional   Stock       Total Stockholders’ 
   Common Stock   Paid-In   Subscription   Accumulated   Equity 
   Shares   Amount   Capital   Payable   Deficit   (Deficit) 
Balance, June 30, 2018   18,040,497   $18   $86,022   $-   $(80,375)  $5,665 
                               
Issuance of common stock for services   27,738    -    -    -    -    - 
Stock-based compensation   -    -    355    -    -    355 
Issuance of common stock, sold for cash, net   5,357,052    5    5,127    -    -    5,132 
Warrant antidilution price protection adjustment             333         (333)   - 
Payments for employee withholding taxes related to share-based awards.   -    -    (15)   -    -    (15)
Net loss for the three months ended September 30, 2018   -    -         -    (2,500)   (2,500)
Balance, September 30, 2018   23,425,287   $23   $91,822   $-   $(83,208)  $8,637 
                               
Balance, June 30, 2019   25,227,475   $25   $94,391   $-   $(90,491)  $3,925 
                               
Issuance of common stock, sold for cash, net   3,037,038   $3   $3,627   $-         3,630 
Issuance of common stock for services   19,258    -    -    -    -    - 
Stock-based compensation   -    -    204    -    -    204 
Issuance of common stock upon exercise of warrants   4,514    -    5    -    -    5 
Payments for employee withholding taxes related to share-based awards   -    -    (31)   -    -    (31)
Net loss for the three months ended September 30, 2019   -    -    -    -    (2,585)   (2,585)
Balance, September 30, 2019   28,288,285   $28   $98,196   $-   $(93,076)  $5,148 
                               
For The Nine Months Ended September 30, 2018 and 2019                              
                               
Balance, December 31, 2017   16,404,195   $16   $81,103   $-   $(73,597)  $7,522 
                               
Issuance of common stock, sold for cash, net   5,357,052    5    5,127              5,132 
Issuance of common stock for services   174,481    1    34    (8)   -    27 
Stock-based compensation   -    -    3,062    -    -    3,062 
Stock subscribed but not issued   -    -    (8)   8    -    - 
Issuance of common stock upon cashless exercise of stock options   13,900    -    -    -    -    - 
Issuance of common stock upon exercise of warrants   1,475,659    1    2,213    -    -    2,214 
Payments for employee withholding taxes related to share-based awards   -    -    (42)   -    -    (42)
Warrant antidilution price protection adjustment             333         (333)     
Net loss for the nine months ended September 30, 2018   -    -    -    -    (9,278)   (9,278)
Balance, September 30, 2018   23,425,287   $23   $91,822   $-   $(83,208)  $8,637 
                               
Balance, December 31, 2018   23,471,999   $24   $92,128   $-   $(85,838)  $6,314 
                               
Issuance of common stock, sold for cash, net   3,037,038   $3   $3,627              3,630 
Issuance of common stock for services   144,054    -    34    -    -    34 
Stock-based compensation   -    -    675    -    -    675 
Issuance of common stock upon exercise of warrants   1,610,210    1    1,787    -    -    1,788 
Issuance of common stock upon exercise of stock options   24,984    -    -    -    -    - 
Payments for employee withholding taxes related to share-based awards   -    -    (55)   -    -    (55)
Net loss for the nine months ended September 30, 2019   -    -    -    -    (7,238)   (7,238)
Balance, September 30, 2019   28,288,285   $28   $98,196   $-   $(93,076)  $5,148 

 

The accompanying notes are an integral part of these financial statements.

 

See accompanying notes to financial statements.

 

3

 

 

SENESTECH, INC.

CONDENSED STATEMENTS OF CASH FLOWS

(In thousands)

(Unaudited)

  

   For the Nine Months 
   Ended September 30, 
   2019   2018 
CASH FLOWS FROM OPERATING ACTIVITIES        
Net loss  $(7,238)  $(9,278)
Adjustments to reconcile net loss to net cash used in operating activities:          
Gain on investments held to maturity   -    (44)
Depreciation and amortization   314    332 
Stock-based compensation   675    3,090 
Loss on sale of equipment   3    15 
Loss on early extinguishment of debt   -    10 
Loss on remeasurement of common stock warrant liability   -    1 
(Increase) decrease in current assets:          
Accounts receivable   (16)   (36)
Prepaid expenses   38    (166)
Inventory   (24)   (578)
Deposits   3    7 
Increase (decrease) in current liabilities:          
Accounts payable   118    (185)
Accrued expenses   46    (66)
Deferred rent   (11)   (18)
Net cash used in operating activities   (6,092)   (6,916)
           
CASH FLOWS FROM INVESTING ACTIVITIES          
Proceeds received on sale of securities held to maturity   -    2,619 
Proceeds received on sale of equipment   -    185 
Purchase of property and equipment   (64)   (212)
Net cash provided by (used in) investing activities   (64)   2,592 
           
CASH FLOWS FROM FINANCING ACTIVITIES          
Proceeds from the issuance of common stock, net   3,631    5,132 
Proceeds from the issuance of notes payable        9 
Repayments of notes payable   (184)   (236)
Repayments of notes payable, related parties   -    (12)
Repayments of capital lease obligations   -    (50)
Proceeds from the exercise of warrants   1,789    2,213 
Payment of employee withholding taxes related to share-based awards   (55)   (42)
Net cash provided by financing activities   5,181    7,014 
           
NET CHANGE IN CASH   (975)   2,690 
CASH AT BEGINNING OF PERIOD   4,920    2,101 
CASH AT END OF PERIOD  $3,945   $4,791 
           
SUPPLEMENTAL INFORMATION:          
Interest paid  $34   $60 
Income taxes paid  $-   $- 
           
NON-CASH INVESTING AND FINANCING ACTIVITIES:          
    Deemed dividend       $333 
Purchases of equipment under capital lease obligations  $-   $37 
Common stock issued on accrued bonus  $32   $- 

  

See accompanying notes to financial statements.

 

4

 

 

SENESTECH, INC.

 NOTES TO CONDENSED FINANCIAL STATEMENTS

(In thousands, except share and per share data)

 

Note 1 - Organization and Description of Business

 

SenesTech, Inc. (referred to in this report as “SenesTech,” the “Company,” “we” or “us”) was formed in July 2004 and incorporated in the state of Nevada. The Company subsequently reincorporated in the state of Delaware in November 2015. Our corporate headquarters is in Flagstaff, Arizona. We have developed and are commercializing a global, proprietary technology for managing animal pest populations, initially rat populations, through fertility control.

 

Although myriad tools are available to fight rat infestations, communities, food producers, zoos and sanctuaries and others continue to face challenges in controlling today’s infestations. Infestations result in significant infrastructure damage, as well as pose additional risks to the health and food security of communities. In addition to these challenges, the pest management industry and pest management professionals (PMPs) are being increasingly asked for new solutions to help solve the problem. With growing concerns about rat resistance to rodenticides and a growing interest in non-lethal options, it is becoming increasingly important for PMPs to have new tools at their disposal. Our goal is to provide customers with not only a solution to combat their most difficult infestations, but also offer a non-lethal option to serve customers that are looking to decrease or remove the amount of poison used in their pest management programs.

 

Our first fertility control product, ContraPest, is a liquid bait containing the active ingredients 4-vinylcyclohexene diepoxide (VCD) and triptolide. When consumed, ContraPest targets reproduction, limiting fertility in male and female rats beginning with the first breeding cycle following consumption. ContraPest is being marketed for use in controlling rat populations, specifically Norway and roof rats. On August 23, 2015, the United States Environmental Protection Agency (EPA) granted registration approval for ContraPest as a Restricted Product Due to Professional Expertise (referred to in this report as a “Restricted Use designation”), effective August 2, 2016. On October 18, 2018, the EPA approved the removal of the Restricted Use designation. We believe ContraPest is the first and only non-lethal fertility control product approved by the EPA for the management of rodent populations.

 

In addition to the EPA registration of ContraPest in the United States, we must obtain registration from the various state regulatory agencies prior to selling in each state. As of the date of this report, we have received registration for ContraPest in all 50 states and the District of Columbia, 47 of which have approved the removal of the Restricted Use designation.

 

We expect to continue to pursue regulatory approvals and amendments to existing registration in the United States for ContraPest, and if ContraPest begins to generate sufficient revenue, regulatory approvals for any additional jurisdictions beyond the United States.

 

Potential Need for Additional Capital

 

Since our inception, we have sustained significant operating losses in the course of our research and development and commercialization activities and expect such losses to continue for the near future. We have generated limited revenue to date from product sales, research grants and licensing fees received under our former license agreement with Neogen. In 2017, we began to prepare and launch commercialization of our first product, ContraPest. We have primarily funded our operations to date through the sale of equity securities, including convertible preferred stock, common stock and warrants to purchase common stock.

 

We have also raised capital through debt financing, consisting primarily of convertible notes; and, to a lesser extent, payments received in connection with product sales, research grants and licensing fees.

 

Through September 30, 2019, we had received net proceeds of $67.2 million from sales of our common stock, preferred stock and warrant exercises and issuance of convertible and other promissory notes, an aggregate of $1.7 million from licensing fees and an aggregate of $0.5 million in net product sales. At September 30, 2019, we had an accumulated deficit of $93.1 million and cash and cash equivalents of $3.9 million.

 

Our ultimate success depends upon the outcome of a combination of factors, including: (i) successful commercialization of ContraPest and maintaining and obtaining regulatory approvals of our products and product candidates, (ii) market acceptance, commercial viability and profitability of ContraPest and other products; (iii) the ability to market our products and establish an effective sales force and marketing infrastructure to generate significant revenue; (iv) the success of our research and development; (v) our ability to retain and attract key personnel to develop, operate and grow our business; and (vi) our ability to meet our working capital needs.

 

Based upon our current operating plan, we expect that cash and cash equivalents at September 30, 2019, in combination with anticipated revenue and any additional sales of our equity securities, will be sufficient to fund our current operations for at least the next six months. We have taken and will continue to take actions to reduce our operating expenses and to concentrate our resources toward the successful commercialization of ContraPest in the U. S. However, if anticipated revenue targets and margin targets are not achieved and we are unable to raise necessary capital through the sale of our securities, we may be required take other measures that could impair our ability to be successful and operate as a going concern. In any event, we are likely to require additional capital in order to fund our operating losses and research and development activities until we become profitable. We may never achieve profitability or generate positive cash flows, and unless and until we do, we will continue to need to raise capital through equity or debt financing. If such equity or debt financing is not available at adequate levels or on acceptable terms, we may need to delay, limit or terminate commercialization and development efforts.

 

5

 

 

SENESTECH, INC.

 NOTES TO CONDENSED FINANCIAL STATEMENTS

(In thousands, except share and per share data)

 

Note 1 - Organization and Description of Business – (continued)

 

Basis of Presentation

 

The accompanying unaudited condensed financial statements of the Company have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”) for interim financial reporting. Certain information and footnote disclosures normally included in the annual financial statements prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) have been condensed or omitted pursuant to such rules and regulations. In the Company’s opinion, the unaudited condensed financial statements include all material adjustments, all of which are of a normal and recurring nature, necessary to present fairly the Company’s financial position as of September 30, 2019, the Company’s operating results for the three and nine months ended September 30, 2019 and 2018, and the Company’s cash flows for the nine months ended September 30, 2019 and 2018. The accompanying financial information as of December 31, 2018 is derived from audited financial statements. Interim results are not necessarily indicative of results for a full year. The information included in this Quarterly Report on Form 10-Q should be read in conjunction with the Company’s Annual Report on Form 10-K, as amended by Form 10-K/A, for the year ended December 31, 2018, both filed with the SEC on March 29, 2019. All amounts shown in these financial statements and accompanying notes are in thousands, except percentages and per share and share amounts. 

 

Note 2 - Summary of Significant Accounting Policies

 

Use of Estimates

 

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts and classification of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements and reported amounts of revenues and expenses during the reporting period. The significant estimates in the Company’s financial statements include the valuation of preferred stock, common stock and related warrants, and other stock-based awards. Actual results could differ from such estimates.

 

Reclassifications

 

Certain prior year amounts have been reclassified to conform to the current period presentation. These reclassifications had no material impact on net earnings, financial position or cash flows.

 

Accounts Receivable

 

Accounts receivable consist primarily of trade receivables. The Company provides an allowance for doubtful trade receivables equal to the estimated uncollectible amounts. That estimate is based on historical collection experience, current economic and market conditions and a review of the current status of each customer’s trade accounts receivable. The allowance for doubtful trade receivables was less than $1 at September 30, 2019 and at December 31, 2018.

 

Inventories

 

Inventories are stated at the lower of cost or market value, using the first-in, first-out convention. Inventories consist of raw materials, work in progress and finished goods.

 

Components of inventory are:

 

   September 30,   December 31, 
   2019   2018 
Raw materials  $1,063   $1,111 
Work in progress   3     
Finished goods   223    154 
Total inventory   1,289    1,265 
Less:          
Reserve for obsolete   (4)   (4)
Total net inventory  $1,285   $1,261 

 

Prepaid Expenses

 

Prepaid expenses consist primarily of payments made for director and officer insurance, director compensation, rent, legal and inventory purchase deposits and seminar fees to be expensed in the current year.

 

6

 

 

SENESTECH, INC.
NOTES TO CONDENSED FINANCIAL STATEMENTS
(In thousands, except share and per share data)

 

Note 2 - Summary of Significant Accounting Policies – (continued)

 

Property and Equipment

 

Property and equipment are stated at cost less accumulated depreciation. Equipment held under capital leases are stated at the present value of minimum lease payments less accumulated amortization.

 

Depreciation on property and equipment is computed using the straight-line method over the estimated useful lives of the respective assets. The cost of leasehold improvements is amortized over the life of the improvement or the term of the lease, whichever is shorter. Equipment held under capital leases is amortized over the shorter of the lease term or estimated useful life of the asset. The Company incurs repair and maintenance costs on its major equipment, which are expensed as incurred.

 

Impairment of Long-Lived Assets

 

Long-lived assets, such as property and equipment, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. If circumstances require long-lived assets or asset groups to be tested for possible impairment, the Company compares the undiscounted cash flows expected to be generated from the use of the asset or asset group to its carrying amount. If the carrying amount of the long-lived asset or asset group is not recoverable on an undiscounted cash flow basis, an impairment charge is recognized to the extent that the carrying amount exceeds its fair value. Fair value is determined through various valuation techniques, such as discounted cash flow models and the use of third-party independent appraisals. The Company has not recorded an impairment of long-lived assets since its inception.

 

Revenue Recognition

 

Effective January 1, 2018, the Company adopted ASC 606 — Revenue from Contracts with Customers. Under ASC 606, the Company recognizes revenue from the commercial sales of products, licensing agreements and contracts to perform pilot studies by applying the following steps: (1) identify the contract with a customer; (2) identify the performance obligations in the contract; (3) determine the transaction price; (4) allocate the transaction price to each performance obligation in the contract; and (5) recognize revenue when each performance obligation is satisfied. For the comparative periods, revenue has not been adjusted and continues to be reported under ASC 605 — Revenue Recognition. Under ASC 605, revenue is recognized when the following criteria are met: (1) persuasive evidence of an arrangement exists; (2) the performance of service has been rendered to a customer or delivery has occurred; (3) the amount of the fee to be paid by a customer is fixed and determinable; and (4) the collectability of the fee is reasonably assured. The performance obligations identified by the Company under Accounting Standards Codification (“ASC”) Topic 606, Revenue From Contracts With Customers, are straightforward and similar to the unit of account and performance obligation determination under ASC Topic 605, Revenue Recognition. There was no impact on the Company’s financial statements as a result of adopting ASC 606 for the three months or nine months ended September 30, 2019 and 2018, respectively.

 

The Company recognizes revenue when product leaves its dock at a fixed selling price on payment terms of 30 to 120 days from invoicing. The Company recognizes other revenue earned from pilot studies upon the performance of specific services under the respective service contract.

 

The Company derives revenue primarily from commercial sales of products.

 

Research and Development

 

Research and development costs are expensed as incurred. Research and development expenses primarily consist of salaries and benefits for research and development employees, stock-based compensation, consulting fees, lab supplies, costs incurred related to conducting scientific trials and field studies, and regulatory compliance costs. Also, included in research and development expenses is an allocation of facilities related costs, including depreciation of research and development equipment.

 

Stock-based Compensation

 

Employee stock-based awards, consisting of restricted stock units and stock options expected to be settled in shares of the Company’s common stock, are recorded as equity awards. The grant date fair value of stock options is measured using the Black-Scholes option pricing model. The Company expenses the grant date fair value of its stock options on a straight-line basis over their respective vesting periods. Performance-based awards are expensed over the performance period when the related performance goals are probable of being achieved.

 

For equity instruments issued to non-employees, the stock-based consideration is measured using a fair value method. The measurement of the stock-based compensation is subject to re-measurement as the underlying equity instruments vest.

 

7

 

 

SENESTECH, INC.
NOTES TO CONDENSED FINANCIAL STATEMENTS
(In thousands, except share and per share data)

 

Note 2 - Summary of Significant Accounting Policies – (continued)

 

The stock-based compensation expense recorded for the three and nine months ended September 30, 2019 and 2018,

 

is as follows:

 

   Three Months Ended
September 30,
   Nine Months Ended
September 30,
 
   2019   2018   2019   2018 
                 
Research and development  $1   $29   $11   $87 
General and administrative   203    326    661    3,003 
Total stock-based compensation expense  $204   $355   $675   $3,090 

 

See Note 11 for additional discussion on stock-based compensation.

 

Income Taxes

 

Company accounts for income taxes under the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements. Under this method, deferred tax assets and liabilities are determined based on the differences between the financial statement and tax bases of assets and liabilities and net operating loss carryforwards using enacted tax rates in effect for the year in which the differences are expected to reverse. The effect of a change in tax rates on deferred tax assets and liabilities is recognized in the period that includes the enactment date.

 

The Company records net deferred tax assets to the extent it believes these assets will more likely than not be realized. These deferred tax assets are subject to periodic assessments as to recoverability and if it is determined that it is more likely than not that the benefits will not be realized, valuation allowances are recorded which would increase the provision for income taxes. In making such determination, the Company considers all available positive and negative evidence, including future reversals of existing taxable temporary differences, projected future taxable income, tax planning strategies and recent financial operations. The Company currently maintains a full allowance against its deferred tax assets.

 

The Company applies a more-likely-than-not recognition threshold for all tax uncertainties. Only those benefits that have a greater than fifty percent likelihood of being sustained upon examination by the taxing authorities are recognized. Based on its evaluation, the Company has concluded there are no significant uncertain tax positions requiring recognition in its financial statements.

 

The Company recognizes interest and/or penalties related to uncertain tax positions in income tax expense. There are no uncertain tax positions as of September 30, 2019 or December 31, 2018 and as such, no interest or penalties were recorded in income tax expense.

 

Comprehensive Loss

 

Net loss and comprehensive loss were the same for all periods presented; therefore, a separate statement of comprehensive loss is not included in the accompanying financial statements.

 

Loss Per Share Attributable to Common Stockholders

 

Basic loss per share attributable to common stockholders is calculated by dividing the net loss attributable to common stockholders by the weighted average number of common shares outstanding during the period. Diluted loss per share attributable to common stockholders is computed by dividing the loss attributable to common stockholders by the weighted average number of common shares and potentially dilutive securities outstanding for the period determined using the treasury stock and if-converted methods. For purposes of the computation of diluted loss per share attributable to common stockholders, common stock purchase warrants, and common stock options are considered to be potentially dilutive securities but have been excluded from the calculation of diluted loss per share attributable to common stockholders because their effect would be anti-dilutive given the net loss reported for the three and nine months ended September 30, 2019 and 2018. Therefore, basic and diluted loss per share attributable to common stockholders are the same for each period presented.

 

The following table sets forth the outstanding potentially dilutive securities that have been excluded in the calculation of diluted loss per share attributable to common stockholders (in common stock equivalent shares):

 

   September 30, 
   2019   2018 
Common stock purchase warrants   9,783,278    11,714,940 
Restricted stock unit   117,465    172,912 
Common stock options   2,747,677    1,725,771 
Total   12,648,420    13,613,623 

 

8

 

 

SENESTECH, INC.
NOTES TO CONDENSED FINANCIAL STATEMENTS
(In thousands, except share and per share data)

 

Note 2 - Summary of Significant Accounting Policies – (continued)

 

Adoption of New Accounting Standards:

 

In May 2014, the FASB issued ASU 2014-09, Revenue from Contracts with Customers. Since ASU 2014-09 was issued, several additional ASUs have been issued to clarify various elements of the guidance. These standards provide guidance on recognizing revenue, including a five-step model to determine when revenue recognition is appropriate. The standard requires that an entity recognize revenue to depict the transfer of control of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. Effective January 1, 2018, the Company adopted ASU 2014-09, “Revenue from Contracts with Customers” using the modified retrospective method to all contracts that were not completed as of the date of adoption. The results of operations for reported periods after January 1, 2018 are presented under this amended guidance, while prior period amounts are reported in accordance with ASC 605 — Revenue Recognition. There was no material impact on our financial position, results of operations, or cash flows.

 

In January 2016, the FASB issued ASU 2016-01, Recognition and Measurement of Financial Assets and Financial Liabilities (“ASU 2016-01”). This standard affects the accounting for equity instruments, financial liabilities under the fair value option and the presentation and disclosure requirements of financial instruments. ASU 2016-01 is effective the first quarter of 2018. The Company has adopted the provisions of ASU 2016-01 on its financial statements. There was no material impact on our financial position, results of operations, or cash flows.

 

In February 2016, the FASB issued ASU 2016-02, Leases (“ASU 2016-02”). This standard amends various aspects of existing accounting guidance for leases, including the recognition of a right-of-use asset and a lease liability on the balance sheet for all leases with terms longer than 12 months. Leases will be classified as either finance or operating, with classification affecting the pattern of expense recognition in the income statement. This standard also introduces new disclosure requirements for leasing arrangements. ASU 2016-02 is effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years for public business entities. Early adoption was permitted, and the new standard had been adopted using a modified retrospective approach and provides for certain practical expedients.

 

On January 1, 2019, the Company adopted the new leasing standard and all related amendments. The Company elected the optional transition method provided by the FASB in ASU 2018-11, Leases (Topic 842): Targeted Improvements, and as a result, has not restated its condensed consolidated financial statements for prior periods presented. The Company has elected the practical expedients upon transition to retain the lease classification and initial direct costs for any leases that existed prior to adoption. The Company has also not reassessed whether any contracts entered into prior to adoption are leases.

 

ASU 2016-02 did not have a material impact on the Company’s Condensed Consolidated Statements of Comprehensive Income. The cumulative effect of the changes made to the Company’s Consolidated Balance Sheet as of January 1, 2019 for the adoption of the new leasing standard was as follows:

 

   Balance @
December 31, 2018
   Adjustment Due
to ASC 842
   Balance @
January 1,
2019
 
Right to Use Asset - Long Term      $87   $87 
                
Lease Liability – Long Term      $(87)  $(87)

 

At September 30, 2019, the balance remaining in Right to Use Asset-Long Term and Lease Liability-Long Term was $29,000 and ($29,000) respectively.

 

The Company determines if an arrangement is a lease at lease inception. Operating lease right-of-use (ROU) assets and operating lease liabilities are recognized based on the present value of the future minimum lease payments over the lease term at commencement date. As most of the Company’s lease contracts do not include an implicit rate, the Company uses its incremental borrowing rate based on information available at commencement date in determining the present value of future payments. The incremental borrowing rate is estimated to approximate the interest rate on a collateralized basis with similar terms and payments, and in economic environments where the leased asset is located. The operating lease ROU asset also includes any initial direct costs and lease payments made prior to lease commencement and excludes lease incentives incurred.

 

The Company’s lease terms may include options to extend or terminate the lease when it is reasonably certain that we will exercise that option. Operating lease expense for minimum lease payments is recognized on a straight-line basis over the lease term. The Company has certain lease agreements that contain both lease and non-lease components, which it has elected to account for as a single lease component for all asset classes.

 

See Note 12, Commitments and Contingencies, for future minimum lease payments and maturities.

 

9

 

 

SENESTECH, INC.
NOTES TO CONDENSED FINANCIAL STATEMENTS
(In thousands, except share and per share data)

 

Note 2 - Summary of Significant Accounting Policies – (continued)

 

Accounting Standards Issued but Not Yet Adopted

 

In August 2018, the FASB issued authoritative guidance intended to address a customer’s accounting for implementation costs incurred in a cloud computing arrangement that is a service contract. This guidance aligns the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software. The guidance also requires presentation of the capitalized implementation costs in the statement of financial position and in the statement of cash flows in the same line item that a prepayment for the fees of the associated hosting arrangement would be presented, and the expense related to the capitalized implementation costs to be presented in the same line item in the statement of operations as the fees associated with the hosting element (service) of the arrangement. This guidance is effective for annual periods beginning after December 15, 2019, including interim periods within those annual periods, with early adoption permitted. We are currently evaluating the potential impact on our financial position, results of operations and statement of cash flows upon adoption of this guidance. We do not expect this guidance to have a significant impact, or potential significant impact, to our unaudited condensed consolidated interim financial statements.

 

Other than the items noted above, there have been no new accounting pronouncements not yet effective or adopted in the current year that we believe have a significant impact, or potential significant impact, to our unaudited condensed consolidated interim financial statements.

 

Note 3 - Fair Value Measurements

 

The Company issued common stock warrants to purchase shares of common stock in June of 2015 (see Note 9 — Stock-based Compensation for more details) that contain a cash settlement provision resulting in a common stock warrant liability that is revalued at the end of each reporting period.

 

We value these warrant derivatives at fair value. The accounting guidance for fair value, among other things, establishes a consistent framework for measuring fair value and expands disclosure for each major asset and liability category measured at fair value on either a recurring or nonrecurring basis. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction between market participants at the reporting date. The framework for measuring fair value consists of a three-level valuation hierarchy that prioritizes the inputs to valuation techniques used to measure fair value based upon whether such inputs are observable or unobservable. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect market assumptions made by the reporting entity. The three-level hierarchy for the inputs to valuation techniques is briefly summarized as follows: 

 

Level 1—Inputs are unadjusted, quoted prices in active markets for identical assets or liabilities at the measurement date;

 

Level 2—Inputs are observable, unadjusted quoted prices in active markets for similar assets or liabilities, unadjusted quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the related assets or liabilities; and

 

Level 3—Unobservable inputs that are significant to the measurement of the fair value of the assets or liabilities that are supported by little or no market data.

 

An asset’s or liability’s fair value measurement level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement. Valuation techniques used need to maximize the use of observable inputs and minimize the use of unobservable inputs.

 

Assets and liabilities measured at fair value are based on one or more of the following three valuation techniques:

 

  A. Market approach: Prices and other relevant information generated by market transactions involving identical or comparable assets or liabilities.

 

  B. Cost approach: Amount that would be required to replace the service capacity of an asset (replacement cost).

 

  C. Income approach: Techniques to convert future amounts to a single present amount based upon market expectations, including present value techniques, option-pricing and excess earnings models.

 

The Company’s common stock warrant liabilities are classified as Level 3 because there is limited activity or less transparency around the inputs to valuation.

 

10

 

 

SENESTECH, INC.

NOTES TO CONDENSED FINANCIAL STATEMENTS

(In thousands, except share and per share data)

 

Note 3 - Fair Value Measurements – (continued)

 

Items Measured at Fair Value on a Recurring Basis 

 

The following table sets forth the Company’s financial instruments that were measured at fair value on a recurring basis by level within the fair value hierarchy (in thousands):

 

   September 30, 2019 
   Level 1   Level 2   Level 3   Total 
Financial Liabilities:                
Common stock warrant liability (1)  $   $   $

<1

   $

<1

 
Total  $   $   $<1   $

<1

 

 

   December 31, 2018 
   Level 1   Level 2   Level 3   Total 
Financial Assets:                
Money market funds  $   $   $   $ 
                     
Corporate fixed income debt securities                
                     
Total  $   $   $   $ 
Financial Liabilities:                    
Common stock warrant liability (1)  $   $   $   $ 
Total  $   $   $   $ 

 

(1)There was no change (net) in the fair value of the common stock warrant for the three and nine months ended September 30, 2019. If there had been, it would have been recorded to other income (expense) and interest expense in the statements of operations and comprehensive loss.

 

Financial Instruments Not Carried at Fair Value

 

The carrying amounts of the Company’s financial instruments, including accounts payable and accrued liabilities, approximate fair value due to their short maturities. The estimated fair value of the convertible notes and other notes, not recorded at fair value, are recorded at cost or amortized cost which was deemed to estimate fair value.

 

Note 4 - Credit Risk

 

The Company is potentially subject to concentrations of credit risk in its accounts receivable. Credit risk with respect to receivables is limited due to the number of companies comprising the Company’s customer base. Although the Company is directly affected by the financial condition of its customers, management does not believe significant credit risks exist at September 30, 2019 or December 31, 2018. The Company does not require collateral or other securities to support its accounts receivable.

 

11

 

 

SENESTECH, INC.

NOTES TO CONDENSED FINANCIAL STATEMENTS

(In thousands, except share and per share data)

 

 

Note 5 - Prepaid Expenses

 

Prepaid expenses consist of the following:

 

   September 30,   December 31, 
   2019   2018 
Director compensation  $-   $100 
Director and officer insurance   161    121 
NASDAQ fees   14      
Legal retainer   25    25 
Marketing programs and conferences   54    53 
Professional services retainer   15    8 
Rent   -    19 
Equipment service deposits   2    3 
Foreign patent registration   22    - 
Engineering, software licenses and other   11    13 
Total prepaid expenses  $304   $342 

 

Note 6 - Property and Equipment

 

Property and equipment, net consist of the following:

 

         September 30,   December 31, 
      Useful Life  2019   2018 
Research and development equipment     5 years  $1,582   $1,552 
Office and computer equipment  (1)  3 years   753    742 
Autos     5 years   54    54 
Furniture and fixtures     7 years   37    37 
Leasehold improvements     *   283    283 
          2,709    2,668 
Less accumulated depreciation and amortization         (1,879)   (1,585)
Total        $830   $1,083 

 

* Shorter of lease term or estimated useful life

 

(1)In August 2019, the Company disposed of computer equipment with a net book value of $2 resulting in a loss on the disposal of fixed assets of less than $1. In April and May 2019, the Company disposed of obsolete computer equipment with a net book value of $2 resulting in a loss on disposal of fixed assets of $2.

 

Depreciation and amortization expense was approximately $101 and $108 for the three months ended September 30, 2019 and 2018, respectively, and $314 and $332 for the nine months ended September 30, 2019 and 2018, respectively.

 

Note 7 - Accrued Expenses

 

Accrued expenses consist of the following:

 

   September 30,   December 31, 
   2019   2018 
Compensation and related benefits  $264   $479 
Accrued Litigation   507    269 
Board Compensation   9    23 
Other   5     
Total accrued expenses  $785   $771 

 

12

 

 

SENESTECH, INC.

NOTES TO CONDENSED FINANCIAL STATEMENTS

(In thousands, except share and per share data)

 

Note 8 - Borrowings

 

A summary of the Company’s borrowings, including capital lease obligations, is as follows:

 

   September 30,   December 31, 
   2019   2018 
Short-term debt:        
Current portion of long-term debt   129    219 
Total short-term debt  $129   $219 
Long-term debt:          
Capital lease obligations  $175   $232 
Other promissory notes   121    248 
Total   296    480 
Less: current portion of long-term debt   (129)   (219)
Total long-term debt  $167   $261 

 

Capital Lease Obligations 

 

Capital lease obligations are for computer and lab equipment leased through GreatAmerica Financial Services, Thermo Fisher Scientific, Navitas Credit Corp. and ENGS Commercial Finance Co. These capital leases expire at various dates through July 2023 and carry interest rates ranging from 6.4% to 11.6%.

 

Other Promissory Notes

 

Also included in the table above are three notes payable to Direct Capital, one note to M2 Financing and one note to Fidelity Capital, all for the financing of fixed assets. These notes expire at various dates through June 2022 and carry interest rates ranging from 10.88% to 13.28%.

 

Note 9 - Common Stock Warrants and Common Stock Warrant Liability

 

The table summarizes the common stock warrant activity as of September 30, 2019 as follows:

 

Common Stock Warrants  Number
of
Warrants
   Date
Issued
  Term  Exercise Price 
               
Outstanding at December 31, 2017   6,431,785            
                 
Warrants issued   1,133,909   June 2018  5 Years  $1.82 
Common Stock Offering Warrants Issued   5,357,052   August 2018  5 Years  $1.15(1)
Common Stock Offering - Dealer Manager Warrants   267,853   August 2018  5 Years  $1.725 
Warrants exercised   (1,475,659)           
Expired Warrants   (488,119)           
Outstanding at December 31, 2018   11,226,821            
Warrants issued   166,667   July 2019  5 Years  $1.6875 
Warrants Exercised   (1,298,210)  August 2018     $1.15 
Warrants Exercised   (312,000)  August 2018     $0.95 
Outstanding at September 30, 2019   9,783,278            

 

(1)The common stock warrants issued in November 2017 with an initial exercise price of $1.50 per share adjusted downward to $0.95 per share effective July 24, 2018 in connection with our Rights Offering, and may be subject to further downward adjustments, pursuant to antidilution price adjustment protection contained within those warrants.

 

13

 

 

SENESTECH, INC.

NOTES TO CONDENSED FINANCIAL STATEMENTS

(In thousands, except share and per share data)

 

Note 9 - Common Stock Warrants and Common Stock Warrant Liability – (continued)

 

On November 21, 2017, the Company issued a total of 4,657,500 detachable common stock warrants issued with the second public offering of 5,860,000 shares of its common stock at $1.00 per share. The common stock warrant is exercisable until five years from the date of grant. The common shares of the Company’s stock and detachable warrants exist independently as separate securities. As such, the Company estimated the fair value of the common stock warrants, exercisable at $1.50 per share, to be $661 using a lattice model based on the following significant inputs: Common stock price of $1.00; comparable company volatility of 73.8%; remaining term 5 years; dividend yield of 0% and risk-free interest rate of 1.87. The initial exercise price of these warrants was $1.50 per share, which adjusted downward to $1.47 on July 24, 2018, the record date of the Right’s Offering and downward to $0.95 per share on August 13, 2018, the date of the Rights Offering, pursuant to antidilution price adjustment protection contained within these warrants. Per guidance of ASC 260, the Company recorded a deemed dividend of $333 on the 3,181,841 unexercised warrants that contained this antidilution price adjustment protection provision and was calculated as the difference between the fair value of the warrants immediately prior to downward exercise price adjustment and immediately after the adjustment using a Black Scholes model based on the following significant inputs: On July 24, 2018: Common stock price of $1.38; comparable company volatility of 72.4%; remaining term 4.33 years; dividend yield of 0% and risk-free interest rate of 2.83. On August 13, 2018: Common stock price of $1.02; comparable company volatility of 74.0%; remaining term 4.25 years; dividend yield of 0% and risk-free interest rate of 2.75.

 

On June 20, 2018, the Company entered into an agreement with a holder of 1,133,909 of the November 2017 warrants to exercise its original warrant representing 1,133,909 shares of Common Stock for cash at the $1.50 exercise price for gross proceeds of $1.7 million and the Company issued to holder a new warrant to purchase 1,133,909 shares of Common Stock at an exercise price of $1.82 per share. The new warrant did not contain the antidilution price adjustment protection that was contained within the exercised warrants. In June 2018, the Company recorded stock compensation expense of $1.7 million representing the fair value of the of 1,133,909 inducement warrants issued. The Company estimated the fair value of the common stock warrants, exercisable at $1.82 per share, to be $1.7 million using a Black Scholes model based on the following significant inputs: Common stock price of $2.11; comparable company volatility of 72.6%; remaining term 5 years; dividend yield of 0% and risk-free interest rate of 2.8%. Also, in June 2018, an additional 341,750 of the November 8, 2017 warrants that were in the money at the time of exercise, were exercised for gross proceeds of $513.

 

On August 13, 2018, in connection with a Rights Offering of 5,357,052 shares of its common stock, the Company issued 5,357,052 warrants to purchase shares of its common stock at an exercise price of $1.15 per share. The Company estimated the fair value of the common stock warrants, exercisable at $1.15 per share, to be $3.6 million using a Monte Carlo model based on the following significant inputs: common stock price of $0.94; comparable company volatility of 159.0%; remaining term 5 years; dividend yield of 0% and risk-free interest rate of 2.77%.

 

In connection with the closing of the Rights Offering, the Company issued a warrant to purchase 267,853 shares of common stock to Maxim Partners LLC, an affiliate of the dealer-manager of the Rights Offering. The Company estimated the fair value of the common stock warrants, exercisable at $1.725 per share, to be $169 using a using a Monte Carlo model based on the following significant inputs: common stock price of $0.94; comparable company volatility of 159.0%; remaining term 5 years; dividend yield of 0% and risk-free interest rate of 2.77%.

 

Common Stock Warrant Issued to Underwriter of Common Stock Offering

 

In July 2019, the Company issued to H.C. Wainwright & Co., as placement agent, a warrant to purchase 166,667 shares of common stock at an exercise price of $1.6875 per share as consideration for providing services in connection with a common stock offering in July 2019. The warrant was fully vested and exercisable on the date of issuance. The common stock warrant is exercisable until five years from the date of grant. The Company estimated the fair value of the common stock warrants, exercisable at $1.6875 per share, to be $127 using a lattice model based on the following significant inputs: Common stock price of $1.34; comparable company volatility of 133.3%; remaining term 5 years; dividend yield of 0% and risk-free interest rate of 2.07%.

 

University of Arizona Common Stock Warrant

 

In connection with the June 2015 amended and restated exclusive license agreement with the University of Arizona (“University”), the Company issued to the University a common stock warrant to purchase 15,000 shares of common stock at an exercise price of $7.50 per share. The warrant was fully vested and exercisable on the date of grant, and expires, if not exercised, five years from the date of grant. In the event of a “terminating change” of the Company, as defined in the warrant agreement, the warrant holder would be paid in cash the aggregate fair market value of the underlying shares immediately prior to the consummation of the terminating change event. Due to the cash settlement provision, the derivative warrant liability was recorded at fair value and is revalued at the end of each reporting period. The changes in fair value are reported in other income (expense) in the statements of operations and comprehensive loss. The estimated fair value of the derivative warrant liability was $53 at the date of grant.

 

The estimated fair value of the derivative warrant liability was $0 at September 30, 2019. As this derivative warrant liability is revalued at the end of each reporting period, the fair values as determined at the date of grant and subsequent periods was based on the following significant inputs using a Monte Carlo option pricing model: common stock price of $7.91; comparable company volatility of 77.7% of the underlying common stock; risk-free rates of 1.93%; and dividend yield of 0%; including the probability assessment of a terminating change event occurring. The change in fair value of the derivative warrant liability was ($0) and $0 for the three and nine months ended September 30, 2019. As such, no entry was recorded in other income (expense) in the accompanying statements of operations and comprehensive loss.

 

14

 

 

SENESTECH, INC.

NOTES TO CONDENSED FINANCIAL STATEMENTS

(In thousands, except share and per share data)

 

Note 10 - Stockholders’ Deficit

 

Capital Stock

 

The Company was organized under the laws of the state of Nevada on July 27, 2004 and was subsequently reincorporated under the laws of the state of Delaware on November 10, 2015. In connection with the reincorporation, as approved by the stockholders, the Company changed its authorized capital stock to consist of (i) 100 million shares of common stock, $.001 par value, and (ii) 2 million shares of preferred stock, $0.001 par value, designated as Series A convertible preferred stock. In December 2015, the Company amended its Certificate of Incorporation to change its authorized capital stock to provide for 15 million authorized shares of preferred stock of which 7,515,000 was designated as Series B convertible preferred stock, par value $.001 per share.

 

Common Stock

 

The Company had 28,288,285 and 23,471,999 shares of common stock issued and outstanding as of September 30, 2019 and December 31, 2018, respectively. 

 

During the nine months ended September 30, 2019, the Company issued an aggregate of 4,816,286 shares of common stock as follows:

 

  an aggregate of 3,037,038 shares in connection with a public offering generating net proceeds to the Company of approximately $3.6 million, as further described below
  an aggregate of 1,610,210 shares for the exercise of outstanding warrants for gross proceeds of $1.8 million (see Note 9 — Common Stock Warrants and Common Stock Warrant Liability for further details)
  An aggregate of 105,474 shares for service as a result of the vesting of restricted stock units
  3,022 shares for the exercise of stock options
  21,962 shares for the cashless exercise of stock options and
  an aggregate of 38,580 shares to certain employees in net settlement of bonus compensation totaling $32.

 

Public Offering

 

On July 16, 2019, the Company issued 3,037,038 shares of common stock, including 696,296 shares to the Company’s chief executive officer and 7,408 shares to an employee of the Company, in a public offering of shares of the Company’s common stock at $1.35 per share, resulting in net proceeds of approximately $3.6 million after deducting certain fees due to the placement agent and other transaction expenses. In addition, the Company issued a warrant to purchase 166,667 shares of the Company’s common stock to the placement agent at an exercise price of $1.6875 per share.

 

Note 11 - Stock-based Compensation

 

On June 12, 2018, the Company’s stockholders approved the 2018 Equity Incentive Plan (the “2018 Plan”) to replace the Company’s 2015 Equity Incentive Plan (the “2015 Plan”). The 2018 Plan authorizes the issuance of 1,000,000 shares of our common stock. In addition, up to 2,874,280 shares of our common stock reserved for issuance under the 2015 Plan became available for issuance under the 2018 Plan to the extent such shares were available for issuance under the 2015 Plan as of June 12, 2018 or cease to be subject to awards outstanding under the 2015 Plan, such as by expiration, cancellation, or forfeiture of such awards.

 

Stock options are generally issued with an exercise price equal to no less than fair value at the date of grant. Options granted under the 2018 Plan generally vest immediately, or ratably over a two- to 36-month period coinciding with their respective service periods; however, participants may exercise their options prior to vesting as provided by the 2018 Plan. Unvested shares issued for options exercised early may be subject to a repurchase by the Company if the participant terminates, at the original exercise price. Options under the 2018 Plan generally have a contractual term of five years. Certain stock option awards provide for accelerated vesting upon a change in control.

 

As of September 30, 2019, the Company had 632,936 shares of common stock available for issuance under the 2018 Plan.

 

The Company measures the fair value of stock options with service-based and performance-based vesting criteria to employees, directors and consultants on the date of grant using the Black-Scholes option pricing model. The fair value of equity instruments issued to non-employees is re-measured as the award vests. The Black-Scholes valuation model requires the Company to make certain estimates and assumptions, including assumptions related to the expected price volatility of the Company’s stock, the period under which the options will be outstanding, the rate of return on risk-free investments, and the expected dividend yield for the Company’s stock.

 

15

 

 

SENESTECH, INC.

NOTES TO CONDENSED FINANCIAL STATEMENTS

(In thousands, except share and per share data)

 

Note 11 - Stock-based Compensation – (continued)

 

The weighted-average assumptions used in the Black-Scholes option-pricing model used to calculate the fair value of options granted during the nine months ended September 30, 2019 were as follows:

 

   Employee  Non-Employee
Expected volatility  76.4%-80.6 %  N/A
Expected dividend yield    N/A
Expected term (in years)  3.0-6.0  N/A
Risk-free interest rate  1.63% -2.48 %  N/A

 

The weighted average grant date fair value of options granted during the nine months ended September 30, 2019 was $1.29 per share, as per the table below.

 

Due to the Company’s limited operating history and lack of company-specific historical or implied volatility, the expected volatility assumption was determined based on historical volatilities from traded options of biotech companies of comparable in size and stability, whose share prices are publicly available. The expected dividend assumption is based on the Company’s history and expectation of dividend payouts. The Company has not paid and does not intend to pay dividends. The expected term of options granted to employees is calculated based on the mid-point between the vesting date and the end of the contractual term according to the simplified method as described in SEC Staff Accounting Bulletin 110 because the Company does not have sufficient historical exercise data to provide a reasonable basis upon which to estimate the expected term due to the limited period of time its awards have been outstanding. For non-employee options, the expected term of options granted is the contractual term of the options. The risk-free interest rate is determined by reference to the implied yields of U.S. Treasury securities with a remaining term equal to the expected term assumed at the time of grant.

 

The following table summarizes the stock option activity, for both equity plans, for the periods indicated as follows:

 

   Number of
Options
   Weighted
Average
Exercise
Price Per
Share
   Weighted
Average
Remaining
Contractual
Term
(years)
   Aggregate
Intrinsic
Value (1)
 
Outstanding at December 31, 2018   1,721,771   $1.57    4.0   $ 
Granted   1,167,906   $1.29    4.9   $ 
Exercised   (63,990)  $0.65       $ 
Forfeited   (59,500)  $       $ 
Expired   (18,510)  $       $ 
Outstanding at September 30, 2019   2,747,677   $1.40    3.9   $ 
Exercisable at September 30, 2019   1,667,064   $1.55    2.8   $ 

 

(1) The aggregate intrinsic value in the table was calculated based on the difference between the estimated fair market value of the Company’s stock and the exercise price of the underlying options. The estimated stock values used in the calculation was $1.01 and $0.59 per share for the nine months ended September 30, 2019 and the year ended December 31, 2018, respectively.

 

Restricted Stock Units

 

The following table summarizes restricted stock unit activity for the nine months ended September 30, 2019:

 

   Number of
Units
   Weighted Average
Grant-Date Fair
Value Per Unit
 
Outstanding as of December 31, 2018   136,245   $0.98 
Granted   123,727   $1.51 
Vested   (142,507)  $1.10 
Forfeited      $ 
Outstanding as of September 30, 2019   117,465   $1.42 

 

16

 

 

SENESTECH, INC.

NOTES TO CONDENSED FINANCIAL STATEMENTS

(In thousands, except share and per share data)

 

Note 11 - Stock-based Compensation – (continued)

 

The stock-based compensation expense was recorded as follows:

 

   Three Months Ended
September 30,
   Nine Months Ended
September 30,
 
   2019   2018   2019   2018 
                 
Research and development  $1   $29   $11   $87 
General and administrative   203    326    664    3,003 
Total stock-based compensation expense  $204   $355   $675   $3,090 

 

The allocation between research and development and selling, general and administrative expense was based on the department and services performed by the employee or non-employee.

 

At September 30, 2019, the total compensation cost related to restricted stock units and unvested options not yet recognized was $1,205, which will be recognized over a weighted average period of 36 months, assuming the employees and non-employees complete their service period required for vesting.

 

Note 12 - Commitments and Contingencies

 

Legal Proceedings 

 

The Company may be subject to legal proceedings and claims arising from contracts or other matters from time to time in the ordinary course of business. Management is not aware of any pending or threatened litigation where the ultimate disposition or resolution could have a material adverse effect on its financial position, results of operations or liquidity.

 

On February 20, 2018, New Enterprises, Ltd. (“New Enterprises”), filed a lawsuit against the Company and Roth Capital Partners, LLC (“Roth”) in the U.S. District Court for the District of Arizona (the “Court”). The complaint alleges nine counts against the Company, including that the Company: engaged in common law fraud and securities fraud to induce the chairman of New Enterprises into investing in the Company; failed to register New Enterprises’ requested transfer; breached stock certificates and the lock-up contract; tortuously interfered with prospective business advantage; and was liable for conversion. New Enterprises is seeking monetary damages, including compensatory damages, punitive damages, and attorney’s fees. On December 3, 2018, the Court issued its order granting the Company’s and Roth’s motions to dismiss all of New Enterprises’ claims but gave them leave to file a motion to amend the complaint. On January 25, 2019, New Enterprises moved for leave to file an amended complaint, alleging similar claims against the Company and Roth, and the court granted that motion. On April 5, 2019, New Enterprises filed an amended complaint, alleging similar claims against the Company and Roth. The Company and Roth moved to dismiss the amended complaint, and on August 16, 2019, the Court issued its order denying the Company’s and Roth’s motions to dismiss. Roth has made a claim for indemnification to the Company based on contractual indemnification agreements, but to date the Company has not accepted Roth’s indemnification demand.

 

On April 20, 2018, the Company’s former Executive Vice President and Chief Operating Officer Andrew Altman filed a charge of employment discrimination with the Equal Employment Opportunity Commission (EEOC) against the Company. Mr. Altman claimed that he was terminated after he expressed opposition to an email that Cheryl Dyer, Chief Research Officer, had sent out to the management team, in which she criticized a Mormon newspaper. The Company filed a position statement on May 21, 2018. No substantive action has been taken since then, and the Company has not heard anything further either from the EEOC or Mr. Altman’s attorneys.

 

Lease Commitments

 

The Company is obligated under capital leases for certain research and computer equipment that expire on various dates through July 2023. At September 30, 2019, the gross amount of office and computer equipment, and research equipment and the related accumulated amortization recorded under the capital leases was $498 and $252, respectively.

 

In February 2012, the Company entered into an operating lease for its corporate headquarters. The lease was due to expire in January 2015. In December 2013, the Company amended its lease to expand into the remaining area in the building and extended the term to December 31, 2019. In February 2014, the Company further amended the lease to expand into an adjacent building. The lease requires escalating rental payments over the lease term. Minimum rental payments under the operating lease are recognized on a straight-line basis over the term of the lease and accordingly, the Company records the difference between the cash rent payments and the recognition of rent expense as a deferred rent liability. The lease is guaranteed by the President of the Company. We are currently in discussions to extend the current lease.

 

17

 

 

SENESTECH, INC.

NOTES TO CONDENSED FINANCIAL STATEMENTS

(In thousands, except share and per share data)

 

Note 12 - Commitments and Contingencies – (continued)

 

On November 16, 2016, we leased an additional 1,954 square feet of research and development space, also in Flagstaff. This lease expired on November 15, 2018 but was extended for an additional 24 months, through November 2020. A subsequent amendment to the lease allows for the Company to cancel the lease at any time through the lease term with 30-day notice. In June 2019, the Company cancelled approximately 1,000 square feet of this leased space, and the fixed rental payment was reduced for the remaining term of the lease. The lease extension requires fixed rental payments over the lease term. Minimum rental payments under the operating lease are recognized on a straight-line basis over the term of the lease as expense, and accordingly, the Company recorded no deferred rent liability under this lease.

 

Total rent expense was $187 and $183 for the nine months ended September 30, 2019 and September 30, 2018, respectively. The future minimum lease payments under our non-cancellable operating lease and our capital lease as of September 30, 2019 are as follows:

 

   Capital
Leases
   Operating
Lease
 
Years Ending December 31,        
2019   24    62 
2020   78    24 
2021   63     
2022   33     
2023   3      
Total minimum lease payments  $201   $86 

 

   Capital
Leases
 
     
Less: amounts representing interest (6.39%, ranging from 10.48% to 11.56%)  $26 
      
Present value of minimum lease payments   175 
      
Less: current installments under capital lease obligations   70 
      
Total long-term portion  $105 

 

Note 13 - Subsequent Events

  

On November 1, 2019, the Company net issued 311 shares of common stock in satisfaction of a cashless exercise of vested common stock options.

 

The Company has evaluated subsequent events from the balance sheet date through November 14, 2019, the date at which the financial statements were issued, and determined that there were no other items that require adjustment to or disclosure in the financial statements.

 

18

 

 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

As used in this Quarterly Report on Form 10-Q, “SenesTech,” the “Company,” “we,” “us” or “our” refer to SenesTech, Inc., a Delaware corporation. The following Management’s Discussion and Analysis of Financial Condition and Results of Operations should be read in conjunction with our condensed consolidated financial statements and related notes.

 

Forward-Looking Statements

 

Some statements and information contained in this Management’s Discussion and Analysis of Financial Condition and Results of Operations, notes to our condensed consolidated financial statements and elsewhere in this report are not historical facts but are forward- looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). In some cases, readers can identify forward- looking statements by terms such as “may,” “will,” “should,” “expect,” “plan,” “intend,” “forecast,” “anticipate,” “believe,” “estimate,” “predict,” “potential,” “continue,” or the negative of these terms or other comparable terminology, which when used are meant to signify the statement as forward-looking. These forward-looking statements include, but are not limited to, our expectations, assumptions and estimates regarding new and current accounting and tax standards and policies; our expectations and plans regarding our operating plan, including operating expenses, product sales and revenue expectations, profitability and cash flows; anticipated financing; our beliefs regarding our revenue targets and the sufficiency of our liquidity and capital resources; possible outcomes of ongoing litigation; our ongoing and planned commercialization of ContraPest and product development of our other product candidates; our expectations regarding regulatory approval of our products or product candidates; and statements about our plans, objectives, expectations and intentions and other statements that are not historical facts. These forward-looking statements are not guarantees of future performance and involve known and unknown risks, uncertainties and situations that are difficult to predict and that may cause our own, or our industry’s actual results, to be materially different from the future results that are expressed or implied by these statements. Accordingly, actual results may differ materially from those anticipated or expressed in such statements as a result of a variety of factors, including those discussed in Item 1A of Part II of our Annual Report on Form 10-K, as amended by Form 10-K/A, for the year ended December 31, 2018, both filed with the SEC on March 29, 2019 (collectively, the “2018 Annual Report”), entitled “Risk Factors,” and those contained from time to time in our other filings with the Securities and Exchange Commission. Readers are cautioned not to place undue reliance on the forward-looking statements, which speak only as of the date made. Except as required by law, we undertake no obligation to update any forward-looking statement, whether as a result of new information, future events or otherwise.

 

Overview

 

Since our inception, we have sustained significant operating losses in the course of our research and development and commercialization activities and expect such losses to continue for the near future. We have generated limited revenue to date from product sales, research grants and licensing fees received under our former license agreement with Neogen. In 2017, we began to prepare and launch commercialization of our first product, ContraPest. We have primarily funded our operations to date through the sale of equity securities, including convertible preferred stock, common stock and warrants to purchase common stock. Public equity sales include:

 

(i) an initial public offering of 1,875,000 shares of our common stock at $8.00 per share for gross proceeds of $15 million on December 8, 2016 with warrants to purchase an additional 187,500 shares issued to Roth Capital Partners, LLC with an exercise price of $9.60 per share, as underwriter,

 

(ii) a public offering on November 21, 2017 of 5,860,000 shares of our common stock at $1.00 per share for gross proceeds of $5.9 million, with warrants issued to investors to purchase an additional 4,657,500 shares of our common stock with an initial exercise price of $1.50 per share that subsequently adjusted downward to $0.95 per share pursuant to antidilution price protection contained within those warrants, and warrants issued to Roth Capital Partners, LLC, as underwriter, to purchase an additional 945,000 shares with an exercise price of $1.50 per share,

 

(iii) a private placement of warrants to purchase 1,133,909 shares of common stock in June 2018 with an exercise price of $1.82 per share for gross proceeds of $2.1 million, in connection with an inducement agreement with a holder of outstanding warrants issued in November 2017 to exercise its original warrant representing 1,133,909 shares at an exercise price of $1.50 per share,

 

(iv) a rights offering in August 2018 (the “Rights Offering”), where we accepted subscriptions for 5,357,052 units for a purchase price of $1.15 per unit for gross proceeds of $6.2 million, with each unit consisting of one share of our common stock and one warrant, with each warrant exercisable for one share of our common stock at an exercise price of $1.15 per share, and warrants issued to an affiliate of Maxim Group, LLC, as dealer-manager, to purchase an additional 267,853 shares at $1.725 per share,

 

19

 

 

(v) issuance of 312,000 shares and 1,266,399 shares of common stock as a result of the exercise of warrants during the nine months ended September 30, 2019 at an exercise price of $0.95 and $1.15 per warrant, respectively for gross proceeds of $1.8 million, and
   
(vi) issuance of 3,037,038 shares of common stock at $1.35 per share for gross proceeds of $4.1 million, in a public offering on July 16, 2019, with warrants to purchase an additional 166,667 shares issued to H.C. Wainwright & Co. with an exercise price of $1.6875 per share, as placement agent for the public offering.

 

We have also raised capital through debt financing, consisting primarily of convertible notes; and, to a lesser extent, payments received in connection with product sales, research grants and licensing fees.

 

Through September 30, 2019, we had received net proceeds of $67.2 million from our sales of common stock, preferred stock and warrant exercises and issuance of convertible and other promissory notes, an aggregate of $1.7 million from licensing fees and an aggregate of $0.5 million in net product sales. At September 30, 2019, we had an accumulated deficit of $93.1 million and cash and cash equivalents of $3.9 million.

 

We have incurred significant operating losses every year since our inception. Our net losses were $2.6 million and $7.2 million for the three and nine months ended September 30, 2019 and $2.5 million and $9.3 million for the three and nine months ended September 30, 2018, respectively. We expect to continue to incur significant expenses and generate operating losses for at least the next 12 months.

 

We have historically utilized, and intend to continue to utilize, various forms of stock-based awards in order to hire, retain and motivate talented employees, consultants and directors and encourage them to devote their best efforts to our business and financial success. In addition, we believe that our ability to grant stock-based awards is a valuable and necessary compensation tool that aligns the long-term financial interests of our employees, consultants and directors with the financial interests of our stockholders.

 

As a result, a significant portion of our operating expenses includes stock-based compensation expense. Stock-based compensation expense has been, and will continue to be for the foreseeable future, a significant recurring expense in our business and an important part of our compensation strategy. Specifically, our stock-based compensation expense for the three and nine months ended September 30, 2019 was $204,000 and $675,000, which represented 7.8% and 9.3%, respectively, of our total operating expenses for those periods and $355,000 and $3.1 million for the same periods in 2018, which represented 14.3% and 33.4%, respectively, of our total operating expenses for those periods. .

 

Our ultimate success depends upon the outcome of a combination of factors, including: (i) successful commercialization of ContraPest and maintaining and obtaining regulatory approvals of our products and product candidates, (ii) market acceptance, commercial viability and profitability of ContraPest and other products; (iii) our ability to market our products and establish an effective sales force and marketing infrastructure to generate significant revenue; (iv) the success of our research and development; (v) our ability to retain and attract key personnel to develop, operate and grow our business; and (vi) our ability to meet our working capital needs.

 

Based upon our current operating plan, we expect that cash and cash equivalents at September 30, 2019, in combination with anticipated revenue and any additional sales of our equity securities, will be sufficient to fund our current operations for at least the next six months. We have taken and will continue to take actions to reduce our operating expenses and to concentrate our resources toward the successful commercialization of ContraPest in the U. S. However, if anticipated revenue targets and margin targets are not achieved and we are unable to raise necessary capital through the sale of our securities, we may be required to take other measures that could impair our ability to be successful and operate as a going concern. In any event, we are likely to require additional capital in order to fund our operating losses and research and development activities until we become profitable. We may never achieve profitability or generate positive cash flows, and unless and until we do, we will continue to need to raise capital through equity or debt financing. If such equity or debt financing is not available at adequate levels or on acceptable terms, we may need to delay, limit or terminate commercialization and development efforts.

 

Components of our Results of Operations

 

Net Sales

 

Net sales are comprised primarily of sales, net of discounts and promotions, of ContraPest and related components, to our distributors and customers. 

 

20

 

 

Operating Expenses

 

Research and Development Expenses

 

Research and development expenses consist primarily of costs incurred in connection with the research and development of ContraPest and our other product candidates, which include:

 

Employee related expenses, including salaries, related benefits, travel and stock-based compensation expense for employees engaged in research and development functions;

 

Expenses incurred in connection with the development of our product candidates; and

 

Facilities, depreciation and other expenses, which include direct and allocated expenses for rent and maintenance of facilities, insurance and supplies.

 

We expense research and development costs as incurred.

 

We also continue to develop our supply chain, particularly identifying and improving our sourcing of key ingredients for our product candidates. At this time, we cannot reasonably estimate the costs for further development of ContraPest or the cost associated with the development of our supply chain.

 

Selling, General and Administrative Expenses

 

Selling, general and administrative expenses consist primarily of salaries and related costs, including stock-based compensation, for personnel in executive, finance, sales, marketing and administrative functions. Selling, general and administrative expenses also include direct and allocated facility-related costs as well as professional fees for legal, consulting, accounting, contract sales expenses and audit services.

 

We anticipate that our selling, general and administrative expenses may increase in the future as we increase our headcount to support commercialization of ContraPest and further development of our product candidates.

 

Interest Income

 

Interest income consists primarily of interest income earned on cash and cash equivalents.

 

Interest Expense

 

Interest expense consists primarily of interest accrued on our capital lease and note commitments.

 

Other Income (Expense), Net

 

Other income (expense), net, consists primarily of recognized change in value of short-term investments and income (expense) related to the year-over-year fair market value adjustment of our derivative warrant and the net gain or losses from the disposition of fixed assets.

 

Income Taxes

 

Deferred tax assets and liabilities are determined based on differences between the financial statement and tax basis of assets and liabilities, as well as a consideration of net operating loss and credit carry forwards, using enacted tax rates in effect for the period in which the differences are expected to impact taxable income. A valuation allowance is established, when necessary, to reduce deferred tax assets to the amount that is more likely than not to be realized. The Company’s effective tax rate has been affected by the full valuation allowance on the Company’s deferred tax assets.

 

Since our inception, we have not recorded any U.S. federal or state income tax benefits for the net losses we have incurred in each year or for our earned research and development tax credits, due to our uncertainty of realizing a benefit from those items. At September 30, 2019, the Company has federal and state net operating loss carryforwards of approximately $59.4 million and $46.0 million, respectively, not considering any potential Internal Revenue Code of 1986 (“IRC”) Section 382 annual limitation discussed below. The federal loss carryforwards begin to expire in 2023, unless previously utilized. Approximately $10.5 million of those federal loss carryforwards, however, do not expire due to changes in U.S. tax law under the Tax Cuts and Jobs Act of 2017. Additionally, the utilization of the net operating loss and tax credit carryforwards could be subject to an annual limitation under IRC sections 382 and 383, and similar state tax provisions due to ownership change limitations that have occurred previously or that could occur in the future. These ownership changes limit the amount of net operating loss carryforwards and other deferred tax assets that can be utilized to offset future taxable income and tax, respectively. In general, an ownership change, as defined by IRC Sections 382 and 383. results from transactions increasing ownership of certain stockholders or public groups in the stock of the corporation by more than 50 percent points over a three-year period. The Company has not conducted an analysis of an ownership change under IRC Section 382. To the extent that a study is completed, and an ownership change is deemed to occur, the Company’s ability to utilize its net operating losses could be limited.

 

21

 

  

Comparison of the Three and Nine Months Ended September 30, 2019 and 2018

 

The following table summarizes our results of operations for the three and nine months ended September 30, 2019 and 2018:

 

   For the Three Months   For the Nine Months 
   Ended September 30,   Ended September 30, 
   2019   2018   2019   2018 
                 
Revenue:                
Sales  $36   $105   $79   $160 
Cost of sales   25    114    58    153 
Gross profit (loss)   11    (9)   21    7 
                     
Operating expenses:                    
Research and development   432    476    1,359    1,746 
Selling, general and administrative   2,173    2,013    5,908    7,506 
Total operating expenses   2,605    2,489    7,267    9,252 
                     
Net operating loss   (2,594)   (2,498)   (7,246)   (9,245)
                     
Other income (expense):                    
Interest income   19    1    45    8 
Interest expense   (10)   (16)   (34)   (60)
Other income (expense)   -    13    (3)   19 
Total other income (expense)   9    (2)   8    (33)
                     
Net loss and comprehensive loss   (2,585)   (2,500)   (7,238)   (9,278)
Deemed dividend-warrant price protection adjustment   -    333    -    333 
Net loss attributable to common shareholders  $(2,585)  $(2,833)  $(7,238)  $(9,611)
                     
                     
Weighted average common shares outstanding - basic and fully diluted   27,891,501    20,862,216    25,336,837    18,036,982 
                     
Net loss per common share - basic and fully diluted  $(0.09)  $(0.14)  $(0.29)  $(0.53)

 

Three Months Ended September 30, 2019 compared to Three Months Ended September 30, 2018:

 

Net Sales

 

Net sales were $36,000 for the three months ended September 30, 2019 and $105,000 for the same period in 2018. Sales were lower in 2019 due to the transition to the removal of ContraPest’s ‘restricted use only’ status at the state level and our shift to a pull through sales strategy directed at end users. This strategy has shown significant initial promise however, we have experienced an increase in lead-to-conversion time resulting in a longer sales process.

 

Cost of Sales

 

Cost of sales was $25,000 for the three months ended September 30, 2019, compared to $114,000 for the three months ended September 30, 2018. Cost of sales were lower in 2019 due to lower sales volume in the third quarter of 2019 and no scrap expense associated with manufacturing scale up activities that were experienced during the third quarter of 2018.

 

Gross Profit

 

Gross profit for the three months ended September 30, 2019 was $11,000 or 30.6% of net sales, compared to a gross loss of ($9,000) or 8.6% of net sales, for the same period in 2018. The increase in gross profit was a direct result of a decrease in scrap related to scaleup activities.

 

22

 

  

Research and Development Expenses

 

   Three Months Ended
September 30,
   Increase  
   2019   2018   (Decrease) 
   (in thousands) 
Direct research and development expenses:            
Unallocated expenses:            
Personnel related (including stock-based compensation)  $206   $274   $(68)
Facility-related   60    57    3 
Other   166    145    21 
Total research and development expenses  $432   $476   $(44)

 

Research and development expenses were $432,000 for the three months ended September 30, 2019, compared to $476,000 for the same period in 2018. The $44,000 decrease in research and development expenses was primarily due to a decrease of $68,000 in personnel-related costs, including stock-based compensation expense, due to the classification of certain field support employees to sales and marketing and option grants fully vesting resulting in lower expense. With more focus on commercialization of ContraPest, we determined that these certain field support employees previously classified as research and development are now refocused on sales and marketing efforts and thus, reclassified as such.

 

Facility-related expense increased $3,000 due primarily to facility lease payment escalation.

 

The increase in other research and development expenses of $21,000 was primarily due to a reclass of other expenses related to certain field support employees to sales and marketing as described above.

 

We also continue to develop our supply chain, particularly identifying and improving our sourcing of key ingredients for our product candidates.

 

Selling, General and Administrative Expenses

 

Selling, general and administrative expenses were approximately $2.2 million for the three months ended September 30, 2019, as compared to approximately $2.0 million for the three months ended September 30, 2018. The increase of $200,000 in selling, general and administrative expenses was primarily due to increases in salary and wages expenses associated with the reclassification of certain field support employees from research and development of $100,000 and increased professional services expenses of $100,000 due to increased legal activity in the quarter ending September 30, 2019.

 

Interest Income/Expense, Net

 

We recorded interest income of $9,000, net, for the three months ended September 30, 2019, as compared to interest expense, net of $15,000 for the same period in 2018. The $24,000 increase in interest income, net for the period was a result of decreased interest on capital leases and promissory notes that expired during 2019 and higher interest income as a result of higher average daily cash balances and interest rates year over year.

 

Other Income (Expense)

 

We recorded no other income/expense, net, for the three months ended September 30, 2019, compared to $13,000 of other income for the same period in 2018. The $13,000 net decrease in other income was primarily due to decreased, year-over-year fair market value adjustment of our derivative warrant.  

 

23

 

 

Nine Months Ended September 30, 2019 compared to Nine Months Ended September 30, 2018:

 

Net Sales

 

Net sales were $79,000 for the nine months ended September 30, 2019 and $160,000 for the same period in 2018. Sales were lower in 2019 due to the transition to the removal of ContraPest’s ‘restricted use only’ status at the state level and our shift to pull through sales strategy directed at end users. This strategy has shown significant initial promise however, we have experienced an increase in lead to conversion time resulting in a longer sales process. 

 

Cost of Sales

 

Cost of sales was $58,000 for the nine months ended September 30, 2019, compared to $153,000 for the nine months ended September 30, 2018. Cost of sales were lower in 2019 primarily due to lower sales volume and no scrap expense associated with manufacturing scale up activities that were experienced during 2018.

 

Gross Profit

 

Gross profit for the nine months ended September 30, 2019 was $21,000 or 26.6% of net sales, compared to a gross profit of $7,000 or 4.4% of net sales, for the same period in 2018. The increase in gross profit was a direct result of a decrease in scrap due to related to scaleup activities.

 

24

 

  

Research and Development Expenses

 

   Nine Months Ended
September 30,
   Increase 
   2019   2018   (Decrease) 
   (in thousands) 
Direct research and development expenses:            
Unallocated expenses:               
Personnel related (including stock-based compensation)  $661   $1,124   $(463)
Facility-related   184    172    12 
Other   514    450    64 
Total research and development expenses  $1,359   $1,746   $(387)

 

Research and development expenses were $1.4 million for the nine months ended September 30, 2019, compared to $1.7 million for the same period in 2018. The $300,000 decrease in research and development expenses was primarily due to a decrease of $463,000 in personnel-related costs, including stock-based compensation expense, due to the classification of certain field support employees to sales and marketing offset by an increase in depreciation expense of $143,000. With more focus on commercialization of ContraPest, it was determined that these certain field support employees previously classified as research and development are now refocused on sales and marketing efforts and thus, reclassified as such.

 

Facility-related expense increased $12,000 due primarily to facility lease payment escalation.

 

The increase in other research and development expenses of $64,000 was primarily due to a reclass of other expenses related to certain field support employees to sales and marketing as described above.

 

We also continue to develop our supply chain, particularly identifying and improving our sourcing key ingredients for our product candidates.

 

Selling, General and Administrative Expenses

 

Selling, general and administrative expenses were approximately $5.9 million for the nine months ended September 30, 2019, as compared to approximately $7.5 million for the nine months ended September 30, 2018. The decrease of $1.6 million in selling, general and administrative expenses was primarily due to lower stock compensation expenses of $2.3 million associated with inducement warrants issued in June 2018 and $347,000 due to option grants fully vesting and resulting in lower stock compensation expense, offset by increased salary and wages of $605,000 associated with the reclassification of certain field support employees and an increase of $348,000 in professional services expense. The increase in professional services expenses was primarily due to increased legal and Board of Directors related expenses. 

 

Interest Income/Expense, Net

 

We recorded interest income of $11,000, net, for the nine months ended September 30, 2019, as compared to interest expense, net of $52,000 for the same period in 2018. The $63,000 increase in interest incomes was a result of decreased interest on capital leases and promissory notes that expired during the nine months ended September 30, 2019, and higher interest income as a result of higher average daily cash balance and interest rates year over year.

 

Other Income (Expense)

 

We recorded $3,000 of other expense, net, for the nine months ended September 30, 2019, compared to $19,000 of other income for the same period in 2018. The $22,000 net decrease in other income was primarily due to decreased, year-over-year fair market value adjustment of our derivative warrant as well as recognition of $3,000 of loss due to disposal of certain fixed asset during 2019.  

 

25

 

 

Liquidity and Capital Resources

  

Since our inception, we have sustained significant operating losses in the course of our research and development activities and commercialization efforts and expect such losses to continue for the near future. We have generated limited revenue to date from product sales, research grants and licensing fees received under our former license agreement with Neogen. In 2017, we began full scale marketing of our first product, ContraPest. We have funded our operations to date through the sale of equity securities, including convertible preferred stock, common stock and warrants to purchase common stock; debt financing, consisting primarily of convertible notes; and, to a lesser extent, payments received in connection with product sales, research grants and licensing fees. Through September 30, 2019, we had received net proceeds of $67.2 million from our sales of common stock, preferred stock and warrant exercises and issuance of convertible and other promissory notes, an aggregate of $1.7 million from licensing fees and an aggregate of $0.5 million in net product sales. At September 30, 2019, we had an accumulated deficit of $93.1 million and cash and cash equivalents of $3.9 million.

 

Our ultimate success depends upon the outcome of a combination of factors, including: (i) successful commercialization of ContraPest and maintaining and obtaining regulatory approval of our products and product candidates; (ii) market acceptance, commercial viability and profitability of ContraPest and other products; (iii) the ability to market our products and establish an effective sales force and marketing infrastructure to generate significant revenue; (iv) the success of our research and development; (v) the ability to retain and attract key personnel to develop, operate and grow our business; and (vi) our ability to meet our working capital needs.

 

Based upon our current operating plan, we expect that cash and cash equivalents at September 30, 2019, in combination with anticipated revenue and any additional sales of our equity securities, will be sufficient to fund our current operations for at least the next six months. We have taken and will continue to take actions to reduce our operating expenses and to concentrate our resources toward the successful commercialization of ContraPest in the U. S. however, if anticipated revenue targets and margin targets are not achieved and we are unable to raise necessary capital through the sale of our securities, we may be required to take other measures that could impair our ability to be successful and operate as a going concern. In any event, we are likely to require additional capital in order to fund our operating losses and research and development activities until we become profitable. We may never achieve profitability or generate positive cash flows, and unless and until we do, we will continue to need to raise capital through equity or debt financing. If such equity or debt financing is not available at adequate levels or on acceptable terms, we may need to delay, limit or terminate commercialization and development efforts.

 

Additional Funding Requirements

 

We expect our expenses to increase in connection with our ongoing activities, particularly as we market and focus on sales of ContraPest, and as we advance field studies of our product candidates in development. In addition, we will continue to incur costs associated with operating as a public company.

 

In particular, we expect to incur substantial and increased expenses as we:

 

Work to maximize market acceptance for, and generate sales of, our products;

 

Manage the infrastructure for the sales, marketing and distribution of ContraPest and any other product candidates for which we may receive regulatory approval;

 

Continue the development of ContraPest and our other product candidates, including engaging in any necessary field studies;

 

Seek additional regulatory approvals for ContraPest and our other product candidates;

 

Scale up manufacturing processes and quantities to meet future demand of ContraPest and any other product candidates for which we receive regulatory approval;

 

Continue product development of ContraPest and advance our research and development activities and advance the research and development programs for other product candidates;

 

Maintain, expand and protect our intellectual property portfolio; and

 

Add operational, financial and management information systems and personnel, including personnel to support our product development and commercialization efforts and operations as a public company.

 

26

 

  

Cash Flows

 

The following table summarizes our sources and uses of cash for each of the periods presented:

 

   Nine Months Ended
September 30,
 
   2019   2018 
     
Cash used in operating activities  $(6,092)  $(6,916)
Cash (used in) provided by investing activities   (64)   2,592 
Cash provided by financing activities   5,181    7,014 
Net (decrease) increase in cash and cash equivalents  $(975)  $2,690 

 

Operating Activities.

 

During the nine months ended September 30, 2019, operating activities used $6.1 million of cash, primarily resulting from our net loss of $7.2 million offset by changes in our operating assets and liabilities of $154,000 and by non-cash charges of $992,000, consisting primarily of stock-based compensation, depreciation and amortization. Our net loss was primarily attributable to research and development activities and our selling, general and administrative expenses, as we generated limited product revenue during the period. Net cash provided by changes in our operating assets and liabilities for the nine months ended September 30, 2019, consisted primarily of a net increase in accrued expenses and accounts payable of $164,000, a decrease in prepaid expenses of $38,000 and a decrease in deposits of $3,000 offset by an increase in inventory of $24,000, an increase in receivables of $16,000 and a decrease in deferred rent of $11,000.

 

27

 

 

During the nine months ended September 30, 2018, operating activities used $6.9 million of cash, primarily resulting from our net loss of $9.3 million and by changes in our operating assets and liabilities of $1.1 million, partially offset by non-cash charges of $3.4 million, consisting primarily of stock-based compensation, depreciation and amortization. Our net loss was primarily attributable to research and development activities and our selling, general and administrative expenses, as we generated limited product revenue during the period. Net cash used by changes in our operating assets and liabilities for the nine months ended September 30, 2018 consisted primarily of an increase in inventory of $578,000, prepaid expenses of $166,000, a decrease in accounts payable/accrued expenses of $251,000, an increase in receivables of $36,000 and a decrease in deferred rent of $18,000, offset by a decrease in deposits of $7,000.

 

Investing Activities.

 

For the nine months ended September 30, 2019, we used $64,000 in net cash related to investing activities due to purchases of property and equipment.

 

For the nine months ended September 30, 2018, net cash of $2.6 million was provided by investing activities consisting of $2.6 million of proceeds received from the sale of securities and $185,000 of proceeds from the sale of equipment offset by $212,000 in purchases of property and equipment.

 

Financing Activities.

 

During the nine months ended September 30, 2019, net cash provided by financing activities was $5.2 million as a result of $3.6 million in net proceeds from the issuance of common stock and net proceeds of $1.8 million from the exercise of warrants offset by payments of $184,000 related to notes payable and $55,000 of payments for employee withholding taxes related to share-based awards.

 

During the nine months ended September 30, 2018, net cash provided by financing activities was $7.0 million as a result of $5.1 million in proceeds from the issuance of common stock, net, $2.2 million in proceeds from warrant exercises and $9,000 in proceeds from issuances of notes, offset by $248,000 of repayments of related to notes payable and notes payable, related party, $50,000 in repayments of capital lease obligations and $42,000 of payments for employee withholding taxes related to share-based awards.

  

Off-Balance Sheet Arrangements

 

None.

 

Critical Accounting Policies and Significant Judgments and Estimates

 

Our financial statements are prepared in accordance with U.S. GAAP. The preparation of our financial statements and related disclosures requires us to make estimates, assumptions and judgments that affect the reported amounts of assets, liabilities, revenue, costs and expenses, and the disclosure of contingent assets and liabilities in our financial statements. We base our estimates on historical experience, known trends and events and various other factors that we believe are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. We evaluate our estimates and assumptions on an ongoing basis. Our actual results may differ from these estimates under different assumptions or conditions.

 

While our significant accounting policies are described in more detail in Note 2 to our financial statements included elsewhere in this Quarterly Report on Form 10-Q, we believe that the following accounting policies are those most critical to the judgments and estimates used in the preparation of our financial statements.

 

28

 

  

Revenue Recognition

 

Effective January 1, 2018, the Company adopted ASC 606 — Revenue from Contracts with Customers. Under ASC 606, the Company recognizes revenue from the commercial sales of products, licensing agreements and contracts to perform pilot studies by applying the following steps: (1) identify the contract with a customer; (2) identify the performance obligations in the contract; (3) determine the transaction price; (4) allocate the transaction price to each performance obligation in the contract; and (5) recognize revenue when each performance obligation is satisfied. For the comparative periods, revenue has not been adjusted and continues to be reported under ASC 605 — Revenue Recognition. Under ASC 605, revenue is recognized when the following criteria are met: (1) persuasive evidence of an arrangement exists; (2) the performance of service has been rendered to a customer or delivery has occurred; (3) the amount of fee to be paid by a customer is fixed and determinable; and (4) the collectability of the fee is reasonably assured.

 

There was no impact on the Company’s financial statements as a result of adopting ASC 606 for the three months and nine months ended September 30, 2019 and 2018, respectively.

 

Stock-Based Compensation

 

We recognize compensation costs related to stock options granted to employees based on the estimated fair value of the awards on the date of grant, net of estimated forfeitures, in accordance with ASC Topic 718 —  Stock Compensation (“ASC 718”). We estimate the grant date fair value of the awards, and the resulting stock-based compensation expense, using the Black-Scholes option-pricing model. The grant date fair value of stock-based awards is expensed on a straight-line basis over the vesting period of the respective award. We account for stock-based compensation arrangements with non-employees using a fair value approach. The fair value of these stock options is measured using the Black-Scholes option-pricing model reflecting the same assumptions as applied to employee options in each of the reported periods, other than the expected life, which is assumed to be the remaining contractual life of the option. The fair value of the stock options granted to non-employees is re-measured as the stock options vest and is recognized in the statements of operations and comprehensive loss during the period the related services are rendered.

 

We recorded stock-based compensation expense of approximately $204,000 and $675,000 for the three and nine months ended September 30, 2019, respectively and $355,000 and $3.1 million for the three and nine months ended September 30, 2018, respectively. We expect to grant stock options and other equity-based awards in the future, and to the extent that we do, our stock-based compensation expense recognized in future periods will likely increase.

 

The Black-Scholes option-pricing model requires the use of highly subjective and complex assumptions, which determine the fair value of stock-based awards. If we had made different assumptions, our stock-based compensation expense, net loss and loss per share of common stock could have been significantly different. Our assumptions are as follows:

 

Expected term.  The expected term represents the period that the stock-based awards are expected to be outstanding. Our historical share option exercise experience does not provide a reasonable basis upon which to estimate an expected term because of a lack of sufficient data. Therefore, we estimate the expected term by using the simplified method, which calculates the expected term as the average of the time-to-vesting and the contractual life of the options.

 

Expected volatility.   Expected volatility is derived from the average historical volatilities of publicly traded companies within our industry that we consider to be comparable to our business over a period approximately equal to the expected term. We intend to continue to consistently apply this process using the same or similar public companies until a sufficient amount of historical information regarding the volatility of our own common stock price becomes available, or unless circumstances change such that the identified companies are no longer similar to us, in which case, more suitable companies whose share prices are publicly available would be utilized in the calculation.

 

Risk-free interest rate.  The risk-free interest rate is based on the U.S. Treasury yield in effect at the time of grant for zero coupon U.S. Treasury notes with maturities approximately equal to the expected term.

 

Expected dividend.  The expected dividend is assumed to be zero as we have never paid dividends and have no current plans to pay any dividends on our common stock.

 

Expected forfeitures.  We use historical data to estimate pre-vesting option forfeitures and record stock-based compensation expense only for those awards that are expected to vest. To the extent actual forfeitures differ from the estimates, the difference will be recorded as a cumulative adjustment in the period that the estimates are revised.

 

29

 

  

Significant Factors, Assumptions and Methodologies Used in Determining Fair Value of Our Common Stock

 

As noted above, we are required to estimate the fair value of the common stock underlying our stock-based awards when performing the fair value calculations using the Black-Scholes option-pricing model. In the absence of an active market for our common stock, we utilized methodologies in accordance with the framework of the American Institute of Certified Public Accountants’ Technical Practice Aid, Valuation of Privately-Held Company Equity Securities Issued as Compensation, to estimate the fair value of our common stock. In addition, we have conducted periodic assessments of the valuation of our common stock.

 

The assumptions underlying these valuations represent management’s best estimates, which involve inherent uncertainties and the application of management’s judgment. If we had made different assumptions than those used, the amount of our stock-based compensation expense, net income and net income per share amounts could have been significantly different. The fair value per share of our common stock for purposes of determining stock-based compensation expense is the closing price of our common stock as reported on the applicable grant date. The compensation cost that has been included in the statements of operations and comprehensive loss for all stock-based compensation arrangements is as follows:

 

   Three Months Ended September 30,   Nine Months Ended      September 30, 
   2019   2018   2019   2018 
                 
Research and development  $1   $29   $11   $87 
General and administrative   203    326    664    3,003 
Total stock-based compensation expense  $204   $355   $675   $3,090 

 

The intrinsic value of stock options outstanding as of September 30, 2019 was $0.

 

Emerging Growth Company Status

 

The Jumpstart Our Business Startups Act of 2012, or the JOBS Act, permits an “emerging growth company” such as us to take advantage of an extended transition period to comply with new or revised accounting standards applicable to public companies until those standards would otherwise apply to private companies. We have irrevocably elected to “opt out” of this provision and, as a result, we intend to comply with new or revised accounting standards when they are required to be adopted by public companies that are not emerging growth companies.  

 

Item 3. Quantitative and Qualitative Disclosures about Market Risk

 

Not applicable.

 

Item 4. Controls and Procedures

 

Evaluation of Disclosure Controls and Procedures

 

We conducted an evaluation (pursuant to Rule 13a-15(b) of the Exchange Act), under the supervision and with the participation of management, including the Chief Executive Officer and Chief Financial Officer, of the effectiveness of the Company’s disclosure controls and procedures (as defined in Rule 13a-15(e)) as of the end of the period covered by this report.

 

These disclosure controls and procedures are designed to ensure that information required to be disclosed in our reports that are filed or submitted under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. Our disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that this information is accumulated and communicated to management, including the principal executive and principal financial officer, or persons performing similar functions, as appropriate, to allow timely decisions regarding required disclosure.

 

Based on the evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that these disclosure controls and procedures were effective as of the end of the period covered by this report.

 

Changes in Internal Control over Financial Reporting

 

There was no change in our internal control over financial reporting that occurred during the quarter ended

September 30, 2019, that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

 

30

 

  

PART II. OTHER INFORMATION

 

Item 1. Legal Proceedings

 

For information regarding legal proceedings in which we are involved, see Note 12 -- Commitments and Contingencies under the subsection titled “Legal Proceedings” in our Notes to Condensed Financial Statements in Part I, Item 1 of this Quarterly Report on Form 10-Q.

 

Item 1A. Risk Factors

 

There have been no material changes in the risk factors set forth in Part I, Item 1A, “Risk Factors” in our 2018 Annual Report.

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

 

None.

 

Item 3. Defaults Upon Senior Securities

 

None.

 

Item 4. Mine Safety Disclosures

 

Not applicable.

 

Item 5. Other Information

 

Effective November 10, 2019, Drs. Loretta Mayer and Cheryl Dyer discontinued their service as Chief Science Officer and Chief Research Officer, respectively, and employment with the company. While the terms of their departures are currently being finalized, under the terms of their current employment agreements, Drs. Loretta Mayer’s and Cheryl Dyer would receive their current salary and paid health insurance for a period of 12 months from the date of employment termination. The Company estimates the liability for this salary and insurance continuation to be $750.

 

In addition, Dr. Jamie Bechtel, currently lead independent director of the Company, succeeds Dr. Mayer as Chairman of the Board. Dr. Mayer remains a Director of the Company.

 

 

31

 

  

Item 6.  Exhibits

 

INDEX TO EXHIBITS

 

Exhibit       Filed or
Furnished
      Incorporated by Reference
Number   Description   Herewith   Form   Filing Date   Exhibit   File No.
                         
31.1   Certification of Chief Executive Officer pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934   X                
                         
31.2   Certification of Chief Financial Officer pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934   X                
                         
32.1   Certification of Chief Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002   X                
                         
32.2   Certification of Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002   X                
                         
101.INS   XBRL Instance Document   X                
                         
101.SCH   XBRL Taxonomy Extension Schema   X                
                         
101.CAL   XBRL Taxonomy Extension Calculation Linkbase   X                
                         
101.DEF   XBRL Taxonomy Extension Definition Linkbase   X                
                         
101.LAB   XBRL Taxonomy Extension Label Linkbase   X                
                         
101.PRE   XBRL Taxonomy Extension Presentation Linkbase   X                
                         
104   [Cover Page Interactive Data File (formatted in Inline XBRL and contained in Exhibit 101)][If tagging]                  

 

32

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

  SENESTECH, INC.
(Registrant)
     
Dated: November 14, 2019 By: /s/ Kenneth Siegel
    Kenneth Siegel
    Chief Executive Officer
     
Dated: November 14, 2019 By: /s/ Thomas C. Chesterman
    Thomas C. Chesterman
    Chief Financial Officer and Treasurer

 

 

33

 

 

EX-31.1 2 f10q0919ex31-1_senestechinc.htm CERTIFICATION

Exhibit 31.1

 

CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO 

 RULE 13(a)-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934

 

I, Kenneth Siegel, certify that: 

 

1. I have reviewed this Quarterly Report on Form 10-Q of SenesTech, Inc.;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Dated: November 14, 2019 /s/ Kenneth Siegel
  Kenneth Siegel
  Chief Executive Officer  

 

EX-31.2 3 f10q0919ex31-2_senestechinc.htm CERTIFICATION

Exhibit 31.2

 

CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO 

 RULE 13(a)-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934

 

I, Thomas C. Chesterman, certify that:

 

1. I have reviewed this Quarterly Report on Form 10-Q of SenesTech, Inc.;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Dated: November 14, 2019 /s/ Thomas C. Chesterman
  Thomas C. Chesterman
  Chief Financial Officer and Treasurer

 

EX-32.1 4 f10q0919ex32-1_senestechinc.htm CERTIFICATION

Exhibit 32.1

 

CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. SECTION 1350

 

Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, I, Kenneth Siegel, Chief Executive Officer and Chief Scientific Officer of SenesTech, Inc., certify that:

 

1. To my knowledge, this report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

2. To my knowledge, the information contained in this report fairly presents, in all material respects, the financial condition and results of operations of SenesTech, Inc.

 

Dated: November 14, 2019 /s/ Kenneth Siegel
  Kenneth Siegel
  Chief Executive Officer

 

EX-32.2 5 f10q0919ex32-2_senestechinc.htm CERTIFICATION

Exhibit 32.2

 

CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO 18 U.S.C. SECTION 1350

 

Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, I, Thomas C. Chesterman, Chief Financial Officer and Treasurer of SenesTech, Inc., certify that:

 

1. To my knowledge, this report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

2. To my knowledge, the information contained in this report fairly presents, in all material respects, the financial condition and results of operations of SenesTech, Inc.

 

Dated: November 14, 2019 /s/ Thomas C. Chesterman
  Thomas C. Chesterman
  Chief Financial Officer and Treasurer

 

EX-101.INS 6 snes-20190930.xml XBRL INSTANCE FILE 0001680378 2019-06-30 0001680378 2018-12-31 0001680378 2017-12-31 0001680378 2018-06-30 0001680378 us-gaap:ComputerEquipmentMember 2019-04-30 0001680378 us-gaap:ComputerEquipmentMember 2019-05-31 0001680378 us-gaap:CommonStockMember 2018-06-30 0001680378 us-gaap:CommonStockMember 2017-12-31 0001680378 us-gaap:AdditionalPaidInCapitalMember 2018-06-30 0001680378 us-gaap:AdditionalPaidInCapitalMember 2017-12-31 0001680378 us-gaap:RetainedEarningsMember 2018-06-30 0001680378 us-gaap:RetainedEarningsMember 2017-12-31 0001680378 us-gaap:CommonStockMember 2018-12-31 0001680378 us-gaap:CommonStockMember 2019-06-30 0001680378 us-gaap:AdditionalPaidInCapitalMember 2018-12-31 0001680378 us-gaap:AdditionalPaidInCapitalMember 2019-06-30 0001680378 us-gaap:RetainedEarningsMember 2018-12-31 0001680378 us-gaap:RetainedEarningsMember 2019-06-30 0001680378 snes:ResearchAndDevelopmentEquipmentMember 2018-12-31 0001680378 snes:OfficeAndComputerEquipmentMember 2018-12-31 0001680378 snes:AutosTrucksMember 2018-12-31 0001680378 us-gaap:FurnitureAndFixturesMember 2018-12-31 0001680378 us-gaap:LeaseholdImprovementsMember 2018-12-31 0001680378 2019-09-30 0001680378 2019-07-01 2019-09-30 0001680378 2018-07-01 2018-09-30 0001680378 2018-01-01 2018-09-30 0001680378 2019-01-01 2019-09-30 0001680378 2018-09-30 0001680378 us-gaap:CommonStockMember 2019-07-01 2019-09-30 0001680378 us-gaap:CommonStockMember 2019-09-30 0001680378 us-gaap:CommonStockMember 2018-01-01 2018-09-30 0001680378 us-gaap:CommonStockMember 2018-09-30 0001680378 us-gaap:AdditionalPaidInCapitalMember 2019-07-01 2019-09-30 0001680378 us-gaap:AdditionalPaidInCapitalMember 2019-09-30 0001680378 us-gaap:AdditionalPaidInCapitalMember 2018-01-01 2018-09-30 0001680378 us-gaap:AdditionalPaidInCapitalMember 2018-09-30 0001680378 snes:StockSubscriptionPayableMember 2018-01-01 2018-09-30 0001680378 us-gaap:RetainedEarningsMember 2019-07-01 2019-09-30 0001680378 us-gaap:RetainedEarningsMember 2019-09-30 0001680378 us-gaap:RetainedEarningsMember 2018-01-01 2018-09-30 0001680378 us-gaap:RetainedEarningsMember 2018-09-30 0001680378 us-gaap:CommonStockMember 2018-07-01 2018-09-30 0001680378 us-gaap:AdditionalPaidInCapitalMember 2018-07-01 2018-09-30 0001680378 us-gaap:RetainedEarningsMember 2018-07-01 2018-09-30 0001680378 us-gaap:CommonStockMember 2019-01-01 2019-09-30 0001680378 us-gaap:AdditionalPaidInCapitalMember 2019-01-01 2019-09-30 0001680378 us-gaap:RetainedEarningsMember 2019-01-01 2019-09-30 0001680378 snes:OfficeAndComputerEquipmentMember 2019-01-01 2019-09-30 0001680378 snes:AutosTrucksMember 2019-01-01 2019-09-30 0001680378 us-gaap:FurnitureAndFixturesMember 2019-01-01 2019-09-30 0001680378 snes:ResearchAndDevelopmentEquipmentMember 2019-01-01 2019-09-30 0001680378 snes:OfficeAndComputerEquipmentMember 2019-09-30 0001680378 snes:ResearchAndDevelopmentEquipmentMember 2019-09-30 0001680378 snes:AutosTrucksMember 2019-09-30 0001680378 us-gaap:FurnitureAndFixturesMember 2019-09-30 0001680378 us-gaap:LeaseholdImprovementsMember 2019-09-30 0001680378 us-gaap:ComputerEquipmentMember 2019-08-31 0001680378 us-gaap:CapitalLeaseObligationsMember 2019-01-01 2019-09-30 0001680378 us-gaap:NotesPayableOtherPayablesMember 2019-01-01 2019-09-30 0001680378 us-gaap:NotesPayableOtherPayablesMember srt:MaximumMember 2019-09-30 0001680378 us-gaap:CapitalLeaseObligationsMember srt:MinimumMember 2019-09-30 0001680378 us-gaap:CapitalLeaseObligationsMember srt:MaximumMember 2019-09-30 0001680378 us-gaap:NotesPayableOtherPayablesMember srt:MinimumMember 2019-09-30 0001680378 2019-11-14 0001680378 us-gaap:ResearchAndDevelopmentExpenseMember 2019-01-01 2019-09-30 0001680378 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2019-01-01 2019-09-30 0001680378 us-gaap:ResearchAndDevelopmentExpenseMember 2018-01-01 2018-09-30 0001680378 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2018-01-01 2018-09-30 0001680378 us-gaap:ResearchAndDevelopmentExpenseMember 2019-07-01 2019-09-30 0001680378 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2019-07-01 2019-09-30 0001680378 us-gaap:ResearchAndDevelopmentExpenseMember 2018-07-01 2018-09-30 0001680378 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2018-07-01 2018-09-30 0001680378 us-gaap:WarrantMember 2019-01-01 2019-09-30 0001680378 us-gaap:RestrictedStockUnitsRSUMember 2019-01-01 2019-09-30 0001680378 snes:CommonStockOptionsMember 2019-01-01 2019-09-30 0001680378 us-gaap:WarrantMember 2018-01-01 2018-09-30 0001680378 us-gaap:RestrictedStockUnitsRSUMember 2018-01-01 2018-09-30 0001680378 snes:CommonStockOptionsMember 2018-01-01 2018-09-30 0001680378 2019-01-02 0001680378 srt:RestatementAdjustmentMember 2018-12-31 0001680378 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member 2019-09-30 0001680378 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member 2019-09-30 0001680378 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member 2019-09-30 0001680378 us-gaap:FairValueMeasurementsRecurringMember 2019-09-30 0001680378 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member us-gaap:MoneyMarketFundsMember 2018-12-31 0001680378 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member us-gaap:MoneyMarketFundsMember 2018-12-31 0001680378 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member us-gaap:CorporateDebtSecuritiesMember 2018-12-31 0001680378 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member us-gaap:MoneyMarketFundsMember 2018-12-31 0001680378 us-gaap:MoneyMarketFundsMember us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0001680378 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member us-gaap:CorporateDebtSecuritiesMember 2018-12-31 0001680378 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member us-gaap:CorporateDebtSecuritiesMember 2018-12-31 0001680378 us-gaap:CorporateDebtSecuritiesMember us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0001680378 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member 2018-12-31 0001680378 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member 2018-12-31 0001680378 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member 2018-12-31 0001680378 us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0001680378 2018-01-01 2018-12-31 0001680378 snes:WarrantsIssuedMember 2018-01-01 2018-12-31 0001680378 snes:WarrantsIssuedMember 2018-12-31 0001680378 snes:CommonStockOfferingWarrantsIssuedMember 2018-01-01 2018-12-31 0001680378 snes:CommonStockOfferingWarrantsIssuedMember 2017-12-31 0001680378 snes:CommonStockOfferingWarrantsIssuedMember 2018-12-31 0001680378 snes:CommonStockOfferingDealerManagerWarrantsMember 2018-01-01 2018-12-31 0001680378 snes:CommonStockOfferingDealerManagerWarrantsMember 2018-12-31 0001680378 snes:CommonStockOfferingWarrantsIssuedMember 2017-01-01 2017-12-31 0001680378 snes:CommonStockOfferingUnderwriterWarrantsMember 2017-01-01 2017-12-31 0001680378 snes:CommonStockOfferingUnderwriterWarrantsMember 2017-12-31 0001680378 2017-01-01 2017-12-31 0001680378 2016-12-31 0001680378 snes:UniversityOfArizonaCommonStockWarrantMember snes:LicenseAgreementMember 2015-06-02 2015-06-15 0001680378 snes:UniversityOfArizonaCommonStockWarrantMember snes:LicenseAgreementMember 2015-06-15 0001680378 snes:CommonStockWarrantIssuedToUnderwriterOfCommonStockOfferingMember snes:HCWainwrightAndCoMember 2019-09-30 0001680378 snes:CommonStockWarrantIssuedToUnderwriterOfCommonStockOfferingMember snes:HCWainwrightAndCoMember 2019-01-01 2019-09-30 0001680378 snes:CommonStockWarrantIssuedToUnderwriterOfCommonStockOfferingMember snes:HCWainwrightAndCoMember 2019-07-25 2019-07-31 0001680378 snes:CommonStockWarrantIssuedToUnderwriterOfCommonStockOfferingMember snes:HCWainwrightAndCoMember 2019-07-31 0001680378 snes:CommonStockWarrantsIssuedToParticipantsInOfferingOfTheCompanysCommonStockMember 2017-11-21 0001680378 snes:PublicOfferingMember 2017-11-21 0001680378 snes:CommonStockWarrantsIssuedToParticipantsInOfferingOfTheCompanysCommonStockMember 2017-11-20 2017-11-21 0001680378 snes:CommonStockWarrantIssuedToUnderwriterOfCommonStockOfferingMember 2018-08-13 0001680378 snes:RightOfferingMember us-gaap:WarrantMember snes:MaximPartnersLLCMember 2018-08-13 0001680378 snes:RightOfferingMember 2018-09-12 2018-09-13 0001680378 snes:RightOfferingMember us-gaap:WarrantMember snes:MaximPartnersLLCMember 2018-08-12 2018-08-13 0001680378 snes:RightOfferingMember 2018-08-12 2018-08-13 0001680378 snes:RightOfferingMember 2018-08-13 0001680378 snes:CommonStockWarrantsIssuedToParticipantsInOfferingOfTheCompanysCommonStockMember 2018-06-20 0001680378 snes:CommonStockWarrantsIssuedToParticipantsInOfferingOfTheCompanysCommonStockMember 2018-06-02 2018-06-30 0001680378 snes:CommonStockWarrantsIssuedToParticipantsInOfferingOfTheCompanysCommonStockMember 2019-09-30 0001680378 snes:CommonStockWarrantsIssuedToParticipantsInOfferingOfTheCompanysCommonStockMember 2018-06-19 2018-06-20 0001680378 snes:NewWarrantsMember 2019-09-30 0001680378 snes:UniversityOfArizonaCommonStockWarrantMember 2019-07-01 2019-09-30 0001680378 snes:UniversityOfArizonaCommonStockWarrantMember 2019-01-01 2019-09-30 0001680378 snes:CommonStockWarrantIssuedToUnderwriterOfCommonStockOfferingMember 2018-07-24 0001680378 snes:UniversityOfArizonaCommonStockWarrantMember 2019-09-30 0001680378 snes:NewWarrantsMember 2018-06-20 0001680378 snes:NewWarrantsMember 2018-06-02 2018-06-30 0001680378 snes:CommonStockWarrantIssuedToUnderwriterOfCommonStockOfferingMember 2018-07-23 2018-07-24 0001680378 snes:CommonStockWarrantIssuedToUnderwriterOfCommonStockOfferingMember 2018-08-12 2018-08-13 0001680378 us-gaap:RestrictedStockMember 2019-01-01 2019-09-30 0001680378 us-gaap:IPOMember 2019-01-01 2019-09-30 0001680378 us-gaap:RestrictedStockUnitsRSUMember 2019-01-01 2019-09-30 0001680378 us-gaap:WarrantMember 2019-01-01 2019-09-30 0001680378 us-gaap:CommonStockMember 2019-01-01 2019-09-30 0001680378 2015-12-31 0001680378 us-gaap:SeriesAPreferredStockMember 2015-12-31 0001680378 2015-11-10 0001680378 us-gaap:SeriesAPreferredStockMember 2015-11-10 0001680378 us-gaap:CommonStockMember 2015-11-10 0001680378 us-gaap:CommonStockMember 2015-10-31 0001680378 us-gaap:IPOMember 2019-07-15 2019-07-16 0001680378 us-gaap:IPOMember 2019-07-16 0001680378 snes:WarrantsIssuedMember 2019-07-01 2019-07-31 0001680378 srt:ChiefExecutiveOfficerMember 2019-07-15 2019-07-16 0001680378 snes:EmployeesMember 2019-07-15 2019-07-16 0001680378 snes:WarrantsMember 2019-07-31 0001680378 snes:EmployeeMember 2019-01-01 2019-09-30 0001680378 snes:EmployeeMember srt:MinimumMember 2019-01-01 2019-09-30 0001680378 snes:EmployeeMember srt:MaximumMember 2019-01-01 2019-09-30 0001680378 us-gaap:RestrictedStockUnitsRSUMember 2018-12-31 0001680378 us-gaap:RestrictedStockUnitsRSUMember 2019-09-30 0001680378 snes:EquityIncentivePlan2018Member 2019-09-30 0001680378 snes:EquityIncentivePlan2018Member 2018-06-12 0001680378 snes:EquityIncentivePlan2018Member 2018-06-11 2018-06-12 0001680378 snes:StockOptionPlan20082009Member us-gaap:RestrictedStockUnitsRSUMember 2019-09-30 0001680378 snes:StockOptionPlan20082009Member 2019-01-01 2019-09-30 0001680378 snes:ResearchAndDevelopmentMember 2016-11-15 2016-11-16 0001680378 snes:ResearchAndDevelopmentMember 2016-11-16 0001680378 snes:ResearchAndDevelopmentMember 2019-07-31 0001680378 us-gaap:SubsequentEventMember 2019-10-28 2019-11-01 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure utr:sqft 1083000 2000 2000 830000 2000 3925000 6314000 7522000 5665000 18000 16000 86022000 81103000 -80375000 -73597000 24000 25000 92128000 94391000 -85838000 -90491000 5148000 8637000 28000 23000 98196000 91822000 -93076000 -83208000 0.001 0.001 100000000 100000000 100000000 100000000 23471999 28288285 23471999 28288285 -2585000 -2500000 -9278000 -7238000 -2585000 -9278000 -2500000 -7238000 -15000 -3000 100000 121000 161000 14000 25000 25000 53000 54000 8000 15000 19000 3000 2000 13000 11000 2668000 1552000 742000 54000 37000 283000 2709000 753000 1582000 54000 37000 283000 1585000 1879000 479000 264000 269000 507000 23000 9000 5000 219000 129000 232000 175000 248000 121000 480000 296000 261000 167000 7754000 6554000 29000 87000 87000 6671000 5695000 9000 6000 1261000 1285000 342000 304000 139000 155000 4920000 2101000 3945000 4791000 1440000 1406000 16000 5000 29000 87000 87000 261000 167000 1163000 1205000 771000 785000 173000 291000 219000 129000 7754000 6554000 -85838000 -93076000 92128000 98196000 24000 28000 11000 -9000 7000 21000 25000 114000 153000 58000 36000 105000 160000 79000 -2594000 -2498000 -9245000 -7246000 2605000 2489000 9252000 7267000 2173000 2013000 7506000 5908000 432000 476000 1746000 1359000 -0.09 -0.14 -0.53 -0.29 27891501 20862216 18036982 25336837 -2585000 -2833000 -9611000 -7238000 9000 -2000 -33000 8000 13000 19000 -3000 53000 0 0 10000 16000 60000 34000 19000 1000 8000 45000 -1000 -10000 3090000 675000 1700000 101000 108000 332000 314000 44000 -7000 -3000 578000 24000 166000 -38000 36000 16000 -6916000 -6092000 -18000 -11000 -66000 46000 -185000 118000 2592000 -64000 212000 64000 185000 2619000 2690000 -975000 7014000 5181000 42000 55000 2213000 1789000 50000 12000 236000 184000 60000 34000 32000 37000 333000 333000 333000 -333000 333000 -333000 5132000 3631000 9000 18040497 16404195 23471999 25227475 28288285 23425287 27000 34000 1000 34000 -8000 34000 174481 27738 144054 105474 3630000 5132000 5132000 3630000 3000 5000 3627000 5127000 5000 5127000 3000 3627000 3600000000 3037038 5357052 5357052 3037038 3037038 4816286 3580 696296 7408 204000 355000 3062000 675000 204000 3062000 355000 675000 -31000 -15000 -42000 -55000 -31000 -42000 -15000 -55000 -8000 8000 5000 2214000 1788000 1000 5000 2213000 1000 1787000 4514 1475659 1610210 13900 24984 3022 22000 P3Y P5Y P7Y P5Y Various dates through July 2023 Various dates through June 2022 0.1328 0.064 0.1160 0.1088 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Use of Estimates</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts and classification of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements and reported amounts of revenues and expenses during the reporting period. The significant estimates in the Company's financial statements include the valuation of preferred stock, common stock and related warrants, and other stock-based awards. Actual results could differ from such estimates.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">Components of inventory are:</font></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <table cellspacing="0" cellpadding="0" style="font: 10pt/normal Times New Roman, Times, Serif; border-collapse: collapse; font-size-adjust: none; font-stretch: normal; width: 100%"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="font-weight: bold; white-space: nowrap"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="2" style="text-align: center; font-weight: bold; white-space: nowrap"><font style="font: 10pt Times New Roman, Times, Serif"><b>September&#160;30,</b></font></td> <td style="font-weight: bold; white-space: nowrap"><font style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></font></td> <td style="font-weight: bold; white-space: nowrap"><font style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></font></td> <td colspan="2" style="text-align: center; font-weight: bold; white-space: nowrap"><font style="font: 10pt Times New Roman, Times, Serif"><b>December&#160;31,</b></font></td> <td style="font-weight: bold; white-space: nowrap"><font style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></font></td></tr> <tr style="vertical-align: bottom"> <td><font style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></font></td> <td style="padding-bottom: 1.5pt; font-weight: bold"><font style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></font></td> <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif"><b>2019</b></font></td> <td style="padding-bottom: 1.5pt; font-weight: bold"><font style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></font></td> <td style="padding-bottom: 1.5pt; font-weight: bold"><font style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></font></td> <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif"><b>2018</b></font></td> <td style="padding-bottom: 1.5pt; font-weight: bold"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255)"> <td style="width: 78%; text-align: left; text-indent: -8.65pt; padding-left: 8.65pt"><font style="font: 10pt Times New Roman, Times, Serif">Raw materials</font></td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="width: 1%; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 8%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,063</font></td> <td style="width: 1%; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="width: 1%; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 8%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,111</font></td> <td style="width: 1%; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: left; text-indent: -8.65pt; padding-left: 8.65pt"><font style="font: 10pt Times New Roman, Times, Serif">Work in progress</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">3</font></td> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#8212;</font></td> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255)"> <td style="text-align: left; text-indent: -8.65pt; padding-bottom: 1.5pt; padding-left: 8.65pt"><font style="font: 10pt Times New Roman, Times, Serif">Finished goods</font></td> <td style="padding-bottom: 1.5pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: left; border-bottom: black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right; border-bottom: black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif">223</font></td> <td style="text-align: left; padding-bottom: 1.5pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="padding-bottom: 1.5pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: left; border-bottom: black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right; border-bottom: black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif">154</font></td> <td style="text-align: left; padding-bottom: 1.5pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: left; text-indent: -8.65pt; padding-left: 0.25in"><font style="font: 10pt Times New Roman, Times, Serif">Total inventory</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,289</font></td> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,265</font></td> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255)"> <td style="text-indent: -8.65pt; padding-left: 8.65pt"><font style="font: 10pt Times New Roman, Times, Serif">Less:</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: left; text-indent: -8.65pt; padding-bottom: 1.5pt; padding-left: 8.65pt"><font style="font: 10pt Times New Roman, Times, Serif">Reserve for obsolete</font></td> <td style="padding-bottom: 1.5pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: left; border-bottom: black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right; border-bottom: black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif">(4</font></td> <td style="text-align: left; padding-bottom: 1.5pt"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td> <td style="padding-bottom: 1.5pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: left; border-bottom: black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right; border-bottom: black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif">(4</font></td> <td style="text-align: left; padding-bottom: 1.5pt"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255)"> <td style="text-align: left; text-indent: -8.65pt; padding-bottom: 4pt; padding-left: 8.65pt"><font style="font: 10pt Times New Roman, Times, Serif">Total net inventory</font></td> <td style="padding-bottom: 4pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: left; border-bottom: black 4pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right; border-bottom: black 4pt double"><font style="font: 10pt Times New Roman, Times, Serif">1,285</font></td> <td style="text-align: left; padding-bottom: 4pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="padding-bottom: 4pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: left; border-bottom: black 4pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right; border-bottom: black 4pt double"><font style="font: 10pt Times New Roman, Times, Serif">1,261</font></td> <td style="text-align: left; padding-bottom: 4pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr></table> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">The stock-based compensation expense recorded for the three and nine months ended September 30, 2019 and 2018,</font></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">is as follows:</font></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <table cellspacing="0" cellpadding="0" style="font: 10pt/normal Times New Roman, Times, Serif; border-collapse: collapse; font-size-adjust: none; font-stretch: normal; width: 100%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; white-space: nowrap"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="padding-bottom: 1.5pt; font-weight: bold; white-space: nowrap"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="6" style="text-align: center; font-weight: bold; border-bottom: black 1.5pt solid; white-space: nowrap"><font style="font: 10pt Times New Roman, Times, Serif"><b>Three Months Ended<br /> September 30,</b></font></td> <td style="padding-bottom: 1.5pt; font-weight: bold; white-space: nowrap"><font style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></font></td> <td style="padding-bottom: 1.5pt; font-weight: bold; white-space: nowrap"><font style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></font></td> <td colspan="6" style="text-align: center; font-weight: bold; border-bottom: black 1.5pt solid; white-space: nowrap"><font style="font: 10pt Times New Roman, Times, Serif"><b>Nine Months Ended<br /> September 30,</b></font></td> <td style="padding-bottom: 1.5pt; font-weight: bold; white-space: nowrap"><font style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></font></td></tr> <tr style="vertical-align: bottom"> <td><font style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></font></td> <td style="padding-bottom: 1.5pt; font-weight: bold"><font style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></font></td> <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif"><b>2019</b></font></td> <td style="padding-bottom: 1.5pt; font-weight: bold"><font style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></font></td> <td style="padding-bottom: 1.5pt; font-weight: bold"><font style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></font></td> <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif"><b>2018</b></font></td> <td style="padding-bottom: 1.5pt; font-weight: bold"><font style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></font></td> <td style="padding-bottom: 1.5pt; font-weight: bold"><font style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></font></td> <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif"><b>2019</b></font></td> <td style="padding-bottom: 1.5pt; font-weight: bold"><font style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></font></td> <td style="padding-bottom: 1.5pt; font-weight: bold"><font style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></font></td> <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif"><b>2018</b></font></td> <td style="padding-bottom: 1.5pt; font-weight: bold"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom"> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="2" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="2" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="2" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="2" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255)"> <td style="width: 52%; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Research and development</font></td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="width: 1%; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 9%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1</font></td> <td style="width: 1%; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="width: 1%; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 9%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">29</font></td> <td style="width: 1%; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="width: 1%; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 9%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">11</font></td> <td style="width: 1%; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="width: 1%; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 9%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">87</font></td> <td style="width: 1%; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: left; padding-bottom: 1.5pt"><font style="font: 10pt Times New Roman, Times, Serif">General and administrative</font></td> <td style="padding-bottom: 1.5pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: left; border-bottom: black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right; border-bottom: black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif">203</font></td> <td style="text-align: left; padding-bottom: 1.5pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="padding-bottom: 1.5pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: left; border-bottom: black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right; border-bottom: black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif">326</font></td> <td style="text-align: left; padding-bottom: 1.5pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="padding-bottom: 1.5pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: left; border-bottom: black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right; border-bottom: black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif">661</font></td> <td style="text-align: left; padding-bottom: 1.5pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="padding-bottom: 1.5pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: left; border-bottom: black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right; border-bottom: black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif">3,003</font></td> <td style="text-align: left; padding-bottom: 1.5pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255)"> <td style="text-align: left; padding-bottom: 4pt"><font style="font: 10pt Times New Roman, Times, Serif">Total stock-based compensation expense</font></td> <td style="padding-bottom: 4pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: left; border-bottom: black 4pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right; border-bottom: black 4pt double"><font style="font: 10pt Times New Roman, Times, Serif">204</font></td> <td style="text-align: left; padding-bottom: 4pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="padding-bottom: 4pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: left; border-bottom: black 4pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right; border-bottom: black 4pt double"><font style="font: 10pt Times New Roman, Times, Serif">355</font></td> <td style="text-align: left; padding-bottom: 4pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="padding-bottom: 4pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: left; border-bottom: black 4pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right; border-bottom: black 4pt double"><font style="font: 10pt Times New Roman, Times, Serif">675</font></td> <td style="text-align: left; padding-bottom: 4pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="padding-bottom: 4pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: left; border-bottom: black 4pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right; border-bottom: black 4pt double"><font style="font: 10pt Times New Roman, Times, Serif">3,090</font></td> </tr></table> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">The following table sets forth the outstanding potentially dilutive securities that have been excluded in the calculation of diluted loss per share attributable to common stockholders (in common stock equivalent shares):</font></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <table cellspacing="0" cellpadding="0" style="font: 10pt/normal Times New Roman, Times, Serif; border-collapse: collapse; font-size-adjust: none; font-stretch: normal; width: 100%"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="padding-bottom: 1.5pt; font-weight: bold; white-space: nowrap"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="6" style="text-align: center; font-weight: bold; border-bottom: black 1.5pt solid; white-space: nowrap"><font style="font: 10pt Times New Roman, Times, Serif"><b>September 30,</b></font></td> <td style="padding-bottom: 1.5pt; font-weight: bold; white-space: nowrap"><font style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></font></td></tr> <tr style="vertical-align: bottom"> <td><font style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></font></td> <td style="padding-bottom: 1.5pt; font-weight: bold"><font style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></font></td> <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif"><b>2019</b></font></td> <td style="padding-bottom: 1.5pt; font-weight: bold"><font style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></font></td> <td style="padding-bottom: 1.5pt; font-weight: bold"><font style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></font></td> <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif"><b>2018</b></font></td> <td style="padding-bottom: 1.5pt; font-weight: bold"><font style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></font></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255)"> <td style="width: 78%; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Common stock purchase warrants</font></td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="width: 1%; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="width: 8%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">9,783,278</font></td> <td style="width: 1%; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="width: 1%; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="width: 8%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">11,714,940</font></td> <td style="width: 1%; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Restricted stock unit</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">117,465</font></td> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">172,912</font></td> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255)"> <td style="text-align: left; padding-bottom: 1.5pt"><font style="font: 10pt Times New Roman, Times, Serif">Common stock options</font></td> <td style="padding-bottom: 1.5pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: left; border-bottom: black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right; border-bottom: black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif">2,747,677</font></td> <td style="text-align: left; padding-bottom: 1.5pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="padding-bottom: 1.5pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: left; border-bottom: black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right; border-bottom: black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif">1,725,771</font></td> <td style="text-align: left; padding-bottom: 1.5pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 4pt; padding-left: 9pt"><font style="font: 10pt Times New Roman, Times, Serif">Total</font></td> <td style="padding-bottom: 4pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: left; border-bottom: black 4pt double"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right; border-bottom: black 4pt double"><font style="font: 10pt Times New Roman, Times, Serif">12,648,420</font></td> <td style="text-align: left; padding-bottom: 4pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="padding-bottom: 4pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: left; border-bottom: black 4pt double"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right; border-bottom: black 4pt double"><font style="font: 10pt Times New Roman, Times, Serif">13,613,623</font></td> <td style="text-align: left; padding-bottom: 4pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">The cumulative effect of the changes made to the Company's Consolidated Balance Sheet as of January 1, 2019 for the adoption of the new leasing standard was as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.25in">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 10pt/normal Times New Roman, Times, Serif; border-collapse: collapse; font-size-adjust: none; font-stretch: normal; width: 100%"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td> <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: black 1.5pt solid">Balance @<br /> December&#160;31, 2018</td> <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td> <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td> <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: black 1.5pt solid">Adjustment Due<br /> to ASC 842</td> <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td> <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td> <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: black 1.5pt solid">Balance @<br /> January&#160;1,<br /> 2019</td> <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255)"> <td style="width: 67%; text-align: left">Right to Use Asset - Long Term</td> <td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td> <td style="width: 8%; text-align: right">&#8212;</td> <td style="width: 1%; text-align: left">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">$</td> <td style="width: 8%; text-align: right">87</td> <td style="width: 1%; text-align: left">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">$</td> <td style="width: 8%; text-align: right">87</td> <td style="width: 1%; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255)"> <td style="text-align: left">Lease Liability &#8211; Long Term</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#8212;</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">$</td> <td style="text-align: right">(87</td> <td style="text-align: left">)</td> <td>&#160;</td> <td style="text-align: left">$</td> <td style="text-align: right">(87</td> <td style="text-align: left">)</td></tr> </table> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">Prepaid expenses consist of the following:</font></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <table cellspacing="0" cellpadding="0" style="font: 10pt/normal Times New Roman, Times, Serif; border-collapse: collapse; font-size-adjust: none; font-stretch: normal; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center; white-space: nowrap"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="font-weight: bold; white-space: nowrap"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="2" style="text-align: center; font-weight: bold; white-space: nowrap"><font style="font: 10pt Times New Roman, Times, Serif"><b>September 30,</b></font></td> <td style="font-weight: bold; white-space: nowrap"><font style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></font></td> <td style="font-weight: bold; white-space: nowrap"><font style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></font></td> <td colspan="2" style="text-align: center; font-weight: bold; white-space: nowrap"><font style="font: 10pt Times New Roman, Times, Serif"><b>December 31,</b></font></td> <td style="font-weight: bold; white-space: nowrap"><font style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></font></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></font></td> <td style="padding-bottom: 1.5pt; font-weight: bold"><font style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></font></td> <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif"><b>2019</b></font></td> <td style="padding-bottom: 1.5pt; font-weight: bold"><font style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></font></td> <td style="padding-bottom: 1.5pt; font-weight: bold"><font style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></font></td> <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif"><b>2018</b></font></td> <td style="padding-bottom: 1.5pt; font-weight: bold"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255)"> <td style="width: 78%; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Director compensation</font></td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="width: 1%; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 8%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="width: 1%; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="width: 1%; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 8%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">100</font></td> <td style="width: 1%; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Director and officer insurance</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">161</font></td> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">121</font></td> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255)"> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">NASDAQ fees</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">14</font></td> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Legal retainer</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">25</font></td> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">25</font></td> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255)"> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Marketing programs and conferences</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">54</font></td> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">53</font></td> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Professional services retainer</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">15</font></td> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">8</font></td> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255)"> <td><font style="font: 10pt Times New Roman, Times, Serif">Rent</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">19</font></td> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Equipment service deposits</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2</font></td> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">3</font></td> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255)"> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Foreign patent registration</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">22</font></td> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: left; padding-bottom: 1.5pt"><font style="font: 10pt Times New Roman, Times, Serif">Engineering, software licenses and other</font></td> <td style="padding-bottom: 1.5pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: left; border-bottom: black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right; border-bottom: black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif">11</font></td> <td style="text-align: left; padding-bottom: 1.5pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="padding-bottom: 1.5pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: left; border-bottom: black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right; border-bottom: black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif">13</font></td> <td style="text-align: left; padding-bottom: 1.5pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255)"> <td style="text-align: left; padding-bottom: 4pt"><font style="font: 10pt Times New Roman, Times, Serif">Total prepaid expenses</font></td> <td style="padding-bottom: 4pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: left; border-bottom: black 4pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right; border-bottom: black 4pt double"><font style="font: 10pt Times New Roman, Times, Serif">304</font></td> <td style="text-align: left; padding-bottom: 4pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="padding-bottom: 4pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: left; border-bottom: black 4pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right; border-bottom: black 4pt double"><font style="font: 10pt Times New Roman, Times, Serif">342</font></td> <td style="text-align: left; padding-bottom: 4pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr></table> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">Accrued expenses consist of the following:</font></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <table cellspacing="0" cellpadding="0" style="font: 10pt/normal Times New Roman, Times, Serif; border-collapse: collapse; font-size-adjust: none; font-stretch: normal; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center; white-space: nowrap"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="font-weight: bold; white-space: nowrap"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="2" style="text-align: center; font-weight: bold; white-space: nowrap"><font style="font: 10pt Times New Roman, Times, Serif"><b>September&#160;30,</b></font></td> <td style="font-weight: bold; white-space: nowrap"><font style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></font></td> <td style="font-weight: bold; white-space: nowrap"><font style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></font></td> <td colspan="2" style="text-align: center; font-weight: bold; white-space: nowrap"><font style="font: 10pt Times New Roman, Times, Serif"><b>December&#160;31,</b></font></td> <td style="font-weight: bold; white-space: nowrap"><font style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></font></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></font></td> <td style="padding-bottom: 1.5pt; font-weight: bold"><font style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></font></td> <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif"><b>2019</b></font></td> <td style="padding-bottom: 1.5pt; font-weight: bold"><font style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></font></td> <td style="padding-bottom: 1.5pt; font-weight: bold"><font style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></font></td> <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif"><b>2018</b></font></td> <td style="padding-bottom: 1.5pt; font-weight: bold"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255)"> <td style="width: 78%; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Compensation and related benefits</font></td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="width: 1%; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 8%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">264</font></td> <td style="width: 1%; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="width: 1%; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 8%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">479</font></td> <td style="width: 1%; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Accrued Litigation</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">507</font></td> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">269</font></td> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255)"> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Board Compensation</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">9</font></td> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">23</font></td> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt"><font style="font: 10pt Times New Roman, Times, Serif">Other</font></td> <td style="padding-bottom: 1.5pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: left; border-bottom: black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right; border-bottom: black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif">5</font></td> <td style="text-align: left; padding-bottom: 1.5pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="padding-bottom: 1.5pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: left; border-bottom: black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right; border-bottom: black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif">&#8212;</font></td> <td style="text-align: left; padding-bottom: 1.5pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255)"> <td style="text-align: left; padding-bottom: 4pt"><font style="font: 10pt Times New Roman, Times, Serif">Total accrued expenses</font></td> <td style="padding-bottom: 4pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: left; border-bottom: black 4pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right; border-bottom: black 4pt double"><font style="font: 10pt Times New Roman, Times, Serif">785</font></td> <td style="text-align: left; padding-bottom: 4pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="padding-bottom: 4pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: left; border-bottom: black 4pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right; border-bottom: black 4pt double"><font style="font: 10pt Times New Roman, Times, Serif">771</font></td></tr></table> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">A summary of the Company&#8217;s borrowings, including capital lease obligations, is as follows:</font></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <table cellspacing="0" cellpadding="0" style="font: 10pt/normal Times New Roman, Times, Serif; border-collapse: collapse; font-size-adjust: none; font-stretch: normal; width: 100%"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="font-weight: bold; white-space: nowrap"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="2" style="text-align: center; font-weight: bold; white-space: nowrap"><font style="font: 10pt Times New Roman, Times, Serif"><b>September&#160;30,</b></font></td> <td style="font-weight: bold; white-space: nowrap"><font style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></font></td> <td style="font-weight: bold; white-space: nowrap"><font style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></font></td> <td colspan="2" style="text-align: center; font-weight: bold; white-space: nowrap"><font style="font: 10pt Times New Roman, Times, Serif"><b>December&#160;31,</b></font></td> <td style="font-weight: bold; white-space: nowrap"><font style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></font></td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"><font style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></font></td> <td style="padding-bottom: 1.5pt; font-weight: bold"><font style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></font></td> <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif"><b>2019</b></font></td> <td style="padding-bottom: 1.5pt; font-weight: bold"><font style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></font></td> <td style="padding-bottom: 1.5pt; font-weight: bold"><font style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></font></td> <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif"><b>2018</b></font></td> <td style="padding-bottom: 1.5pt; font-weight: bold"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom"> <td><font style="font: 10pt Times New Roman, Times, Serif">Short-term debt:</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="2"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="2"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255)"> <td style="width: 78%; text-align: left; text-indent: -9pt; padding-bottom: 1.5pt; padding-left: 0.25in"><font style="font: 10pt Times New Roman, Times, Serif">Current portion of long-term debt</font></td> <td style="width: 1%; padding-bottom: 1.5pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="width: 1%; text-align: left; border-bottom: black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="width: 8%; text-align: right; border-bottom: black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif">129</font></td> <td style="width: 1%; text-align: left; padding-bottom: 1.5pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="width: 1%; padding-bottom: 1.5pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="width: 1%; text-align: left; border-bottom: black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="width: 8%; text-align: right; border-bottom: black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif">219</font></td> <td style="width: 1%; text-align: left; padding-bottom: 1.5pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: left; text-indent: -9pt; padding-left: 27pt"><font style="font: 10pt Times New Roman, Times, Serif">Total short-term debt</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">129</font></td> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">219</font></td> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255)"> <td style="text-align: left; text-indent: -9pt; padding-left: 9pt"><font style="font: 10pt Times New Roman, Times, Serif">Long-term debt:</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: left; text-indent: -9pt; padding-left: 0.25in"><font style="font: 10pt Times New Roman, Times, Serif">Capital lease obligations</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">175</font></td> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">232</font></td> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255)"> <td style="text-align: left; text-indent: -9pt; padding-bottom: 1.5pt; padding-left: 0.25in"><font style="font: 10pt Times New Roman, Times, Serif">Other promissory notes</font></td> <td style="padding-bottom: 1.5pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: left; border-bottom: black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right; border-bottom: black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif">121</font></td> <td style="text-align: left; padding-bottom: 1.5pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="padding-bottom: 1.5pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: left; border-bottom: black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right; border-bottom: black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif">248</font></td> <td style="text-align: left; padding-bottom: 1.5pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-indent: -9pt; padding-left: 27pt"><font style="font: 10pt Times New Roman, Times, Serif">Total</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">296</font></td> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">480</font></td> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255)"> <td style="text-align: left; text-indent: -9pt; padding-bottom: 1.5pt; padding-left: 27pt"><font style="font: 10pt Times New Roman, Times, Serif">Less: current portion of long-term debt</font></td> <td style="padding-bottom: 1.5pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: left; border-bottom: black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right; border-bottom: black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif">(129</font></td> <td style="text-align: left; padding-bottom: 1.5pt"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td> <td style="padding-bottom: 1.5pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: left; border-bottom: black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right; border-bottom: black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif">(219</font></td> <td style="text-align: left; padding-bottom: 1.5pt"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: left; text-indent: -9pt; padding-bottom: 4pt; padding-left: 27pt"><font style="font: 10pt Times New Roman, Times, Serif">Total long-term debt</font></td> <td style="padding-bottom: 4pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: left; border-bottom: black 4pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right; border-bottom: black 4pt double"><font style="font: 10pt Times New Roman, Times, Serif">167</font></td> <td style="text-align: left; padding-bottom: 4pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="padding-bottom: 4pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: left; border-bottom: black 4pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right; border-bottom: black 4pt double"><font style="font: 10pt Times New Roman, Times, Serif">261</font></td> <td style="text-align: left; padding-bottom: 4pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> </table> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">The table summarizes the common stock warrant activity as of September 30, 2019 as follows:</font></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <table cellspacing="0" cellpadding="0" style="font: 10pt/normal Times New Roman, Times, Serif; border-collapse: collapse; font-size-adjust: none; font-stretch: normal; width: 100%"> <tr style="vertical-align: bottom"> <td style="font-weight: bold; border-bottom: black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif"><b>Common Stock Warrants</b></font></td> <td style="padding-bottom: 1.5pt; font-weight: bold"><font style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></font></td> <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif"><b>Number<br /> of<br /> Warrants</b></font></td> <td style="padding-bottom: 1.5pt; font-weight: bold"><font style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></font></td> <td style="padding-bottom: 1.5pt; font-weight: bold"><font style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></font></td> <td style="text-align: center; font-weight: bold; border-bottom: black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif"><b>Date<br /> Issued</b></font></td> <td style="padding-bottom: 1.5pt; font-weight: bold"><font style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></font></td> <td style="text-align: center; font-weight: bold; border-bottom: black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif"><b>Term</b></font></td> <td style="padding-bottom: 1.5pt; font-weight: bold"><font style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></font></td> <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif"><b>Exercise Price</b></font></td> <td style="padding-bottom: 1.5pt; font-weight: bold"><font style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></font></td></tr> <tr style="vertical-align: bottom"> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="2" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="2"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255)"> <td style="width: 54%"><font style="font: 10pt Times New Roman, Times, Serif">Outstanding at December 31, 2017</font></td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="width: 1%; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="width: 8%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">6,431,785</font></td> <td style="width: 1%; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="width: 11%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="width: 11%; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="width: 1%; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="width: 8%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="width: 1%; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255)"> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Warrants issued</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,133,909</font></td> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">June 2018</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">5 Years</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1.82</font></td> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Common Stock Offering Warrants Issued</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">5,357,052</font></td> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">August 2018</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">5 Years</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1.15</font></td> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">(1)</font></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255)"> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Common Stock Offering - Dealer Manager Warrants</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">267,853</font></td> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">August 2018</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">5 Years</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1.725</font></td> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: left; padding-left: 9pt"><font style="font: 10pt Times New Roman, Times, Serif">Warrants exercised</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(1,475,659</font></td> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255)"> <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 9pt"><font style="font: 10pt Times New Roman, Times, Serif">Expired Warrants</font></td> <td style="padding-bottom: 1.5pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: left; border-bottom: black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right; border-bottom: black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif">(488,119</font></td> <td style="text-align: left; padding-bottom: 1.5pt"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td> <td style="padding-bottom: 1.5pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="padding-bottom: 1.5pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="padding-bottom: 1.5pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: center; padding-bottom: 1.5pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="padding-bottom: 1.5pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: left; padding-bottom: 1.5pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right; padding-bottom: 1.5pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: left; padding-bottom: 1.5pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Outstanding at December 31, 2018</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">11,226,821</font></td> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255)"> <td style="text-align: left; padding-left: 9pt"><font style="font: 10pt Times New Roman, Times, Serif">Warrants issued</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">166,667</font></td> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">July 2019</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">5 Years</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1.6875</font></td> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: left; padding-left: 9pt"><font style="font: 10pt Times New Roman, Times, Serif">Warrants Exercised</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(1,298,210</font></td> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">August 2018</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1.15</font></td> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255)"> <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 9pt"><font style="font: 10pt Times New Roman, Times, Serif">Warrants Exercised</font></td> <td style="padding-bottom: 1.5pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: left; border-bottom: black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right; border-bottom: black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif">(312,000</font></td> <td style="text-align: left; padding-bottom: 1.5pt"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td> <td style="padding-bottom: 1.5pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right; padding-bottom: 1.5pt"><font style="font: 10pt Times New Roman, Times, Serif">August 2018</font></td> <td style="padding-bottom: 1.5pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: center; padding-bottom: 1.5pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="padding-bottom: 1.5pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: left; padding-bottom: 1.5pt"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right; padding-bottom: 1.5pt"><font style="font: 10pt Times New Roman, Times, Serif">0.95</font></td> <td style="text-align: left; padding-bottom: 1.5pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Outstanding at September 30, 2019</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">9,783,278</font></td> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> </table> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <table cellspacing="0" cellpadding="0" style="font: 10pt/normal Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; font-size-adjust: none; font-stretch: normal; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0px"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="width: 0.25in"><font style="font: 10pt Times New Roman, Times, Serif">(1)</font></td> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">The common stock warrants issued in November 2017 with an initial exercise price of $1.50 per share adjusted downward to $0.95 per share effective July 24, 2018 in connection with our Rights Offering, and may be subject to further downward adjustments, pursuant to antidilution price adjustment protection contained within those warrants.</font></td></tr></table> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">The weighted-average assumptions used in the Black-Scholes option-pricing model used to calculate the fair value of options granted during the nine months ended September 30, 2019 were as follows:</font></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <table cellspacing="0" cellpadding="0" style="font: 10pt/normal Times New Roman, Times, Serif; border-collapse: collapse; font-size-adjust: none; font-stretch: normal; width: 100%"> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><font style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></font></td> <td style="padding-bottom: 1.5pt; font-weight: bold"><font style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></font></td> <td style="text-align: center; font-weight: bold; border-bottom: black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif"><b>Employee</b></font></td> <td style="padding-bottom: 1.5pt; font-weight: bold"><font style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></font></td> <td style="text-align: center; font-weight: bold; border-bottom: black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif"><b>Non-Employee</b></font></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255)"> <td style="width: 76%; text-align: left; font-weight: normal"><font style="font: 10pt Times New Roman, Times, Serif">Expected volatility</font></td> <td style="width: 1%; font-weight: normal"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="width: 11%; text-align: center; font-weight: normal"><font style="font: 10pt Times New Roman, Times, Serif">76.4%-80.6 %</font></td> <td style="width: 1%; font-weight: bold"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="width: 11%; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">N/A</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: left; font-weight: normal"><font style="font: 10pt Times New Roman, Times, Serif">Expected dividend yield</font></td> <td style="font-weight: normal"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: center; font-weight: normal"><font style="font: 10pt Times New Roman, Times, Serif">&#8212;</font></td> <td style="font-weight: normal"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: center; font-weight: normal"><font style="font: 10pt Times New Roman, Times, Serif">N/A</font></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255)"> <td style="text-align: left; font-weight: normal"><font style="font: 10pt Times New Roman, Times, Serif">Expected term (in years)</font></td> <td style="font-weight: normal"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: center; font-weight: normal"><font style="font: 10pt Times New Roman, Times, Serif">3.0-6.0</font></td> <td style="font-weight: normal"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: center; font-weight: normal"><font style="font: 10pt Times New Roman, Times, Serif">N/A</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: left; font-weight: normal"><font style="font: 10pt Times New Roman, Times, Serif">Risk-free interest rate</font></td> <td style="font-weight: normal"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: center; font-weight: normal"><font style="font: 10pt Times New Roman, Times, Serif">1.63% -2.48 %</font></td> <td style="font-weight: normal"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: center; font-weight: normal"><font style="font: 10pt Times New Roman, Times, Serif">N/A</font></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 10pt/normal Times New Roman, Times, Serif; border-collapse: collapse; font-size-adjust: none; font-stretch: normal; width: 100%"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td> <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: black 1.5pt solid">Number of<br /> Options</td> <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td> <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td> <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: black 1.5pt solid">Weighted<br /> Average<br /> Exercise<br /> Price Per<br /> Share</td> <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td> <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td> <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: black 1.5pt solid">Weighted<br /> Average<br /> Remaining<br /> Contractual<br /> Term<br /> (years)</td> <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td> <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td> <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: black 1.5pt solid">Aggregate<br /> Intrinsic<br /> Value (1)</td> <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255)"> <td style="width: 52%">Outstanding at December 31, 2018</td> <td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td> <td style="width: 9%; text-align: right">1,721,771</td> <td style="width: 1%; text-align: left">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">$</td> <td style="width: 9%; text-align: right">1.57</td> <td style="width: 1%; text-align: left">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td> <td style="width: 9%; text-align: right">4.0</td> <td style="width: 1%; text-align: left">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">$</td> <td style="width: 9%; text-align: right">&#8212;</td> <td style="width: 1%; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Granted</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">1,167,906</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">$</td> <td style="text-align: right">1.29</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">4.9</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">$</td> <td style="text-align: right">&#8212;</td> <td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255)"> <td>Exercised</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">(63,990</td> <td style="text-align: left">)</td> <td>&#160;</td> <td style="text-align: left">$</td> <td style="text-align: right">0.65</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#8212;</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">$</td> <td style="text-align: right">&#8212;</td> <td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Forfeited</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">(59,500</td> <td style="text-align: left">)</td> <td>&#160;</td> <td style="text-align: left">$</td> <td style="text-align: right">&#8212;</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#8212;</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">$</td> <td style="text-align: right">&#8212;</td> <td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255)"> <td style="padding-bottom: 1.5pt">Expired</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="text-align: left; border-bottom: black 1.5pt solid">&#160;</td> <td style="text-align: right; border-bottom: black 1.5pt solid">(18,510</td> <td style="text-align: left; padding-bottom: 1.5pt">)</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="text-align: left; padding-bottom: 1.5pt">$</td> <td style="text-align: right; padding-bottom: 1.5pt">&#8212;</td> <td style="text-align: left; padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="text-align: left; padding-bottom: 1.5pt">&#160;</td> <td style="text-align: right; padding-bottom: 1.5pt">&#8212;</td> <td style="text-align: left; padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="text-align: left; padding-bottom: 1.5pt">$</td> <td style="text-align: right; padding-bottom: 1.5pt">&#8212;</td> <td style="text-align: left; padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 4pt">Outstanding at September 30, 2019</td> <td style="padding-bottom: 4pt">&#160;</td> <td style="text-align: left; border-bottom: black 4pt double">&#160;</td> <td style="text-align: right; border-bottom: black 4pt double">2,747,677</td> <td style="text-align: left; padding-bottom: 4pt">&#160;</td> <td style="padding-bottom: 4pt">&#160;</td> <td style="text-align: left; padding-bottom: 4pt">$</td> <td style="text-align: right; padding-bottom: 4pt">1.40</td> <td style="text-align: left; padding-bottom: 4pt">&#160;</td> <td style="padding-bottom: 4pt">&#160;</td> <td style="text-align: left; padding-bottom: 4pt">&#160;</td> <td style="text-align: right; padding-bottom: 4pt">3.9</td> <td style="text-align: left; padding-bottom: 4pt">&#160;</td> <td style="padding-bottom: 4pt">&#160;</td> <td style="text-align: left; padding-bottom: 4pt">$</td> <td style="text-align: right; padding-bottom: 4pt">&#8212;</td> <td style="text-align: left; padding-bottom: 4pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255)"> <td>Exercisable at September 30, 2019</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">1,667,064</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">$</td> <td style="text-align: right">1.55</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">2.8</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">$</td> <td style="text-align: right">&#8212;</td> <td style="text-align: left">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 10pt/normal Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in">(1)</td> <td>The aggregate intrinsic value in the table was calculated based on the difference between the estimated fair market value of the Company's stock and the exercise price of the underlying options. The estimated stock values used in the calculation was $1.01 and $0.59 per share for the nine months ended September 30, 2019 and the year ended December 31, 2018, respectively.</td></tr></table> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">The following table summarizes restricted stock unit activity for the nine months ended September 30, 2019:</font></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <table cellspacing="0" cellpadding="0" style="font: 10pt/normal Times New Roman, Times, Serif; border-collapse: collapse; font-size-adjust: none; font-stretch: normal; width: 100%"> <tr style="vertical-align: bottom"> <td><font style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></font></td> <td style="padding-bottom: 1.5pt; font-weight: bold"><font style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></font></td> <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif"><b>Number of<br /> Units</b></font></td> <td style="padding-bottom: 1.5pt; font-weight: bold"><font style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></font></td> <td style="padding-bottom: 1.5pt; font-weight: bold"><font style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></font></td> <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif"><b>Weighted Average<br /> Grant-Date Fair<br /> Value Per Unit</b></font></td> <td style="padding-bottom: 1.5pt; font-weight: bold"><font style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></font></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255)"> <td style="width: 78%"><font style="font: 10pt Times New Roman, Times, Serif">Outstanding as of December 31, 2018</font></td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="width: 1%; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="width: 8%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">136,245</font></td> <td style="width: 1%; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="width: 1%; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 8%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0.98</font></td> <td style="width: 1%; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Granted</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">123,727</font></td> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1.51</font></td> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255)"> <td><font style="font: 10pt Times New Roman, Times, Serif">Vested</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(142,507</font></td> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1.10</font></td> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Forfeited</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#8212;</font></td> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#8212;</font></td> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255)"> <td><font style="font: 10pt Times New Roman, Times, Serif">Outstanding as of September 30, 2019</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">117,465</font></td> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1.42</font></td> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr></table> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">The stock-based compensation expense was recorded as follows:</font></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <table cellspacing="0" cellpadding="0" style="font: 10pt/normal Times New Roman, Times, Serif; border-collapse: collapse; font-size-adjust: none; font-stretch: normal; width: 100%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="padding-bottom: 1.5pt; font-weight: bold"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="6" style="text-align: center; font-weight: bold; border-bottom: black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif"><b>Three Months Ended<br /> September 30,</b></font></td> <td style="padding-bottom: 1.5pt; font-weight: bold"><font style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></font></td> <td style="padding-bottom: 1.5pt; font-weight: bold"><font style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></font></td> <td colspan="6" style="text-align: center; font-weight: bold; border-bottom: black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif"><b>Nine Months Ended<br /> September 30,</b></font></td> <td style="padding-bottom: 1.5pt; font-weight: bold"><font style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></font></td></tr> <tr style="vertical-align: bottom"> <td><font style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></font></td> <td style="padding-bottom: 1.5pt; font-weight: bold"><font style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></font></td> <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif"><b>2019</b></font></td> <td style="padding-bottom: 1.5pt; font-weight: bold"><font style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></font></td> <td style="padding-bottom: 1.5pt; font-weight: bold"><font style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></font></td> <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif"><b>2018</b></font></td> <td style="padding-bottom: 1.5pt; font-weight: bold"><font style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></font></td> <td style="padding-bottom: 1.5pt; font-weight: bold"><font style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></font></td> <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif"><b>2019</b></font></td> <td style="padding-bottom: 1.5pt; font-weight: bold"><font style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></font></td> <td style="padding-bottom: 1.5pt; font-weight: bold"><font style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></font></td> <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif"><b>2018</b></font></td> <td style="padding-bottom: 1.5pt; font-weight: bold"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom"> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="2" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="2" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="2" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="2" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255)"> <td style="width: 52%; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Research and development</font></td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="width: 1%; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 9%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1</font></td> <td style="width: 1%; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="width: 1%; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 9%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">29</font></td> <td style="width: 1%; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="width: 1%; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 9%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">11</font></td> <td style="width: 1%; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="width: 1%; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 9%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">87</font></td> <td style="width: 1%; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: left; padding-bottom: 1.5pt"><font style="font: 10pt Times New Roman, Times, Serif">General and administrative</font></td> <td style="padding-bottom: 1.5pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: left; border-bottom: black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right; border-bottom: black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif">203</font></td> <td style="text-align: left; padding-bottom: 1.5pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="padding-bottom: 1.5pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: left; border-bottom: black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right; border-bottom: black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif">326</font></td> <td style="text-align: left; padding-bottom: 1.5pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="padding-bottom: 1.5pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: left; border-bottom: black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right; border-bottom: black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif">664</font></td> <td style="text-align: left; padding-bottom: 1.5pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="padding-bottom: 1.5pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: left; border-bottom: black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right; border-bottom: black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif">3,003</font></td> <td style="text-align: left; padding-bottom: 1.5pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255)"> <td style="text-align: left; padding-bottom: 4pt"><font style="font: 10pt Times New Roman, Times, Serif">Total stock-based compensation expense</font></td> <td style="padding-bottom: 4pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: left; border-bottom: black 4pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right; border-bottom: black 4pt double"><font style="font: 10pt Times New Roman, Times, Serif">204</font></td> <td style="text-align: left; padding-bottom: 4pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="padding-bottom: 4pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: left; border-bottom: black 4pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right; border-bottom: black 4pt double"><font style="font: 10pt Times New Roman, Times, Serif">355</font></td> <td style="text-align: left; padding-bottom: 4pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="padding-bottom: 4pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: left; border-bottom: black 4pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right; border-bottom: black 4pt double"><font style="font: 10pt Times New Roman, Times, Serif">675</font></td> <td style="text-align: left; padding-bottom: 4pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="padding-bottom: 4pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: left; border-bottom: black 4pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right; border-bottom: black 4pt double"><font style="font: 10pt Times New Roman, Times, Serif">3,090</font></td> <td style="text-align: left; padding-bottom: 4pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr></table> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">The future minimum lease payments under our non-cancellable operating lease and our capital lease as of September 30, 2019 are as follows:</font></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <table cellspacing="0" cellpadding="0" style="font: 10pt/normal Times New Roman, Times, Serif; border-collapse: collapse; font-size-adjust: none; font-stretch: normal; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="padding-bottom: 1.5pt; font-weight: bold"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif"><b>Capital<br /> Leases</b></font></td> <td style="padding-bottom: 1.5pt; font-weight: bold"><font style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></font></td> <td style="padding-bottom: 1.5pt; font-weight: bold"><font style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></font></td> <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif"><b>Operating<br /> Lease</b></font></td> <td style="padding-bottom: 1.5pt; font-weight: bold"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left; font-weight: bold"><font style="font: 10pt Times New Roman, Times, Serif">Years Ending December 31,</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="2"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="2"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255)"> <td style="width: 78%; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">2019</font></td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="width: 1%; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="width: 8%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">24</font></td> <td style="width: 1%; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="width: 1%; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="width: 8%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">62</font></td> <td style="width: 1%; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">2020</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">78</font></td> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">24</font></td> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255)"> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">2021</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">63</font></td> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#8212;</font></td> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">2022</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">33</font></td> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#8212;</font></td> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255)"> <td style="text-align: left; padding-bottom: 1.5pt"><font style="font: 10pt Times New Roman, Times, Serif">2023</font></td> <td style="padding-bottom: 1.5pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: left; border-bottom: black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right; border-bottom: black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif">3</font></td> <td style="text-align: left; padding-bottom: 1.5pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="padding-bottom: 1.5pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: left; border-bottom: black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right; border-bottom: black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: left; padding-bottom: 1.5pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: left; padding-bottom: 4pt"><font style="font: 10pt Times New Roman, Times, Serif">Total minimum lease payments</font></td> <td style="padding-bottom: 4pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: left; border-bottom: black 4pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right; border-bottom: black 4pt double"><font style="font: 10pt Times New Roman, Times, Serif">201</font></td> <td style="text-align: left; padding-bottom: 4pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="padding-bottom: 4pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: left; border-bottom: black 4pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right; border-bottom: black 4pt double"><font style="font: 10pt Times New Roman, Times, Serif">86</font></td> <td style="text-align: left; padding-bottom: 4pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> </table> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <table cellspacing="0" cellpadding="0" style="font: 10pt/normal Times New Roman, Times, Serif; border-collapse: collapse; font-size-adjust: none; font-stretch: normal; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center; padding-bottom: 1.5pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="padding-bottom: 1.5pt; font-weight: bold"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif"><b>Capital <br /> Leases</b></font></td> <td style="padding-bottom: 1.5pt; font-weight: bold"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="2" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255)"> <td style="width: 89%; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Less: amounts representing interest (6.39%, ranging from 10.48% to 11.56%)</font></td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="width: 1%; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 8%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">26</font></td> <td style="width: 1%; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255)"> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Present value of minimum lease payments</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">175</font></td> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255)"> <td style="text-align: left; padding-bottom: 1.5pt"><font style="font: 10pt Times New Roman, Times, Serif">Less: current installments under capital lease obligations</font></td> <td style="padding-bottom: 1.5pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: left; border-bottom: black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right; border-bottom: black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif">70</font></td> <td style="text-align: left; padding-bottom: 1.5pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255)"> <td style="text-align: left; padding-bottom: 4pt"><font style="font: 10pt Times New Roman, Times, Serif">Total long-term portion</font></td> <td style="padding-bottom: 4pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: left; border-bottom: black 4pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right; border-bottom: black 4pt double"><font style="font: 10pt Times New Roman, Times, Serif">105</font></td> <td style="text-align: left; padding-bottom: 4pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr></table> SenesTech, Inc. 0001680378 10-Q 2019-09-30 false --12-31 Yes 001-37941 DE Non-accelerated Filer Yes true true true false Common Stock, $0.001 par value SNES NASDAQ 28288596 Q3 2019 1.6875 1.82 1.15 1.15 1.725 1.50 7.50 1.6875 1.6875 1.50 0.95 1.50 1.82 1.47 7.91 1.82 1.6875 4 67200000 1700000 500000 3900000 166667 1133909 5357052 267853 4657500 945000 5357052 1133909 1111000 1063000 3000 154000 223000 1265000 1289000 4000 4000 204000 355000 3090000 675000 11000 664000 87000 3003000 1000 203000 29000 326000 13613623 12648420 9783278 117465 2747677 11714940 172912 1725771 1000 1000 3000 1000 1000 1000 1000 1000 11226821 6431785 9783278 829285 1298210 -1475659 -312000 9783278 -488119 2019-07 2018-06 2018-08 2018-08 2017-11 2017-11 2018-08 2018-08 P5Y P5Y P5Y P5Y P5Y P5Y 0.95 1.15 1610210 15000 166667 4657500 5860000 1133909 1133909 341750 1133909 P5Y P5Y P5Y Lattice model Monte Carlo option pricing model 0.59 1.01 1 1.34 1.02 0.94 0.94 2.11 1.38 127000 661000 169000 3600000 1.333 0.738 1.590 1.590 0.726 0.777 0.724 0.740 0.764 0.806 P5Y P5Y P5Y P5Y P5Y P4Y3M29D P4Y3M P3Y P6Y 0.00 0.00 0.00 0.00 0.00 0 0.00 0.00 0.0207 0.0187 0.0277 0.0277 0.028 0.0193 0.0283 0.0275 0.0163 0.0248 1000 1700000 1700000 513000 1610210000 5357052 3037038 333000 3181841000 15000000 7515000 10000000 2000000 0.001 0.001 0.001 32000 21962 38580 1.35 3600000 166667 1721771 2747677 1167906 59500 18510 1667064 1.57 1.4 1.29 0.65 1.55 P4Y P4Y10M24D P3Y10M24D P2Y9M18D 136245 117465 123727 142507 0.98 1.42 1.51 1.10 1000000 2874280 632936 1205000 1.29 P0Y36M 24000 78000 63000 33000 3000 201000 62000 24000 86000 26000 175000 70000 105000 183000 187000 498000 252000 1954 1000 2018-11-15 P30D 219000 129000 P0Y24M <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">The following table sets forth the Company's financial instruments that were measured at fair value on a recurring basis by level within the fair value hierarchy (in thousands):</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 10pt/normal Times New Roman, Times, Serif; border-collapse: collapse; font-size-adjust: none; font-stretch: normal; width: 100%"> <tr style="vertical-align: bottom"> <td style="font-weight: bold; white-space: nowrap">&#160;</td> <td style="padding-bottom: 1.5pt; font-weight: bold; white-space: nowrap">&#160;</td> <td colspan="14" style="text-align: center; font-weight: bold; border-bottom: black 1.5pt solid; white-space: nowrap">September 30, 2019</td> <td style="padding-bottom: 1.5pt; font-weight: bold; white-space: nowrap">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold">&#160;</td> <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td> <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: black 1.5pt solid">Level 1</td> <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td> <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td> <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: black 1.5pt solid">Level 2</td> <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td> <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td> <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: black 1.5pt solid">Level 3</td> <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td> <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td> <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: black 1.5pt solid">Total</td> <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: normal">Financial Liabilities:</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255)"> <td style="width: 52%; text-align: left; padding-bottom: 1.5pt; padding-left: 9pt; font-weight: normal">Common stock warrant liability (1)</td> <td style="width: 1%; padding-bottom: 1.5pt; font-weight: normal">&#160;</td> <td style="width: 1%; text-align: left; font-weight: normal; border-bottom: black 1.5pt solid">$</td> <td style="width: 9%; text-align: right; font-weight: normal; border-bottom: black 1.5pt solid">&#8212;</td> <td style="width: 1%; text-align: left; padding-bottom: 1.5pt; font-weight: normal">&#160;</td> <td style="width: 1%; padding-bottom: 1.5pt; font-weight: normal">&#160;</td> <td style="width: 1%; text-align: left; font-weight: normal; border-bottom: black 1.5pt solid">$</td> <td style="width: 9%; text-align: right; font-weight: normal; border-bottom: black 1.5pt solid">&#8212;</td> <td style="width: 1%; text-align: left; padding-bottom: 1.5pt; font-weight: normal">&#160;</td> <td style="width: 1%; padding-bottom: 1.5pt; font-weight: normal">&#160;</td> <td style="width: 1%; text-align: left; font-weight: normal; border-bottom: black 1.5pt solid">$</td> <td style="width: 9%; text-align: right; font-weight: normal; border-bottom: black 1.5pt solid">&#60;1</td> <td style="width: 1%; text-align: left; padding-bottom: 1.5pt; font-weight: normal">&#160;</td> <td style="width: 1%; padding-bottom: 1.5pt; font-weight: normal">&#160;</td> <td style="width: 1%; text-align: left; font-weight: normal; border-bottom: black 1.5pt solid">$</td> <td style="width: 9%; text-align: right; font-weight: normal; border-bottom: black 1.5pt solid">&#60;1</td> <td style="width: 1%; text-align: left; padding-bottom: 1.5pt; font-weight: normal">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 4pt; padding-left: 0.25in; font-weight: normal">Total</td> <td style="padding-bottom: 4pt; font-weight: normal">&#160;</td> <td style="text-align: left; font-weight: normal; border-bottom: black 4pt double">$</td> <td style="text-align: right; font-weight: normal; border-bottom: black 4pt double">&#8212;</td> <td style="text-align: left; padding-bottom: 4pt; font-weight: normal">&#160;</td> <td style="padding-bottom: 4pt; font-weight: normal">&#160;</td> <td style="text-align: left; font-weight: normal; border-bottom: black 4pt double">$</td> <td style="text-align: right; font-weight: normal; border-bottom: black 4pt double">&#8212;</td> <td style="text-align: left; padding-bottom: 4pt; font-weight: normal">&#160;</td> <td style="padding-bottom: 4pt; font-weight: normal">&#160;</td> <td style="text-align: left; font-weight: normal; border-bottom: black 4pt double">$</td> <td style="text-align: right; font-weight: normal; border-bottom: black 4pt double">&#60;1</td> <td style="text-align: left; padding-bottom: 4pt; font-weight: normal">&#160;</td> <td style="padding-bottom: 4pt; font-weight: normal">&#160;</td> <td style="text-align: left; font-weight: normal; border-bottom: black 4pt double">$</td> <td style="text-align: right; font-weight: normal; border-bottom: black 4pt double">&#60;1</td> <td style="text-align: left; padding-bottom: 4pt; font-weight: normal">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 10pt/normal Times New Roman, Times, Serif; border-collapse: collapse; font-size-adjust: none; font-stretch: normal; width: 100%"> <tr style="vertical-align: bottom"> <td style="font-weight: bold">&#160;</td> <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td> <td colspan="14" style="text-align: center; font-weight: bold; border-bottom: black 1.5pt solid">December 31, 2018</td> <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold">&#160;</td> <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td> <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: black 1.5pt solid">Level 1</td> <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td> <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td> <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: black 1.5pt solid">Level 2</td> <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td> <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td> <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: black 1.5pt solid">Level 3</td> <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td> <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td> <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: black 1.5pt solid">Total</td> <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: normal">Financial Assets:</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255)"> <td style="width: 52%; text-align: left; padding-left: 9pt; font-weight: normal">Money market funds</td> <td style="width: 1%; font-weight: normal">&#160;</td> <td style="width: 1%; text-align: left; font-weight: normal">$</td> <td style="width: 9%; text-align: right; font-weight: normal">&#8212;</td> <td style="width: 1%; text-align: left; font-weight: normal">&#160;</td> <td style="width: 1%; font-weight: normal">&#160;</td> <td style="width: 1%; text-align: left; font-weight: normal">$</td> <td style="width: 9%; text-align: right; font-weight: normal">&#8212;</td> <td style="width: 1%; text-align: left; font-weight: normal">&#160;</td> <td style="width: 1%; font-weight: normal">&#160;</td> <td style="width: 1%; text-align: left; font-weight: normal">$</td> <td style="width: 9%; text-align: right; font-weight: normal">&#8212;</td> <td style="width: 1%; text-align: left; font-weight: normal">&#160;</td> <td style="width: 1%; font-weight: normal">&#160;</td> <td style="width: 1%; text-align: left; font-weight: normal">$</td> <td style="width: 9%; text-align: right; font-weight: normal">&#8212;</td> <td style="width: 1%; text-align: left; font-weight: normal">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="font-weight: bold">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255)"> <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 9pt; font-weight: normal">Corporate fixed income debt securities</td> <td style="padding-bottom: 1.5pt; font-weight: normal">&#160;</td> <td style="text-align: left; font-weight: normal; border-bottom: black 1.5pt solid">&#160;</td> <td style="text-align: right; font-weight: normal; border-bottom: black 1.5pt solid">&#8212;</td> <td style="text-align: left; padding-bottom: 1.5pt; font-weight: normal">&#160;</td> <td style="padding-bottom: 1.5pt; font-weight: normal">&#160;</td> <td style="text-align: left; font-weight: normal; border-bottom: black 1.5pt solid">&#160;</td> <td style="text-align: right; font-weight: normal; border-bottom: black 1.5pt solid">&#8212;</td> <td style="text-align: left; padding-bottom: 1.5pt; font-weight: normal">&#160;</td> <td style="padding-bottom: 1.5pt; font-weight: normal">&#160;</td> <td style="text-align: left; font-weight: normal; border-bottom: black 1.5pt solid">&#160;</td> <td style="text-align: right; font-weight: normal; border-bottom: black 1.5pt solid">&#8212;</td> <td style="text-align: left; padding-bottom: 1.5pt; font-weight: normal">&#160;</td> <td style="padding-bottom: 1.5pt; font-weight: normal">&#160;</td> <td style="text-align: left; font-weight: normal; border-bottom: black 1.5pt solid">&#160;</td> <td style="text-align: right; font-weight: normal; border-bottom: black 1.5pt solid">&#8212;</td> <td style="text-align: left; padding-bottom: 1.5pt; font-weight: normal">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="font-weight: bold">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255)"> <td style="padding-bottom: 4pt; padding-left: 0.25in; font-weight: normal">Total</td> <td style="padding-bottom: 4pt; font-weight: normal">&#160;</td> <td style="text-align: left; font-weight: normal; border-bottom: black 4pt double">$</td> <td style="text-align: right; font-weight: normal; border-bottom: black 4pt double">&#8212;</td> <td style="text-align: left; padding-bottom: 4pt; font-weight: normal">&#160;</td> <td style="padding-bottom: 4pt; font-weight: normal">&#160;</td> <td style="text-align: left; font-weight: normal; border-bottom: black 4pt double">$</td> <td style="text-align: right; font-weight: normal; border-bottom: black 4pt double">&#8212;</td> <td style="text-align: left; padding-bottom: 4pt; font-weight: normal">&#160;</td> <td style="padding-bottom: 4pt; font-weight: normal">&#160;</td> <td style="text-align: left; font-weight: normal; border-bottom: black 4pt double">$</td> <td style="text-align: right; font-weight: normal; border-bottom: black 4pt double">&#8212;</td> <td style="text-align: left; padding-bottom: 4pt; font-weight: normal">&#160;</td> <td style="padding-bottom: 4pt; font-weight: normal">&#160;</td> <td style="text-align: left; font-weight: normal; border-bottom: black 4pt double">$</td> <td style="text-align: right; font-weight: normal; border-bottom: black 4pt double">&#8212;</td> <td style="text-align: left; padding-bottom: 4pt; font-weight: normal">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: left; font-weight: normal">Financial Liabilities:</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255)"> <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 9pt; font-weight: normal">Common stock warrant liability (1)</td> <td style="padding-bottom: 1.5pt; font-weight: normal">&#160;</td> <td style="text-align: left; font-weight: normal; border-bottom: black 1.5pt solid">$</td> <td style="text-align: right; font-weight: normal; border-bottom: black 1.5pt solid">&#8212;</td> <td style="text-align: left; padding-bottom: 1.5pt; font-weight: normal">&#160;</td> <td style="padding-bottom: 1.5pt; font-weight: normal">&#160;</td> <td style="text-align: left; font-weight: normal; border-bottom: black 1.5pt solid">$</td> <td style="text-align: right; font-weight: normal; border-bottom: black 1.5pt solid">&#8212;</td> <td style="text-align: left; padding-bottom: 1.5pt; font-weight: normal">&#160;</td> <td style="padding-bottom: 1.5pt; font-weight: normal">&#160;</td> <td style="text-align: left; font-weight: normal; border-bottom: black 1.5pt solid">$</td> <td style="text-align: right; font-weight: normal; border-bottom: black 1.5pt solid">&#8212;</td> <td style="text-align: left; padding-bottom: 1.5pt; font-weight: normal">&#160;</td> <td style="padding-bottom: 1.5pt; font-weight: normal">&#160;</td> <td style="text-align: left; font-weight: normal; border-bottom: black 1.5pt solid">$</td> <td style="text-align: right; font-weight: normal; border-bottom: black 1.5pt solid">&#8212;</td> <td style="text-align: left; padding-bottom: 1.5pt; font-weight: normal">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 4pt; padding-left: 0.25in; font-weight: normal">Total</td> <td style="padding-bottom: 4pt; font-weight: normal">&#160;</td> <td style="text-align: left; font-weight: normal; border-bottom: black 4pt double">$</td> <td style="text-align: right; font-weight: normal; border-bottom: black 4pt double">&#8212;</td> <td style="text-align: left; padding-bottom: 4pt; font-weight: normal">&#160;</td> <td style="padding-bottom: 4pt; font-weight: normal">&#160;</td> <td style="text-align: left; font-weight: normal; border-bottom: black 4pt double">$</td> <td style="text-align: right; font-weight: normal; border-bottom: black 4pt double">&#8212;</td> <td style="text-align: left; padding-bottom: 4pt; font-weight: normal">&#160;</td> <td style="padding-bottom: 4pt; font-weight: normal">&#160;</td> <td style="text-align: left; font-weight: normal; border-bottom: black 4pt double">$</td> <td style="text-align: right; font-weight: normal; border-bottom: black 4pt double">&#8212;</td> <td style="text-align: left; padding-bottom: 4pt; font-weight: normal">&#160;</td> <td style="padding-bottom: 4pt; font-weight: normal">&#160;</td> <td style="text-align: left; font-weight: normal; border-bottom: black 4pt double">$</td> <td style="text-align: right; font-weight: normal; border-bottom: black 4pt double">&#8212;</td> <td style="text-align: left; padding-bottom: 4pt; font-weight: normal">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 10pt/normal Times New Roman, Times, Serif; margin-top: 0px; margin-bottom: 0pt; font-size-adjust: none; font-stretch: normal; width: 100%"> <tr style="text-align: justify; vertical-align: top"> <td style="width: 0in">&#160;</td> <td style="width: 0.25in; text-align: left">(1)</td> <td style="text-align: left">There was no change (net) in the fair value of the common stock warrant for the three and nine months ended September 30, 2019. If there had been, it would have been recorded to other income (expense) and interest expense in the statements of operations and comprehensive loss.</td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Property and equipment, net consist of the following:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 10pt/normal Times New Roman, Times, Serif; border-collapse: collapse; font-size-adjust: none; font-stretch: normal; width: 100%"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap">&#160;</td> <td style="white-space: nowrap">&#160;</td> <td style="white-space: nowrap">&#160;</td> <td style="white-space: nowrap">&#160;</td> <td style="text-align: center; white-space: nowrap">&#160;</td> <td style="font-weight: bold; white-space: nowrap">&#160;</td> <td colspan="2" style="text-align: center; font-weight: bold; white-space: nowrap">September 30,</td> <td style="font-weight: bold; white-space: nowrap">&#160;</td> <td style="font-weight: bold; white-space: nowrap">&#160;</td> <td colspan="2" style="text-align: center; font-weight: bold; white-space: nowrap">December 31,</td> <td style="font-weight: bold; white-space: nowrap">&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td>&#160;</td> <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td> <td style="text-align: center; font-weight: bold; border-bottom: black 1.5pt solid">Useful Life</td> <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td> <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: black 1.5pt solid">2019</td> <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td> <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td> <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: black 1.5pt solid">2018</td> <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255)"> <td style="width: 62%; text-align: left; text-indent: -9pt; padding-left: 9pt">Research and development equipment</td> <td style="width: 1%">&#160;</td> <td style="width: 3%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 11%; text-align: right">5 years</td> <td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">$</td> <td style="width: 8%; text-align: right">1,582</td> <td style="width: 1%; text-align: left">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">$</td> <td style="width: 8%; text-align: right">1,552</td> <td style="width: 1%; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: left; text-indent: -9pt; padding-left: 9pt">Office and computer equipment</td> <td>&#160;</td> <td style="text-align: right">(1)</td> <td>&#160;</td> <td style="text-align: right">3 years</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">753</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">742</td> <td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255)"> <td style="text-indent: -9pt; padding-left: 9pt">Autos</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">5 years</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">54</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">54</td> <td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: left; text-indent: -9pt; padding-left: 9pt">Furniture and fixtures</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">7 years</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">37</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">37</td> <td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255)"> <td style="text-align: left; text-indent: -9pt; padding-bottom: 1.5pt; padding-left: 9pt">Leasehold improvements</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="text-align: right; padding-bottom: 1.5pt">*</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="text-align: left; border-bottom: black 1.5pt solid">&#160;</td> <td style="text-align: right; border-bottom: black 1.5pt solid">283</td> <td style="text-align: left; padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="text-align: left; border-bottom: black 1.5pt solid">&#160;</td> <td style="text-align: right; border-bottom: black 1.5pt solid">283</td> <td style="text-align: left; padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-indent: -9pt; padding-left: 9pt">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">2,709</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">2,668</td> <td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255)"> <td style="text-align: left; text-indent: -9pt; padding-bottom: 1.5pt; padding-left: 9pt">Less accumulated depreciation and amortization</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="text-align: right; padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="text-align: left; border-bottom: black 1.5pt solid">&#160;</td> <td style="text-align: right; border-bottom: black 1.5pt solid">(1,879</td> <td style="text-align: left; padding-bottom: 1.5pt">)</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="text-align: left; border-bottom: black 1.5pt solid">&#160;</td> <td style="text-align: right; border-bottom: black 1.5pt solid">(1,585</td> <td style="text-align: left; padding-bottom: 1.5pt">)</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-indent: -9pt; padding-bottom: 4pt; padding-left: 9pt">Total</td> <td style="padding-bottom: 4pt">&#160;</td> <td style="padding-bottom: 4pt">&#160;</td> <td style="padding-bottom: 4pt">&#160;</td> <td style="text-align: right; padding-bottom: 4pt">&#160;</td> <td style="padding-bottom: 4pt">&#160;</td> <td style="text-align: left; border-bottom: black 4pt double">$</td> <td style="text-align: right; border-bottom: black 4pt double">830</td> <td style="text-align: left; padding-bottom: 4pt">&#160;</td> <td style="padding-bottom: 4pt">&#160;</td> <td style="text-align: left; border-bottom: black 4pt double">$</td> <td style="text-align: right; border-bottom: black 4pt double">1,083</td> <td style="text-align: left; padding-bottom: 4pt">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">* Shorter of lease term or estimated useful life</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 10pt/normal Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; font-size-adjust: none; font-stretch: normal; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in">(1)</td> <td>In August 2019, the Company disposed of computer equipment with a net book value of $2 resulting in a loss on the disposal of fixed assets of less than $1. In April and May 2019, the Company disposed of obsolete computer equipment with a net book value of $2 resulting in a loss on disposal of fixed assets of $2.</td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Note 1 - Organization and Description of Business</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">SenesTech, Inc. (referred to in this report as "SenesTech," the "Company," "we" or "us") was formed in July 2004 and incorporated in the state of Nevada. The Company subsequently reincorporated in the state of Delaware in November 2015. Our corporate headquarters is in Flagstaff, Arizona. We have developed and are commercializing a global, proprietary technology for managing animal pest populations, initially rat populations, through fertility control.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 8.15pt; text-align: left">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">Although myriad tools are available to fight rat infestations, communities, food producers, zoos and sanctuaries and others continue to face challenges in controlling today's infestations. Infestations result in significant infrastructure damage, as well as pose additional risks to the health and food security of communities. In addition to these challenges, the pest management industry and pest management professionals (PMPs) are being increasingly asked for new solutions to help solve the problem. With growing concerns about rat resistance to rodenticides and a growing interest in non-lethal options, it is becoming increasingly important for PMPs to have new tools at their disposal. Our goal is to provide customers with not only a solution to combat their most difficult infestations, but also offer a non-lethal option to serve customers that are looking to decrease or remove the amount of poison used in their pest management programs.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 8.15pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">Our first fertility control product, ContraPest, is a liquid bait containing the active ingredients 4-vinylcyclohexene diepoxide (VCD) and triptolide. When consumed, ContraPest targets reproduction, limiting fertility in male and female rats beginning with the first breeding cycle following consumption. ContraPest is being marketed for use in controlling rat populations, specifically Norway and roof rats. On August 23, 2015, the United States Environmental Protection Agency (EPA) granted registration approval for ContraPest as a Restricted Product Due to Professional Expertise (referred to in this report as a "Restricted Use designation"), effective August 2, 2016. On October 18, 2018, the EPA approved the removal of the Restricted Use designation. We believe ContraPest is the first and only non-lethal fertility control product approved by the EPA for the management of rodent populations.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 8.15pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">In addition to the EPA registration of ContraPest in the United States, we must obtain registration from the various state regulatory agencies prior to selling in each state. As of the date of this report, we have received registration for ContraPest in all 50 states and the District of Columbia, 47 of which have approved the removal of the Restricted Use designation.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 8.15pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">We expect to continue to pursue regulatory approvals and amendments to existing registration in the United States for ContraPest, and if ContraPest begins to generate sufficient revenue, regulatory approvals for any additional jurisdictions beyond the United States.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 8.15pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Potential Need for Additional Capital</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">Since our inception, we have sustained significant operating losses in the course of our research and development and commercialization activities and expect such losses to continue for the near future. We have generated limited revenue to date from product sales, research grants and licensing fees received under our former license agreement with Neogen. In 2017, we began to prepare and launch commercialization of our first product, ContraPest. We have primarily funded our operations to date through the sale of equity securities, including convertible preferred stock, common stock and warrants to purchase common stock.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">We have also raised capital through debt financing, consisting primarily of convertible notes; and, to a lesser extent, payments received in connection with product sales, research grants and licensing fees.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 8.15pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">Through September 30, 2019, we had received net proceeds of $67.2 million from sales of our common stock, preferred stock and warrant exercises and issuance of convertible and other promissory notes, an aggregate of $1.7 million from licensing fees and an aggregate of $0.5 million in net product sales. At September 30, 2019, we had an accumulated deficit of $93.1 million and cash and cash equivalents of $3.9 million.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 8.15pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">Our ultimate success depends upon the outcome of a combination of factors, including: (i) successful commercialization of ContraPest and maintaining and obtaining regulatory approvals of our products and product candidates, (ii) market acceptance, commercial viability and profitability of ContraPest and other products; (iii) the ability to market our products and establish an effective sales force and marketing infrastructure to generate significant revenue; (iv) the success of our research and development; (v) our ability to retain and attract key personnel to develop, operate and grow our business; and (vi) our ability to meet our working capital needs.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 8.15pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">Based upon our current operating plan, we expect that cash and cash equivalents at September 30, 2019, in combination with anticipated revenue and any additional sales of our equity securities, will be sufficient to fund our current operations for at least the next six months. We have taken and will continue to take actions to reduce our operating expenses and to concentrate our resources toward the successful commercialization of ContraPest in the U. S. However, if anticipated revenue targets and margin targets are not achieved and we are unable to raise necessary capital through the sale of our securities, we may be required take other measures that could impair our ability to be successful and operate as a going concern. In any event, we are likely to require additional capital in order to fund our operating losses and research and development activities until we become profitable. We may never achieve profitability or generate positive cash flows, and unless and until we do, we will continue to need to raise capital through equity or debt financing. If such equity or debt financing is not available at adequate levels or on acceptable terms, we may need to delay, limit or terminate commercialization and development efforts.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Basis of Presentation</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">The accompanying unaudited condensed financial statements of the Company have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission ("SEC") for interim financial reporting. Certain information and footnote disclosures normally included in the annual financial statements prepared in accordance with U.S. generally accepted accounting principles ("U.S. GAAP") have been condensed or omitted pursuant to such rules and regulations. In the Company's opinion, the unaudited condensed financial statements include all material adjustments, all of which are of a normal and recurring nature, necessary to present fairly the Company's financial position as of September 30, 2019, the Company's operating results for the three and nine months ended September 30, 2019 and 2018, and the Company's cash flows for the nine months ended September 30, 2019 and 2018. The accompanying financial information as of December 31, 2018 is derived from audited financial statements. Interim results are not necessarily indicative of results for a full year. The information included in this Quarterly Report on Form 10-Q should be read in conjunction with the Company's Annual Report on Form 10-K, as amended by Form 10-K/A, for the year ended December 31, 2018, both filed with the SEC on March 29, 2019. All amounts shown in these financial statements and accompanying notes are in thousands, except percentages and per share and share amounts.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Note 2 - Summary of Significant Accounting Policies</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Use of Estimates</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts and classification of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements and reported amounts of revenues and expenses during the reporting period. The significant estimates in the Company's financial statements include the valuation of preferred stock, common stock and related warrants, and other stock-based awards. Actual results could differ from such estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Reclassifications</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">Certain prior year amounts have been reclassified to conform to the current period presentation. These reclassifications had no material impact on net earnings, financial position or cash flows.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Accounts Receivable</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">Accounts receivable consist primarily of trade receivables. The Company provides an allowance for doubtful trade receivables equal to the estimated uncollectible amounts. That estimate is based on historical collection experience, current economic and market conditions and a review of the current status of each customer's trade accounts receivable. The allowance for doubtful trade receivables was less than $1 at September 30, 2019 and at December 31, 2018.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Inventories</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">Inventories are stated at the lower of cost or market value, using the first-in, first-out convention. Inventories consist of raw materials, work in progress and finished goods.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">Components of inventory are:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 10pt/normal Times New Roman, Times, Serif; border-collapse: collapse; font-size-adjust: none; font-stretch: normal; width: 100%"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap">&#160;</td> <td style="font-weight: bold; white-space: nowrap">&#160;</td> <td colspan="2" style="text-align: center; font-weight: bold; white-space: nowrap">September&#160;30,</td> <td style="font-weight: bold; white-space: nowrap">&#160;</td> <td style="font-weight: bold; white-space: nowrap">&#160;</td> <td colspan="2" style="text-align: center; font-weight: bold; white-space: nowrap">December&#160;31,</td> <td style="font-weight: bold; white-space: nowrap">&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td> <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: black 1.5pt solid">2019</td> <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td> <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td> <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: black 1.5pt solid">2018</td> <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255)"> <td style="width: 78%; text-align: left; text-indent: -8.65pt; padding-left: 8.65pt">Raw materials</td> <td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">$</td> <td style="width: 8%; text-align: right">1,063</td> <td style="width: 1%; text-align: left">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">$</td> <td style="width: 8%; text-align: right">1,111</td> <td style="width: 1%; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: left; text-indent: -8.65pt; padding-left: 8.65pt">Work in progress</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">3</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#8212;</td> <td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255)"> <td style="text-align: left; text-indent: -8.65pt; padding-bottom: 1.5pt; padding-left: 8.65pt">Finished goods</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="text-align: left; border-bottom: black 1.5pt solid">&#160;</td> <td style="text-align: right; border-bottom: black 1.5pt solid">223</td> <td style="text-align: left; padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="text-align: left; border-bottom: black 1.5pt solid">&#160;</td> <td style="text-align: right; border-bottom: black 1.5pt solid">154</td> <td style="text-align: left; padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: left; text-indent: -8.65pt; padding-left: 0.25in">Total inventory</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">1,289</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">1,265</td> <td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255)"> <td style="text-indent: -8.65pt; padding-left: 8.65pt">Less:</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: left; text-indent: -8.65pt; padding-bottom: 1.5pt; padding-left: 8.65pt">Reserve for obsolete</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="text-align: left; border-bottom: black 1.5pt solid">&#160;</td> <td style="text-align: right; border-bottom: black 1.5pt solid">(4</td> <td style="text-align: left; padding-bottom: 1.5pt">)</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="text-align: left; border-bottom: black 1.5pt solid">&#160;</td> <td style="text-align: right; border-bottom: black 1.5pt solid">(4</td> <td style="text-align: left; padding-bottom: 1.5pt">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255)"> <td style="text-align: left; text-indent: -8.65pt; padding-bottom: 4pt; padding-left: 8.65pt">Total net inventory</td> <td style="padding-bottom: 4pt">&#160;</td> <td style="text-align: left; border-bottom: black 4pt double">$</td> <td style="text-align: right; border-bottom: black 4pt double">1,285</td> <td style="text-align: left; padding-bottom: 4pt">&#160;</td> <td style="padding-bottom: 4pt">&#160;</td> <td style="text-align: left; border-bottom: black 4pt double">$</td> <td style="text-align: right; border-bottom: black 4pt double">1,261</td> <td style="text-align: left; padding-bottom: 4pt">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Prepaid Expenses</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">Prepaid expenses consist primarily of payments made for director and officer insurance, director compensation, rent, legal and inventory purchase deposits and seminar fees to be expensed in the current year.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Property and Equipment</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">Property and equipment are stated at cost less accumulated depreciation. Equipment held under capital leases are stated at the present value of minimum lease payments less accumulated amortization.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">Depreciation on property and equipment is computed using the straight-line method over the estimated useful lives of the respective assets. The cost of leasehold improvements is amortized over the life of the improvement or the term of the lease, whichever is shorter. Equipment held under capital leases is amortized over the shorter of the lease term or estimated useful life of the asset. The Company incurs repair and maintenance costs on its major equipment, which are expensed as incurred.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Impairment of Long-Lived Assets</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">Long-lived assets, such as property and equipment, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. If circumstances require long-lived assets or asset groups to be tested for possible impairment, the Company compares the undiscounted cash flows expected to be generated from the use of the asset or asset group to its carrying amount. If the carrying amount of the long-lived asset or asset group is not recoverable on an undiscounted cash flow basis, an impairment charge is recognized to the extent that the carrying amount exceeds its fair value. Fair value is determined through various valuation techniques, such as discounted cash flow models and the use of third-party independent appraisals. The Company has not recorded an impairment of long-lived assets since its inception.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Revenue Recognition</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">Effective January 1, 2018, the Company adopted ASC 606 &#8212; <i>Revenue from Contracts with Customers. </i>Under ASC 606, the Company recognizes revenue from the commercial sales of products, licensing agreements and contracts to perform pilot studies by applying the following steps: (1) identify the contract with a customer; (2) identify the performance obligations in the contract; (3) determine the transaction price; (4) allocate the transaction price to each performance obligation in the contract; and (5) recognize revenue when each performance obligation is satisfied. For the comparative periods, revenue has not been adjusted and continues to be reported under ASC 605 &#8212; <i>Revenue Recognition. </i>Under ASC 605, revenue is recognized when the following criteria are met: (1) persuasive evidence of an arrangement exists; (2) the performance of service has been rendered to a customer or delivery has occurred; (3) the amount of the fee to be paid by a customer is fixed and determinable; and (4) the collectability of the fee is reasonably assured. The performance obligations identified by the Company under Accounting Standards Codification ("ASC") Topic 606, Revenue From Contracts With Customers, are straightforward and similar to the unit of account and performance obligation determination under ASC Topic 605, <i>Revenue Recognition</i>. There was no impact on the Company's financial statements as a result of adopting ASC 606 for the three months or nine months ended September 30, 2019 and 2018, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">The Company recognizes revenue when product leaves its dock at a fixed selling price on payment terms of 30 to 120 days from invoicing. The Company recognizes other revenue earned from pilot studies upon the performance of specific services under the respective service contract.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">The Company derives revenue primarily from commercial sales of products.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Research and Development</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">Research and development costs are expensed as incurred. Research and development expenses primarily consist of salaries and benefits for research and development employees, stock-based compensation, consulting fees, lab supplies, costs incurred related to conducting scientific trials and field studies, and regulatory compliance costs. Also, included in research and development expenses is an allocation of facilities related costs, including depreciation of research and development equipment.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Stock-based Compensation</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">Employee stock-based awards, consisting of restricted stock units and stock options expected to be settled in shares of the Company's common stock, are recorded as equity awards. The grant date fair value of stock options is measured using the Black-Scholes option pricing model. The Company expenses the grant date fair value of its stock options on a straight-line basis over their respective vesting periods. Performance-based awards are expensed over the performance period when the related performance goals are probable of being achieved.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">For equity instruments issued to non-employees, the stock-based consideration is measured using a fair value method. The measurement of the stock-based compensation is subject to re-measurement as the underlying equity instruments vest.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">The stock-based compensation expense recorded for the three and nine months ended September 30, 2019 and 2018,&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">is as follows:</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 10pt/normal Times New Roman, Times, Serif; border-collapse: collapse; font-size-adjust: none; font-stretch: normal; width: 100%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; white-space: nowrap">&#160;</td> <td style="padding-bottom: 1.5pt; font-weight: bold; white-space: nowrap">&#160;</td> <td colspan="6" style="text-align: center; font-weight: bold; border-bottom: black 1.5pt solid; white-space: nowrap">Three Months Ended<br /> September 30,</td> <td style="padding-bottom: 1.5pt; font-weight: bold; white-space: nowrap">&#160;</td> <td style="padding-bottom: 1.5pt; font-weight: bold; white-space: nowrap">&#160;</td> <td colspan="6" style="text-align: center; font-weight: bold; border-bottom: black 1.5pt solid; white-space: nowrap">Nine Months Ended<br /> September 30,</td> <td style="padding-bottom: 1.5pt; font-weight: bold; white-space: nowrap">&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td> <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: black 1.5pt solid">2019</td> <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td> <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td> <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: black 1.5pt solid">2018</td> <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td> <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td> <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: black 1.5pt solid">2019</td> <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td> <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td> <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: black 1.5pt solid">2018</td> <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255)"> <td style="width: 52%; text-align: left">Research and development</td> <td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">$</td> <td style="width: 9%; text-align: right">1</td> <td style="width: 1%; text-align: left">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">$</td> <td style="width: 9%; text-align: right">29</td> <td style="width: 1%; text-align: left">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">$</td> <td style="width: 9%; text-align: right">11</td> <td style="width: 1%; text-align: left">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">$</td> <td style="width: 9%; text-align: right">87</td> <td style="width: 1%; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: left; padding-bottom: 1.5pt">General and administrative</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="text-align: left; border-bottom: black 1.5pt solid">&#160;</td> <td style="text-align: right; border-bottom: black 1.5pt solid">203</td> <td style="text-align: left; padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="text-align: left; border-bottom: black 1.5pt solid">&#160;</td> <td style="text-align: right; border-bottom: black 1.5pt solid">326</td> <td style="text-align: left; padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="text-align: left; border-bottom: black 1.5pt solid">&#160;</td> <td style="text-align: right; border-bottom: black 1.5pt solid">661</td> <td style="text-align: left; padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="text-align: left; border-bottom: black 1.5pt solid">&#160;</td> <td style="text-align: right; border-bottom: black 1.5pt solid">3,003</td> <td style="text-align: left; padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255)"> <td style="text-align: left; padding-bottom: 4pt">Total stock-based compensation expense</td> <td style="padding-bottom: 4pt">&#160;</td> <td style="text-align: left; border-bottom: black 4pt double">$</td> <td style="text-align: right; border-bottom: black 4pt double">204</td> <td style="text-align: left; padding-bottom: 4pt">&#160;</td> <td style="padding-bottom: 4pt">&#160;</td> <td style="text-align: left; border-bottom: black 4pt double">$</td> <td style="text-align: right; border-bottom: black 4pt double">355</td> <td style="text-align: left; padding-bottom: 4pt">&#160;</td> <td style="padding-bottom: 4pt">&#160;</td> <td style="text-align: left; border-bottom: black 4pt double">$</td> <td style="text-align: right; border-bottom: black 4pt double">675</td> <td style="text-align: left; padding-bottom: 4pt">&#160;</td> <td style="padding-bottom: 4pt">&#160;</td> <td style="text-align: left; border-bottom: black 4pt double">$</td> <td style="text-align: right; border-bottom: black 4pt double">3,090</td> <td style="text-align: left; padding-bottom: 4pt">&#160;</td></tr> </table> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">See Note 11 for additional discussion on stock-based compensation.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Income Taxes</b></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">Company accounts for income taxes under the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements. Under this method, deferred tax assets and liabilities are determined based on the differences between the financial statement and tax bases of assets and liabilities and net operating loss carryforwards using enacted tax rates in effect for the year in which the differences are expected to reverse. The effect of a change in tax rates on deferred tax assets and liabilities is recognized in the period that includes the enactment date.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">The Company records net deferred tax assets to the extent it believes these assets will more likely than not be realized. These deferred tax assets are subject to periodic assessments as to recoverability and if it is determined that it is more likely than not that the benefits will not be realized, valuation allowances are recorded which would increase the provision for income taxes. In making such determination, the Company considers all available positive and negative evidence, including future reversals of existing taxable temporary differences, projected future taxable income, tax planning strategies and recent financial operations. The Company currently maintains a full allowance against its deferred tax assets.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">The Company applies a more-likely-than-not recognition threshold for all tax uncertainties. Only those benefits that have a greater than fifty percent likelihood of being sustained upon examination by the taxing authorities are recognized. Based on its evaluation, the Company has concluded there are no significant uncertain tax positions requiring recognition in its financial statements.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: left">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">The Company recognizes interest and/or penalties related to uncertain tax positions in income tax expense. There are no uncertain tax positions as of September 30, 2019 or December 31, 2018 and as such, no interest or penalties were recorded in income tax expense.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Comprehensive Loss</b></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">Net loss and comprehensive loss were the same for all periods presented; therefore, a separate statement of comprehensive loss is not included in the accompanying financial statements.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Loss Per Share Attributable to Common Stockholders</b></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">Basic loss per share attributable to common stockholders is calculated by dividing the net loss attributable to common stockholders by the weighted average number of common shares outstanding during the period. Diluted loss per share attributable to common stockholders is computed by dividing the loss attributable to common stockholders by the weighted average number of common shares and potentially dilutive securities outstanding for the period determined using the treasury stock and if-converted methods. For purposes of the computation of diluted loss per share attributable to common stockholders, common stock purchase warrants, and common stock options are considered to be potentially dilutive securities but have been excluded from the calculation of diluted loss per share attributable to common stockholders because their effect would be anti-dilutive given the net loss reported for the three and nine months ended September 30, 2019 and 2018. Therefore, basic and diluted loss per share attributable to common stockholders are the same for each period presented.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">The following table sets forth the outstanding potentially dilutive securities that have been excluded in the calculation of diluted loss per share attributable to common stockholders (in common stock equivalent shares):</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 10pt/normal Times New Roman, Times, Serif; border-collapse: collapse; font-size-adjust: none; font-stretch: normal; width: 100%"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap">&#160;</td> <td style="padding-bottom: 1.5pt; font-weight: bold; white-space: nowrap">&#160;</td> <td colspan="6" style="text-align: center; font-weight: bold; border-bottom: black 1.5pt solid; white-space: nowrap">September 30,</td> <td style="padding-bottom: 1.5pt; font-weight: bold; white-space: nowrap">&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td> <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: black 1.5pt solid">2019</td> <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td> <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td> <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: black 1.5pt solid">2018</td> <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255)"> <td style="width: 78%; text-align: left">Common stock purchase warrants</td> <td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td> <td style="width: 8%; text-align: right">9,783,278</td> <td style="width: 1%; text-align: left">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td> <td style="width: 8%; text-align: right">11,714,940</td> <td style="width: 1%; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: left">Restricted stock unit</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">117,465</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">172,912</td> <td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255)"> <td style="text-align: left; padding-bottom: 1.5pt">Common stock options</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="text-align: left; border-bottom: black 1.5pt solid">&#160;</td> <td style="text-align: right; border-bottom: black 1.5pt solid">2,747,677</td> <td style="text-align: left; padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="text-align: left; border-bottom: black 1.5pt solid">&#160;</td> <td style="text-align: right; border-bottom: black 1.5pt solid">1,725,771</td> <td style="text-align: left; padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 4pt; padding-left: 9pt">Total</td> <td style="padding-bottom: 4pt">&#160;</td> <td style="text-align: left; border-bottom: black 4pt double">&#160;</td> <td style="text-align: right; border-bottom: black 4pt double">12,648,420</td> <td style="text-align: left; padding-bottom: 4pt">&#160;</td> <td style="padding-bottom: 4pt">&#160;</td> <td style="text-align: left; border-bottom: black 4pt double">&#160;</td> <td style="text-align: right; border-bottom: black 4pt double">13,613,623</td> <td style="text-align: left; padding-bottom: 4pt">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Adoption of New Accounting Standards<i>:</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">In May 2014, the FASB issued ASU 2014-09, <i>Revenue from Contracts with Customers</i>. Since ASU 2014-09 was issued, several additional ASUs have been issued to clarify various elements of the guidance. These standards provide guidance on recognizing revenue, including a five-step model to determine when revenue recognition is appropriate. The standard requires that an entity recognize revenue to depict the transfer of control of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. Effective January 1, 2018, the Company adopted ASU 2014-09, <i>"Revenue from Contracts with Customers" </i>using the modified retrospective method to all contracts that were not completed as of the date of adoption. The results of operations for reported periods after January 1, 2018 are presented under this amended guidance, while prior period amounts are reported in accordance with ASC 605 &#8212; <i>Revenue Recognition</i>. There was no material impact on our financial position, results of operations, or cash flows.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">In January 2016, the FASB issued ASU 2016-01, <i>Recognition and Measurement of Financial Assets and Financial Liabilities </i>("ASU 2016-01"). This standard affects the accounting for equity instruments, financial liabilities under the fair value option and the presentation and disclosure requirements of financial instruments. ASU 2016-01 is effective the first quarter of 2018. The Company has adopted the provisions of ASU 2016-01 on its financial statements. There was no material impact on our financial position, results of operations, or cash flows.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">In February 2016, the FASB issued ASU 2016-02, <i>Leases </i>("ASU 2016-02"). This standard amends various aspects of existing accounting guidance for leases, including the recognition of a right-of-use asset and a lease liability on the balance sheet for all leases with terms longer than 12 months. Leases will be classified as either finance or operating, with classification affecting the pattern of expense recognition in the income statement. This standard also introduces new disclosure requirements for leasing arrangements. ASU 2016-02 is effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years for public business entities. Early adoption was permitted, and the new standard had been adopted using a modified retrospective approach and provides for certain practical expedients.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">On January 1, 2019, the Company adopted the new leasing standard and all related amendments. The Company elected the optional transition method provided by the FASB in ASU 2018-11,&#160;<i>Leases (Topic 842): Targeted Improvements</i>, and as a result, has not restated its condensed consolidated financial statements for prior periods presented. The Company has elected the practical expedients upon transition to retain the lease classification and initial direct costs for any leases that existed prior to adoption. The Company has also not reassessed whether any contracts entered into prior to adoption are leases.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">ASU 2016-02 did not have a material impact on the Company's Condensed Consolidated Statements of Comprehensive Income. The cumulative effect of the changes made to the Company's Consolidated Balance Sheet as of January 1, 2019 for the adoption of the new leasing standard was as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.25in">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 10pt/normal Times New Roman, Times, Serif; border-collapse: collapse; font-size-adjust: none; font-stretch: normal; width: 100%"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td> <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: black 1.5pt solid">Balance @<br /> December&#160;31, 2018</td> <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td> <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td> <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: black 1.5pt solid">Adjustment Due<br /> to ASC 842</td> <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td> <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td> <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: black 1.5pt solid">Balance @<br /> January&#160;1,<br /> 2019</td> <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255)"> <td style="width: 67%; text-align: left">Right to Use Asset - Long Term</td> <td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td> <td style="width: 8%; text-align: right">&#8212;</td> <td style="width: 1%; text-align: left">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">$</td> <td style="width: 8%; text-align: right">87</td> <td style="width: 1%; text-align: left">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">$</td> <td style="width: 8%; text-align: right">87</td> <td style="width: 1%; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255)"> <td style="text-align: left">Lease Liability &#8211; Long Term</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#8212;</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">$</td> <td style="text-align: right">(87</td> <td style="text-align: left">)</td> <td>&#160;</td> <td style="text-align: left">$</td> <td style="text-align: right">(87</td> <td style="text-align: left">)</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.25in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">At September 30, 2019, the balance remaining in Right to Use Asset-Long Term and Lease Liability-Long Term was $29,000 and ($29,000) respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">The Company determines if an arrangement is a lease at lease inception. Operating lease right-of-use (ROU) assets and operating lease liabilities are recognized based on the present value of the future minimum lease payments over the lease term at commencement date. As most of the Company's lease contracts do not include an implicit rate, the Company uses its incremental borrowing rate based on information available at commencement date in determining the present value of future payments. The incremental borrowing rate is estimated to approximate the interest rate on a collateralized basis with similar terms and payments, and in economic environments where the leased asset is located. The operating lease ROU asset also includes any initial direct costs and lease payments made prior to lease commencement and excludes lease incentives incurred.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">The Company's lease terms may include options to extend or terminate the lease when it is reasonably certain that we will exercise that option. Operating lease expense for minimum lease payments is recognized on a straight-line basis over the lease term. The Company has certain lease agreements that contain both lease and non-lease components, which it has elected to account for as a single lease component for all asset classes.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">See Note 12, Commitments and Contingencies, for future minimum lease payments and maturities.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Accounting Standards Issued but Not Yet Adopted</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">In August 2018, the FASB issued authoritative guidance intended to address a customer's accounting for implementation costs incurred in a cloud computing arrangement that is a service contract. This guidance aligns the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software. The guidance also requires presentation of the capitalized implementation costs in the statement of financial position and in the statement of cash flows in the same line item that a prepayment for the fees of the associated hosting arrangement would be presented, and the expense related to the capitalized implementation costs to be presented in the same line item in the statement of operations as the fees associated with the hosting element (service) of the arrangement. This guidance is effective for annual periods beginning after December&#160;15, 2019, including interim periods within those annual periods, with early adoption permitted. We are currently evaluating the potential impact on our financial position, results of operations and statement of cash flows upon adoption of this guidance. We do not expect this guidance to have a significant impact, or potential significant impact, to our unaudited condensed consolidated interim financial statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">Other than the items noted above, there have been no new accounting pronouncements not yet effective or adopted in the current year that we believe have a significant impact, or potential significant impact, to our unaudited condensed consolidated interim financial statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Note 3 - Fair Value Measurements</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">The Company issued common stock warrants to purchase shares of common stock in June of 2015 (see Note 9 &#8212; Stock-based Compensation for more details) that contain a cash settlement provision resulting in a common stock warrant liability that is revalued at the end of each reporting period.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">We value these warrant derivatives at fair value. The accounting guidance for fair value, among other things, establishes a consistent framework for measuring fair value and expands disclosure for each major asset and liability category measured at fair value on either a recurring or nonrecurring basis. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction between market participants at the reporting date. The framework for measuring fair value consists of a three-level valuation hierarchy that prioritizes the inputs to valuation techniques used to measure fair value based upon whether such inputs are observable or unobservable. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect market assumptions made by the reporting entity. The three-level hierarchy for the inputs to valuation techniques is briefly summarized as follows:<i>&#160;</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36.7pt"><i>Level 1</i>&#8212;Inputs are unadjusted, quoted prices in active markets for identical assets or liabilities at the measurement date;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36.7pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36.7pt"><i>Level 2</i>&#8212;Inputs are observable, unadjusted quoted prices in active markets for similar assets or liabilities, unadjusted quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the related assets or liabilities; and</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36.7pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36.7pt"><i>Level 3</i>&#8212;Unobservable inputs that are significant to the measurement of the fair value of the assets or liabilities that are supported by little or no market data.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36.7pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">An asset's or liability's fair value measurement level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement. Valuation techniques used need to maximize the use of observable inputs and minimize the use of unobservable inputs.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">Assets and liabilities measured at fair value are based on one or more of the following three valuation techniques:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 10pt/normal Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal; width: 100%"> <tr style="vertical-align: top"> <td style="width: 24px; font-size: 10pt">&#160;</td> <td style="width: 24px; font-size: 10pt">A.</td> <td>Market approach: Prices and other relevant information generated by market transactions involving identical or comparable assets or liabilities.</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 10pt/normal Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal; width: 100%"> <tr style="vertical-align: top"> <td style="width: 24px">&#160;</td> <td style="width: 24px">B.</td> <td>Cost approach: Amount that would be required to replace the service capacity of an asset (replacement cost).</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 10pt/normal Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal; width: 100%"> <tr style="vertical-align: top"> <td style="width: 24px">&#160;</td> <td style="width: 24px">C.</td> <td>Income approach: Techniques to convert future amounts to a single present amount based upon market expectations, including present value techniques, option-pricing and excess earnings models.</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">The Company's common stock warrant liabilities are classified as Level 3 because there is limited activity or less transparency around the inputs to valuation.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Items Measured at Fair Value on a Recurring Basis</b>&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">The following table sets forth the Company's financial instruments that were measured at fair value on a recurring basis by level within the fair value hierarchy (in thousands):</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 10pt/normal Times New Roman, Times, Serif; border-collapse: collapse; font-size-adjust: none; font-stretch: normal; width: 100%"> <tr style="vertical-align: bottom"> <td style="font-weight: bold; white-space: nowrap">&#160;</td> <td style="padding-bottom: 1.5pt; font-weight: bold; white-space: nowrap">&#160;</td> <td colspan="14" style="text-align: center; font-weight: bold; border-bottom: black 1.5pt solid; white-space: nowrap">September 30, 2019</td> <td style="padding-bottom: 1.5pt; font-weight: bold; white-space: nowrap">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold">&#160;</td> <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td> <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: black 1.5pt solid">Level 1</td> <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td> <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td> <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: black 1.5pt solid">Level 2</td> <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td> <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td> <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: black 1.5pt solid">Level 3</td> <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td> <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td> <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: black 1.5pt solid">Total</td> <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: normal">Financial Liabilities:</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255)"> <td style="width: 52%; text-align: left; padding-bottom: 1.5pt; padding-left: 9pt; font-weight: normal">Common stock warrant liability (1)</td> <td style="width: 1%; padding-bottom: 1.5pt; font-weight: normal">&#160;</td> <td style="width: 1%; text-align: left; font-weight: normal; border-bottom: black 1.5pt solid">$</td> <td style="width: 9%; text-align: right; font-weight: normal; border-bottom: black 1.5pt solid">&#8212;</td> <td style="width: 1%; text-align: left; padding-bottom: 1.5pt; font-weight: normal">&#160;</td> <td style="width: 1%; padding-bottom: 1.5pt; font-weight: normal">&#160;</td> <td style="width: 1%; text-align: left; font-weight: normal; border-bottom: black 1.5pt solid">$</td> <td style="width: 9%; text-align: right; font-weight: normal; border-bottom: black 1.5pt solid">&#8212;</td> <td style="width: 1%; text-align: left; padding-bottom: 1.5pt; font-weight: normal">&#160;</td> <td style="width: 1%; padding-bottom: 1.5pt; font-weight: normal">&#160;</td> <td style="width: 1%; text-align: left; font-weight: normal; border-bottom: black 1.5pt solid">$</td> <td style="width: 9%; text-align: right; font-weight: normal; border-bottom: black 1.5pt solid">&#60;1</td> <td style="width: 1%; text-align: left; padding-bottom: 1.5pt; font-weight: normal">&#160;</td> <td style="width: 1%; padding-bottom: 1.5pt; font-weight: normal">&#160;</td> <td style="width: 1%; text-align: left; font-weight: normal; border-bottom: black 1.5pt solid">$</td> <td style="width: 9%; text-align: right; font-weight: normal; border-bottom: black 1.5pt solid">&#60;1</td> <td style="width: 1%; text-align: left; padding-bottom: 1.5pt; font-weight: normal">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 4pt; padding-left: 0.25in; font-weight: normal">Total</td> <td style="padding-bottom: 4pt; font-weight: normal">&#160;</td> <td style="text-align: left; font-weight: normal; border-bottom: black 4pt double">$</td> <td style="text-align: right; font-weight: normal; border-bottom: black 4pt double">&#8212;</td> <td style="text-align: left; padding-bottom: 4pt; font-weight: normal">&#160;</td> <td style="padding-bottom: 4pt; font-weight: normal">&#160;</td> <td style="text-align: left; font-weight: normal; border-bottom: black 4pt double">$</td> <td style="text-align: right; font-weight: normal; border-bottom: black 4pt double">&#8212;</td> <td style="text-align: left; padding-bottom: 4pt; font-weight: normal">&#160;</td> <td style="padding-bottom: 4pt; font-weight: normal">&#160;</td> <td style="text-align: left; font-weight: normal; border-bottom: black 4pt double">$</td> <td style="text-align: right; font-weight: normal; border-bottom: black 4pt double">&#60;1</td> <td style="text-align: left; padding-bottom: 4pt; font-weight: normal">&#160;</td> <td style="padding-bottom: 4pt; font-weight: normal">&#160;</td> <td style="text-align: left; font-weight: normal; border-bottom: black 4pt double">$</td> <td style="text-align: right; font-weight: normal; border-bottom: black 4pt double">&#60;1</td> <td style="text-align: left; padding-bottom: 4pt; font-weight: normal">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 10pt/normal Times New Roman, Times, Serif; border-collapse: collapse; font-size-adjust: none; font-stretch: normal; width: 100%"> <tr style="vertical-align: bottom"> <td style="font-weight: bold">&#160;</td> <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td> <td colspan="14" style="text-align: center; font-weight: bold; border-bottom: black 1.5pt solid">December 31, 2018</td> <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold">&#160;</td> <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td> <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: black 1.5pt solid">Level 1</td> <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td> <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td> <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: black 1.5pt solid">Level 2</td> <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td> <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td> <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: black 1.5pt solid">Level 3</td> <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td> <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td> <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: black 1.5pt solid">Total</td> <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: normal">Financial Assets:</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255)"> <td style="width: 52%; text-align: left; padding-left: 9pt; font-weight: normal">Money market funds</td> <td style="width: 1%; font-weight: normal">&#160;</td> <td style="width: 1%; text-align: left; font-weight: normal">$</td> <td style="width: 9%; text-align: right; font-weight: normal">&#8212;</td> <td style="width: 1%; text-align: left; font-weight: normal">&#160;</td> <td style="width: 1%; font-weight: normal">&#160;</td> <td style="width: 1%; text-align: left; font-weight: normal">$</td> <td style="width: 9%; text-align: right; font-weight: normal">&#8212;</td> <td style="width: 1%; text-align: left; font-weight: normal">&#160;</td> <td style="width: 1%; font-weight: normal">&#160;</td> <td style="width: 1%; text-align: left; font-weight: normal">$</td> <td style="width: 9%; text-align: right; font-weight: normal">&#8212;</td> <td style="width: 1%; text-align: left; font-weight: normal">&#160;</td> <td style="width: 1%; font-weight: normal">&#160;</td> <td style="width: 1%; text-align: left; font-weight: normal">$</td> <td style="width: 9%; text-align: right; font-weight: normal">&#8212;</td> <td style="width: 1%; text-align: left; font-weight: normal">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="font-weight: bold">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255)"> <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 9pt; font-weight: normal">Corporate fixed income debt securities</td> <td style="padding-bottom: 1.5pt; font-weight: normal">&#160;</td> <td style="text-align: left; font-weight: normal; border-bottom: black 1.5pt solid">&#160;</td> <td style="text-align: right; font-weight: normal; border-bottom: black 1.5pt solid">&#8212;</td> <td style="text-align: left; padding-bottom: 1.5pt; font-weight: normal">&#160;</td> <td style="padding-bottom: 1.5pt; font-weight: normal">&#160;</td> <td style="text-align: left; font-weight: normal; border-bottom: black 1.5pt solid">&#160;</td> <td style="text-align: right; font-weight: normal; border-bottom: black 1.5pt solid">&#8212;</td> <td style="text-align: left; padding-bottom: 1.5pt; font-weight: normal">&#160;</td> <td style="padding-bottom: 1.5pt; font-weight: normal">&#160;</td> <td style="text-align: left; font-weight: normal; border-bottom: black 1.5pt solid">&#160;</td> <td style="text-align: right; font-weight: normal; border-bottom: black 1.5pt solid">&#8212;</td> <td style="text-align: left; padding-bottom: 1.5pt; font-weight: normal">&#160;</td> <td style="padding-bottom: 1.5pt; font-weight: normal">&#160;</td> <td style="text-align: left; font-weight: normal; border-bottom: black 1.5pt solid">&#160;</td> <td style="text-align: right; font-weight: normal; border-bottom: black 1.5pt solid">&#8212;</td> <td style="text-align: left; padding-bottom: 1.5pt; font-weight: normal">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="font-weight: bold">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255)"> <td style="padding-bottom: 4pt; padding-left: 0.25in; font-weight: normal">Total</td> <td style="padding-bottom: 4pt; font-weight: normal">&#160;</td> <td style="text-align: left; font-weight: normal; border-bottom: black 4pt double">$</td> <td style="text-align: right; font-weight: normal; border-bottom: black 4pt double">&#8212;</td> <td style="text-align: left; padding-bottom: 4pt; font-weight: normal">&#160;</td> <td style="padding-bottom: 4pt; font-weight: normal">&#160;</td> <td style="text-align: left; font-weight: normal; border-bottom: black 4pt double">$</td> <td style="text-align: right; font-weight: normal; border-bottom: black 4pt double">&#8212;</td> <td style="text-align: left; padding-bottom: 4pt; font-weight: normal">&#160;</td> <td style="padding-bottom: 4pt; font-weight: normal">&#160;</td> <td style="text-align: left; font-weight: normal; border-bottom: black 4pt double">$</td> <td style="text-align: right; font-weight: normal; border-bottom: black 4pt double">&#8212;</td> <td style="text-align: left; padding-bottom: 4pt; font-weight: normal">&#160;</td> <td style="padding-bottom: 4pt; font-weight: normal">&#160;</td> <td style="text-align: left; font-weight: normal; border-bottom: black 4pt double">$</td> <td style="text-align: right; font-weight: normal; border-bottom: black 4pt double">&#8212;</td> <td style="text-align: left; padding-bottom: 4pt; font-weight: normal">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: left; font-weight: normal">Financial Liabilities:</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255)"> <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 9pt; font-weight: normal">Common stock warrant liability (1)</td> <td style="padding-bottom: 1.5pt; font-weight: normal">&#160;</td> <td style="text-align: left; font-weight: normal; border-bottom: black 1.5pt solid">$</td> <td style="text-align: right; font-weight: normal; border-bottom: black 1.5pt solid">&#8212;</td> <td style="text-align: left; padding-bottom: 1.5pt; font-weight: normal">&#160;</td> <td style="padding-bottom: 1.5pt; font-weight: normal">&#160;</td> <td style="text-align: left; font-weight: normal; border-bottom: black 1.5pt solid">$</td> <td style="text-align: right; font-weight: normal; border-bottom: black 1.5pt solid">&#8212;</td> <td style="text-align: left; padding-bottom: 1.5pt; font-weight: normal">&#160;</td> <td style="padding-bottom: 1.5pt; font-weight: normal">&#160;</td> <td style="text-align: left; font-weight: normal; border-bottom: black 1.5pt solid">$</td> <td style="text-align: right; font-weight: normal; border-bottom: black 1.5pt solid">&#8212;</td> <td style="text-align: left; padding-bottom: 1.5pt; font-weight: normal">&#160;</td> <td style="padding-bottom: 1.5pt; font-weight: normal">&#160;</td> <td style="text-align: left; font-weight: normal; border-bottom: black 1.5pt solid">$</td> <td style="text-align: right; font-weight: normal; border-bottom: black 1.5pt solid">&#8212;</td> <td style="text-align: left; padding-bottom: 1.5pt; font-weight: normal">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 4pt; padding-left: 0.25in; font-weight: normal">Total</td> <td style="padding-bottom: 4pt; font-weight: normal">&#160;</td> <td style="text-align: left; font-weight: normal; border-bottom: black 4pt double">$</td> <td style="text-align: right; font-weight: normal; border-bottom: black 4pt double">&#8212;</td> <td style="text-align: left; padding-bottom: 4pt; font-weight: normal">&#160;</td> <td style="padding-bottom: 4pt; font-weight: normal">&#160;</td> <td style="text-align: left; font-weight: normal; border-bottom: black 4pt double">$</td> <td style="text-align: right; font-weight: normal; border-bottom: black 4pt double">&#8212;</td> <td style="text-align: left; padding-bottom: 4pt; font-weight: normal">&#160;</td> <td style="padding-bottom: 4pt; font-weight: normal">&#160;</td> <td style="text-align: left; font-weight: normal; border-bottom: black 4pt double">$</td> <td style="text-align: right; font-weight: normal; border-bottom: black 4pt double">&#8212;</td> <td style="text-align: left; padding-bottom: 4pt; font-weight: normal">&#160;</td> <td style="padding-bottom: 4pt; font-weight: normal">&#160;</td> <td style="text-align: left; font-weight: normal; border-bottom: black 4pt double">$</td> <td style="text-align: right; font-weight: normal; border-bottom: black 4pt double">&#8212;</td> <td style="text-align: left; padding-bottom: 4pt; font-weight: normal">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 10pt/normal Times New Roman, Times, Serif; margin-top: 0px; margin-bottom: 0pt; font-size-adjust: none; font-stretch: normal; width: 100%"> <tr style="text-align: justify; vertical-align: top"> <td style="width: 0in">&#160;</td> <td style="width: 0.25in; text-align: left">(1)</td> <td style="text-align: left">There was no change (net) in the fair value of the common stock warrant for the three and nine months ended September 30, 2019. If there had been, it would have been recorded to other income (expense) and interest expense in the statements of operations and comprehensive loss.</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Financial Instruments Not Carried at Fair Value</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">The carrying amounts of the Company's financial instruments, including accounts payable and accrued liabilities, approximate fair value due to their short maturities. The estimated fair value of the convertible notes and other notes, not recorded at fair value, are recorded at cost or amortized cost which was deemed to estimate fair value.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Note 4 - Credit Risk</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">The Company is potentially subject to concentrations of credit risk in its accounts receivable. Credit risk with respect to receivables is limited due to the number of companies comprising the Company's customer base. Although the Company is directly affected by the financial condition of its customers, management does not believe significant credit risks exist at September 30, 2019 or December 31, 2018. The Company does not require collateral or other securities to support its accounts receivable.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Note 5 - Prepaid Expenses</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">Prepaid expenses consist of the following:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 10pt/normal Times New Roman, Times, Serif; border-collapse: collapse; font-size-adjust: none; font-stretch: normal; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center; white-space: nowrap">&#160;</td> <td style="font-weight: bold; white-space: nowrap">&#160;</td> <td colspan="2" style="text-align: center; font-weight: bold; white-space: nowrap">September 30,</td> <td style="font-weight: bold; white-space: nowrap">&#160;</td> <td style="font-weight: bold; white-space: nowrap">&#160;</td> <td colspan="2" style="text-align: center; font-weight: bold; white-space: nowrap">December 31,</td> <td style="font-weight: bold; white-space: nowrap">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td> <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: black 1.5pt solid">2019</td> <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td> <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td> <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: black 1.5pt solid">2018</td> <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255)"> <td style="width: 78%; text-align: left">Director compensation</td> <td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">$</td> <td style="width: 8%; text-align: right">-</td> <td style="width: 1%; text-align: left">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">$</td> <td style="width: 8%; text-align: right">100</td> <td style="width: 1%; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: left">Director and officer insurance</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">161</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">121</td> <td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255)"> <td style="text-align: left">NASDAQ fees</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">14</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: left">Legal retainer</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">25</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">25</td> <td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255)"> <td style="text-align: left">Marketing programs and conferences</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">54</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">53</td> <td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: left">Professional services retainer</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">15</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">8</td> <td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255)"> <td>Rent</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">-</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">19</td> <td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: left">Equipment service deposits</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">2</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">3</td> <td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255)"> <td style="text-align: left">Foreign patent registration</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">22</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">-</td> <td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: left; padding-bottom: 1.5pt">Engineering, software licenses and other</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="text-align: left; border-bottom: black 1.5pt solid">&#160;</td> <td style="text-align: right; border-bottom: black 1.5pt solid">11</td> <td style="text-align: left; padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="text-align: left; border-bottom: black 1.5pt solid">&#160;</td> <td style="text-align: right; border-bottom: black 1.5pt solid">13</td> <td style="text-align: left; padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255)"> <td style="text-align: left; padding-bottom: 4pt">Total prepaid expenses</td> <td style="padding-bottom: 4pt">&#160;</td> <td style="text-align: left; border-bottom: black 4pt double">$</td> <td style="text-align: right; border-bottom: black 4pt double">304</td> <td style="text-align: left; padding-bottom: 4pt">&#160;</td> <td style="padding-bottom: 4pt">&#160;</td> <td style="text-align: left; border-bottom: black 4pt double">$</td> <td style="text-align: right; border-bottom: black 4pt double">342</td> <td style="text-align: left; padding-bottom: 4pt">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Note 6 - Property and Equipment</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">Property and equipment, net consist of the following:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 10pt/normal Times New Roman, Times, Serif; border-collapse: collapse; font-size-adjust: none; font-stretch: normal; width: 100%"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap">&#160;</td> <td style="white-space: nowrap">&#160;</td> <td style="white-space: nowrap">&#160;</td> <td style="white-space: nowrap">&#160;</td> <td style="text-align: center; white-space: nowrap">&#160;</td> <td style="font-weight: bold; white-space: nowrap">&#160;</td> <td colspan="2" style="text-align: center; font-weight: bold; white-space: nowrap">September 30,</td> <td style="font-weight: bold; white-space: nowrap">&#160;</td> <td style="font-weight: bold; white-space: nowrap">&#160;</td> <td colspan="2" style="text-align: center; font-weight: bold; white-space: nowrap">December 31,</td> <td style="font-weight: bold; white-space: nowrap">&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td>&#160;</td> <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td> <td style="text-align: center; font-weight: bold; border-bottom: black 1.5pt solid">Useful Life</td> <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td> <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: black 1.5pt solid">2019</td> <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td> <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td> <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: black 1.5pt solid">2018</td> <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255)"> <td style="width: 62%; text-align: left; text-indent: -9pt; padding-left: 9pt">Research and development equipment</td> <td style="width: 1%">&#160;</td> <td style="width: 3%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 11%; text-align: right">5 years</td> <td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">$</td> <td style="width: 8%; text-align: right">1,582</td> <td style="width: 1%; text-align: left">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">$</td> <td style="width: 8%; text-align: right">1,552</td> <td style="width: 1%; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: left; text-indent: -9pt; padding-left: 9pt">Office and computer equipment</td> <td>&#160;</td> <td style="text-align: right">(1)</td> <td>&#160;</td> <td style="text-align: right">3 years</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">753</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">742</td> <td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255)"> <td style="text-indent: -9pt; padding-left: 9pt">Autos</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">5 years</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">54</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">54</td> <td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: left; text-indent: -9pt; padding-left: 9pt">Furniture and fixtures</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">7 years</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">37</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">37</td> <td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255)"> <td style="text-align: left; text-indent: -9pt; padding-bottom: 1.5pt; padding-left: 9pt">Leasehold improvements</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="text-align: right; padding-bottom: 1.5pt">*</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="text-align: left; border-bottom: black 1.5pt solid">&#160;</td> <td style="text-align: right; border-bottom: black 1.5pt solid">283</td> <td style="text-align: left; padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="text-align: left; border-bottom: black 1.5pt solid">&#160;</td> <td style="text-align: right; border-bottom: black 1.5pt solid">283</td> <td style="text-align: left; padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-indent: -9pt; padding-left: 9pt">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">2,709</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">2,668</td> <td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255)"> <td style="text-align: left; text-indent: -9pt; padding-bottom: 1.5pt; padding-left: 9pt">Less accumulated depreciation and amortization</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="text-align: right; padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="text-align: left; border-bottom: black 1.5pt solid">&#160;</td> <td style="text-align: right; border-bottom: black 1.5pt solid">(1,879</td> <td style="text-align: left; padding-bottom: 1.5pt">)</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="text-align: left; border-bottom: black 1.5pt solid">&#160;</td> <td style="text-align: right; border-bottom: black 1.5pt solid">(1,585</td> <td style="text-align: left; padding-bottom: 1.5pt">)</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-indent: -9pt; padding-bottom: 4pt; padding-left: 9pt">Total</td> <td style="padding-bottom: 4pt">&#160;</td> <td style="padding-bottom: 4pt">&#160;</td> <td style="padding-bottom: 4pt">&#160;</td> <td style="text-align: right; padding-bottom: 4pt">&#160;</td> <td style="padding-bottom: 4pt">&#160;</td> <td style="text-align: left; border-bottom: black 4pt double">$</td> <td style="text-align: right; border-bottom: black 4pt double">830</td> <td style="text-align: left; padding-bottom: 4pt">&#160;</td> <td style="padding-bottom: 4pt">&#160;</td> <td style="text-align: left; border-bottom: black 4pt double">$</td> <td style="text-align: right; border-bottom: black 4pt double">1,083</td> <td style="text-align: left; padding-bottom: 4pt">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">* Shorter of lease term or estimated useful life&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 10pt/normal Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; font-size-adjust: none; font-stretch: normal; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in">(1)</td> <td>In August 2019, the Company disposed of computer equipment with a net book value of $2 resulting in a loss on the disposal of fixed assets of less than $1. In April and May 2019, the Company disposed of obsolete computer equipment with a net book value of $2 resulting in a loss on disposal of fixed assets of $2.</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">Depreciation and amortization expense was approximately $101 and $108 for the three months ended September 30, 2019 and 2018, respectively, and $314 and $332 for the nine months ended September 30, 2019 and 2018, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Note 7 - Accrued Expenses</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">Accrued expenses consist of the following:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 10pt/normal Times New Roman, Times, Serif; border-collapse: collapse; font-size-adjust: none; font-stretch: normal; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center; white-space: nowrap">&#160;</td> <td style="font-weight: bold; white-space: nowrap">&#160;</td> <td colspan="2" style="text-align: center; font-weight: bold; white-space: nowrap">September&#160;30,</td> <td style="font-weight: bold; white-space: nowrap">&#160;</td> <td style="font-weight: bold; white-space: nowrap">&#160;</td> <td colspan="2" style="text-align: center; font-weight: bold; white-space: nowrap">December&#160;31,</td> <td style="font-weight: bold; white-space: nowrap">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td> <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: black 1.5pt solid">2019</td> <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td> <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td> <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: black 1.5pt solid">2018</td> <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255)"> <td style="width: 78%; text-align: left">Compensation and related benefits</td> <td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">$</td> <td style="width: 8%; text-align: right">264</td> <td style="width: 1%; text-align: left">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">$</td> <td style="width: 8%; text-align: right">479</td> <td style="width: 1%; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: left">Accrued Litigation</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">507</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">269</td> <td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255)"> <td style="text-align: left">Board Compensation</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">9</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">23</td> <td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt">Other</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="text-align: left; border-bottom: black 1.5pt solid">&#160;</td> <td style="text-align: right; border-bottom: black 1.5pt solid">5</td> <td style="text-align: left; padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="text-align: left; border-bottom: black 1.5pt solid">&#160;</td> <td style="text-align: right; border-bottom: black 1.5pt solid">&#8212;</td> <td style="text-align: left; padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255)"> <td style="text-align: left; padding-bottom: 4pt">Total accrued expenses</td> <td style="padding-bottom: 4pt">&#160;</td> <td style="text-align: left; border-bottom: black 4pt double">$</td> <td style="text-align: right; border-bottom: black 4pt double">785</td> <td style="text-align: left; padding-bottom: 4pt">&#160;</td> <td style="padding-bottom: 4pt">&#160;</td> <td style="text-align: left; border-bottom: black 4pt double">$</td> <td style="text-align: right; border-bottom: black 4pt double">771</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Note 8 - Borrowings</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">A summary of the Company's borrowings, including capital lease obligations, is as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 10pt/normal Times New Roman, Times, Serif; border-collapse: collapse; font-size-adjust: none; font-stretch: normal; width: 100%"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap">&#160;</td> <td style="font-weight: bold; white-space: nowrap">&#160;</td> <td colspan="2" style="text-align: center; font-weight: bold; white-space: nowrap">September&#160;30,</td> <td style="font-weight: bold; white-space: nowrap">&#160;</td> <td style="font-weight: bold; white-space: nowrap">&#160;</td> <td colspan="2" style="text-align: center; font-weight: bold; white-space: nowrap">December&#160;31,</td> <td style="font-weight: bold; white-space: nowrap">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td> <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: black 1.5pt solid">2019</td> <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td> <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td> <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: black 1.5pt solid">2018</td> <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr> <tr style="vertical-align: bottom"> <td>Short-term debt:</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255)"> <td style="width: 78%; text-align: left; text-indent: -9pt; padding-bottom: 1.5pt; padding-left: 0.25in">Current portion of long-term debt</td> <td style="width: 1%; padding-bottom: 1.5pt">&#160;</td> <td style="width: 1%; text-align: left; border-bottom: black 1.5pt solid">&#160;</td> <td style="width: 8%; text-align: right; border-bottom: black 1.5pt solid">129</td> <td style="width: 1%; text-align: left; padding-bottom: 1.5pt">&#160;</td> <td style="width: 1%; padding-bottom: 1.5pt">&#160;</td> <td style="width: 1%; text-align: left; border-bottom: black 1.5pt solid">&#160;</td> <td style="width: 8%; text-align: right; border-bottom: black 1.5pt solid">219</td> <td style="width: 1%; text-align: left; padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: left; text-indent: -9pt; padding-left: 27pt">Total short-term debt</td> <td>&#160;</td> <td style="text-align: left">$</td> <td style="text-align: right">129</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">$</td> <td style="text-align: right">219</td> <td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255)"> <td style="text-align: left; text-indent: -9pt; padding-left: 9pt">Long-term debt:</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: left; text-indent: -9pt; padding-left: 0.25in">Capital lease obligations</td> <td>&#160;</td> <td style="text-align: left">$</td> <td style="text-align: right">175</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">$</td> <td style="text-align: right">232</td> <td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255)"> <td style="text-align: left; text-indent: -9pt; padding-bottom: 1.5pt; padding-left: 0.25in">Other promissory notes</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="text-align: left; border-bottom: black 1.5pt solid">&#160;</td> <td style="text-align: right; border-bottom: black 1.5pt solid">121</td> <td style="text-align: left; padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="text-align: left; border-bottom: black 1.5pt solid">&#160;</td> <td style="text-align: right; border-bottom: black 1.5pt solid">248</td> <td style="text-align: left; padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-indent: -9pt; padding-left: 27pt">Total</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">296</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">480</td> <td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255)"> <td style="text-align: left; text-indent: -9pt; padding-bottom: 1.5pt; padding-left: 27pt">Less: current portion of long-term debt</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="text-align: left; border-bottom: black 1.5pt solid">&#160;</td> <td style="text-align: right; border-bottom: black 1.5pt solid">(129</td> <td style="text-align: left; padding-bottom: 1.5pt">)</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="text-align: left; border-bottom: black 1.5pt solid">&#160;</td> <td style="text-align: right; border-bottom: black 1.5pt solid">(219</td> <td style="text-align: left; padding-bottom: 1.5pt">)</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: left; text-indent: -9pt; padding-bottom: 4pt; padding-left: 27pt">Total long-term debt</td> <td style="padding-bottom: 4pt">&#160;</td> <td style="text-align: left; border-bottom: black 4pt double">$</td> <td style="text-align: right; border-bottom: black 4pt double">167</td> <td style="text-align: left; padding-bottom: 4pt">&#160;</td> <td style="padding-bottom: 4pt">&#160;</td> <td style="text-align: left; border-bottom: black 4pt double">$</td> <td style="text-align: right; border-bottom: black 4pt double">261</td> <td style="text-align: left; padding-bottom: 4pt">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i>Capital Lease Obligations&#160;</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">Capital lease obligations are for computer and lab equipment leased through GreatAmerica Financial Services, Thermo Fisher Scientific, Navitas Credit Corp. and ENGS Commercial Finance Co. These capital leases expire at various dates through July 2023 and carry interest rates ranging from 6.4% to 11.6%.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i>Other Promissory Notes</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">Also included in the table above are three notes payable to Direct Capital, one note to M2 Financing and one note to Fidelity Capital, all for the financing of fixed assets. These notes expire at various dates through June 2022 and carry interest rates ranging from 10.88% to 13.28%.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Note 9 - Common Stock Warrants and Common Stock Warrant Liability</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">The table summarizes the common stock warrant activity as of September 30, 2019 as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 10pt/normal Times New Roman, Times, Serif; border-collapse: collapse; font-size-adjust: none; font-stretch: normal; width: 100%"> <tr style="vertical-align: bottom"> <td style="font-weight: bold; border-bottom: black 1.5pt solid">Common Stock Warrants</td> <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td> <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: black 1.5pt solid">Number<br /> of<br /> Warrants</td> <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td> <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td> <td style="text-align: center; font-weight: bold; border-bottom: black 1.5pt solid">Date<br /> Issued</td> <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td> <td style="text-align: center; font-weight: bold; border-bottom: black 1.5pt solid">Term</td> <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td> <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: black 1.5pt solid">Exercise Price</td> <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="text-align: center">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: center">&#160;</td> <td>&#160;</td> <td style="text-align: center">&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255)"> <td style="width: 54%">Outstanding at December 31, 2017</td> <td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td> <td style="width: 8%; text-align: right">6,431,785</td> <td style="width: 1%; text-align: left">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 11%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 11%; text-align: center">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td> <td style="width: 8%; text-align: right">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: center">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255)"> <td style="text-align: left">Warrants issued</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">1,133,909</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: right">June 2018</td> <td>&#160;</td> <td style="text-align: center">5 Years</td> <td>&#160;</td> <td style="text-align: left">$</td> <td style="text-align: right">1.82</td> <td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: left">Common Stock Offering Warrants Issued</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">5,357,052</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: right">August 2018</td> <td>&#160;</td> <td style="text-align: center">5 Years</td> <td>&#160;</td> <td style="text-align: left">$</td> <td style="text-align: right">1.15</td> <td style="text-align: left">(1)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255)"> <td style="text-align: left">Common Stock Offering - Dealer Manager Warrants</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">267,853</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: right">August 2018</td> <td>&#160;</td> <td style="text-align: center">5 Years</td> <td>&#160;</td> <td style="text-align: left">$</td> <td style="text-align: right">1.725</td> <td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: left; padding-left: 9pt">Warrants exercised</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">(1,475,659</td> <td style="text-align: left">)</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: center">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255)"> <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 9pt">Expired Warrants</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="text-align: left; border-bottom: black 1.5pt solid">&#160;</td> <td style="text-align: right; border-bottom: black 1.5pt solid">(488,119</td> <td style="text-align: left; padding-bottom: 1.5pt">)</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="text-align: center; padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="text-align: left; padding-bottom: 1.5pt">&#160;</td> <td style="text-align: right; padding-bottom: 1.5pt">&#160;</td> <td style="text-align: left; padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Outstanding at December 31, 2018</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">11,226,821</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: center">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255)"> <td style="text-align: left; padding-left: 9pt">Warrants issued</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">166,667</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: right">July 2019</td> <td>&#160;</td> <td style="text-align: center">5 Years</td> <td>&#160;</td> <td style="text-align: left">$</td> <td style="text-align: right">1.6875</td> <td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: left; padding-left: 9pt">Warrants Exercised</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">(1,298,210</td> <td style="text-align: left">)</td> <td>&#160;</td> <td style="text-align: right">August 2018</td> <td>&#160;</td> <td style="text-align: center">&#160;</td> <td>&#160;</td> <td style="text-align: left">$</td> <td style="text-align: right">1.15</td> <td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255)"> <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 9pt">Warrants Exercised</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="text-align: left; border-bottom: black 1.5pt solid">&#160;</td> <td style="text-align: right; border-bottom: black 1.5pt solid">(312,000</td> <td style="text-align: left; padding-bottom: 1.5pt">)</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="text-align: right; padding-bottom: 1.5pt">August 2018</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="text-align: center; padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="text-align: left; padding-bottom: 1.5pt">$</td> <td style="text-align: right; padding-bottom: 1.5pt">0.95</td> <td style="text-align: left; padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Outstanding at September 30, 2019</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">9,783,278</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: center">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 10pt/normal Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; font-size-adjust: none; font-stretch: normal; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0px">&#160;</td> <td style="width: 0.25in">(1)</td> <td style="text-align: left">The common stock warrants issued in November 2017 with an initial exercise price of $1.50 per share adjusted downward to $0.95 per share effective July 24, 2018 in connection with our Rights Offering, and may be subject to further downward adjustments, pursuant to antidilution price adjustment protection contained within those warrants.</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">On November 21, 2017, the Company issued a total of 4,657,500 detachable common stock warrants issued with the second public offering of 5,860,000 shares of its common stock at $1.00 per share. The common stock warrant is exercisable until five years from the date of grant. The common shares of the Company's stock and detachable warrants exist independently as separate securities. As such, the Company estimated the fair value of the common stock warrants, exercisable at $1.50 per share, to be $661 using a lattice model based on the following significant inputs: Common stock price of $1.00; comparable company volatility of 73.8%; remaining term 5 years; dividend yield of 0% and risk-free interest rate of 1.87. The initial exercise price of these warrants was $1.50 per share, which adjusted downward to $1.47 on July 24, 2018, the record date of the Right's Offering and downward to $0.95 per share on August 13, 2018, the date of the Rights Offering, pursuant to antidilution price adjustment protection contained within these warrants. Per guidance of ASC 260, the Company recorded a deemed dividend of $333 on the 3,181,841 unexercised warrants that contained this antidilution price adjustment protection provision and was calculated as the difference between the fair value of the warrants immediately prior to downward exercise price adjustment and immediately after the adjustment using a Black Scholes model based on the following significant inputs: On July 24, 2018: Common stock price of $1.38; comparable company volatility of 72.4%; remaining term 4.33 years; dividend yield of 0% and risk-free interest rate of 2.83. On August 13, 2018: Common stock price of $1.02; comparable company volatility of 74.0%; remaining term 4.25 years; dividend yield of 0% and risk-free interest rate of 2.75.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">On June 20, 2018, the Company entered into an agreement with a holder of 1,133,909 of the November 2017 warrants to exercise its original warrant representing 1,133,909 shares of Common Stock for cash at the $1.50 exercise price for gross proceeds of $1.7 million and the Company issued to holder a new warrant to purchase 1,133,909 shares of Common Stock at an exercise price of $1.82 per share. The new warrant did not contain the antidilution price adjustment protection that was contained within the exercised warrants. In June 2018, the Company recorded stock compensation expense of $1.7 million representing the fair value of the of 1,133,909 inducement warrants issued. The Company estimated the fair value of the common stock warrants, exercisable at $1.82 per share, to be $1.7 million using a Black Scholes model based on the following significant inputs: Common stock price of $2.11; comparable company volatility of 72.6%; remaining term 5 years; dividend yield of 0% and risk-free interest rate of 2.8%. Also, in June 2018, an additional 341,750 of the November 8, 2017 warrants that were in the money at the time of exercise, were exercised for gross proceeds of $513.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">On August 13, 2018, in connection with a Rights Offering of 5,357,052 shares of its common stock, the Company issued 5,357,052 warrants to purchase shares of its common stock at an exercise price of $1.15 per share. The Company estimated the fair value of the common stock warrants, exercisable at $1.15 per share, to be $3.6 million using a Monte Carlo model based on the following significant inputs: common stock price of $0.94; comparable company volatility of 159.0%; remaining term 5 years; dividend yield of 0% and risk-free interest rate of 2.77%.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">In connection with the closing of the Rights Offering, the Company issued a warrant to purchase 267,853 shares of common stock to Maxim Partners LLC, an affiliate of the dealer-manager of the Rights Offering. The Company estimated the fair value of the common stock warrants, exercisable at $1.725 per share, to be $169 using a using a Monte Carlo model based on the following significant inputs: common stock price of $0.94; comparable company volatility of 159.0%; remaining term 5 years; dividend yield of 0% and risk-free interest rate of 2.77%.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i>Common Stock Warrant Issued to Underwriter of Common Stock Offering&#160;</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">In July 2019, the Company issued to H.C. Wainwright &#38; Co., as placement agent, a warrant to purchase 166,667 shares of common stock at an exercise price of $1.6875 per share as consideration for providing services in connection with a common stock offering in July 2019. The warrant was fully vested and exercisable on the date of issuance. The common stock warrant is exercisable until five years from the date of grant. The Company estimated the fair value of the common stock warrants, exercisable at $1.6875 per share, to be $127 using a lattice model based on the following significant inputs: Common stock price of $1.34; comparable company volatility of 133.3%; remaining term 5 years; dividend yield of 0% and risk-free interest rate of 2.07%.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i>University of Arizona Common Stock Warrant</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">In connection with the June 2015 amended and restated exclusive license agreement with the University of Arizona ("University"), the Company issued to the University a common stock warrant to purchase 15,000 shares of common stock at an exercise price of $7.50 per share. The warrant was fully vested and exercisable on the date of grant, and expires, if not exercised, five years from the date of grant. In the event of a "terminating change" of the Company, as defined in the warrant agreement, the warrant holder would be paid in cash the aggregate fair market value of the underlying shares immediately prior to the consummation of the terminating change event. Due to the cash settlement provision, the derivative warrant liability was recorded at fair value and is revalued at the end of each reporting period. The changes in fair value are reported in other income (expense) in the statements of operations and comprehensive loss. The estimated fair value of the derivative warrant liability was $53 at the date of grant.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 9.05pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">The estimated fair value of the derivative warrant liability was $0 at September 30, 2019. As this derivative warrant liability is revalued at the end of each reporting period, the fair values as determined at the date of grant and subsequent periods was based on the following significant inputs using a Monte Carlo option pricing model: common stock price of $7.91; comparable company volatility of 77.7% of the underlying common stock; risk-free rates of 1.93%; and dividend yield of 0%; including the probability assessment of a terminating change event occurring. The change in fair value of the derivative warrant liability was ($0) and $0 for the three and nine months ended September 30, 2019. As such, no entry was recorded in other income (expense) in the accompanying statements of operations and comprehensive loss.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Note 10 - Stockholders' Deficit</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Capital Stock</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">The Company was organized under the laws of the state of Nevada on July 27, 2004 and was subsequently reincorporated under the laws of the state of Delaware on November 10, 2015. In connection with the reincorporation, as approved by the stockholders, the Company changed its authorized capital stock to consist of (i) 100 million shares of common stock, $.001 par value, and (ii) 2 million shares of preferred stock, $0.001 par value, designated as Series A convertible preferred stock. In December 2015, the Company amended its Certificate of Incorporation to change its authorized capital stock to provide for 15 million authorized shares of preferred stock of which 7,515,000 was designated as Series B convertible preferred stock, par value $.001 per share.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Common Stock</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">The Company had 28,288,285 and 23,471,999 shares of common stock issued and outstanding as of September 30, 2019 and December 31, 2018, respectively.&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">During the nine months ended September 30, 2019, the Company issued an aggregate of 4,816,286 shares of common stock as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 10pt/normal Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in">&#160;</td> <td style="width: 24px">&#9679;</td> <td>an aggregate of 3,037,038 shares in connection with a public offering generating net proceeds to the Company of approximately $3.6 million, as further described below</td></tr> <tr style="vertical-align: top"> <td>&#160;</td> <td>&#9679;</td> <td>an aggregate of 1,610,210 shares for the exercise of outstanding warrants for gross proceeds of $1.8 million (see Note 9 &#8212; Common Stock Warrants and Common Stock Warrant Liability for further details) </td></tr> <tr style="vertical-align: top"> <td>&#160;</td> <td>&#9679;</td> <td>An aggregate of 105,474 shares for service as a result of the vesting of restricted stock units</td></tr> <tr style="vertical-align: top"> <td>&#160;</td> <td>&#9679;</td> <td>3,022 shares for the exercise of stock options</td></tr> <tr style="vertical-align: top"> <td>&#160;</td> <td>&#9679;</td> <td>21,962 shares for the cashless exercise of stock options and</td></tr> <tr style="vertical-align: top"> <td>&#160;</td> <td>&#9679;</td> <td>an aggregate of 38,580 shares to certain employees in net settlement of bonus compensation totaling $32.</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Public Offering </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">On July 16, 2019, the Company issued 3,037,038 shares of common stock, including 696,296 shares to the Company's chief executive officer and 7,408 shares to an employee of the Company, in a public offering of shares of the Company's common stock at $1.35 per share, resulting in net proceeds of approximately $3.6 million after deducting certain fees due to the placement agent and other transaction expenses. In addition, the Company issued a warrant to purchase 166,667 shares of the Company's common stock to the placement agent at an exercise price of $1.6875 per share.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Note 11 - Stock-based Compensation</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">On June 12, 2018, the Company's stockholders approved the 2018 Equity Incentive Plan (the "2018 Plan") to replace the Company's 2015 Equity Incentive Plan (the "2015 Plan"). The 2018 Plan authorizes the issuance of 1,000,000 shares of our common stock. In addition, up to 2,874,280 shares of our common stock reserved for issuance under the 2015 Plan became available for issuance under the 2018 Plan to the extent such shares were available for issuance under the 2015 Plan as of June 12, 2018 or cease to be subject to awards outstanding under the 2015 Plan, such as by expiration, cancellation, or forfeiture of such awards.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">Stock options are generally issued with an exercise price equal to no less than fair value at the date of grant. Options granted under the 2018 Plan generally vest immediately, or ratably over a two- to 36-month period coinciding with their respective service periods; however, participants may exercise their options prior to vesting as provided by the 2018 Plan. Unvested shares issued for options exercised early may be subject to a repurchase by the Company if the participant terminates, at the original exercise price. Options under the 2018 Plan generally have a contractual term of five years. Certain stock option awards provide for accelerated vesting upon a change in control.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">As of September 30, 2019, the Company had 632,936 shares of common stock available for issuance under the 2018 Plan.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">The Company measures the fair value of stock options with service-based and performance-based vesting criteria to employees, directors and consultants on the date of grant using the Black-Scholes option pricing model. The fair value of equity instruments issued to non-employees is re-measured as the award vests. The Black-Scholes valuation model requires the Company to make certain estimates and assumptions, including assumptions related to the expected price volatility of the Company's stock, the period under which the options will be outstanding, the rate of return on risk-free investments, and the expected dividend yield for the Company's stock.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">The weighted-average assumptions used in the Black-Scholes option-pricing model used to calculate the fair value of options granted during the nine months ended September 30, 2019 were as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 10pt/normal Times New Roman, Times, Serif; border-collapse: collapse; font-size-adjust: none; font-stretch: normal; width: 100%"> <tr style="vertical-align: bottom"> <td style="font-weight: bold">&#160;</td> <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td> <td style="text-align: center; font-weight: bold; border-bottom: black 1.5pt solid">Employee</td> <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td> <td style="text-align: center; font-weight: bold; border-bottom: black 1.5pt solid">Non-Employee</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255)"> <td style="width: 76%; text-align: left; font-weight: normal">Expected volatility</td> <td style="width: 1%; font-weight: normal">&#160;</td> <td style="width: 11%; text-align: center; font-weight: normal">76.4%-80.6 %</td> <td style="width: 1%; font-weight: bold">&#160;</td> <td style="width: 11%; text-align: center">N/A</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: left; font-weight: normal">Expected dividend yield</td> <td style="font-weight: normal">&#160;</td> <td style="text-align: center; font-weight: normal">&#8212;</td> <td style="font-weight: normal">&#160;</td> <td style="text-align: center; font-weight: normal">N/A</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255)"> <td style="text-align: left; font-weight: normal">Expected term (in years)</td> <td style="font-weight: normal">&#160;</td> <td style="text-align: center; font-weight: normal">3.0-6.0</td> <td style="font-weight: normal">&#160;</td> <td style="text-align: center; font-weight: normal">N/A</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: left; font-weight: normal">Risk-free interest rate</td> <td style="font-weight: normal">&#160;</td> <td style="text-align: center; font-weight: normal">1.63% -2.48 %</td> <td style="font-weight: normal">&#160;</td> <td style="text-align: center; font-weight: normal">N/A</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">The weighted average grant date fair value of options granted during the nine months ended September 30, 2019 was $1.29 per share, as per the table below.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">Due to the Company's limited operating history and lack of company-specific historical or implied volatility, the expected volatility assumption was determined based on historical volatilities from traded options of biotech companies of comparable in size and stability, whose share prices are publicly available. The expected dividend assumption is based on the Company's history and expectation of dividend payouts. The Company has not paid and does not intend to pay dividends. The expected term of options granted to employees is calculated based on the mid-point between the vesting date and the end of the contractual term according to the simplified method as described in SEC Staff Accounting Bulletin 110 because the Company does not have sufficient historical exercise data to provide a reasonable basis upon which to estimate the expected term due to the limited period of time its awards have been outstanding. For non-employee options, the expected term of options granted is the contractual term of the options. The risk-free interest rate is determined by reference to the implied yields of U.S. Treasury securities with a remaining term equal to the expected term assumed at the time of grant.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">The following table summarizes the stock option activity, for both equity plans, for the periods indicated as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 10pt/normal Times New Roman, Times, Serif; border-collapse: collapse; font-size-adjust: none; font-stretch: normal; width: 100%"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td> <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: black 1.5pt solid">Number of<br /> Options</td> <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td> <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td> <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: black 1.5pt solid">Weighted<br /> Average<br /> Exercise<br /> Price Per<br /> Share</td> <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td> <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td> <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: black 1.5pt solid">Weighted<br /> Average<br /> Remaining<br /> Contractual<br /> Term<br /> (years)</td> <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td> <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td> <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: black 1.5pt solid">Aggregate<br /> Intrinsic<br /> Value (1)</td> <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255)"> <td style="width: 52%">Outstanding at December 31, 2018</td> <td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td> <td style="width: 9%; text-align: right">1,721,771</td> <td style="width: 1%; text-align: left">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">$</td> <td style="width: 9%; text-align: right">1.57</td> <td style="width: 1%; text-align: left">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td> <td style="width: 9%; text-align: right">4.0</td> <td style="width: 1%; text-align: left">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">$</td> <td style="width: 9%; text-align: right">&#8212;</td> <td style="width: 1%; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Granted</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">1,167,906</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">$</td> <td style="text-align: right">1.29</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">4.9</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">$</td> <td style="text-align: right">&#8212;</td> <td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255)"> <td>Exercised</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">(63,990</td> <td style="text-align: left">)</td> <td>&#160;</td> <td style="text-align: left">$</td> <td style="text-align: right">0.65</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#8212;</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">$</td> <td style="text-align: right">&#8212;</td> <td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Forfeited</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">(59,500</td> <td style="text-align: left">)</td> <td>&#160;</td> <td style="text-align: left">$</td> <td style="text-align: right">&#8212;</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#8212;</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">$</td> <td style="text-align: right">&#8212;</td> <td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255)"> <td style="padding-bottom: 1.5pt">Expired</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="text-align: left; border-bottom: black 1.5pt solid">&#160;</td> <td style="text-align: right; border-bottom: black 1.5pt solid">(18,510</td> <td style="text-align: left; padding-bottom: 1.5pt">)</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="text-align: left; padding-bottom: 1.5pt">$</td> <td style="text-align: right; padding-bottom: 1.5pt">&#8212;</td> <td style="text-align: left; padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="text-align: left; padding-bottom: 1.5pt">&#160;</td> <td style="text-align: right; padding-bottom: 1.5pt">&#8212;</td> <td style="text-align: left; padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="text-align: left; padding-bottom: 1.5pt">$</td> <td style="text-align: right; padding-bottom: 1.5pt">&#8212;</td> <td style="text-align: left; padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 4pt">Outstanding at September 30, 2019</td> <td style="padding-bottom: 4pt">&#160;</td> <td style="text-align: left; border-bottom: black 4pt double">&#160;</td> <td style="text-align: right; border-bottom: black 4pt double">2,747,677</td> <td style="text-align: left; padding-bottom: 4pt">&#160;</td> <td style="padding-bottom: 4pt">&#160;</td> <td style="text-align: left; padding-bottom: 4pt">$</td> <td style="text-align: right; padding-bottom: 4pt">1.40</td> <td style="text-align: left; padding-bottom: 4pt">&#160;</td> <td style="padding-bottom: 4pt">&#160;</td> <td style="text-align: left; padding-bottom: 4pt">&#160;</td> <td style="text-align: right; padding-bottom: 4pt">3.9</td> <td style="text-align: left; padding-bottom: 4pt">&#160;</td> <td style="padding-bottom: 4pt">&#160;</td> <td style="text-align: left; padding-bottom: 4pt">$</td> <td style="text-align: right; padding-bottom: 4pt">&#8212;</td> <td style="text-align: left; padding-bottom: 4pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255)"> <td>Exercisable at September 30, 2019</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">1,667,064</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">$</td> <td style="text-align: right">1.55</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">2.8</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">$</td> <td style="text-align: right">&#8212;</td> <td style="text-align: left">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 10pt/normal Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in">(1)</td> <td>The aggregate intrinsic value in the table was calculated based on the difference between the estimated fair market value of the Company's stock and the exercise price of the underlying options. The estimated stock values used in the calculation was $1.01 and $0.59 per share for the nine months ended September 30, 2019 and the year ended December 31, 2018, respectively.</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><b><i>&#160;</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b><i>Restricted Stock Units</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">The following table summarizes restricted stock unit activity for the nine months ended September 30, 2019:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 10pt/normal Times New Roman, Times, Serif; border-collapse: collapse; font-size-adjust: none; font-stretch: normal; width: 100%"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td> <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: black 1.5pt solid">Number of<br /> Units</td> <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td> <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td> <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: black 1.5pt solid">Weighted Average<br /> Grant-Date Fair<br /> Value Per Unit</td> <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255)"> <td style="width: 78%">Outstanding as of December 31, 2018</td> <td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td> <td style="width: 8%; text-align: right">136,245</td> <td style="width: 1%; text-align: left">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">$</td> <td style="width: 8%; text-align: right">0.98</td> <td style="width: 1%; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Granted</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">123,727</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">$</td> <td style="text-align: right">1.51</td> <td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255)"> <td>Vested</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">(142,507</td> <td style="text-align: left">)</td> <td>&#160;</td> <td style="text-align: left">$</td> <td style="text-align: right">1.10</td> <td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Forfeited</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#8212;</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">$</td> <td style="text-align: right">&#8212;</td> <td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255)"> <td>Outstanding as of September 30, 2019</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">117,465</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">$</td> <td style="text-align: right">1.42</td> <td style="text-align: left">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">&#160;&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">The stock-based compensation expense was recorded as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 10pt/normal Times New Roman, Times, Serif; border-collapse: collapse; font-size-adjust: none; font-stretch: normal; width: 100%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td> <td colspan="6" style="text-align: center; font-weight: bold; border-bottom: black 1.5pt solid">Three Months Ended<br /> September 30,</td> <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td> <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td> <td colspan="6" style="text-align: center; font-weight: bold; border-bottom: black 1.5pt solid">Nine Months Ended<br /> September 30,</td> <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td> <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: black 1.5pt solid">2019</td> <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td> <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td> <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: black 1.5pt solid">2018</td> <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td> <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td> <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: black 1.5pt solid">2019</td> <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td> <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td> <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: black 1.5pt solid">2018</td> <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255)"> <td style="width: 52%; text-align: left">Research and development</td> <td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">$</td> <td style="width: 9%; text-align: right">1</td> <td style="width: 1%; text-align: left">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">$</td> <td style="width: 9%; text-align: right">29</td> <td style="width: 1%; text-align: left">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">$</td> <td style="width: 9%; text-align: right">11</td> <td style="width: 1%; text-align: left">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">$</td> <td style="width: 9%; text-align: right">87</td> <td style="width: 1%; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: left; padding-bottom: 1.5pt">General and administrative</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="text-align: left; border-bottom: black 1.5pt solid">&#160;</td> <td style="text-align: right; border-bottom: black 1.5pt solid">203</td> <td style="text-align: left; padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="text-align: left; border-bottom: black 1.5pt solid">&#160;</td> <td style="text-align: right; border-bottom: black 1.5pt solid">326</td> <td style="text-align: left; padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="text-align: left; border-bottom: black 1.5pt solid">&#160;</td> <td style="text-align: right; border-bottom: black 1.5pt solid">664</td> <td style="text-align: left; padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="text-align: left; border-bottom: black 1.5pt solid">&#160;</td> <td style="text-align: right; border-bottom: black 1.5pt solid">3,003</td> <td style="text-align: left; padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255)"> <td style="text-align: left; padding-bottom: 4pt">Total stock-based compensation expense</td> <td style="padding-bottom: 4pt">&#160;</td> <td style="text-align: left; border-bottom: black 4pt double">$</td> <td style="text-align: right; border-bottom: black 4pt double">204</td> <td style="text-align: left; padding-bottom: 4pt">&#160;</td> <td style="padding-bottom: 4pt">&#160;</td> <td style="text-align: left; border-bottom: black 4pt double">$</td> <td style="text-align: right; border-bottom: black 4pt double">355</td> <td style="text-align: left; padding-bottom: 4pt">&#160;</td> <td style="padding-bottom: 4pt">&#160;</td> <td style="text-align: left; border-bottom: black 4pt double">$</td> <td style="text-align: right; border-bottom: black 4pt double">675</td> <td style="text-align: left; padding-bottom: 4pt">&#160;</td> <td style="padding-bottom: 4pt">&#160;</td> <td style="text-align: left; border-bottom: black 4pt double">$</td> <td style="text-align: right; border-bottom: black 4pt double">3,090</td> <td style="text-align: left; padding-bottom: 4pt">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">The allocation between research and development and selling, general and administrative expense was based on the department and services performed by the employee or non-employee.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">At September 30, 2019, the total compensation cost related to restricted stock units and unvested options not yet recognized was $1,205, which will be recognized over a weighted average period of 36 months, assuming the employees and non-employee<b>s</b> complete their service period required for vesting.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Note 12 - Commitments and Contingencies</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i>Legal Proceedings</i>&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">The Company may be subject to legal proceedings and claims arising from contracts or other matters from time to time in the ordinary course of business. Management is not aware of any pending or threatened litigation where the ultimate disposition or resolution could have a material adverse effect on its financial position, results of operations or liquidity.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">On February 20, 2018, New Enterprises, Ltd. ("New Enterprises"), filed a lawsuit against the Company and Roth Capital Partners, LLC ("Roth") in the U.S. District Court for the District of Arizona (the "Court"). The complaint alleges nine counts against the Company, including that the Company: engaged in common law fraud and securities fraud to induce the chairman of New Enterprises into investing in the Company; failed to register New Enterprises' requested transfer; breached stock certificates and the lock-up contract; tortuously interfered with prospective business advantage; and was liable for conversion. New Enterprises is seeking monetary damages, including compensatory damages, punitive damages, and attorney's fees. On December 3, 2018, the Court issued its order granting the Company's and Roth's motions to dismiss all of New Enterprises' claims but gave them leave to file a motion to amend the complaint.&#160;On January 25, 2019, New Enterprises moved for leave to file an amended complaint, alleging similar claims against the Company and Roth, and the court granted that motion. On April&#160;5, 2019, New Enterprises filed an amended complaint, alleging similar claims against the Company and Roth. The Company and Roth moved to dismiss the amended complaint, and on August 16, 2019, the Court issued its order denying the Company's and Roth's motions to dismiss. Roth has made a claim for indemnification to the Company based on contractual indemnification agreements, but to date the Company has not accepted Roth's indemnification demand.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">On April 20, 2018, the Company's former Executive Vice President and Chief Operating Officer Andrew Altman filed a charge of employment discrimination with the Equal Employment Opportunity Commission (EEOC) against the Company. Mr. Altman claimed that he was terminated after he expressed opposition to an email that Cheryl Dyer, Chief Research Officer, had sent out to the management team, in which she criticized a Mormon newspaper. The Company filed a position statement on May 21, 2018. No substantive action has been taken since then, and the Company has not heard anything further either from the EEOC or Mr. Altman's attorneys.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i>Lease Commitments</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i>&#160;</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">The Company is obligated under capital leases for certain research and computer equipment that expire on various dates through July 2023. At September 30, 2019, the gross amount of office and computer equipment, and research equipment and the related accumulated amortization recorded under the capital leases was $498 and $252, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">In February 2012, the Company entered into an operating lease for its corporate headquarters. The lease was due to expire in January 2015. In December 2013, the Company amended its lease to expand into the remaining area in the building and extended the term to December 31, 2019. In February 2014, the Company further amended the lease to expand into an adjacent building. The lease requires escalating rental payments over the lease term. Minimum rental payments under the operating lease are recognized on a straight-line basis over the term of the lease and accordingly, the Company records the difference between the cash rent payments and the recognition of rent expense as a deferred rent liability. The lease is guaranteed by the President of the Company. We are currently in discussions to extend the current lease.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">On November 16, 2016, we leased an additional 1,954 square feet of research and development space, also in Flagstaff. This lease expired on November 15, 2018 but was extended for an additional 24 months, through November 2020. A subsequent amendment to the lease allows for the Company to cancel the lease at any time through the lease term with 30-day notice. In June 2019, the Company cancelled approximately 1,000 square feet of this leased space, and the fixed rental payment was reduced for the remaining term of the lease. The lease extension requires fixed rental payments over the lease term. Minimum rental payments under the operating lease are recognized on a straight-line basis over the term of the lease as expense, and accordingly, the Company recorded no deferred rent liability under this lease.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">Total rent expense was $187 and $183 for the nine months ended September 30, 2019 and September 30, 2018, respectively. The future minimum lease payments under our non-cancellable operating lease and our capital lease as of September 30, 2019 are as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 10pt/normal Times New Roman, Times, Serif; border-collapse: collapse; font-size-adjust: none; font-stretch: normal; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: left">&#160;</td> <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td> <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: black 1.5pt solid">Capital<br /> Leases</td> <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td> <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td> <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: black 1.5pt solid">Operating<br /> Lease</td> <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left; font-weight: bold">Years Ending December 31,</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255)"> <td style="width: 78%; text-align: left">2019</td> <td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td> <td style="width: 8%; text-align: right">24</td> <td style="width: 1%; text-align: left">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td> <td style="width: 8%; text-align: right">62</td> <td style="width: 1%; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: left">2020</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">78</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">24</td> <td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255)"> <td style="text-align: left">2021</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">63</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#8212;</td> <td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: left">2022</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">33</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#8212;</td> <td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255)"> <td style="text-align: left; padding-bottom: 1.5pt">2023</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="text-align: left; border-bottom: black 1.5pt solid">&#160;</td> <td style="text-align: right; border-bottom: black 1.5pt solid">3</td> <td style="text-align: left; padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="text-align: left; border-bottom: black 1.5pt solid">&#160;</td> <td style="text-align: right; border-bottom: black 1.5pt solid">&#160;</td> <td style="text-align: left; padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: left; padding-bottom: 4pt">Total minimum lease payments</td> <td style="padding-bottom: 4pt">&#160;</td> <td style="text-align: left; border-bottom: black 4pt double">$</td> <td style="text-align: right; border-bottom: black 4pt double">201</td> <td style="text-align: left; padding-bottom: 4pt">&#160;</td> <td style="padding-bottom: 4pt">&#160;</td> <td style="text-align: left; border-bottom: black 4pt double">$</td> <td style="text-align: right; border-bottom: black 4pt double">86</td> <td style="text-align: left; padding-bottom: 4pt">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 10pt/normal Times New Roman, Times, Serif; border-collapse: collapse; font-size-adjust: none; font-stretch: normal; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center; padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td> <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: black 1.5pt solid">Capital <br /> Leases</td> <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td>&#160;</td> <td colspan="2" style="text-align: center">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255)"> <td style="width: 89%; text-align: left">Less: amounts representing interest (6.39%, ranging from 10.48% to 11.56%)</td> <td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">$</td> <td style="width: 8%; text-align: right">26</td> <td style="width: 1%; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255)"> <td style="text-align: left">Present value of minimum lease payments</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">175</td> <td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255)"> <td style="text-align: left; padding-bottom: 1.5pt">Less: current installments under capital lease obligations</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="text-align: left; border-bottom: black 1.5pt solid">&#160;</td> <td style="text-align: right; border-bottom: black 1.5pt solid">70</td> <td style="text-align: left; padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255)"> <td style="text-align: left; padding-bottom: 4pt">Total long-term portion</td> <td style="padding-bottom: 4pt">&#160;</td> <td style="text-align: left; border-bottom: black 4pt double">$</td> <td style="text-align: right; border-bottom: black 4pt double">105</td> <td style="text-align: left; padding-bottom: 4pt">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Reclassifications</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">Certain prior year amounts have been reclassified to conform to the current period presentation. These reclassifications had no material impact on net earnings, financial position or cash flows.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Accounts Receivable</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">Accounts receivable consist primarily of trade receivables. The Company provides an allowance for doubtful trade receivables equal to the estimated uncollectible amounts. That estimate is based on historical collection experience, current economic and market conditions and a review of the current status of each customer's trade accounts receivable. The allowance for doubtful trade receivables was less than $1 at September 30, 2019 and at December 31, 2018.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Inventories</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">Inventories are stated at the lower of cost or market value, using the first-in, first-out convention. Inventories consist of raw materials, work in progress and finished goods.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">Components of inventory are:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 10pt/normal Times New Roman, Times, Serif; border-collapse: collapse; font-size-adjust: none; font-stretch: normal; width: 100%"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap">&#160;</td> <td style="font-weight: bold; white-space: nowrap">&#160;</td> <td colspan="2" style="text-align: center; font-weight: bold; white-space: nowrap">September&#160;30,</td> <td style="font-weight: bold; white-space: nowrap">&#160;</td> <td style="font-weight: bold; white-space: nowrap">&#160;</td> <td colspan="2" style="text-align: center; font-weight: bold; white-space: nowrap">December&#160;31,</td> <td style="font-weight: bold; white-space: nowrap">&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td> <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: black 1.5pt solid">2019</td> <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td> <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td> <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: black 1.5pt solid">2018</td> <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255)"> <td style="width: 78%; text-align: left; text-indent: -8.65pt; padding-left: 8.65pt">Raw materials</td> <td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">$</td> <td style="width: 8%; text-align: right">1,063</td> <td style="width: 1%; text-align: left">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">$</td> <td style="width: 8%; text-align: right">1,111</td> <td style="width: 1%; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: left; text-indent: -8.65pt; padding-left: 8.65pt">Work in progress</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">3</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#8212;</td> <td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255)"> <td style="text-align: left; text-indent: -8.65pt; padding-bottom: 1.5pt; padding-left: 8.65pt">Finished goods</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="text-align: left; border-bottom: black 1.5pt solid">&#160;</td> <td style="text-align: right; border-bottom: black 1.5pt solid">223</td> <td style="text-align: left; padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="text-align: left; border-bottom: black 1.5pt solid">&#160;</td> <td style="text-align: right; border-bottom: black 1.5pt solid">154</td> <td style="text-align: left; padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: left; text-indent: -8.65pt; padding-left: 0.25in">Total inventory</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">1,289</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">1,265</td> <td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255)"> <td style="text-indent: -8.65pt; padding-left: 8.65pt">Less:</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: left; text-indent: -8.65pt; padding-bottom: 1.5pt; padding-left: 8.65pt">Reserve for obsolete</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="text-align: left; border-bottom: black 1.5pt solid">&#160;</td> <td style="text-align: right; border-bottom: black 1.5pt solid">(4</td> <td style="text-align: left; padding-bottom: 1.5pt">)</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="text-align: left; border-bottom: black 1.5pt solid">&#160;</td> <td style="text-align: right; border-bottom: black 1.5pt solid">(4</td> <td style="text-align: left; padding-bottom: 1.5pt">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255)"> <td style="text-align: left; text-indent: -8.65pt; padding-bottom: 4pt; padding-left: 8.65pt">Total net inventory</td> <td style="padding-bottom: 4pt">&#160;</td> <td style="text-align: left; border-bottom: black 4pt double">$</td> <td style="text-align: right; border-bottom: black 4pt double">1,285</td> <td style="text-align: left; padding-bottom: 4pt">&#160;</td> <td style="padding-bottom: 4pt">&#160;</td> <td style="text-align: left; border-bottom: black 4pt double">$</td> <td style="text-align: right; border-bottom: black 4pt double">1,261</td> </tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Prepaid Expenses</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">Prepaid expenses consist primarily of payments made for director and officer insurance, director compensation, rent, legal and inventory purchase deposits and seminar fees to be expensed in the current year.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Property and Equipment</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">Property and equipment are stated at cost less accumulated depreciation. Equipment held under capital leases are stated at the present value of minimum lease payments less accumulated amortization.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">Depreciation on property and equipment is computed using the straight-line method over the estimated useful lives of the respective assets. The cost of leasehold improvements is amortized over the life of the improvement or the term of the lease, whichever is shorter. Equipment held under capital leases is amortized over the shorter of the lease term or estimated useful life of the asset. The Company incurs repair and maintenance costs on its major equipment, which are expensed as incurred.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Impairment of Long-Lived Assets</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">Long-lived assets, such as property and equipment, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. If circumstances require long-lived assets or asset groups to be tested for possible impairment, the Company compares the undiscounted cash flows expected to be generated from the use of the asset or asset group to its carrying amount. If the carrying amount of the long-lived asset or asset group is not recoverable on an undiscounted cash flow basis, an impairment charge is recognized to the extent that the carrying amount exceeds its fair value. Fair value is determined through various valuation techniques, such as discounted cash flow models and the use of third-party independent appraisals. The Company has not recorded an impairment of long-lived assets since its inception.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Revenue Recognition</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">Effective January 1, 2018, the Company adopted ASC 606 &#8212; <i>Revenue from Contracts with Customers. </i>Under ASC 606, the Company recognizes revenue from the commercial sales of products, licensing agreements and contracts to perform pilot studies by applying the following steps: (1) identify the contract with a customer; (2) identify the performance obligations in the contract; (3) determine the transaction price; (4) allocate the transaction price to each performance obligation in the contract; and (5) recognize revenue when each performance obligation is satisfied. For the comparative periods, revenue has not been adjusted and continues to be reported under ASC 605 &#8212; <i>Revenue Recognition. </i>Under ASC 605, revenue is recognized when the following criteria are met: (1) persuasive evidence of an arrangement exists; (2) the performance of service has been rendered to a customer or delivery has occurred; (3) the amount of the fee to be paid by a customer is fixed and determinable; and (4) the collectability of the fee is reasonably assured. The performance obligations identified by the Company under Accounting Standards Codification ("ASC") Topic 606, Revenue From Contracts With Customers, are straightforward and similar to the unit of account and performance obligation determination under ASC Topic 605, <i>Revenue Recognition</i>. There was no impact on the Company's financial statements as a result of adopting ASC 606 for the three months or nine months ended September 30, 2019 and 2018, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">The Company recognizes revenue when product leaves its dock at a fixed selling price on payment terms of 30 to 120 days from invoicing. The Company recognizes other revenue earned from pilot studies upon the performance of specific services under the respective service contract.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">The Company derives revenue primarily from commercial sales of products.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Research and Development</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">Research and development costs are expensed as incurred. Research and development expenses primarily consist of salaries and benefits for research and development employees, stock-based compensation, consulting fees, lab supplies, costs incurred related to conducting scientific trials and field studies, and regulatory compliance costs. Also, included in research and development expenses is an allocation of facilities related costs, including depreciation of research and development equipment.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Stock-based Compensation</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">Employee stock-based awards, consisting of restricted stock units and stock options expected to be settled in shares of the Company's common stock, are recorded as equity awards. The grant date fair value of stock options is measured using the Black-Scholes option pricing model. The Company expenses the grant date fair value of its stock options on a straight-line basis over their respective vesting periods. Performance-based awards are expensed over the performance period when the related performance goals are probable of being achieved.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">For equity instruments issued to non-employees, the stock-based consideration is measured using a fair value method. The measurement of the stock-based compensation is subject to re-measurement as the underlying equity instruments vest.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">The stock-based compensation expense recorded for the three and nine months ended September 30, 2019 and 2018,&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">is as follows:</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 10pt/normal Times New Roman, Times, Serif; border-collapse: collapse; font-size-adjust: none; font-stretch: normal; width: 100%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; white-space: nowrap">&#160;</td> <td style="padding-bottom: 1.5pt; font-weight: bold; white-space: nowrap">&#160;</td> <td colspan="6" style="text-align: center; font-weight: bold; border-bottom: black 1.5pt solid; white-space: nowrap">Three Months Ended<br /> September 30,</td> <td style="padding-bottom: 1.5pt; font-weight: bold; white-space: nowrap">&#160;</td> <td style="padding-bottom: 1.5pt; font-weight: bold; white-space: nowrap">&#160;</td> <td colspan="6" style="text-align: center; font-weight: bold; border-bottom: black 1.5pt solid; white-space: nowrap">Nine Months Ended<br /> September 30,</td> <td style="padding-bottom: 1.5pt; font-weight: bold; white-space: nowrap">&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td> <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: black 1.5pt solid">2019</td> <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td> <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td> <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: black 1.5pt solid">2018</td> <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td> <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td> <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: black 1.5pt solid">2019</td> <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td> <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td> <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: black 1.5pt solid">2018</td> <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255)"> <td style="width: 52%; text-align: left">Research and development</td> <td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">$</td> <td style="width: 9%; text-align: right">1</td> <td style="width: 1%; text-align: left">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">$</td> <td style="width: 9%; text-align: right">29</td> <td style="width: 1%; text-align: left">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">$</td> <td style="width: 9%; text-align: right">11</td> <td style="width: 1%; text-align: left">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">$</td> <td style="width: 9%; text-align: right">87</td> <td style="width: 1%; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: left; padding-bottom: 1.5pt">General and administrative</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="text-align: left; border-bottom: black 1.5pt solid">&#160;</td> <td style="text-align: right; border-bottom: black 1.5pt solid">203</td> <td style="text-align: left; padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="text-align: left; border-bottom: black 1.5pt solid">&#160;</td> <td style="text-align: right; border-bottom: black 1.5pt solid">326</td> <td style="text-align: left; padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="text-align: left; border-bottom: black 1.5pt solid">&#160;</td> <td style="text-align: right; border-bottom: black 1.5pt solid">661</td> <td style="text-align: left; padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="text-align: left; border-bottom: black 1.5pt solid">&#160;</td> <td style="text-align: right; border-bottom: black 1.5pt solid">3,003</td> <td style="text-align: left; padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255)"> <td style="text-align: left; padding-bottom: 4pt">Total stock-based compensation expense</td> <td style="padding-bottom: 4pt">&#160;</td> <td style="text-align: left; border-bottom: black 4pt double">$</td> <td style="text-align: right; border-bottom: black 4pt double">204</td> <td style="text-align: left; padding-bottom: 4pt">&#160;</td> <td style="padding-bottom: 4pt">&#160;</td> <td style="text-align: left; border-bottom: black 4pt double">$</td> <td style="text-align: right; border-bottom: black 4pt double">355</td> <td style="text-align: left; padding-bottom: 4pt">&#160;</td> <td style="padding-bottom: 4pt">&#160;</td> <td style="text-align: left; border-bottom: black 4pt double">$</td> <td style="text-align: right; border-bottom: black 4pt double">675</td> <td style="text-align: left; padding-bottom: 4pt">&#160;</td> <td style="padding-bottom: 4pt">&#160;</td> <td style="text-align: left; border-bottom: black 4pt double">$</td> <td style="text-align: right; border-bottom: black 4pt double">3,090</td> <td style="text-align: left; padding-bottom: 4pt">&#160;</td></tr> </table> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">See Note 11 for additional discussion on stock-based compensation.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Income Taxes</b></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">Company accounts for income taxes under the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements. Under this method, deferred tax assets and liabilities are determined based on the differences between the financial statement and tax bases of assets and liabilities and net operating loss carryforwards using enacted tax rates in effect for the year in which the differences are expected to reverse. The effect of a change in tax rates on deferred tax assets and liabilities is recognized in the period that includes the enactment date.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">The Company records net deferred tax assets to the extent it believes these assets will more likely than not be realized. These deferred tax assets are subject to periodic assessments as to recoverability and if it is determined that it is more likely than not that the benefits will not be realized, valuation allowances are recorded which would increase the provision for income taxes. In making such determination, the Company considers all available positive and negative evidence, including future reversals of existing taxable temporary differences, projected future taxable income, tax planning strategies and recent financial operations. The Company currently maintains a full allowance against its deferred tax assets.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">The Company applies a more-likely-than-not recognition threshold for all tax uncertainties. Only those benefits that have a greater than fifty percent likelihood of being sustained upon examination by the taxing authorities are recognized. Based on its evaluation, the Company has concluded there are no significant uncertain tax positions requiring recognition in its financial statements.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: left">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">The Company recognizes interest and/or penalties related to uncertain tax positions in income tax expense. There are no uncertain tax positions as of September 30, 2019 or December 31, 2018 and as such, no interest or penalties were recorded in income tax expense.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Comprehensive Loss</b></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">Net loss and comprehensive loss were the same for all periods presented; therefore, a separate statement of comprehensive loss is not included in the accompanying financial statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Loss Per Share Attributable to Common Stockholders</b></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">Basic loss per share attributable to common stockholders is calculated by dividing the net loss attributable to common stockholders by the weighted average number of common shares outstanding during the period. Diluted loss per share attributable to common stockholders is computed by dividing the loss attributable to common stockholders by the weighted average number of common shares and potentially dilutive securities outstanding for the period determined using the treasury stock and if-converted methods. For purposes of the computation of diluted loss per share attributable to common stockholders, common stock purchase warrants, and common stock options are considered to be potentially dilutive securities but have been excluded from the calculation of diluted loss per share attributable to common stockholders because their effect would be anti-dilutive given the net loss reported for the three and nine months ended September 30, 2019 and 2018. Therefore, basic and diluted loss per share attributable to common stockholders are the same for each period presented.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">The following table sets forth the outstanding potentially dilutive securities that have been excluded in the calculation of diluted loss per share attributable to common stockholders (in common stock equivalent shares):</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 10pt/normal Times New Roman, Times, Serif; border-collapse: collapse; font-size-adjust: none; font-stretch: normal; width: 100%"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap">&#160;</td> <td style="padding-bottom: 1.5pt; font-weight: bold; white-space: nowrap">&#160;</td> <td colspan="6" style="text-align: center; font-weight: bold; border-bottom: black 1.5pt solid; white-space: nowrap">September 30,</td> <td style="padding-bottom: 1.5pt; font-weight: bold; white-space: nowrap">&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td> <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: black 1.5pt solid">2019</td> <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td> <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td> <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: black 1.5pt solid">2018</td> <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255)"> <td style="width: 78%; text-align: left">Common stock purchase warrants</td> <td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td> <td style="width: 8%; text-align: right">9,783,278</td> <td style="width: 1%; text-align: left">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td> <td style="width: 8%; text-align: right">11,714,940</td> <td style="width: 1%; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: left">Restricted stock unit</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">117,465</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">172,912</td> <td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255)"> <td style="text-align: left; padding-bottom: 1.5pt">Common stock options</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="text-align: left; border-bottom: black 1.5pt solid">&#160;</td> <td style="text-align: right; border-bottom: black 1.5pt solid">2,747,677</td> <td style="text-align: left; padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="text-align: left; border-bottom: black 1.5pt solid">&#160;</td> <td style="text-align: right; border-bottom: black 1.5pt solid">1,725,771</td> <td style="text-align: left; padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 4pt; padding-left: 9pt">Total</td> <td style="padding-bottom: 4pt">&#160;</td> <td style="text-align: left; border-bottom: black 4pt double">&#160;</td> <td style="text-align: right; border-bottom: black 4pt double">12,648,420</td> <td style="text-align: left; padding-bottom: 4pt">&#160;</td> <td style="padding-bottom: 4pt">&#160;</td> <td style="text-align: left; border-bottom: black 4pt double">&#160;</td> <td style="text-align: right; border-bottom: black 4pt double">13,613,623</td> </tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Adoption of New Accounting Standards<i>:</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">In May 2014, the FASB issued ASU 2014-09, <i>Revenue from Contracts with Customers</i>. Since ASU 2014-09 was issued, several additional ASUs have been issued to clarify various elements of the guidance. These standards provide guidance on recognizing revenue, including a five-step model to determine when revenue recognition is appropriate. The standard requires that an entity recognize revenue to depict the transfer of control of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. Effective January 1, 2018, the Company adopted ASU 2014-09, <i>"Revenue from Contracts with Customers" </i>using the modified retrospective method to all contracts that were not completed as of the date of adoption. The results of operations for reported periods after January 1, 2018 are presented under this amended guidance, while prior period amounts are reported in accordance with ASC 605 &#8212; <i>Revenue Recognition</i>. There was no material impact on our financial position, results of operations, or cash flows.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">In January 2016, the FASB issued ASU 2016-01, <i>Recognition and Measurement of Financial Assets and Financial Liabilities </i>("ASU 2016-01"). This standard affects the accounting for equity instruments, financial liabilities under the fair value option and the presentation and disclosure requirements of financial instruments. ASU 2016-01 is effective the first quarter of 2018. The Company has adopted the provisions of ASU 2016-01 on its financial statements. There was no material impact on our financial position, results of operations, or cash flows.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">In February 2016, the FASB issued ASU 2016-02, <i>Leases </i>("ASU 2016-02"). This standard amends various aspects of existing accounting guidance for leases, including the recognition of a right-of-use asset and a lease liability on the balance sheet for all leases with terms longer than 12 months. Leases will be classified as either finance or operating, with classification affecting the pattern of expense recognition in the income statement. This standard also introduces new disclosure requirements for leasing arrangements. ASU 2016-02 is effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years for public business entities. Early adoption was permitted, and the new standard had been adopted using a modified retrospective approach and provides for certain practical expedients.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">On January 1, 2019, the Company adopted the new leasing standard and all related amendments. The Company elected the optional transition method provided by the FASB in ASU 2018-11,&#160;<i>Leases (Topic 842): Targeted Improvements</i>, and as a result, has not restated its condensed consolidated financial statements for prior periods presented. The Company has elected the practical expedients upon transition to retain the lease classification and initial direct costs for any leases that existed prior to adoption. The Company has also not reassessed whether any contracts entered into prior to adoption are leases.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">ASU 2016-02 did not have a material impact on the Company's Condensed Consolidated Statements of Comprehensive Income. The cumulative effect of the changes made to the Company's Consolidated Balance Sheet as of January 1, 2019 for the adoption of the new leasing standard was as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.25in">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 10pt/normal Times New Roman, Times, Serif; border-collapse: collapse; font-size-adjust: none; font-stretch: normal; width: 100%"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td> <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: black 1.5pt solid">Balance @<br /> December&#160;31, 2018</td> <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td> <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td> <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: black 1.5pt solid">Adjustment Due<br /> to ASC 842</td> <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td> <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td> <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: black 1.5pt solid">Balance @<br /> January&#160;1,<br /> 2019</td> <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255)"> <td style="width: 67%; text-align: left">Right to Use Asset - Long Term</td> <td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td> <td style="width: 8%; text-align: right">&#8212;</td> <td style="width: 1%; text-align: left">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">$</td> <td style="width: 8%; text-align: right">87</td> <td style="width: 1%; text-align: left">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">$</td> <td style="width: 8%; text-align: right">87</td> <td style="width: 1%; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255)"> <td style="text-align: left">Lease Liability &#8211; Long Term</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#8212;</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">$</td> <td style="text-align: right">(87</td> <td style="text-align: left">)</td> <td>&#160;</td> <td style="text-align: left">$</td> <td style="text-align: right">(87</td> <td style="text-align: left">)</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.25in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">At September 30, 2019, the balance remaining in Right to Use Asset-Long Term and Lease Liability-Long Term was $29,000 and ($29,000) respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">The Company determines if an arrangement is a lease at lease inception. Operating lease right-of-use (ROU) assets and operating lease liabilities are recognized based on the present value of the future minimum lease payments over the lease term at commencement date. As most of the Company's lease contracts do not include an implicit rate, the Company uses its incremental borrowing rate based on information available at commencement date in determining the present value of future payments. The incremental borrowing rate is estimated to approximate the interest rate on a collateralized basis with similar terms and payments, and in economic environments where the leased asset is located. The operating lease ROU asset also includes any initial direct costs and lease payments made prior to lease commencement and excludes lease incentives incurred.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">The Company's lease terms may include options to extend or terminate the lease when it is reasonably certain that we will exercise that option. Operating lease expense for minimum lease payments is recognized on a straight-line basis over the lease term. The Company has certain lease agreements that contain both lease and non-lease components, which it has elected to account for as a single lease component for all asset classes.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">See Note 12, Commitments and Contingencies, for future minimum lease payments and maturities.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Accounting Standards Issued but Not Yet Adopted</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">In August 2018, the FASB issued authoritative guidance intended to address a customer's accounting for implementation costs incurred in a cloud computing arrangement that is a service contract. This guidance aligns the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software. The guidance also requires presentation of the capitalized implementation costs in the statement of financial position and in the statement of cash flows in the same line item that a prepayment for the fees of the associated hosting arrangement would be presented, and the expense related to the capitalized implementation costs to be presented in the same line item in the statement of operations as the fees associated with the hosting element (service) of the arrangement. This guidance is effective for annual periods beginning after December&#160;15, 2019, including interim periods within those annual periods, with early adoption permitted. We are currently evaluating the potential impact on our financial position, results of operations and statement of cash flows upon adoption of this guidance. We do not expect this guidance to have a significant impact, or potential significant impact, to our unaudited condensed consolidated interim financial statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">Other than the items noted above, there have been no new accounting pronouncements not yet effective or adopted in the current year that we believe have a significant impact, or potential significant impact, to our unaudited condensed consolidated interim financial statements.</p> 311 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><b>Note 13 - Subsequent Events</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On November 1, 2019, the Company net issued 311 shares of common stock in satisfaction of a cashless exercise of vested common stock options.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Company has evaluated subsequent events from the balance sheet date through November 14, 2019, the date at which the financial statements were issued, and determined that there were no other items that require adjustment to or disclosure in the financial statements.</p> Shorter of lease term or estimated useful life There was no change (net) in the fair value of the common stock warrant for the three and nine months ended September 30, 2019. If there had been, it would have been recorded to other income (expense) and interest expense in the statements of operations and comprehensive loss. The common stock warrants issued in November 2017 with an initial exercise price of $1.50 per share adjusted downward to $0.95 per share effective July 24, 2018 in connection with our Rights Offering (as defined in Note 9 below), and may be subject to further downward adjustments, pursuant to antidilution price adjustment protection contained within those warrants. The aggregate intrinsic value in the table was calculated based on the difference between the estimated fair market value of the Company's stock and the exercise price of the underlying options. The estimated stock values used in the calculation was $1.01 and $0.59 per share for the nine months ended September 30, 2019 and the year ended December 31, 2018, respectively. In August 2019, the Company disposed of computer equipment with a net book value of $2 resulting in a loss on the disposal of fixed assets of less than $1. In April and May 2019, the Company disposed of obsolete computer equipment with a net book value of $2 resulting in a loss on disposal of fixed assets of $2. EX-101.SCH 7 snes-20190930.xsd XBRL SCHEMA FILE 00000001 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - CONDENSED BALANCE SHEETS (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - CONDENSED BALANCE SHEETS (Unaudited) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - CONDENSED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT) (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000006 - Statement - CONDENSED STATEMENTS OF CASH FLOWS (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000007 - Disclosure - Organization and Description of Business link:presentationLink link:calculationLink link:definitionLink 00000008 - Disclosure - Summary of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 00000009 - Disclosure - Fair Value Measurements link:presentationLink link:calculationLink link:definitionLink 00000010 - Disclosure - Credit Risk link:presentationLink link:calculationLink link:definitionLink 00000011 - Disclosure - Prepaid Expenses link:presentationLink link:calculationLink link:definitionLink 00000012 - Disclosure - Property and Equipment link:presentationLink link:calculationLink link:definitionLink 00000013 - Disclosure - Accrued Expenses link:presentationLink link:calculationLink link:definitionLink 00000014 - Disclosure - Borrowings link:presentationLink link:calculationLink link:definitionLink 00000015 - Disclosure - Common Stock Warrants and Common Stock Warrant Liability link:presentationLink link:calculationLink link:definitionLink 00000016 - Disclosure - Stockholders' Deficit link:presentationLink link:calculationLink link:definitionLink 00000017 - Disclosure - Stock-based Compensation link:presentationLink link:calculationLink link:definitionLink 00000018 - Disclosure - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 00000019 - Disclosure - Subsequent Events link:presentationLink link:calculationLink link:definitionLink 00000020 - Disclosure - Summary of Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 00000021 - Disclosure - Summary of Significant Accounting Policies (Tables) link:presentationLink link:calculationLink link:definitionLink 00000022 - Disclosure - Fair Value Measurements (Tables) link:presentationLink link:calculationLink link:definitionLink 00000023 - Disclosure - Prepaid Expenses (Tables) link:presentationLink link:calculationLink link:definitionLink 00000024 - Disclosure - Property and Equipment (Tables) link:presentationLink link:calculationLink link:definitionLink 00000025 - Disclosure - Accrued Expenses (Tables) link:presentationLink link:calculationLink link:definitionLink 00000026 - Disclosure - Borrowings (Tables) link:presentationLink link:calculationLink link:definitionLink 00000027 - Disclosure - Common Stock Warrants and Common Stock Warrant Liability (Tables) link:presentationLink link:calculationLink link:definitionLink 00000028 - Disclosure - Stock-based Compensation (Tables) link:presentationLink link:calculationLink link:definitionLink 00000029 - Disclosure - Commitments and Contingencies (Tables) link:presentationLink link:calculationLink link:definitionLink 00000030 - Disclosure - Organization and Description of Business (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000031 - Disclosure - Summary of Significant Accounting Policies (Details) link:presentationLink link:calculationLink link:definitionLink 00000032 - Disclosure - Summary of Significant Accounting Policies (Details 1) link:presentationLink link:calculationLink link:definitionLink 00000033 - Disclosure - Summary of Significant Accounting Policies (Details 2) link:presentationLink link:calculationLink link:definitionLink 00000034 - Disclosure - Summary of Significant Accounting Policies (Details 3) link:presentationLink link:calculationLink link:definitionLink 00000035 - Disclosure - Summary of Significant Accounting Policies (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000036 - Disclosure - Fair Value Measurements (Details) link:presentationLink link:calculationLink link:definitionLink 00000037 - Disclosure - Prepaid Expenses (Details) link:presentationLink link:calculationLink link:definitionLink 00000038 - Disclosure - Property and Equipment (Details) link:presentationLink link:calculationLink link:definitionLink 00000039 - Disclosure - Property and Equipment (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000040 - Disclosure - Accrued Expenses (Details) link:presentationLink link:calculationLink link:definitionLink 00000041 - Disclosure - Borrowings (Details) link:presentationLink link:calculationLink link:definitionLink 00000042 - Disclosure - Borrowings (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000043 - Disclosure - Common Stock Warrants and Common Stock Warrant Liability (Details) link:presentationLink link:calculationLink link:definitionLink 00000044 - Disclosure - Common Stock Warrants and Common Stock Warrant Liability (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000045 - Disclosure - Stockholders' Deficit (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000046 - Disclosure - Stock-based Compensation (Details) link:presentationLink link:calculationLink link:definitionLink 00000047 - Disclosure - Stock-based Compensation (Details 1) link:presentationLink link:calculationLink link:definitionLink 00000048 - Disclosure - Stock-based Compensation (Details 2) link:presentationLink link:calculationLink link:definitionLink 00000049 - Disclosure - Stock-based Compensation (Details 3) link:presentationLink link:calculationLink link:definitionLink 00000050 - Disclosure - Stock-based Compensation (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000051 - Disclosure - Commitments and Contingencies (Details) link:presentationLink link:calculationLink link:definitionLink 00000052 - Disclosure - Commitments and Contingencies (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000053 - Disclosure - Subsequent Events (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 8 snes-20190930_cal.xml XBRL CALCULATION FILE EX-101.DEF 9 snes-20190930_def.xml XBRL DEFINITION FILE EX-101.LAB 10 snes-20190930_lab.xml XBRL LABEL FILE Property, Plant and Equipment, Type [Axis] Obsolete Computer Equipment [Member] Equity Components [Axis] Common Stock [Member] Additional Paid-In Capital [Member] Accumulated Deficit [Member] Research and Development Equipment [Member] Office and Computer Equipment [Member] Autos [Member] Furniture and Fixtures [Member] Leasehold Improvements [Member] Stock Subscription Payable [Member] Long-term Debt, Type [Axis] Capital Lease Obligations [Member] Other Promissory Notes [Member] Range [Axis] Maximum [Member] Minimum [Member] Income Statement Location [Axis] Research and Development Expense [Member] General and Administrative Expenses [Member] Antidilutive Securities [Axis] Common Stock Purchase Warrants [Member] Restricted Stock Units [Member] Common Stock Options [Member] Restatement [Axis] Adjustment Due to ASC 842 [Member] Measurement Frequency [Axis] Fair Value Measurements, Recurring [Member] Fair Value, Hierarchy [Axis] Fair Value Inputs, Level 1 [Member] Fair Value Inputs, Level 2 [Member] Fair Value Inputs, Level 3 [Member] Cash and Cash Equivalents [Axis] Money Market Funds [Member] Financial Instrument [Axis] Corporate Fixed Income Debt Securities [Member] Class of Warrant or Right [Axis] Warrants issued [Member] Common Stock Offering Warrants Issued [Member] Common Stock Offering - Dealer Manager Warrants [Member] Common Stock Offering Underwriter Warrants [Member] University of Arizona Common Stock Warrant [Member] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] License Agreement [Member] Common Stock Warrant Issued to Underwriter of Common Stock Offering [Member] Related Party Transactions By Related Party [Axis] H.C. Wainwright & Co [Member] Common Stock Warrants Issued To Participants in Offering of the Company's Common Stock [Member] Sale of Stock [Axis] Public Offering [Member] Right Offering [Member] Statement Equity Components [Axis] Warrant [Member] Legal Entity [Axis] Maxim Partners LLC [Member] New Warrants November 8, 2017 [Member] Award Type [Axis] Restricted Stock [Member] Public Offering [Member] Class of Stock [Axis] Series A Preferred Stock [Member] Series A Convertible Preferred Stock [Member] Title of Individual [Axis] Chief Executive Officer [Member] Employees [Member] Warrants [Member] Employee [Member] Plan Name [Axis] Equity Incentive Plan 2018 [Member] Stock Option Plan 2008-2009 [Member] Research and Development [Member] Subsequent Event Type [Axis] Subsequent Event [Member] Document And Entity Information Entity Registrant Name Entity Central Index Key Document Type Document Period End Date Amendment Flag Current Fiscal Year End Date Entity Reporting Status Current Entity File Number Entity Incorporation, State or Country Code Entity Filer Category Entity Interactive Data Current Entity Small Business Entity Emerging Growth Company Entity Ex Transition Period Entity Shell Company Title of 12(b) Security Trading Symbol Security Exchange Name Entity Common Stock, Shares Outstanding Document Fiscal Period Focus Document Fiscal Year Focus Statement of Financial Position [Abstract] ASSETS Current assets: Cash Accounts receivable Prepaid expenses Inventory Deposits Total current assets Right to use asset-operating leases Property and equipment, net Total assets LIABILITIES AND STOCKHOLDERS' EQUITY Current liabilities: Short-term debt Accounts payable Accrued expenses Total current liabilities Long-term debt, net Operating lease liability Common stock warrant liability Deferred rent Total liabilities Commitments and contingencies (See note 12) Stockholders' equity: Common stock, $0.001 par value, 100,000,000 shares authorized, 28,288,285 and 23,471,999 shares issued and outstanding at September 30, 2019 and December 31, 2018, respectively Additional paid-in capital Accumulated deficit Total stockholders' equity Total liabilities and stockholders' equity Common stock, par value (in dollars per share) Common stock, authorized Common stock, issued Common stock, outstanding Income Statement [Abstract] Revenue: Sales Cost of sales Gross profit (loss) Operating expenses: Research and development Selling, general and administrative Total operating expenses Net operating loss Other income (expense): Interest income Interest expense Other income (expense) Total other income (expense) Net loss and comprehensive loss Deemed dividend-warrant price protection adjustment Net loss attributable to common shareholders Weighted average common shares outstanding - basic and fully diluted (in shares) Net loss per common share - basic and fully diluted (in dollars per share) Statement [Table] Statement [Line Items] Increase (Decrease) in Stockholders' Equity [Roll Forward] Balance at beginning Balance at beginning (in shares) Issuance of common stock for services Issuance of common stock for services (in shares) Issuance of common stock, sold for cash, net Issuance of common stock, sold for cash, net (in shares) Stock-based compensation Warrant antidilution price protection adjustment Payments for employee withholding taxes related to share-based awards Stock subscribed but not issued Issuance of common stock upon exercise of warrants Issuance of common stock upon exercise of warrants (in shares) Issuance of common stock upon cashles exercise of stock options Issuance of common stock upon cashless exercise of stock options (in shares) Net loss Balance at ending Balance at ending (in shares) Statement of Cash Flows [Abstract] CASH FLOWS FROM OPERATING ACTIVITIES Adjustments to reconcile net loss to net cash used in operating activities: Gain on investments held to maturity Bad debts expense Depreciation and amortization Stock-based compensation Loss on sale of equipment Loss on early extinguishment of debt Loss on remeasurement of common stock warrant liability (Increase) decrease in current assets: Accounts receivable Prepaid expenses Inventory Deposits Increase (decrease) in current liabilities: Accounts payable Accrued expenses Deferred rent Net cash used in operating activities CASH FLOWS FROM INVESTING ACTIVITIES Proceeds received on sale of securities held to maturity Proceeds received on sale of equipment Purchase of property and equipment Net cash provided by (used in) investing activities CASH FLOWS FROM FINANCING ACTIVITIES Proceeds from the issuance of common stock, net Proceeds from the issuance of notes payable Repayments of notes payable Repayments of notes payable, related parties Repayments of capital lease obligations Proceeds from the exercise of warrants Payment of employee withholding taxes related to share-based awards Net cash provided by financing activities NET CHANGE IN CASH CASH AT BEGINNING OF PERIOD CASH AT END OF PERIOD SUPPLEMENTAL INFORMATION: Interest paid Income taxes paid NON-CASH INVESTING AND FINANCING ACTIVITIES: Deemed dividend Purchases of equipment under capital lease obligations Common stock issued on accrued bonus Organization, Consolidation and Presentation of Financial Statements [Abstract] Organization and Description of Business Accounting Policies [Abstract] Summary of Significant Accounting Policies Fair Value Disclosures [Abstract] Fair Value Measurements Risks and Uncertainties [Abstract] Credit Risk Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract] Prepaid Expenses Property, Plant and Equipment [Abstract] Property and Equipment Payables and Accruals [Abstract] Accrued Expenses Debt Disclosure [Abstract] Borrowings Warrants and Rights Note Disclosure [Abstract] Common Stock Warrants and Common Stock Warrant Liability Equity [Abstract] Stockholders' Deficit Share-based Payment Arrangement [Abstract] Stock-based Compensation Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Subsequent Events [Abstract] Subsequent Events Use of Estimates Reclassifications Accounts Receivable Inventories Prepaid Expenses Property and Equipment Impairment of Long-Lived Assets Revenue Recognition Research and Development Stock-based Compensation Income Taxes Comprehensive Loss Loss Per Share Attributable to Common Stockholders Adoption of New Accounting Standards: Accounting Standards Issued but Not Yet Adopted Schedule of inventory Schedule of employee stock-based compensation expense Schedule of outstanding potentially dilutive securities calculation of diluted loss per share attributable to common stockholders Schedule of cumulative effect of the changes made to the Company's Consolidated Balance Sheet Schedule of fair value of financial instruments Schedule of prepaid expenses Schedule of property and equipment Schedule of accrued expenses Schedule of capital lease obligations Schedule of common stock warrant activity Schedule of fair value of options granted Schedule of stock option activity Schedule of summarizes restricted stock unit activity Schedule of stock-based compensation expense Schedule of the future minimum lease payments under non-cancellable operating lease and future minimum capital lease payments Number of shares issued Exercise price (in dollars per share) Unit price (in dollars per unit) Shares issued per share (in dollars per share) Proceeds from the exercise of warrants Proceeds from issuance and sale of common stock, preferred stock, warrants exercise, convertible and other promissory notes Proceeds from licensing fees Proceeds from product sales Cash, cash equivalents and short-term investments Number of subscriptions shares accept Common Stock Offering Warrants Issued Raw materials Work in progress Finished goods Total inventory Less: reserve for obsolete Total net inventory Total stock-based compensation expense Total Right to Use Asset - Long Term Lease Liability - Long Term Allowance for doubtful trade receivables Fair Value, Recurring and Nonrecurring [Table] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value Hierarchy and NAV [Axis] Financial Assets: Held-to-maturity Securities, Fair Value Total Financial Liabilities: Common stock warrant liability Total Director compensation Director and officer insurance NASDAQ fees Legal retainer Marketing programs and conferences Professional services retainer Rent Equipment service deposits Foreign patent registration Engineering, software licenses and other Total prepaid expenses Property, Plant and Equipment, Gross Less accumulated depreciation and amortization Total Property, Plant and Equipment, Useful Life Net book value Loss on the disposal of fixed assets Depreciation and amortization expense Compensation and related benefits Accrued Litigation Board Compensation Other Total accrued expenses Short-term debt: Current portion of long-term debt Total short-term debt Long-term debt: Capital lease obligations Other promissory notes Total Less: current portion of long-term debt Total long-term debt Statistical Measurement [Axis] Description of borrowings expiration period Interest rate on borrowings Outstanding at beginning Warrants issued Warrants Exercised Warrants Exercised Expired Warrants Date Issued Date Issued Date issued Term Excercise price (in dollars per share) Exercise Price (in dollars per share) Exercise Price (in dollars per share) Outstanding at ending Related Party [Axis] Warrants exercised Number of warrant purchased Warrant term Description of method used Share price (in dollars per share) Fair value of common stock warrant Expected volatility rate Expected term Expected dividend rate Risk free interest rate Change in fair value of the derivative warrant liability Derivative liability Fair value adjustment of warrants Proceeds from warrant exercises Stock compensation expense Number of share issued in transaction Deemed dividend Unexercised warrants Preferred stock, authorized Preferred stock, par value (in dollars per share) Common stock, shares, issued Common stock, shares, outstanding Aggregate number of stock issued Gross proceeds Cashless exercise of vested stock options Settlement of compensation Warrants exercised Cashless exercise of stock options Settlement of compensation (in shares) Number of shares issued for services Aggregate number of warrant excercise Number of shares issued in transaction Price per share (in dollars per share) Proceeds from public offering Number of warrant to purchase Exercise price of warrants (in dollars per share) Expected volatility Expected dividend yield Expected term (in years) Risk-free interest rate Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward] Outstanding at beginning Granted Exercised Forfeited Expired Outstanding at ending Exercisable at ending Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Roll Forward] Outstanding at beginning Granted Exercised Forfeited Expired Outstanding at ending Exercisable at ending Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Life [Roll Forward] Outstanding at beginning Granted Outstanding at ending Exercisable at ending Share-based Compensation Arrangement by Share-based Payment Award, Options, Aggregate Intrinsic Value [Roll Forward] Outstanding at beginning Granted Outstanding at ending Exercisable at ending Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares [Roll Forward] Balance at beginning Granted Vested Forfeited Balance at ending Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward] Balance at beginning Granted Vested Forfeited Balance at ending Allocated Share-based Compensation Expense Number of shares authorized Number of additional shares authorized Common stock capital shares reserved for future issuance Share price Compensation cost not yet recognized Aggregate number of common stock issued Weighted average grant date fair value of options granted Vesting period Unvested options weighted average period Capital Leases 2019 2020 2021 2022 2023 Total minimum lease payments Operating Lease 2019 2020 2021 2022 2023 Total minimum lease payments Less: amounts representing interest (6.39%, ranging from 10.48% to 11.56%) Present value of minimum lease payments Less: current installments under capital lease obligations Total long-term portion Rent expense Accumulated amortization Lease commitments extended Area Area cancelled Lease expiration date Lease notice period Subsequent Events (Textual) Employment termination, description Employee liability salary and insurance continuation Cashless exercise of vested common stock options Disclosure of accounting policy pertaining to new accounting standards issued but not yet adopted. Information related to auto trucks. Represents member related to deemed dividend warrant adjustment. It represents value of equipment service deposits. The amount represents the gain (loss) on remeasurement of common stock warrant liability. It represents the amount of inventory purchase deposits. Amount of consideration paid in advance for legal retainer that provides economic benefits within a future period of one year or the normal operating cycle. It represents value of NASDAQ fees. Non cash issuance of capital lease obligations for purchase of equipment. Information related to office and computer equipment. The amount of payments for employee withholding taxes related to share-based awards. Amount of consideration paid in advance for director compensation that provides economic benefits within a future period of one year or the normal operating cycle. Represents prepaid expense disclosure. Disclosure of accounting policy for prepaid expenses. Represents prepaid foreign patents registration. The cash inflow associated with the amount received from holders exercising their stock options and warrants. It represents value of professional services retainer. The amount of rent. The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates. Information related to research and development equipment. It represents the amount of research project agreement. Number of new stock issued during the period. Number of new stock issued during the period. The amount of stock subscribed but not issued. The member stand for Stock Subscription Payable. The entire disclosure for outstanding warrants. It represents proceeds from product sales. The number of warrants issued during the period. Represents the information to pertaining to common stock options. Represents the information pertaining to warrants issued. Information by type of warrant or right issued. The information common stock offering dealer manager warrants. Information by type of warrant or right issued. The number of warrants exercised during the period. The number of warrants exercised during the period. Represents expire warrant. Represents expire warrant. Represents expire warrant. Represents expire warrant. The expiration term of warrants issued during the period. Exercise price per share or per unit of warrants or rights outstanding. Exercise price per share or per unit of warrants or rights outstanding. Information by type of warrant or right issued. It represenst license agreement. Information by type of warrant or right issued. It represents HC Wainwright and Co. Information by type of warrant or right issued. Represents the information pertaining to public offerings. The information of right offering. The information of maxim partners llc. Represents the information pertaining to warrants. Represents the class of warrant or right, terms. The amount represent of the deemed dividend. The amount of unexercised warrants. Represents the information of employees. Represents the information pertaining to warrants. It represents the amount of settlement of compensation. Represents cashless excercise of stock options. It represents the settlement of compensation shares. Information related to employee. Weighted average remaining contractual term for option awards grants in period. Weighted average remaining contractual term for option awards outstanding in period. Represents the equity incentive plan 2018. Information related to stock option plan. It represent share based compensation arrangement by share based payment award unvested options weighted average remaining contractual term. The information of research and development. Area of land cancelled. Represent the lease notice period. Shares of cashless exercise of vested common stock options. IPO [Member] Assets, Current Assets Liabilities, Current Liabilities Stockholders' Equity Attributable to Parent Liabilities and Equity Gross Profit Operating Expenses Operating Income (Loss) Interest Expense, Debt Nonoperating Income (Expense) Shares, Outstanding Debt Securities, Held-to-maturity, Sold, Realized Gain (Loss) Gain (Loss) on Extinguishment of Debt Issuance of warrants (in shares) Increase (Decrease) in Accounts Receivable Increase (Decrease) in Prepaid Expense Increase (Decrease) in Inventories Increase (Decrease) in Deposit Assets Increase (Decrease) in Accounts Payable Increase (Decrease) in Accrued Liabilities Increase (Decrease) in Other Deferred Liability Net Cash Provided by (Used in) Operating Activities Payments to Acquire Property, Plant, and Equipment Net Cash Provided by (Used in) Investing Activities Repayments of Notes Payable Debt Discount on Convertible Notes Repayments of Long-term Capital Lease Obligations Payment, Tax Withholding, Share-based Payment Arrangement Net Cash Provided by (Used in) Financing Activities Cash and Cash Equivalents, Period Increase (Decrease) Prepaid Expenses [Default Label] Property, Plant and Equipment, Policy [Policy Text Block] Share-based Payment Arrangement [Policy Text Block] Inventory, Gross Inventory, LIFO Reserve Assets, Fair Value Disclosure Financial Liabilities Fair Value Disclosure Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Short-term Debt Long-term Debt and Lease Obligation, Including Current Maturities Long-term Debt and Lease Obligation, Current Class of Warrant or Right, Outstanding ClassOfWarrantOrRightExercised1 ClassOfWarrantOrRightIssuedPeriod1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants In Period, Weighted Average Remaining Contractual Term Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Grant Date Intrinsic Value Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value Capital Leases, Future Minimum Payments Due Operating Leases, Future Minimum Payments, Remainder of Fiscal Year Operating Leases, Future Minimum Payments, Due in Two Years Operating Leases, Future Minimum Payments, Due in Three Years Operating Leases, Future Minimum Payments, Due in Four Years Operating Leases, Future Minimum Payments, Due in Five Years Operating Leases, Future Minimum Payments Due EX-101.PRE 11 snes-20190930_pre.xml XBRL PRESENTATION FILE XML 12 R28.htm IDEA: XBRL DOCUMENT v3.19.3
Stock-based Compensation (Tables)
9 Months Ended
Sep. 30, 2019
Share-based Payment Arrangement [Abstract]  
Schedule of fair value of options granted

The weighted-average assumptions used in the Black-Scholes option-pricing model used to calculate the fair value of options granted during the nine months ended September 30, 2019 were as follows:

 

    Employee   Non-Employee
Expected volatility   76.4%-80.6 %   N/A
Expected dividend yield     N/A
Expected term (in years)   3.0-6.0   N/A
Risk-free interest rate   1.63% -2.48 %   N/A
Schedule of stock option activity

 

    Number of
Options
    Weighted
Average
Exercise
Price Per
Share
    Weighted
Average
Remaining
Contractual
Term
(years)
    Aggregate
Intrinsic
Value (1)
 
Outstanding at December 31, 2018     1,721,771     $ 1.57       4.0     $  
Granted     1,167,906     $ 1.29       4.9     $  
Exercised     (63,990 )   $ 0.65           $  
Forfeited     (59,500 )   $           $  
Expired     (18,510 )   $           $  
Outstanding at September 30, 2019     2,747,677     $ 1.40       3.9     $  
Exercisable at September 30, 2019     1,667,064     $ 1.55       2.8     $  

 

(1) The aggregate intrinsic value in the table was calculated based on the difference between the estimated fair market value of the Company's stock and the exercise price of the underlying options. The estimated stock values used in the calculation was $1.01 and $0.59 per share for the nine months ended September 30, 2019 and the year ended December 31, 2018, respectively.
Schedule of summarizes restricted stock unit activity

The following table summarizes restricted stock unit activity for the nine months ended September 30, 2019:

 

    Number of
Units
    Weighted Average
Grant-Date Fair
Value Per Unit
 
Outstanding as of December 31, 2018     136,245     $ 0.98  
Granted     123,727     $ 1.51  
Vested     (142,507 )   $ 1.10  
Forfeited         $  
Outstanding as of September 30, 2019     117,465     $ 1.42  
Schedule of stock-based compensation expense

The stock-based compensation expense was recorded as follows:

 

    Three Months Ended
September 30,
    Nine Months Ended
September 30,
 
    2019     2018     2019     2018  
                         
Research and development   $ 1     $ 29     $ 11     $ 87  
General and administrative     203       326       664       3,003  
Total stock-based compensation expense   $ 204     $ 355     $ 675     $ 3,090  
XML 13 R20.htm IDEA: XBRL DOCUMENT v3.19.3
Summary of Significant Accounting Policies (Policies)
9 Months Ended
Sep. 30, 2019
Accounting Policies [Abstract]  
Use of Estimates

Use of Estimates

 

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts and classification of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements and reported amounts of revenues and expenses during the reporting period. The significant estimates in the Company's financial statements include the valuation of preferred stock, common stock and related warrants, and other stock-based awards. Actual results could differ from such estimates.

Reclassifications

Reclassifications

 

Certain prior year amounts have been reclassified to conform to the current period presentation. These reclassifications had no material impact on net earnings, financial position or cash flows.

Accounts Receivable

Accounts Receivable

 

Accounts receivable consist primarily of trade receivables. The Company provides an allowance for doubtful trade receivables equal to the estimated uncollectible amounts. That estimate is based on historical collection experience, current economic and market conditions and a review of the current status of each customer's trade accounts receivable. The allowance for doubtful trade receivables was less than $1 at September 30, 2019 and at December 31, 2018.

Inventories

Inventories

 

Inventories are stated at the lower of cost or market value, using the first-in, first-out convention. Inventories consist of raw materials, work in progress and finished goods.

 

Components of inventory are:

 

    September 30,     December 31,  
    2019     2018  
Raw materials   $ 1,063     $ 1,111  
Work in progress     3        
Finished goods     223       154  
Total inventory     1,289       1,265  
Less:                
Reserve for obsolete     (4 )     (4 )
Total net inventory   $ 1,285     $ 1,261
Prepaid Expenses

Prepaid Expenses

 

Prepaid expenses consist primarily of payments made for director and officer insurance, director compensation, rent, legal and inventory purchase deposits and seminar fees to be expensed in the current year.

Property and Equipment

Property and Equipment

 

Property and equipment are stated at cost less accumulated depreciation. Equipment held under capital leases are stated at the present value of minimum lease payments less accumulated amortization.

 

Depreciation on property and equipment is computed using the straight-line method over the estimated useful lives of the respective assets. The cost of leasehold improvements is amortized over the life of the improvement or the term of the lease, whichever is shorter. Equipment held under capital leases is amortized over the shorter of the lease term or estimated useful life of the asset. The Company incurs repair and maintenance costs on its major equipment, which are expensed as incurred.

Impairment of Long-Lived Assets

Impairment of Long-Lived Assets

 

Long-lived assets, such as property and equipment, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. If circumstances require long-lived assets or asset groups to be tested for possible impairment, the Company compares the undiscounted cash flows expected to be generated from the use of the asset or asset group to its carrying amount. If the carrying amount of the long-lived asset or asset group is not recoverable on an undiscounted cash flow basis, an impairment charge is recognized to the extent that the carrying amount exceeds its fair value. Fair value is determined through various valuation techniques, such as discounted cash flow models and the use of third-party independent appraisals. The Company has not recorded an impairment of long-lived assets since its inception.

Revenue Recognition

Revenue Recognition

 

Effective January 1, 2018, the Company adopted ASC 606 — Revenue from Contracts with Customers. Under ASC 606, the Company recognizes revenue from the commercial sales of products, licensing agreements and contracts to perform pilot studies by applying the following steps: (1) identify the contract with a customer; (2) identify the performance obligations in the contract; (3) determine the transaction price; (4) allocate the transaction price to each performance obligation in the contract; and (5) recognize revenue when each performance obligation is satisfied. For the comparative periods, revenue has not been adjusted and continues to be reported under ASC 605 — Revenue Recognition. Under ASC 605, revenue is recognized when the following criteria are met: (1) persuasive evidence of an arrangement exists; (2) the performance of service has been rendered to a customer or delivery has occurred; (3) the amount of the fee to be paid by a customer is fixed and determinable; and (4) the collectability of the fee is reasonably assured. The performance obligations identified by the Company under Accounting Standards Codification ("ASC") Topic 606, Revenue From Contracts With Customers, are straightforward and similar to the unit of account and performance obligation determination under ASC Topic 605, Revenue Recognition. There was no impact on the Company's financial statements as a result of adopting ASC 606 for the three months or nine months ended September 30, 2019 and 2018, respectively.

 

The Company recognizes revenue when product leaves its dock at a fixed selling price on payment terms of 30 to 120 days from invoicing. The Company recognizes other revenue earned from pilot studies upon the performance of specific services under the respective service contract.

 

The Company derives revenue primarily from commercial sales of products.

Research and Development

Research and Development

 

Research and development costs are expensed as incurred. Research and development expenses primarily consist of salaries and benefits for research and development employees, stock-based compensation, consulting fees, lab supplies, costs incurred related to conducting scientific trials and field studies, and regulatory compliance costs. Also, included in research and development expenses is an allocation of facilities related costs, including depreciation of research and development equipment.

Stock-based Compensation

Stock-based Compensation

 

Employee stock-based awards, consisting of restricted stock units and stock options expected to be settled in shares of the Company's common stock, are recorded as equity awards. The grant date fair value of stock options is measured using the Black-Scholes option pricing model. The Company expenses the grant date fair value of its stock options on a straight-line basis over their respective vesting periods. Performance-based awards are expensed over the performance period when the related performance goals are probable of being achieved.

 

For equity instruments issued to non-employees, the stock-based consideration is measured using a fair value method. The measurement of the stock-based compensation is subject to re-measurement as the underlying equity instruments vest.

 

The stock-based compensation expense recorded for the three and nine months ended September 30, 2019 and 2018, 

is as follows:

 

    Three Months Ended
September 30,
    Nine Months Ended
September 30,
 
    2019     2018     2019     2018  
                         
Research and development   $ 1     $ 29     $ 11     $ 87  
General and administrative     203       326       661       3,003  
Total stock-based compensation expense   $ 204     $ 355     $ 675     $ 3,090  

 

See Note 11 for additional discussion on stock-based compensation.

Income Taxes

Income Taxes

 

Company accounts for income taxes under the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements. Under this method, deferred tax assets and liabilities are determined based on the differences between the financial statement and tax bases of assets and liabilities and net operating loss carryforwards using enacted tax rates in effect for the year in which the differences are expected to reverse. The effect of a change in tax rates on deferred tax assets and liabilities is recognized in the period that includes the enactment date.

 

The Company records net deferred tax assets to the extent it believes these assets will more likely than not be realized. These deferred tax assets are subject to periodic assessments as to recoverability and if it is determined that it is more likely than not that the benefits will not be realized, valuation allowances are recorded which would increase the provision for income taxes. In making such determination, the Company considers all available positive and negative evidence, including future reversals of existing taxable temporary differences, projected future taxable income, tax planning strategies and recent financial operations. The Company currently maintains a full allowance against its deferred tax assets.

 

The Company applies a more-likely-than-not recognition threshold for all tax uncertainties. Only those benefits that have a greater than fifty percent likelihood of being sustained upon examination by the taxing authorities are recognized. Based on its evaluation, the Company has concluded there are no significant uncertain tax positions requiring recognition in its financial statements.

 

The Company recognizes interest and/or penalties related to uncertain tax positions in income tax expense. There are no uncertain tax positions as of September 30, 2019 or December 31, 2018 and as such, no interest or penalties were recorded in income tax expense.

Comprehensive Loss

Comprehensive Loss

 

Net loss and comprehensive loss were the same for all periods presented; therefore, a separate statement of comprehensive loss is not included in the accompanying financial statements.

Loss Per Share Attributable to Common Stockholders

Loss Per Share Attributable to Common Stockholders

 

Basic loss per share attributable to common stockholders is calculated by dividing the net loss attributable to common stockholders by the weighted average number of common shares outstanding during the period. Diluted loss per share attributable to common stockholders is computed by dividing the loss attributable to common stockholders by the weighted average number of common shares and potentially dilutive securities outstanding for the period determined using the treasury stock and if-converted methods. For purposes of the computation of diluted loss per share attributable to common stockholders, common stock purchase warrants, and common stock options are considered to be potentially dilutive securities but have been excluded from the calculation of diluted loss per share attributable to common stockholders because their effect would be anti-dilutive given the net loss reported for the three and nine months ended September 30, 2019 and 2018. Therefore, basic and diluted loss per share attributable to common stockholders are the same for each period presented.

 

The following table sets forth the outstanding potentially dilutive securities that have been excluded in the calculation of diluted loss per share attributable to common stockholders (in common stock equivalent shares):

 

    September 30,  
    2019     2018  
Common stock purchase warrants     9,783,278       11,714,940  
Restricted stock unit     117,465       172,912  
Common stock options     2,747,677       1,725,771  
Total     12,648,420       13,613,623
Adoption of New Accounting Standards:

Adoption of New Accounting Standards:

 

In May 2014, the FASB issued ASU 2014-09, Revenue from Contracts with Customers. Since ASU 2014-09 was issued, several additional ASUs have been issued to clarify various elements of the guidance. These standards provide guidance on recognizing revenue, including a five-step model to determine when revenue recognition is appropriate. The standard requires that an entity recognize revenue to depict the transfer of control of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. Effective January 1, 2018, the Company adopted ASU 2014-09, "Revenue from Contracts with Customers" using the modified retrospective method to all contracts that were not completed as of the date of adoption. The results of operations for reported periods after January 1, 2018 are presented under this amended guidance, while prior period amounts are reported in accordance with ASC 605 — Revenue Recognition. There was no material impact on our financial position, results of operations, or cash flows.

 

In January 2016, the FASB issued ASU 2016-01, Recognition and Measurement of Financial Assets and Financial Liabilities ("ASU 2016-01"). This standard affects the accounting for equity instruments, financial liabilities under the fair value option and the presentation and disclosure requirements of financial instruments. ASU 2016-01 is effective the first quarter of 2018. The Company has adopted the provisions of ASU 2016-01 on its financial statements. There was no material impact on our financial position, results of operations, or cash flows.

 

In February 2016, the FASB issued ASU 2016-02, Leases ("ASU 2016-02"). This standard amends various aspects of existing accounting guidance for leases, including the recognition of a right-of-use asset and a lease liability on the balance sheet for all leases with terms longer than 12 months. Leases will be classified as either finance or operating, with classification affecting the pattern of expense recognition in the income statement. This standard also introduces new disclosure requirements for leasing arrangements. ASU 2016-02 is effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years for public business entities. Early adoption was permitted, and the new standard had been adopted using a modified retrospective approach and provides for certain practical expedients.

 

On January 1, 2019, the Company adopted the new leasing standard and all related amendments. The Company elected the optional transition method provided by the FASB in ASU 2018-11, Leases (Topic 842): Targeted Improvements, and as a result, has not restated its condensed consolidated financial statements for prior periods presented. The Company has elected the practical expedients upon transition to retain the lease classification and initial direct costs for any leases that existed prior to adoption. The Company has also not reassessed whether any contracts entered into prior to adoption are leases.

 

ASU 2016-02 did not have a material impact on the Company's Condensed Consolidated Statements of Comprehensive Income. The cumulative effect of the changes made to the Company's Consolidated Balance Sheet as of January 1, 2019 for the adoption of the new leasing standard was as follows:

 

    Balance @
December 31, 2018
    Adjustment Due
to ASC 842
    Balance @
January 1,
2019
 
Right to Use Asset - Long Term         $ 87     $ 87  
                         
Lease Liability – Long Term         $ (87 )   $ (87 )

 

At September 30, 2019, the balance remaining in Right to Use Asset-Long Term and Lease Liability-Long Term was $29,000 and ($29,000) respectively.

 

The Company determines if an arrangement is a lease at lease inception. Operating lease right-of-use (ROU) assets and operating lease liabilities are recognized based on the present value of the future minimum lease payments over the lease term at commencement date. As most of the Company's lease contracts do not include an implicit rate, the Company uses its incremental borrowing rate based on information available at commencement date in determining the present value of future payments. The incremental borrowing rate is estimated to approximate the interest rate on a collateralized basis with similar terms and payments, and in economic environments where the leased asset is located. The operating lease ROU asset also includes any initial direct costs and lease payments made prior to lease commencement and excludes lease incentives incurred.

 

The Company's lease terms may include options to extend or terminate the lease when it is reasonably certain that we will exercise that option. Operating lease expense for minimum lease payments is recognized on a straight-line basis over the lease term. The Company has certain lease agreements that contain both lease and non-lease components, which it has elected to account for as a single lease component for all asset classes.

 

See Note 12, Commitments and Contingencies, for future minimum lease payments and maturities.

Accounting Standards Issued but Not Yet Adopted

Accounting Standards Issued but Not Yet Adopted

 

In August 2018, the FASB issued authoritative guidance intended to address a customer's accounting for implementation costs incurred in a cloud computing arrangement that is a service contract. This guidance aligns the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software. The guidance also requires presentation of the capitalized implementation costs in the statement of financial position and in the statement of cash flows in the same line item that a prepayment for the fees of the associated hosting arrangement would be presented, and the expense related to the capitalized implementation costs to be presented in the same line item in the statement of operations as the fees associated with the hosting element (service) of the arrangement. This guidance is effective for annual periods beginning after December 15, 2019, including interim periods within those annual periods, with early adoption permitted. We are currently evaluating the potential impact on our financial position, results of operations and statement of cash flows upon adoption of this guidance. We do not expect this guidance to have a significant impact, or potential significant impact, to our unaudited condensed consolidated interim financial statements.

 

Other than the items noted above, there have been no new accounting pronouncements not yet effective or adopted in the current year that we believe have a significant impact, or potential significant impact, to our unaudited condensed consolidated interim financial statements.

XML 14 R24.htm IDEA: XBRL DOCUMENT v3.19.3
Property and Equipment (Tables)
9 Months Ended
Sep. 30, 2019
Property, Plant and Equipment [Abstract]  
Schedule of property and equipment

Property and equipment, net consist of the following:

 

            September 30,     December 31,  
        Useful Life   2019     2018  
Research and development equipment       5 years   $ 1,582     $ 1,552  
Office and computer equipment   (1)   3 years     753       742  
Autos       5 years     54       54  
Furniture and fixtures       7 years     37       37  
Leasehold improvements       *     283       283  
              2,709       2,668  
Less accumulated depreciation and amortization             (1,879 )     (1,585 )
Total           $ 830     $ 1,083  

 

* Shorter of lease term or estimated useful life

 

(1) In August 2019, the Company disposed of computer equipment with a net book value of $2 resulting in a loss on the disposal of fixed assets of less than $1. In April and May 2019, the Company disposed of obsolete computer equipment with a net book value of $2 resulting in a loss on disposal of fixed assets of $2.
XML 15 R45.htm IDEA: XBRL DOCUMENT v3.19.3
Stockholders' Deficit (Details Narrative) - USD ($)
$ / shares in Units, $ in Thousands
1 Months Ended 3 Months Ended 9 Months Ended 12 Months Ended
Jul. 16, 2019
Jul. 31, 2019
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2019
Sep. 30, 2018
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2015
Nov. 10, 2015
Oct. 31, 2015
Common stock, authorized     100,000,000   100,000,000   100,000,000        
Preferred stock, authorized                 15,000,000 10,000,000  
Preferred stock, par value (in dollars per share)                   $ 0.001  
Common stock, shares, issued     28,288,285   28,288,285   23,471,999        
Common stock, shares, outstanding     28,288,285   28,288,285   23,471,999        
Gross proceeds     $ 3,630 $ 5,132 $ 3,630 $ 5,132          
Settlement of compensation         $ 32            
Warrants exercised         (1,298,210)   1,475,659        
Cashless exercise of stock options         21,962            
Common stock, par value (in dollars per share)     $ 0.001   $ 0.001   $ 0.001        
Common Stock Offering Warrants Issued         166,667          
Settlement of compensation (in shares)         38,580            
Proceeds from issuance and sale of common stock, preferred stock, warrants exercise, convertible and other promissory notes         $ 67,200            
Aggregate number of warrant excercise     1,610,210   1,610,210            
Exercise price of warrants (in dollars per share)     $ 1.6875   $ 1.6875            
Chief Executive Officer [Member]                      
Aggregate number of stock issued 696,296                    
Employees [Member]                      
Aggregate number of stock issued 7,408                    
Common Stock [Member]                      
Common stock, authorized                   100,000,000 100,000,000
Aggregate number of stock issued         4,816,286            
Cashless exercise of vested stock options         3,022            
Series A Preferred Stock [Member]                      
Preferred stock, authorized                 7,515,000 2,000,000  
Preferred stock, par value (in dollars per share)                 $ 0.001 $ 0.001  
Warrant [Member]                      
Proceeds from the exercise of warrants         $ 1,610,210            
Warrants issued [Member]                      
Aggregate number of stock issued   3,580                  
Common Stock Offering Warrants Issued             1,133,909        
Exercise price of warrants (in dollars per share)             $ 1.82        
Warrants [Member]                      
Exercise price of warrants (in dollars per share)   $ 4                  
Public Offering [Member]                      
Aggregate number of stock issued         3,037,038            
Gross proceeds         $ 3,600,000            
Number of shares issued in transaction 3,037,038                    
Price per share (in dollars per share) $ 1.35                    
Proceeds from public offering $ 3,600                    
Number of warrant to purchase 166,667                    
Exercise price of warrants (in dollars per share) $ 1.6875                    
Restricted Stock [Member]                      
Number of shares issued for services         105,474            
XML 16 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 17 R41.htm IDEA: XBRL DOCUMENT v3.19.3
Borrowings (Details) - USD ($)
$ in Thousands
Sep. 30, 2019
Dec. 31, 2018
Short-term debt:    
Current portion of long-term debt $ 129 $ 219
Total short-term debt 129 219
Long-term debt:    
Capital lease obligations 175 232
Other promissory notes 121 248
Total 296 480
Less: current portion of long-term debt (129) (219)
Total long-term debt $ 167 $ 261
XML 18 R49.htm IDEA: XBRL DOCUMENT v3.19.3
Stock-based Compensation (Details 3) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2019
Sep. 30, 2018
Allocated Share-based Compensation Expense $ 204 $ 355 $ 675 $ 3,090
Research and Development Expense [Member]        
Allocated Share-based Compensation Expense 1 29 11 87
General and Administrative Expenses [Member]        
Allocated Share-based Compensation Expense $ 203 $ 326 $ 664 $ 3,003
XML 19 R7.htm IDEA: XBRL DOCUMENT v3.19.3
Organization and Description of Business
9 Months Ended
Sep. 30, 2019
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Organization and Description of Business

Note 1 - Organization and Description of Business

 

SenesTech, Inc. (referred to in this report as "SenesTech," the "Company," "we" or "us") was formed in July 2004 and incorporated in the state of Nevada. The Company subsequently reincorporated in the state of Delaware in November 2015. Our corporate headquarters is in Flagstaff, Arizona. We have developed and are commercializing a global, proprietary technology for managing animal pest populations, initially rat populations, through fertility control.

 

Although myriad tools are available to fight rat infestations, communities, food producers, zoos and sanctuaries and others continue to face challenges in controlling today's infestations. Infestations result in significant infrastructure damage, as well as pose additional risks to the health and food security of communities. In addition to these challenges, the pest management industry and pest management professionals (PMPs) are being increasingly asked for new solutions to help solve the problem. With growing concerns about rat resistance to rodenticides and a growing interest in non-lethal options, it is becoming increasingly important for PMPs to have new tools at their disposal. Our goal is to provide customers with not only a solution to combat their most difficult infestations, but also offer a non-lethal option to serve customers that are looking to decrease or remove the amount of poison used in their pest management programs.

 

Our first fertility control product, ContraPest, is a liquid bait containing the active ingredients 4-vinylcyclohexene diepoxide (VCD) and triptolide. When consumed, ContraPest targets reproduction, limiting fertility in male and female rats beginning with the first breeding cycle following consumption. ContraPest is being marketed for use in controlling rat populations, specifically Norway and roof rats. On August 23, 2015, the United States Environmental Protection Agency (EPA) granted registration approval for ContraPest as a Restricted Product Due to Professional Expertise (referred to in this report as a "Restricted Use designation"), effective August 2, 2016. On October 18, 2018, the EPA approved the removal of the Restricted Use designation. We believe ContraPest is the first and only non-lethal fertility control product approved by the EPA for the management of rodent populations.

 

In addition to the EPA registration of ContraPest in the United States, we must obtain registration from the various state regulatory agencies prior to selling in each state. As of the date of this report, we have received registration for ContraPest in all 50 states and the District of Columbia, 47 of which have approved the removal of the Restricted Use designation.

 

We expect to continue to pursue regulatory approvals and amendments to existing registration in the United States for ContraPest, and if ContraPest begins to generate sufficient revenue, regulatory approvals for any additional jurisdictions beyond the United States.

 

Potential Need for Additional Capital

 

Since our inception, we have sustained significant operating losses in the course of our research and development and commercialization activities and expect such losses to continue for the near future. We have generated limited revenue to date from product sales, research grants and licensing fees received under our former license agreement with Neogen. In 2017, we began to prepare and launch commercialization of our first product, ContraPest. We have primarily funded our operations to date through the sale of equity securities, including convertible preferred stock, common stock and warrants to purchase common stock.

 

We have also raised capital through debt financing, consisting primarily of convertible notes; and, to a lesser extent, payments received in connection with product sales, research grants and licensing fees.

 

Through September 30, 2019, we had received net proceeds of $67.2 million from sales of our common stock, preferred stock and warrant exercises and issuance of convertible and other promissory notes, an aggregate of $1.7 million from licensing fees and an aggregate of $0.5 million in net product sales. At September 30, 2019, we had an accumulated deficit of $93.1 million and cash and cash equivalents of $3.9 million.

 

Our ultimate success depends upon the outcome of a combination of factors, including: (i) successful commercialization of ContraPest and maintaining and obtaining regulatory approvals of our products and product candidates, (ii) market acceptance, commercial viability and profitability of ContraPest and other products; (iii) the ability to market our products and establish an effective sales force and marketing infrastructure to generate significant revenue; (iv) the success of our research and development; (v) our ability to retain and attract key personnel to develop, operate and grow our business; and (vi) our ability to meet our working capital needs.

 

Based upon our current operating plan, we expect that cash and cash equivalents at September 30, 2019, in combination with anticipated revenue and any additional sales of our equity securities, will be sufficient to fund our current operations for at least the next six months. We have taken and will continue to take actions to reduce our operating expenses and to concentrate our resources toward the successful commercialization of ContraPest in the U. S. However, if anticipated revenue targets and margin targets are not achieved and we are unable to raise necessary capital through the sale of our securities, we may be required take other measures that could impair our ability to be successful and operate as a going concern. In any event, we are likely to require additional capital in order to fund our operating losses and research and development activities until we become profitable. We may never achieve profitability or generate positive cash flows, and unless and until we do, we will continue to need to raise capital through equity or debt financing. If such equity or debt financing is not available at adequate levels or on acceptable terms, we may need to delay, limit or terminate commercialization and development efforts.

 

Basis of Presentation

 

The accompanying unaudited condensed financial statements of the Company have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission ("SEC") for interim financial reporting. Certain information and footnote disclosures normally included in the annual financial statements prepared in accordance with U.S. generally accepted accounting principles ("U.S. GAAP") have been condensed or omitted pursuant to such rules and regulations. In the Company's opinion, the unaudited condensed financial statements include all material adjustments, all of which are of a normal and recurring nature, necessary to present fairly the Company's financial position as of September 30, 2019, the Company's operating results for the three and nine months ended September 30, 2019 and 2018, and the Company's cash flows for the nine months ended September 30, 2019 and 2018. The accompanying financial information as of December 31, 2018 is derived from audited financial statements. Interim results are not necessarily indicative of results for a full year. The information included in this Quarterly Report on Form 10-Q should be read in conjunction with the Company's Annual Report on Form 10-K, as amended by Form 10-K/A, for the year ended December 31, 2018, both filed with the SEC on March 29, 2019. All amounts shown in these financial statements and accompanying notes are in thousands, except percentages and per share and share amounts.

XML 20 R3.htm IDEA: XBRL DOCUMENT v3.19.3
CONDENSED BALANCE SHEETS (Unaudited) (Parenthetical) - $ / shares
Sep. 30, 2019
Dec. 31, 2018
Statement of Financial Position [Abstract]    
Common stock, par value (in dollars per share) $ 0.001 $ 0.001
Common stock, authorized 100,000,000 100,000,000
Common stock, issued 28,288,285 23,471,999
Common stock, outstanding 28,288,285 23,471,999
XML 21 R50.htm IDEA: XBRL DOCUMENT v3.19.3
Stock-based Compensation (Details Narrative) - USD ($)
$ / shares in Units, $ in Thousands
9 Months Ended
Jun. 12, 2018
Sep. 30, 2019
Dec. 31, 2018
Share price   $ 1.01 $ 0.59
Weighted average grant date fair value of options granted   $ 1.29  
Equity Incentive Plan 2018 [Member]      
Number of shares authorized 1,000,000    
Number of additional shares authorized 2,874,280    
Common stock capital shares reserved for future issuance   632,936  
Stock Option Plan 2008-2009 [Member]      
Unvested options weighted average period   36 months  
Stock Option Plan 2008-2009 [Member] | Restricted Stock Units [Member]      
Compensation cost not yet recognized   $ 1,205  
XML 22 R35.htm IDEA: XBRL DOCUMENT v3.19.3
Summary of Significant Accounting Policies (Details Narrative) - USD ($)
$ in Thousands
Sep. 30, 2019
Jan. 02, 2019
Dec. 31, 2018
Accounting Policies [Abstract]      
Allowance for doubtful trade receivables $ 1   $ 1
Right to Use Asset - Long Term 29 $ 87
Lease Liability - Long Term $ (29) $ (87)
ZIP 23 0001213900-19-023283-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001213900-19-023283-xbrl.zip M4$L#!!0 ( &A"*![JKJIZNKJZNJ__&_7U>S;_?]B_O+Z^LS[G__\G__7QS\\X__I]_G/BE$E=]Q M5[K4O]86^GONJ[@B[[A?B48,T=*-]]QOHFKC-_K_^7#W&?YTVG_'C<_Y1Z[? M3]'8;T23=>/;W;7?V-*RUN_>OGUY>3G7]&?Q13>^F^>2GJZY>]TV).*W96K$ M_%&X$@;\?# ?#LY?%T#TE6C!3_@=_,3S^*_A S][-^3?#8?_7\I^+-&R3;^? MP>O _<=Y_1^OCX:JO,-_QF>Z\;36V$PX-_^GR^?[Z4E M68E]13,M49/(F?>6JFC?X][CY_/Y6_JK]^C.D]BYU\?P+?[\*)K;EI' /<_O M4 *_RI;_0O#A\5OGQ]"C2NRC$^=1Q7M4)I'G3"*=/^G/;^&'MSA"_0'?'_+> MXP99))(\>0N_>@\JICX2^.D^_IPGO!=LRTA\>/X6?O4?-/M/HKCV'UZ(YB-] MT/TAAFKXQ=!58L:^0W^)>4G3-Q=,D6\9;:[,F;^&A/CQ%#$7RWSO\4O@% MH &_CJ>._A)#G:3;FF5LXL?._1%?FX9?,PUKMQOX,J8'G+G^LR9H'-,BTA+T MP.JM-YO/O'F*V'YGTAET1Q8;4X1?[Y[,*\63CD3?K;/OU'B68IUL;_UO]>D?&7A4(,CE)&0J/B MB>KR^G_.?@&MP4]F@^%T]H^WT9>WW;V-[<_M;0TCJLLQ5-!9;/VR9<#OPOTE MVGZH)>]+5QX'A33K\P*.86>%Y#)0J9"F71?2M 8AS;H^W68U3#>8TB/HX]_N MTO/O2WVUMBUB?/S35M8K(/T+63T2HS$A^@V;Y G)"?S@_B0#,:]K59$4EU9. M5N!)QTAUV7IW:^@@)FMSJX($+S399^_#Y@&T^,6K8I[]XCV<((-_O(WM+DCJ MVWA:RU"\HQJ0,(8IR9#0=B2,:U*<022L=.W>TJ7OQX$!W'D1?!_'U=K@*.L: M_&GNC'Z8[P;'O8ZUP%V4V;BW:-QK-)3\<;^09<4"P8GJK:C(U]JEN%8L43TI M#.R5P8GI 8:']N*A"?UP1RQ1T8C\430T17LR3PH(\G<<[V@JT;]QK=\,P&[( -V(0>8'AH+QZ:T _,(FR31=B$1F (:!," MZM0!DFU:^@H 8!+1D)87FGQ%GHFJKSVYG=KQ$4:,O$LECB/7$1&$W"P6BD1 M(*=\MDC!<4@2IX6+"]O2S0?#EKX?R:J1'@@[K)_(R'M6PR<;%DS+-G N?%)> M\=,I8O5VM"?J>EUBH#8(XY9'SK!XY\\B.[G"O5&]N0B0[*-AQ5T,0BQLX9FSYG M;/FZ'#82&5R:ADO-=F^,G< PT#0&6F[ZA)=D!I>FX=(B*X-%,;0LBJ&;U@># M4#4 M;]Y&XRR8H[9I1VUG0D<2H<-VS2W;-7/JO(DXHG*D6B* MS[KV!*.]NB*/5@P8]K'.=JI9D?15MXCI1MS?6$MBN)]/ DL'F&=H2F.S'!"B M_]P7\559V2N&JQ2X2D.*:5CO[D3MR=M/P9\A$1^_H91^2=R"4-%.!80%%\J\ M$ P*F$$P#H*GHP<;@N ):\'4B_'IZ,'&%N.3TH0\W^='W:V8YS+0V(8^X5CD M=0T .Y)<\&M-TE?$#^S[K$MT-8@&]!V4 ]N59077/5%517OZE6C$$%40[86\ M N5D6@:,P#-QI7LD._Y4,,LD$0:X[+G#3)MU09NU+Z!RZFS;JKS5H+N'VN MC=]%PQ"]@*#17)C-AX/AI.O(NH!V946U$2'W1+(-Q5*(^?%54FV9R"@6)R2* MXNUFX66_WA+C?BD:Y,,FOH$P,D.B:WH=;:>/XX#'UC(4R2(RK8CP35,L\^[^ MVW&HMEH N%>"#) 9$]L"U3ENUD<4#5@I%&D20I+D& 2SNN9"2PH#7J<6X=:Z MY@X<-+!%^$@7X4X!DBW"Q[@(MP^"V[ O($SH[9U,SMX]OT6E$Q?A-5FWPAHFD;3AKA':H? M ]13)"32?_A: TUF?D:G,-]MB/CYM1YK'S8!27PRR)\VT:1-)!DWA= .XR@G M>?['?X(8T#V_H>.00.'N2#4(\$;RQXL"7& [PC !0;P/ ?,H!W!.!#!O"$ ML6+@S0S>3F/$V[B4;<9NLW]TC6R^B,9W8GVR-?E(G!0GH"-36[E9"+L438R" MP?]@A8UG424[A9;C$7/DV\G2YZ' YN%QS,/4QCB;AVVZL=8-T2*8 M0;IU3[/IV)'IF'KKD(DP11,U21'5:\"T86]]K-NR5'M0PZ9DL2G)ED8V%]G2 MF'D>Q@OAI+P-56*EY7/]J*!#67G=7EDJ<7XP*Z])!PB;DMV>DI7X0=B4 MS# E]\KBI.R^JF'3\JE_5*AF@5LGLX0T'[C528"SP*VN +SYP*U. IP%;G4% MX,T';K45X R\)V+&QF:&T?XZEJ)31OI32,XU9. Y\]+-P',3:LUKT[2)?!S3 M\%(535!"+FLWQIWRM/3R?3!W+H[GNF=:RX$34>(,+(V"I7FU')>PNU@07*E. M$10IQ<"42IQ2F3)(=0=2 =4SK7'7P+#1+6RT;UFZ(J)*C"^B)CX1PY/6R<)E MCS38(I5/$3& M11@-:NE:4 M,=.F0\M72!%-\RBB:0V^FVSP^J;)Q'@Q%(NI MI&19,*#EVY8Q<+407'5MT)+549==]JV=C9-.RC8 QDD-8!SW!Y/^0*!@I)_Y ML:>^OFG*,S%,H/UF<6$H?^F:&)C%H3*BWBN?%0EKRU\\&80>QIV&;LL@J'*/ MTO'F4>S2P&M M]&'E*CXH6ATW7:QEDU3N*"L5%,PX#/@5V=31!!<:8V?7+ MIO'N##:+V"QJQRQ"L&:>1=.J70]LYK"9T[:9$S;'IE6'H4S[/-\7]DP!TQM$ ME!?POZ;?:=[0W2P>E@2O>!"UC1EX^U0A7TA%[8UY>^<*PWWM,WGFU3E%KTX8:Y. 3Z>J M#8,?"$L_[PL?8;@[7MQ%E\/L(:LN?*H^8=X?X<0@>KP0K3FRCN*9GV]5(UN2 M3Q-WNZJ1G^=0C4*MJO$K>3FM5+L=AH].BE)S-:J.Z6MI M9&Q2?#F#61=AUK( [*W/8]H71BQ,X!3"!'"D*_6@,4750455^]WOH2T=LY=/ MU]/)QK[Y+76KO(U;R,!2-?0@PPR4XS50HH#$<<\,R*!=4W<0 0/D<0.R9>$) M>[P#7G38'3$M0Y$L(A^1J_OB131DK,,1#KN*Y97M]+-"YOKVYCA@LB>HQ7O$ MYY7!I*!F@3VM9=[=?W/D)@Q'T\%D,!&ZCJ%TJB;,/,-25BR=BOZ8IQ[UA#3L/Y]N53(XN,KD6Q+>8:YM5 D8G0; M/,#6NP?%0DUQK&1/#8V_NT;_SIRU*(+$BW]>*U)2/0SN55%#8%X',./W'P55R2X M$.WC]\B'WJDS(K"A;]?0N\-2Z:;:Z8/?9BHR&+0"!C%U@#+:C!'TU%$'R$EE M6J-7TY'>8 ;_F[M[FI,P+&)PM5QXF%F39\^]=V 8$$]Z4^RB9T*#KIS3 M*>>S?SH%DXJ(AK2\@'[),U'U-4KE2,!CZ" V:X,PP0OU<&FD['W8;+6+4S%Y MCQ0:A90[;D!WUAYAHL M/*Z+VUA\^]$D?]I _\?GHT%%A*E=\S66ZX;M%3I&6>T5/FCD%%]<;+#C*7*^ MW5_M@&!%1-,VR"^*J8\$?OH.GO$:\WX*=X&M);1_OQ0-8B9VX0J!/I2[#Z#O M-J$?>FP4(UM\]ZN](H9HZ3$[I@PRB-(8UVJ@TRNBZ2M%.]3M8;E$^XUKV/L] M)(44 KV%;@X,V1H^YAXP\\^%E=B^;1GO\('TK1]<([X2BW.GP1U91(^MSCAL MC/Z LX&3B:2L1-7\^:P_//N%'\R&H-+^\39-+T4I@D5B%$GC7=L6,?SW7+6] MEV*A3G+'D9R/EI.+N[[]Y-#1KH^@68/RHYOZI:[*Q# =#V8"D9.#4AO.A7&( MCMVV\_6>:HY.AORHDMZG:7J?C@6A(MY32'X\F50E>:?X8')"UWZ].:MR1')3 M-:E%5A>RK*"O3%1O146^UB[%M6*):AH*9Y-!17"*BJX(D3P_&-8BR3MBB8I& MY(^BH2G:DYF&NC[N/JJ9%%$9YB)O.AS/IU5JR[RS0ZA&B\Z+:9)J5Y8RIL-< MX(5JU%U4=$6(' WG?"V2S#=GQ[-A/3+,1=Y\,*I(>JFLTC$_JD8XLU0V\618 MC;XZ6+;H@&:H5":YJ:IF98S*JH@JF/'SR@RATHCD9Q490KOABGD4PG PK4>& M^=3I4!ADG1T!G-^*QHU!*Q[(OXFJ36Z)03ULJ;=HGD,N0-?UUT]GOPS.!^C' MS-!E253&JME:J'3ZN+"MI6XH?Q$YG0P3*,,U:!#V4.SIJB!5NS)K U6'J\NT MCMX#E5'JIM?)2B^$0RQ?RL_G\ST$.;T4("8U_(29,(/_'Q\$<*P9 )V[OLK9,F4#Y'H"!4T!,L=P!@( M%Y5?J0C?7_ ZCS+"],D5DDSD@_#;6^/A-1'-%/'Y H>C#K0.=;![4$8?O=9,VQ U M*?VV8H< (>R4B3:(GL2[_1?&7 !R26WG)B#= M9$M/@*%2#0M.'39X,V5P#@W'U76K/QCT!SNA M(J-&>;FP+=U\,&SI>RK3?#QJA%AO-_')AEV$91LH_$_**WY*17;DK*INLC\3 M6&[1SWZ]6AOZ,RT9G$#W%BO\+E:$M'&')?&13N5/!_,FJ"IC-O*[@5N-2+A4 MY3BK5Z%$6&BW0HFZ)SJB4*)DYU0H.W OIE N),E>V;38)!AWL,57Z,X>/JL$ M/T #%RO=L)2_Z/>)C>>W\Z)^P+(HJI/3=%;D;#JOBU/#)K)72.L#T<@"C/:B M%OEHE_P]W10G*MW*-1D5(.JS8BE/5+BHM8WGPKL681*645('10A)YS483#,1 M$LJQ Z3]ATC6Q9-!2*')+0R#.^?XQG-3D$H.\_0$A+9W+HX^*^*CHH+L2([I MD^3JR]]1RJ'?V:PF=K(3RK($??- C-4'W3#T%_3VYQ]\/CP78MK.V7TZ=2MD M[MX-8Z(K\\VCZDX8\ZNN247UPC!LT!WLJ132TLDI$E.=F32*L,^Z]H3"_:I; MQ+P5-^*CFM_]+T2B(A-[*$1*2A3%^'[2D.(]<;%.D.JU)JDV'LJ[\_&+ M".8KG:#YE^E9^%RP*"%U,)9NJ8\$-S;#6 '3@,]!?GE$ICS_FI9 9,RY:!9) M3:>1'67\H6QR+ZE8G8Q3]7*SQKQ?P ]EFI9;OUE\,PE]NDQC(&L_*>=,6'OM MZZ0,BOC^0#APCC2MD2+/B8?%D['DE7O5UX7\']NTTGICBE#L8*KHKF(RF?(Q M4$W::1WJ,YT5.9F/T_?I'0R5PV\8M+%MYR8@G6[(3H!_-%LH*SVZ2 1;S=IC M2OLFXG[9UV.Y)WS#G5.35"=J91[L#0=1UV4*$F SI=N:9=X1B2C/:/N!J(H? M=^XX5Q([*4I0RF/V';=<:H(N17-)K05SB4ZJ9U%%W^:%=2D:Q@8T)PVQSV_@ MSH5(S'2:[DJC,57R..P:^ 9I3 ?^^2BZ\ZN3QE11>Z/IO PYZJN50M=[DYXQ M:;A\$TW*MLTZ9,%E["5AC [U$O#AY%_$R",FI[94QM2H2QK-SG!'+:E/51L MR4OXYSW3WX#PU*=24=SW7 MA5$Q'<;N%,+-YR&9<41 1G4.&CW\AQ5TS;.;O/==R5IOLM4F"=+[%P MUXX#]U!/95"6S^F;E;)H+E0HAF.!54=S2RVF5LKAWLJA+UV*TFYMA.ST)52. M".2KYO<:[I3K.=Q9.>2EBT38J+7W5=IDK8 M3>2Y!SUE[!,JO73$? MQ?L>DM/74Q*3HX[%:#ZKCIC,-2TB!P;E$9.GOL5HDIL8]X"O',0(DT&"6+QN MO1(,G5(R[EU>*II@6 M/O],W.?+04O477*@TQ)HS(ZD =\ C1G-VG'D3*EZ&K.;*_-(L;Z,-":DDI6( MQE$D+GEOCX7)RPS$T8Z_H6+R,MI'TU&=]&7&'S\<1XVI#/1Y3AVO%N('T50D M?%-1;8ODVYHE56;L#\X'@:IJ![HN@=*#4-Q#*3^JF=+]J-Q#Z7A8)Z4'\;F' M4B'_Z/].\(2:R!?/H%N?R%<;3Q=O%O35P+%U8?@F%=^;SN;\.%A7-!]!U;&U M'^M); UF$T' F^Y:S-:>B9%45!CQ,105,Y-BYSX;#]C&1=<<_B7C,FV>B M[$J8.9C0-3WL:RC3(@\;;(E]%2(J!YKKH2HC/*,SK!*R,@-NEH\HFEE8-K92 MI2!7BYVX0EX5"B7[)FY>*WU%*X-63=\8KU49")0^^ID?>V5AOFD*&!.F8FUN M%A>&\I>NB0&5Z8:,.L%]WBN?%0D[\G/M4Y63J9?AF%F4@^']+#6+K_:P1PP-JF<<_WP.55,-SDIR:[M)M51DDVO3:J2268--AQEI^29.+'"#IRB M&6ZY<3*/4++334Y*RJ-#]+Q/)%$3BRQGE'/?T5)"W'NC6KC[2,TRAREED=:=DMH$BD7P;2;@W]6<$*YY]T MX[,N:C0!"MYQ"Q&9^:,V#FF\G#V7H&O_2528[FZEGLT]D=R*/1C9Y_ZUN2.B MBK=B>2MH*1 :A8-?*-&+*'>ZW M+%J+NE?*H=4KHA%-FLXKT/$T:J;OZ;$P>=DCO:,;O$+4A8MPE!3(&MV6[^^T M#")S(/'0(&#*8"R61OCM25 -[M1+*WM,?FGKQ MG9=)='9I\U$G4EE$[V82EX3L%),QTG%9Q&9W1U5$:S KN2SL1CUG![HMA<[L MFOC@'#M 9H(N<1R%Y>MA89Q.E\7T7R[E.=3PJ"3"821H/:,'_4+ZTU8,DJXJ M?FZ1\Y&*<*F[+Y?P[/ZR45ET&[I$B&PB(?>B2FX67T1IB=>9;4J7=E1OI.R[ M1))+V--&>X?8<&WZV$Z*8 MDW)/;=\16L'B07\07W]7K"4& \*+GW2CPD.@:#'4G+14R5/VL1F7RI-WY>=6 M0>(YS\V:UB"'B>:=%WU\)8:DF#G3*7:4DL ';C')TGVI=&>WMZ>S>3&ZO7&[ M(VMWY&X67EFA-(7GQ?T>(:YP6-JOAP;+G!9 MZ][>BM%5@C$1[#/Q9H[<+'!24%="60 %5MTX,0]Y)?S XY4 7V3D,6R/! M]D.:Y*NNH;&%/X%U!7N_!.T*:[MW9?G-HMQMK'N-8PGD5,Q9T=7D"D.HY2L% MS5I-?G%6[5M#D="]8!&)!A/X159+3A@HB8+,\2;#8<#XRM9_^:1GC4=I"^G- M(R]&>/Y%J EE\%)=X=H:$>]C,%HE,0UG_5:Q%IVS1S=VB0PV-79Q_L# 6I10 MCS+WCHL?[EPXO;_;4NC,;I9,AGQY=):^#4GV!^^S]YV4[H-U_)TH60^7^P)= MDU/?1X/1/) COM-S+M+<"U$*D38!ROCYN&S29L5)$X:C*3^?S\LF;5Y\0(6Q M($Q'T]*E-H_HP#RDS809_'\% UJX_)UNS&.CMJL= XFF0O3T6C&'^0N@Z"]E%;8>#E*K M#;_KTNC-[!S)A[C*'#DMMV&[8)*7C7%+1Z.(H3+) ML->I=W *<#7FF^8JET'2,LA5Y'EN>'#RVE,M4VM5;5R:U0?[N+J^O4G'P<#] MIQHF'+.QDI4SP9X=#H;30>HM207\E+Q_' _'T\%8:)2?,C>,C?-3\A:Q<;QE MU0)=Y&-G7(3A;#J;C<;"8<9&,WXBS":-,A94<%,\Y'$]@^&J,:F':CP[K*ZK M98%IM#UDQ\2L> N%-O$8#4"_(W_:BJE8Q'71.-W=$4E_TF@K MNY(*+146^F::4I9/!YB;/?-(-SWP,) _21!8_L7#;Z<6+:,@E MW0PZ#%1^+4)-I6QE-J; 1.\&6QG+HHR$#K"5/I$]6S+VAZ*RJ:\A"C"O(0GG *Y M;LM#-0"RF2SC"(TI^RZ5Z#P%%T8MH#M/P84H)EHB[V+QSHT/0Q6F1$MG1BE^ MF%#!DC;-GX[CL(JU'93&M#KNG!.1HM,LQPGN:(R7)&;[*CLB>\ .!/X#!_7RE.IF[#]0=JG7RJB/,$FP((=UAUY4DS+V*V&%LZ2/+06!TMP M[>\D)E4YOFCH-Y,L;/6SLLAZ : 30( E"?75VK:(X3?I@4R1H1U=M_J#05\X M^^5V^$L+G:M =IMVJI;Q?0*YL$5\3?@ MF55(?%4>C^;?1% #MLG)T(O)64M#MY^6W'_;ZH83!L(P>"-/"N)JX2A8*H 6 M<'<_'^1)(\B34"I/7FFK.WCIWJ*%XD!_P@_B$]FC%-,RXS_W17Q55O9J9ZV[ MA9FSH_H'Y_Q0F"7QN8_D:IG=B\4MJXJ6A=7!9-193C,.*C\9M(_5U C.-JS\ M8%8*@K_1LF.F!:U;Z;.^?OF;:KU?BUG.^Z''W8$XMWG,KT7A2M'?/WB-O MU_33?_%#]U^E]"VNUN__"Q!371WG$%H$7@3VM=@"&D9(DN'O[X3COA#)VHR M)X(%NW(,55#LHL6)BP61X&D@!2C1#< ")Z[H+0GT!4F%5Q2PZGP21>=J+/Q1 MW5Y-T:/4R(HIJ3I>,HI/(E; 4D9JXE_B1*=G7&CP!?P<*P%\;X<\>,$ :T*S M7=Z("!W^HX]YVG^O1( MA1/IFAQQLW=Y166&+&95)_9Q$%-(AFBVGZ!1157,M8EGRG\]@ M*XE_KT59]O[.R]>C;LC$Z$NZJHIKD[SCO$_O.6RK;RI_D;Y(HW?><1H,@/>] M91!+6N)WV,U[T&:RM<2N!S^>;9E ^@V/N&>"M[**:E\$.P!D^:A;L*G8/HU( MIF_(WALO2\4B?>2;8$\OAKBN5OZ6O(<:RO@+;,F7%A*ORL!U.PB$00,:M)_/ M!!\).+L]0:-%0 QWY.I@P%ON[\G:HF;.EJ7AH!=9]%LX ![]D9$X>IK;BJ,K M(D5AQ!\KC.A'H[ *;0>@W([=E:KOD LDG(_75@R..C\-W.74X_-1%<'6HMQR MIJXJ93*(5MJI#$@WJ>X*C&9=&)##-E$.Q0F2!LD^&; /E=$&UHUWG/'T^$88 MC'J<,)S!O\;CG_9:J([9.YW]^)X+#JY*%I;[C:+)!#GMS\XG5#R>U/"9=YSS M;7$)W8DO/HVX-S1@KVMF'$_/B/^Q02O;IV%7H,6I^B$?,='1-1#:Q:GA>X/) ML$WB*3YH;:#A%(##\WR;Q%.?>J:6^CZ-W*P6_ETWOON$*1JW-O0G@YAI%7%S MLZ=%RJ2""9-5R[9 &NV0__%!P:%E)O!")^32B%6;58=&[/]J5.LG15/,I7LD M@S0_Z;JK[396 >U@E!4>2?@M$%!MHT>AL*#%O=XU&$4 MMMOV'IP+8T4K+H@'W1+5@/'M'@\S>ZM1>XOO";-Y]R32CC$X2CA,QEV02'.& M=TVNBL_$-&/"9MALJ'TSVDVQG#3S#!,M-RUK<4E@/HSQ3'R2%[K!Z8^PY2 6 M85O"(]\2OFGMCO GACV&O=9AKSF#.L>R,:INT0B[*31B9795),W;41=F+1#) MR;K]J)+Z3^73SM4R:43_1]$-;RP^6^2_9L!K)_ F68-$V@.\P&I!/V(6#/X5 MJ.20,MYP,%O.6AJ$T'0W3=$(MX)>ER9'-'S&S_K@ MA@-8H8%Q^B!&FO9VQ_M(TK1:0;/B),>))HP3P/8ESK_75MI96ESJM+@$'T=+ MDM'V$TG%U.XDNDG9X?I5YQ<]H#+VV?GBZ.*/J(OI(P;W%I\*ZV4JB$=?)-T9 M5[7^?)(VL])=U'X%PX&!=@\K.1PF<:M&.W":<2#:-KM:GL+%,@%;37578-2) M3$ &H[;#B&FC5E/=%1AU0AM5$B%1C1G7@0"? ]!L*L+F%'IDLF>R;UX23/9U M2B+'TE1:R8RQ4$DFNE>BVN\B$2,00$NKHA,G==:_JL0\^,KO1U1 MQE16YQYPMYN/HJ$!'DWHA-)T!!FP3KXDO6F2)A;26RX7NF$M:;JK;ENF)6HR MO7Q2Q_O8%5%5-YPG-'C>DYIS'>=2A"\?"4&[VI&B=R4E;"0D6Q6]FR9I"VY1 M8U4W3;S;DC-1JIQH68;R:#L$67KH_LFEK@*<3>X-O5,T<"\EWB#Z+*IX5R=M MQ?R)Y8#FXZO=.: M29K/1Q5D6IJNBJLWEO.AOVA.GL MF&3%4%0SBGB^-^5'O?DHG8>F/<(J23UG#M\KSMP=@8VP(EE$=C6PK2EILR^: M@V&+9D0ETV#:&W7C^@4&B%H ,15Z/ (AC*PK@WG78YJK0NHSE%T?AY>1%\Q6;>R<4, M5#[M2JW5+?0FHUEO)&3=G[+0%0;#$F$X[$WP?Q502&GZHO$RJ4,S$KQ7#QB/8J]H.,HSX0HFYQH8C/_+6JV:&PX MWBT#[U6/%V5G:^-UI0$#*A%-#*^A<3:B(7,OT$:TDGFZP)4"8HG<#Q.\FC:, M/1:.LG7,A"53XG%8FH8K/D+T8/W_8G=^5>(K(CDQ&#Z%0P?CLR9$T%797E"T M8E4>[LHF(0&#OKFXO^1F(X$)M"A872V\)9#OA7[WPR2J%D8C+CQ7W4VF24B#&ZK!@(F=Z&?!U\' I>UM[SL]H8S.!%YJA MK +Y_%""6-R"'DP:%4NC:I],6FEFE7KA =\W&RLF@?%Z++PVLG+&TO>98!#5 M9T5\5%3%VG#^LL*_3[-HMFJ84BZ&S6(RA5J/Y_%-&F4>V^5/1\Y2S&P*.HHR MNW&BB5579$$,@SCI5Y?B6K& '$S*,LA:5.0+3;ZQEL2@MJ9YI9B2JIMVI].H M7,ZH.-U" B9R82JF[T_R4ZQ80M(Q>8#V[6-;DNP3Z*7EV4B9W0)=RC6JG?P2 M\BDZ17-;8>1[2WT4\<>*HAR&>C:EVA*HY7(*-DYU5]*-6-9:JZGN"HPZD;76 MTLC?:E/4KA2#2):^71&#I=@RCM71YQ3EK !>42I1OTVB88EHW0 -;+7;))P6 MQ=!6IUMI97A]L5"DP,Y#T4S;0#=>RN%H;G:T2%E4,2$*ERUN0![M&($C!(/0 M"3 T8H>6S^G7B_NKBW]Q"T+29I:U VQ'B/NB97F9#FR>E*;NASP&5=B =?B9 M/(DJ9Q!+5#2P"QGHFP2]P$H1=(OYD\?"D=B 7T3C.[%H-5M#?S+$E>EWC;MF M2=<6Q""P368F8K.S8LQ,Q&XQ7R46BF9E=DE#-F :WAKZ@IBFHFM@(9I.S?6M M7F0F8RLF =\),X%AH0XL9*T)V65]F,YB+,S0'=%8D;YF49WU@+D%TFB'_(\/ M"FX@6,O%T5V+[^.?MK*F^>>NN9/?8/0E%%86=W1 MC]J3HA'X4WOJ^;28^L)ZP;OZ5# >:=(K#3K$[-Z,@\0JY98YR6JIE-OE$KD, MA$<"PO(K=7:N3G/9)?U+*57JU&SV2%@[]1$XKS9"P7EY>29-A$]BI9*<0LMS9S_<5J7([HJ+,B/*P( M#RO"+;%IED5GO;2W%8X*C%@9GK:6X;D,5MT))L 81*67VCP2C2S2AP-%J&;552+$5%1=19AD];PU M75V%P:8%L!E-LX97-@V;DE1P Y&6KF^*^ZQ8RA,+*"I 2EG)9(.BMPTW((]V MC,#Q@4&8G%*@>=-1EA]TO-[P,GO%QW9@[OC@WPGP,RC4H@E/*=P\\P7G)84& MW;#XR!,(32N:J,W"(QD&RZ%V>\]7-]'8"KNWECA)T743L#C)XPU8F\[*7QE8 MG"2#W2'839/S-0(*EG[8''%X11ZMSL<8TA$U[16TN?&""M&5(6H; M?[&=OC=Q/ T:: BO*YJDVCA#.,F)X 1FW7^-[L/$_%\:*5GR<+FW#P)*I?J(_J -%U] SHNK0FZ\9,BK;0*1AVTZ= M]@1!MOH :E\P:2VE.H02PTU;#8L6D\80FR48)G/]V98BMJ2%*TM4RZVACS!K'0X M0V'3*!1&1>]//!F7;ET.W-,SG=JTWQ3FD^[)HQTC<'Q@&,T&79!'QPWJ5/\[*TRT^8GAKYC1U_Q4[\&T%>K/9UU[1C5 M$S=1ZC+!DH!;F 3,3XI6O6.YYPQVV7>6D_(=?@W,M#/L3Y'?3W)-3XN\M M^'FIJR!^$R]CMS9?=8O\+AJ&J%GFC7&' V1V.%_^84FHV)RT;R=O7OD+7L*\ M>4E?K6"#8J(0N!>':4Z4+.49!('9\+!U\7-NN>$ =F; (TN3/_(T>=I58SEB MEQ24/FETAG+>C*3#]>@/7,%M#,OF*\3@5YLF4>.?!O"D[[75LFH%BEI!1!MHB&*D ML?6LC<)IY?RI2-=T5E@E+=J)!^_':>JT* 2/Y4.V$A.GT..I[^C:@V\V[=L4 MD%R<4^_$C%.V1QQL"C0U!?@>/QSVYH-.5%-I(R1*&H?_MC7"^45DN\)\62OB MF/N#B 8KP-7=#N!/V[ S\UB 3]H3W[O_H)XS1;$YF?#N#<< M3WN#<2>F1!LA4=(X7-A/MFFQ);%+O!_1DL@W7_CG#5]Y3E'3>\']"V.?NR*B M2@SNBZB)3_#?4+#E:4V*-JEF83+MS<:=N,Z[C8!@"R1;(+N_0$Z%YE?(%F\: M*RFPZZ]_'@W$C89EF\9FI\,;OC>:CGN3S)ANN=,.S[CFN=[@C#IS0H7\CZ) M#=,7LSD$%.WZ-K,E#7N@-!D579';\VOA!E+.Z^V1D M6.6[(#MV--NRB5G"/1,5438XGQF\Z&/6%: M]#K;D]APG4*/;$_=%GRSL]CD16Y[BY+_50DW]=1=Q;#VNWL<3ON6O@9NT3_@ M?N$9+@._-'Z5M_A ]_N<&VZ+@_5K@T#WB#@7QHI6AC<[Z]ZT?"0^)-R:%8T$ MX!2-^ZH_.V8:5HR&,;:6G*C!#XJE ,J\I#1NC5.5 M8? D_$>1%=7&;GPJ'-:V[\ 7NN62@C>IB8H&["%10*:UU$$:GCS/TVBRD!*+ MNPHNX_5N>^Z)0V%_$$TBWXH;9.4"Q4&;OUDC/^9OHFJ+^.D" +!RO@O?0M?= MR^.<.SZ(W!=!#8E/,*1;'CG;=.".%\I]0']9'\2FJ]"T3I_H(PIPZ[+29:(Z MCP-@0)=)MBI:A+ZX$!6#>P81TIF@NTT_X3"Y.2JRC4"E#VL &VA-LY8F1S09 MVHNYI.Z%X!1B-]6=UDUU)4A?9?=_M>XZH]5:U3?D>"\PZLI ? 5UGF$P2O*L MY;H/9#J)*:@>D9^CFXK+Y^/K&JR:0#+ELPXKFZ*"O9'/9,9B\)506M%]!Q51 M.YVU'UK,P1>U;/Y).59T4&NY#;*$3- M>J#>KEE7VTQS*)P)O)"5Q!,56 T3K&@X2SVS#42\XM[ _F^#<<]9/30GBI[A M^: _.<\: W*BPCJAM>Q.,;_W%P;97MRJH&"):7&&>P?B+YP M/IIE-AM/5'0IIYIZT.]:@KLTC3/V4E^MB6;2AH*M7Z!+''9?Y3I@,_H PZ/- M/'>J?QH=EDR)GILT#5=\@?=7F_JA]05UFK@7UG,N+IO@MZN"_-T]= C)\<(Y M@ A]YU]V'OR27GC.W1(C]"W5'&P0*AB$.[(2%0WK4@>_O81N#5&R;%$-??\ MFX;0%V\"NPP\Q0.GBC9_:VYHF7EO*]J0#_F_*-T%6!='XH0RCGX^FQ MR*-4M(Q=N>+C.#IO/9.Y1S"32JA?#Z0SBO"K<$IIF^'T9C+LS>5UP)@DUN-\^W4C$6!"63YW'!LFHS+VE@1BY5Z>H' M9!KS474:'IKF9-U^5$EE"C[2A=";CJ:]R32%R_@P&/)(IAKI)K5:SFSR6N// M1Z6LC.V76\E:W6MVF,>9UD7YE8N[DG7X?M9K-AH]X&P[)^ ?T\X3W%6WM$1K'$GGZ[81KZ16"^$ M.%\3TU)6]&F:SPZC]9U8V[1V? 0C5D5M\W>3<^I'8-T%^NI..0C\%M8.8J@; M--S=G/AS[B'4D=,*[2*H]> MC-=RG]J)K>EQ!C'73ED*=7.>,#-"DV)_$'&V,-^L@<-W($T0.DB3MOU-4RR3 MQBM7$T7<7!D'IQ0"K:) $6[:*^@%YJ^) ^;*P$64#5+@1%< F2#"*BT<7;QV M(1FK)UM/H>( T'(8=.+5?=(C<>M4&9[*>'63ZDZ@S(\C]XB/BR&G86S]*[3, M/H']%/K-B6"^A74&(7FT8UNKHR%B1T]G/Q9G.^1K-M&.]ZGHZ'N*H=IJ)HEA[D6(8L?3GK"*&N!YU9+ZG@QE+5(>+70&9S/<\_RAG!3 MD@*NKAAX,-;[L%B;@WF+9GT52E$8]J8"NVJ2W; T[L0-W+7:E849^HV83,4U M#>TW_$CHC0?-Z[AN71UX1*JM!==&'H/%%H[ /RTP":3=WU?@H],MDSV3A)JLT;=-YQ41"I1,2R\HZ43:>D/*?;!J;\]251PW1#FH>HKPFZP[4GSGD% M_>3XG"2N%=@0>-\F)/1S6$J>)7*>7B)GBXXV6Q7%V\48ZDMGJM._W=0YGX_/ M./U9+?!64]T)D-UXZTPRS+HP7K7%\2?;?A6PA8:1Z1/PT2GB$[SA)>6 -*MA MZ^_]%'H\?@GGF+%EEM^O(N(G0[&MDXD0:VFE?2&KT[W50F+PJ1D^DZR5O)H6 M4DG:-G.D81E*54CKN6L.;2T"?@5HGV:]6:(%XFC' !P?%C(OG%U6=\5"1DK1 M?6D3(=H!LN/#^Z1HY!33?Z;U6&7^5 M!4R#;LPZ-5G(?IGSJ9:0_<(2;=N8MXT>AL$:1=OYW)$2,JPK2!=Q0\^X<-A9 MP8G)XE=;&+\J#(I>?E%W;;,V M6Q4KU\5 1B]:-DB[?^-$=\)E&PUDK$,WM<4OEPK41RJ*1OQ?7KQ-M+17.5Z_ MS\0TWW'B"NBSMB&S!ED;Q(2AQ,!9!4>4F!;W9G(^G/_8XS#'"7]8&/H*^CD? MS7[D+)WC87I/?DQ[T?7)!%KEK.1657A>5L/SV..KCE-3M>C0H.;#E*Z(I9&U MI'Q.;YUU@GL659M@4F4P:Q,)R.5".S$LU#9%^,)% KHT-YC./WI =TLLK=#Y ME?EPZ%;")T*R#0,7!D4S+5%5@WG[X5Q\W:]J4/2 I6E?%#OY/$3MM/Q2(<=S MXLE6I<9)8:M2>U:E"H[U51W:MXBQXM:Z@2M.P06'':VV\&B5'W2W$%I@*JK! M8]5_O"U<"LJK*243Y=U'S8+G[L@3O3Q L[Z**Y*Z5-0]T8CY0*1EC[O6I/-_ MO$UJ<;?'2X(,J-=@!;[^#]FD[G(P&/"3V6 XG05[B[06[.Y*EVRT.!\VZ_2, M\8/^OYSV@Z_'-7L+8ZK+'S7Y2K32M[_]'.XEU%JPNPOX5<8G/JGB4^IN%J)J M$J>'4 /!EB\=XWR+G:R\]/N\T!_R3C=)K<4 P'GRCE#]JSW=6X!9,W6O?Q S M!(#8UG9[_:2HY*M-:W^D1QS?'T[G(S[8W[:=W3Y@*N@&T$'G)!)"+O%(Q=A< MZG)ZL5Y]#/:WM\UX-HU+>.I)-]+/K:^ZUA"8RYZ(Y)WB&-;VVWU_L5["D_V*8"NB@]?BS#)L'>0JWL=O)Q13 4Y>E7 M0W^QEEBY3]32"S;:66QK,9V^/H "-14<X>RW;WN!\&YS A854V'#^STW6T\6#'P#@N MX/>;U:.NIE_:OGZ\=]H.O1_'T<=7:8FE'C,MG5\O[J\N_A6F/MA0C,*DSZZR=8 MC&;";#:>3T+Z=$]G<'ZDJTS_!S7G=^2 MUYE7\_-2%4T0Y^\B5O.T;HP[M%P_OA)#4DQR:R@2\7\TW5]-/GXT'!*VH_'M M_NHV843X\\EL.MY6'LU%166LS)P%_]\@+K"(_^V]@LDIFV6#+NHA8#"_=U1RD\Z %T MT.K94?2$Q?7/R]]%17NA7J(+3;[4LR&IS6LG2&P:/Y&8Q!)5#]\7]DC,]$1V M*Z)_6EG3[S1/4#>+AR5Q]R-FX.UCT4ZS_@!6IV%9B$HGD,'YO+6 F:&Z%O8H MI1,'S$&E78M\VFOYSU!%"Z-Z)Q1_/IJV52 1P&2P?]):.'.^K;Q'E,E7\I+/ MNFTOW*E%PD_^[3;\[^O;F^,Q'B+F5IZQ&Y7,VZVA2X3()KJI4)/@A24WQKV( M]\I\_-.&:976FQ4B/TAW?WCVRV0J#/"?+?6'.]Y'JKN%^42(>4 M_J/)]TO=L!Z(L;K6GHEI.0%P:9V$4;J&\XC$TO<9$EXLFIVU+;O\DK3#!/Z9 MNC+%@M.], .X5]P$E+RF0\'?NJI16,I''?)7 S'XT'#3 30]BKJ;S3%/7G,SS] M/./>%H0UHMF%=6B+3=],-/(;GHN3/C_WB*YG&UR6%O66,URO-$LW-G?BRQ<1 M *E HWN<\@?L"_@GM%K&-I^;AG0VSF R+$##[[KQ_5JC%HB911!)TR%[!^GL MDG@60XTGDO!)T11S2>1?=5TN,-CC43P1H>;S$Y%*#H*0((ET1/QJZ)E&.2(! M83*.[YVVF[W7= 79O,\O7Z^_G1S1TQB/)/<'">,>*#IO-VG8CU[]^YEH$2. MOPGTHW,+?8()/LVTA1$&8?+2=5T>P;, P;-4.F0\;II@/AO!@_F@48IS. :: M%7$,P;[O"6>,:$A+V+Y>D6>BZFOT,X:3Q:1V=)>4-X6S:6MY*'$(P$89-0S6ZEI0X#5O+ M6HE#*#0\@C&+:WDC*,Q;RUN9LU"8E,&F9BFRHMK8NQO*JQ#SXZNDVC*1D2-L MQ+9$YP+XCZ*A ?WF+7$NC;^@!9>R6R-)^^[A!/Y?& :X*H.^VIC.YV<6)J/9 M2!@<$=,^WD,GJJ,Y;+6&@^$DA5]N.AL*F"9U?"(!]689BH03%5U2WT 2YMW] MM_2NJ>EH,CXFP<0X=M>TC$)JU_IT-)U,IUV5R3ZK+2DB(1D<_&@^ZJPJ.6"< M%YHW4V'."\K !O>OD/ M?R&B:1LTU!N[ABZW$;L[#U]K ?S,YKI?.29+[I&-E]$XSNQ/MF:G'O+S MMX,WX8AY&T:>N71S=;2V1!T3BRT:OGA2,K'>S3&)JHLCA%U4:[2/Q;T4 MG0X(NTF\T&7BARTG/BMA%Z9)K"T95XHIJ3HVWF';JUF>JK&YFN6I4ENK7:RU M8+@:L*W:I0:."%Z5VE*%6&O.AFH%V++$U242W"[. MZ6'H9T5\5%0ZF?9E]E4-Z&WACR'6/VDO_0FP#=+/MYG^! 0'Z1?V>U%C::^5 MP7W$#^LDOBYU'V1P5"*ZZE+J0?K';:8_Q>R8-$S_/MJF%6B>HCG=))A9R6EYM8B%AGNY#6DKR&^:ZW1RUQ37<)A;JGTUM MV=74S$)6\F(3"@]41-V-@DB, 1*$R4PX5)4DIB9J$?*2$ULCY$U&0WXZ.U1T MHV3J4L=B[L0=UD'=)*WL9L)TU"X5HP2!]B?(@>[+$1;OL$=S68\ M?V!L4]+F)'AG+%WN9G <3AP/US'/3T76 B*_N-GUK: P;5$*E^B]F&N2Z'V% M0>JGO80J(+\XK_)M)3JYXD>UE*=6\EE'/84>#SXN5$6'D%)GTPA@+-"4FI#; M\1\'U;+?:AE49-:,;:(P]41M.=%[-6/MM)>A&5M.]![-6#KE>VL'#E-'QN^O MTYN?@,(L"(59<*X%R$] JMVEW IJBJ1/VRB[17:&O,3?D W=B41 M4P-O-12_3Q)6N$Y%^T756&WW \47NR/!VFJ]'RK,UUF1W=J/JB)E+DXWFPPZ M-ME:4]ZN.R*KK?#[T8IL7_GO!*:'(WYZ\"Z 5O&1YS0.=; 2BN9U4]7G: M%\;>/KK.]?G09H'27( U1_,/O$U-E0MGU:SL*6F0)3(E$YD>-N-+O5S@>T_4 M7OVPV3YR*V[PJXL7T9#]4\T+$.W*2QNWEKK\+>&PIJ,_F0WP'@>H9\VG*W+ MC-OV 5]:E_5OJ?9Q5IRM=MQI-1P5YZ21VZ< 6T+II,=4]8XO(>.]\$5\558X M/AKHF,^?+[-P,#B?ER_\_77)*Z>F#?=*">=\"=.SH1N@AK,TI'O"_*I;]\2R M5()53:XUO D8^1B$TIUMW)TN-QG-N[*ETV=FGFWK"O?*EG4H2!W\#"9=TP& M!Y+W)I'+>HHQ5*KIB>4LL1;8;[H*S:A@)M^)5NJZQK5KCUN01YS6' XK,LWC MY=.2(:EQ+WE@" ;GTYV5ZR2&@!:1VUX1,T^M)Q*0/)X/3E2,&6[:*;CD,-%' M1#_I#WS13VHQWY.4B# YQ2$HR7UU6+S!XJZG(UYG*S?T$%[1MBX1TM%M]:G( M/$FAUR#ST4EJ\CUJY.-JK>H;XI;]_[=I6/_^HFC*REZEENGD)'&<4:9H>J27 MZ6S0@N7N\7"7CUFZQ .VM/'=]1[#5L]VLP*N_3#XV 6:<7-W,D*I>JMV,H*L M:^-U,@*MS,[_Y7;TQ_"+,+\Z"3%69KH[8CQ^&18QQ7^Y'9[ 9"UB6/]R.VE. M0F6;Z%?*LR(33>[>NMIRH!!L^:#E1J;?F MC.7TI%_3\*^?V30<@U,& 0 MT^KD+D(85'4N'2>>5HQ'J_81_.SDY%_Z3D*H++:BS3)L?B]QFG)OSVY"J"KL ML[7BKRM:"UJO*JJYM;)M=D\AS$Y1X WN*H3I^-0$7FF0UH"?G!R"*XW0&@BC M)M>W[7OR?X E;&];W2Q[)>+#]PWLZR]*W*VA2X3()G;M/N/588NEK1&S)8[E M:20=:Q\CI3#-S[=,UU&NJ!5,QX_TODHR,62/^6%M5,#<3#7/@.!93-'R_?P M@5(^_,0?H^O;F]0%F0;#Z2"4L):#)UICY@KK&?K.Q%)4\G XW):M#[Y@N\$VXH+=2FXT@-RQJHY_M\FD*D@P8$BZ25(UBA3.IA MP;TQ[BT10^;1_KDE!FV@/'CL+;TQ"-;)24=9J?Q$ --Z6ELB>ZH=G0Q^QU0. M;@O*T<6!&TR2.@K77!/-I4I,TS,OW$7MQMESE'9YB<#/)X)79FUOEZED=:TY M_91W^CTU'TTDI)TAU\?^KXRC0G'M&?C5TLSRMSO.3Z;R4 MG,1D8LN6QR?=6!#%LG&OIF6[9>KPUG<^+B7P)9G4LJ6QO7RB?&GPLS%?HC1B M2"U?&M0BP>I*)>@*6!JF@U*RH)/(JU!7_DYP,2+RQ3,QQ"<2NC"C<&E1_GQ< MC0K=1W6+A)6Q*&J)$*I*5F8FQ9Y:7FFW0FO[KP=E1&LF1^0L,>H(+][U79221D$14_^"*,KCS/ M41/4EBJO[.,U3"^M8;G2RD%KV?,P>?HGD9#^*M-;X8_Y%WY61@6!_-16:#5? M0T^*9BH2]96GWE2<<8H,@M-UJS\8]0?5+TR92$[PT@=)YJLG.>I'@;^N1(OL M(3^S.1#D2$C)43G0#7/!YQR%886C\/%/6[$VUYH)#5,[[L9:$N-A*6HN-U]U M[9F8,/T.NF1]G_0=/ ^6A.4>-7T#QLR[^V^I_=3#B3 JP^[)RENKA!H-TRDJ M5'XZRK0YZIY0PYHD:QC47OD*P]%T,!E,A!2"%H93H0R7449^ZY/S;W1T&Y?S M2!B7DEN7D=_ZY.PZ !H0=0M6FXC1Y]L%?AAOF0O1_KMCRHB2+I'QK@Q&W@5L MOW\Y>C'2R0S&WOWV@1&I0E?L=UN5<>Q>MDB:6B%;/E:E''R6+9+:5UETL[=K MH"I;A,-1X/O#6IT<#\'/.G*E*4%;RC.Y544-'TJ]"8G&M9;.0^E"NI!E!5\1 MU;WB"J7$\-OLD-)$)\RF(V%6INB2.=L)9-OFXUR*:\7RW@!X$^.9R#"%/MDX M@[SPN!2WLA44QV0HS(>!:)[,)$9Y]/+I[N%Q12+QTO7M BI(\T&'?H*_7^JF M]56W_B! NZ0_:4FS*B*+0$RI(X?!#/XWC]06R& _[=Y"-P@'ZE?&;=F^M-]R MV)\5G,17ST$Y)R/?W!%S^R[YO"T57L]^N1W\,9Q\*7IPDI.5'=WE:(//!-HW M'17@)AZ[G9E.4S*JQ$^**8GJ'T1,&4T5,]6$46BBY>P^.Q=7-KG6'EYT?#OV MVOM4U$]G&:D/=9N7ZJ5!2#&Z)\-<=/L=YZ3\DVX;Q0@?YB+<[SM[G(SC\E!WQV:J,DWJP)AJ]H3[5IDHD0HCHW 7DX*4>;1'1AYH[S4YY' MHQS:;Z7N/8]6**_S'%.[I,YSXV0VR8.3[$K$*T7)" R]MPX#'\]LO M@T2Z=WM)25-^*0Z2I1AH/TH&_?U"D^^ 1%'%FIZ:F53?R+?09ZD(FH67[=B> M0+X6J;5KU;M^QLWL;FXTNB=BH/T=J3F)M M%@G^XIS*XKN1B1[I-"0S^L!7W7+2A!-.OG.3=#L<>&&=.QWMR$?7GM"O<$4> M:>'?S,M60EQ@9&+P\[ FS-)KZ22G4]Y"F233N1^V^QR_SX/^\=7*4'T&G4_" MZ$L0:X>:WG%92DLBVYBL'BQM!IH(V/JLB(]XY:1"S"_0$MA!\HUVAZG2F #^ M0305\P'C_AZ U ^J+GU/3???5.O]FC.MC4I^/EO 2^\X?K"VN =E14SN*WGA M[O25J/6<+WH<5H=8O.=6HO&D:.^XP=G?GJSW#TO"+715U5\P/]Y"2CBD'+XT MK"5GP<]NC:V_PW>*!JI6$55.V9Z._>V_^.%[:RE:W N8J=S*99*#+Q8@#>Z9 M>EMAP1 YPV.;>T2^N<<-I^)DXUX4:ZEHM+? .TL%A@#FY(9[0W_4;1/TDOG3 M.^3\[1K)IYT[_RI#&G\35^OW_\5/!N^3NG D)(%F-->B!*S\? :PQ[_7HBQ[ M?^^0\5;3#9@)AZAYU W8BO;9E ^@V/N&>"5=5$M2_"7 ,)/.H6*,+MTXAP M^H8<9*?_0KVJ^+@J0S]+Q2)]% 7!SE\,<1TG2$O>TZPKN+Y# !!]/EY;+F,E M]@:BA#>UG\_XD3] .,\\_O%8B1BQ_;K#XA'XJ(HP32F9G*FKRA[*[LG:HFL( M-QST.)R]SHLWO3Q3[ZE%; ?WR5SF&<@TKY3]G.,ABIHR %,F%PPF9X,W=9D MM#EUXQUG/#V^$08CL%6&,_C7>/S3/OBZ9N98^/$]%YS/*EG O$J8;M[7^- [ M;KXS P/3P(G1@=YP7_3B5)+B5'=&P+: _^GPI/=,X1\3"4KJ/8O*#/2R*XB8 M#E(JMA]2]SR/]$PO'BK2M!NN0?F4^Q4V-BRL'*ITB9R-UTB,5L\J^I>=0H:_8X5>]AU]M\JJ6?Z1% MB;@BDGMXQ=/#JUGG7:QM&SAV3M4JD;%S*G9.Q,:^-V++5A%@9:]T0+<(ME%01 M-J[^C7[E[%D;.#J(/S_/":C:(FYJ#<5@(\=&CHT<&SDV.TZ MKXUL$UBT9./10BP$CPT5&RHV5&RHVA$O68GAGOX6W$ ML&]KBG5'O%E5+X1M=&*Q 6,#Q@:,#1@;L-JW!\P-=]*[4#94;*C84+&A.MFA MBEEG*TY;#I-1>P*S0U??TM= V_K5_\*3X<"789FIS,&QPP:5Q>8]%S5C@*9] MIHK;S4#1\H:4>Y9,K LEE1,A]LV')=:4?A%-D @G+?$&..Z-1JR?N-URT?J" M?B/%.306ND%_M/":'P[K_&N*1CAXT%J:'-%D(G.[M7K/N6O:)I"P%&7ND1 8 M<\7B7G1;E>&K9T*_P[K6."-E$#.GX_->%.4;XEQ)\1/M4G$O3$NT MB'/]"O"@.X7'\1H1YSZ"U=H@2WA>@>Y4W33/$R99:'X%;B,LLSAYM/+YK8'D M6AN\U ^+N/N7._AOU%;.'!YU%()'$\49BI!X1/4X@ X2!'Q9'E[\ZN>5E!7W MJ6I:.;6[ND(9=<2/J8VXI.,RVHU)7"ZGJ'KF?.F#%=/]KD ;U\]89^3EU>C8 MBHNO0UPYG"AQ\[\4MUIE1U*5%2XHLZ; -Y,L;-7OZ+.R($UP5G'EA'*O3JC$ MG=LV>;6V6D]I2?V3^*1^^@U>:HHF4G\>>R!*6_"5H'$3&#F-9CXC8Q2V2#[XUG*:KZ'"*E MWE&I6"#CR@12DC+($7F5>LX[=S2&9KSDWM:89KH76>FW@[#7(5).%\-#\[>H M*[2D^)SI.$4%J:X'(4U'*:9<)Z*/TDRQ"]O22P!>'6.<8;UK"93&H^.?+B7S MV(%5Z9-M: I>DAU:F!;**W[7N;DT[EED.PW6? M4)L=\].4;JVF01I#H(G%O)R%ID-KHM";#E)XD[N^] N]R22%$_@45W_3W!K: MDF2O;%6T"/I^UP:1%!I^02UP<:4#4W_1+[JUGC=@%; %+-#'&[XWF^90,OL$ MG#<5Z\CD.IZ-*Y1K"TR"/1D#G@K+GQE01G!M(VVDT$5M(&W/?"DE(CA-R[/A MH(P9PL1)W#.S03G;D?W"B-$\)0=,9XA&+*6;_T6;NU^"$44,#+A4T>\"]INQ MXG2#(Z:EK*CA9=,@%D[U@E>.-0HS'")NU10BGC,:G(9TISNOO-:X"_L):*5Q MTST:6'NIK]:BMN%DQ5SK)@PRC+]WU.HWX1^Y A_6DA-IA.ZCKG_?!G7_(' & M,6W5 N%CR+1(HZ YW0F>=EH'R<.33@5;D48W.VB#YZREJ'$_\.<!(U=V-S MJ6O4OJ)_P-NW0#J\2_^\6?BU2^[],/4KQ92 ']O8!H;7%N9]YLGA$3]\U6%@ M>*[/!?FA WQ%3,E0UO1O$.D'VU0TW/:A!!]]69:L9VK0K0GQ&/<$N'L@TK(' M.)?.N3<&61##<'(2:)Z!8@(DUZ") 6B4DK/M.V<4_6_R2V)*/]IB[C4F!QP M"\]_4L4G:&BQZ'$7AO*7K@$MOQ,G<\.-\W(G(-WL&T[V"#$0[LI?.'=%[DG5 M'T6UQZUACAD*L41C T,@+36P\Y\V-+,$QDM\HD]K"BX":TSR6.MK]"I@(D MC(PNXZC)M@2(Z'%_Z;J34F."/K, */ 4_9NF[)A4Y(IF.YV($L%\(U4EVA.A M6')'1,5QMG19W/P=O][V?D[IN0Y\XRX!^+()K"H+6(,U_'-AB+",VQ(>[G*R MN!*?2 ]F)?<"5@;^%]<>#JT-; ;P9"CF=Q/)PHD!,%=QU<'S8>30+=*^<9=7 MCW^/'+\=]WTSR)>SZE&X4@Q3]0X$RK"2 \RQC^B/(%#@T*2$F=R;VR^WYD]T MD!Z)L]9)!MAX\!&P+IK?W>F%LT0#8, Z8SNR 6J61%WC-\_$(E'H"WBP"-11*B20K+Y"N%';0=,M, I05+YH\ T@YM%O=Z7#",@*QJTY: HB M_A%D @.AP^B#\D!;),HCMF<2 VCV^Z:4P",6'3@5+!<'U* 3*?<$5;]!5KH[ M,N)*MS6:,+76%1.:M$U?40.!,1!Y,L256;7RJD%5.2&#,)P+Q0 F=_2SJU^L M'BQO\(5X"Z+HX;"#P:> $29SCZ+BX _?$&$=0$FC3"4+$_K@3UBD%9K\-^H_ M*]I&E39@7"W)*ZS.,.RP9+\">+@WOUU>.6F$%IHU:*\1F"I+0C63:L0OJ SW16'FQ29W"DU MH!Z)JH#Y%!G@+3SHJHIJ+:"-$N?.EIC'C:N9'"*]I-V :L'AIOH^B(]CT3.[ MBS450PB!(("@T+4 QAU?"\5Y#TP);H5PT!]1Z83;6,#VC+[W##:0;INNK0W/ MH$1U7/AQ)J!Y!!8O#@*N(,[4A+:(*"V=5\ZY"]-+HY4=<]T=0!_$E!*Z8AI$ M(LIS=$9%)A)NE<$&&@^<#IP%'9N_4AQ .@)0[=6C(O:XT13_?EDJ0!'MQ(.2 MCR,7V]QA7!\)B&!V8GHY2(K:$5N3=FT;IAT>95>;N6833##9"7]RU1%Y!:%3 M?1PLS,,094N)=0< FP1NF$S;;1I<.V#'IX)T-D+D.=LRWP2 ML0?43 +7H<2.F9_L[ MI2%@#E"G C9IN-E?.UE?;DZ([P=PUWY<9NG6BC[@3C+3A@:+) Y:H]1O4CG +7#Z7U$,'L)%L?YE>B T'41PJ&PI0*&6:LJ#G[ M%[*FVW#L3+0UZ'Y7/*Y0G?4_QBKV.:=DP+H"(ZV A8 WZ:*C%=X-5+[P9. Z M1QR/$)JET VZ7\&*V%Y.ANX52;5EU_ZDWFYT%JQ]'Q@M!M(+E0;QO3YNB1#3 MU9&P.3;#140J42 U+@?.PHA[1$-4<.,F.2K"%RZ]ZVWAN'FUIYY7( /%Z8^3 M9QP&Y0N;5V*^1UCT4'@B];>C?_S5HL4VUN+&J6KB0]*Q\S77WJ;(RP)PUT=V M/#K]P1V!W=(SKIJ3M[+#0P80E@0ZWSDDF$S/!4K*2@';S+/KJ!R]V1B$<2\Z M'[@ ^F',<#J;KG)33-.F_I7(B/O>,J1D!4]YZS2% B[[H%A LSRYOML?^/,I M%R(OHJRHX1%]:7 ^]E]"KPVQPB@!L],*BXS2$!(;-AH*[$)+@UJ//\R'Y[S? M/M7UHKGO3^BC55762[@#!]->XA!(P &8^RD/DW"I#CWM@.: #$(*A[ ;*X9[_2 MM=O( E2C^\TNK3[V:=_OL0/E)W^OX;T'NM#M-$BI8S68>'JG4+P%]N[.I(5E M6B*N3/!U9[\5MU>.>HU#[ :EZ_LE9,=VA/6#PP!OP CX1X, @=.-( M)Z@%,@#1?B<;#I9H$S6XZK@+:1L]=^4F_F"@ Y8V^.@>N]%5 KI1=OI9$5=. M+[I!W9#>ZJ2AHCN6&?=!Q(673BVJEVU0PR%C=:V*CFGK;=[0.QM23)28H'(2 MK=AU@ZZQV\GJ'%%3!_E:#)J9CNH-;:A":T>,F?4":I"2\1C:O.%YB:W)<9RA M+4=W;A8-_;!%&K#82&%.+AHSM! M7+6S:Q\CEZ%10P_:!LQY( G&E)X)HS0=9;9RZKZ9+N)H93MEM<:R>I&9^AB2 M$U6'P6F/SLHG/7!D0W<3B# 4A.,(HL<-RG>BNBJ&DA-$H#?Y04@T+BN$K>C6 MSG$!!VMX[.SDMGLV&X9&=;8U=%7S5+WJ[,E00AJ.HS<8T;7 V"K>M6XJ5&W3 M^;E0]1=J^CA.)UNC42=(B=^EK%/N=T"-*FX[PE&SW)V T'/80*=5">F^,^D) M9\]K.MCRST[QN$>&5Y %%85DXIMT9TN71@HW8JRVD/'HDXDJ;GK.1A7?P:=0 MOY"X;7)X"!RMM0 =8%6CS,.^D8@JK]@!XO5*"R7BU M&SAR'!^:!'E5)3NP& M3CW02V#KH8(#),NH:F4/>+B"A$I9>HK2"_W85LQT70JRXY44G46$^FMMU9_8 M3YZ#W_/>WOM:C3[Q\=6M"(IWF"CT?(5[48JSZ)CE^: MSJ-+V->@D0-&%@;3^?A=Z+J%.QH\TG4#G4PWW@Y/A:FYNXU4$37-QO.-."%X M?'I>*!2E(=.M%5V8OYW#"N(H%FS:F8FX$,!SJ#Z<+3@TNT:QO#FCS_]Z<7$+ M+&ZEN1T)G- P2:V(9%%;.#9BG'BIH@Z$O_T=!+X&$QR=;?AUZB%W)4-=^+BW M,/!W)X:1/N#LT_!7WVN/*P+=8+CQDPYI;@%2#G0,R+X76/P<=Q1.,EKZ%1>2 M$.%;NAPMC2-*\1.N*[@UEZ)\>TN,$[MAYJP<2Q]TCMR\$XQM)[XU1Y>.K:LP M2[M.3%5H9FY9#^'9=(*H)+3+QG/ M>O$&1Z%S0X8-"5T<\:@N($,1UG$8>"P,X- >(-*='<%I!?KT7TXL%[1ZYYR' M C>?X!708OU_<>:2FBK4JA$]S])_;"W@6@I+_<*9IKMM_4_/BXBC1R#T''+[ MX]N+GC]"2+P[-#L"[6$N"%@#BDKD;?>@C+"K+W3;)#XTU]+IP;&8>A4R8\ GJ[>7JU0[Z &"9PR M;"GF/)*/8[WW)?#-.2CYZ(;H'PE[#S3.#-=D?V^7L)(A\%!!H8'M+]64$%Q^ MO;V+&0Q.H'X?V%AY:0WNG#6]@!AWCR52MX\;>8'*B,B^,J";?15>H4#S2'0C MPQU?N%^QVUE-MR:*ZZQ%4-*]3^Q+;KB:=USOQFPDJ)L=\JA.I]O:[2&8YAVR MR;;A!3?Y-A9J'467'8T?/*;;RDB)VAY[30LG;$&U?=FL0T$T,0<]+B>.']@[ M[.D%W'GTJ?XC]=!@I+&,#F8,$%7]!3FCZUCY&9XM$#1(\Z !:T/>-X,BF@0KMI-ZS8I&==&'])MY5H MJV+JHH5.NIU6T&4DJAY^ _EW&EX'@*<1U%/DFH70I;A5U32&$[6D@T.- R/= MT@V,RN2\M^%;7!,,A3@'+>X$(< C[$NEP.$&W4LJVWLN1%Q9%)"B=XV'^RJN M 39=>6CEZNZ/THH%,UR"V6+QSG7W-(0+U5SW-@#'L09< M:^BLU8VC,6@##-&]$K4I9,\, G@XB:D2!MG35!X*3IK(U^-L/^K CVWM*UK/ M_83Y"/1T7',T?K"KP"4CAOCB:WOTK>K&=XXN/OJ3X;F*0=DKYA+H>M+UBDZ] MZA(XJB==\UR BBN3#0J_DAM66I'7>_RWJ[3_)HRMA\_OGUT=DNKJD*V\3N[N MD);?X<#NO&!W7H2K,DRCI?WC2J+-SBVM3!H#[*;09S+FB'5/-/T%@I9:KDRZ?Y[J%EI=:SKQN!(I=T=**6\=%ZW4J MWQ-F)U#-&-BHZC?J]03LEP5A#9 M%^@DA8.I_061:S]?O\7@0T6F5:!HY)QZ#(?L'E=^\EUL3(M?#V"%X146?228LF0X:>=.-IM+K1S,Z?/"3FB<>I>')( XIS:PDS(3NN'V"' 7X&U; MECD71PN5Q$21>-HI?^AE@IJSLE5OJ MW,?\#@'!JV4ZC;2KX*4Y.O6WQPV*8GH5M&4GKL8M\VN(N.[T545S9N"*6$L= M- 'F8D:"U+PB\<_$3PD#Z:_=)'J1!CP[@5]..(];;Q[O^0O=[T<+-#KB___; M^];FMI%DR^\;L?\!X>V.D39 F@^)E-PS$ZN6[5E/N&VO9<_$_70#(D$1W2# MP4.R^M=O/NH%$*! B@^00MP[,S9- EE965E969GGN,:;"'T>11#/-GYBR2X@ M0J[G?Z9GV]S'1)VC'C5S8,]*VZIB3,52B$>8@E1 S9="D1*R@,M> $Z-\-BP MJ5=!+K@!%<:AI@B8W"/'_'MHX)MSA;ENU%(.TXGYJ9$[/FC354[R W4\2XC! MCR&$*!^I+^J*C.HXO"4-RZ=A\5JQN8P=$8<+UZQ-L\YUF09BIZ>5]3!UN6N: M>KRIH9A[,KF%PHO WS%4;RQ[PUSN@J :3R>*J)5) \QB+2O*QOW'8<(-7B-< M'53624)\F.0>+3O)_?P(42!^'A[/YG+G3V -">@T"!%B*GK5H\IR 5#'%3?( M8RLD]EN@L$(?NA9;(#=PQ_2M"?"E\!;3.+M.<](15#MV&V350OW>Q>HB$;B. M,3OP_)-%,[BA26K\#C(#TH7E6.?K,9Z/,=DPL]$=E0'C<^X"\EM)J(1@W*?R MZ<7&- 0OPC%B\R;OF6WKO?HS/GOLH23VG>@'&$H$\8"HJ^Q:8G*WZ3>OZ4??*5H0S\V^ M5*V\6 &,*/=BP!HI)!>)/F3G4-04_I_H.5-288.U&U&7R]SS0RS 3\=8T7Q+ M*$S^HXS<-.8S^-)Y_,8ZZ9Y:'F&Q3QZ%//Q029,B:_=_L4YZC)J4^;IX+>.. MW?K>G6B84>"-_#3X=?]4>PD.R^"L&#,Z#!XY1PB"='9*Y?]BQRGXCG1=U%=0 M_/+%=Q.,T?FIG@;8,!(Y*85>!5>5BVXI E\/]'EOR1 LE0<[&9"!YFY !,5XSX.RA7D2C M%@K+^ZXV,D9%04\\.1QRPLOUD8>UI *XK]$BI##1W_3 O-LAZ&.)$@*# M5BJLXNQ43"BUPA@@8O+II#DG#O%'C]07BO$S;3*EML\+Q..F=,,1D"!BGG4O M\@W$0V/L8(2OC74+Z+Y!-13,1\D[0C+(XLN>\:"4HY='?M+5*^<#:EAFJ-E-2'HCX0&M$ MM-*QH53J*B70(L'2@:*C1T<]2I>>!7\0V Q(95$!JD&9"N\<^J#J/Q[T_O]M M^6Y$#D&"\<'!%<_J&/R,J147S(*W0F+JDJ#B[([1+W.VA&&(<$;Z'5R3W5[' M&CN/,6]U7G ?>@R$5"(+]_5*B;"E4D;AF2V-UY"$.\S8ZD11#DA_$PL[S24= MI#>2.\313"T#@^AY-1![49'+8HV#UH$1WAIHB6\-1*NCB'&_EH%?#PJ.0H%!\ MW<2.@G$LP1G2HD^H,%ZTYF$"3[@, MV\1.PLL&E,3W5'Q"[T%\ESBT,T!1Y2.4*O-4(Z\&?I@X(XG;($6F-YB(UV8B M6\9(Y6^3J9WC6*,WADU<&S9Q'&OTG3!^:Q&A(@/2S1,N>2T8] *C,0V.RY\) MSJM\HBIVD\1G*R54()5;-Q"K,CC2G!2469!8PA!*[ S<10B]FT!&>+O7&1[T M QEIP.X%!J5Y+_ K7CNW;D;3D#:7N3JV$8<0)G2RN[]:1DGF[91G(A'4V]'G M9"7 3%CV(H+S7RHG[T7FEG_OQ@:T"0SXBXX<,I.4\:*\-&62WPPV!'J$.DG) ME6Y^!]G$^'G(DL;YNXE@5)+HH0>]I-^'"G'6"Q#O6%[4Q"D;*C()&;L!WQVI M9:'V #@P29Z2!;MRC*RCQ==,;$3B>S+]GWMV9K>A4WQZ^[L@6(G M]2W,SDMN52\I.]U$0W;5QL]-]6D/-MWD6B[8-UI8O_%:>H=KB4*DR'J-_YKC M2JB+HHY_6CZAAZO[K!04V37=^$TW_N%TXQ^/OAK[JJ-][=A!;DJ_JW4L-=*] M/.G6,.R-P9B<]\I0)\HRTT^O]3J M[U(3)U)\4!!!51,2Z*J/M,$-R0F191/S$ M4MZZR8/KE@K!78;PJEMJ\2XE[V(F23?)D1ISSZ3HM! %ZE2[Y 8.E^S!HR/) MF\4$\EEZ0OB8YRTON"Q&DY5_6-@=Q8(H13R)F#@%J2KQ5/\@$?B%U+CQM#*S M_4&>*J['&C>:5#&5;% T+E(J,1N)ET41$B"<%\X,M/+IBC6<"J7B00CM6?3!D M$:([6+L"0E;!FLF%SEPG$9\6RJ9Z@%69-XTC)[9M=/0JJIXX4U]*4K!!/S W M>3"*& Z!P#?">X\VJKR;(T[;F?,'U75CDWNFYRC?X4F5,=;&8=MG!KO*RP6A/]V0]1H@LR"7[MV3R,L*746)HVCN/WO'.D[_.0 M;+42Y[X3!-QSB8OR3GH2Y#(*$L,A";="[+ZF90I\&Y@K H& _\22FE63)3EW M^'G"?3N&28GZ1H+9.,R56I(N-C7D<,\ : 4MN\66W4++;LGV;]F'QHL5]D9" M&*$H"O2(:R\%-1+''+K$MO4YH,41QL:"T!N<8]V!22>T<\'ZF7B3Y%'2M_+* M\J8A0J+(BM\XC?'96-@Z%V*X/QS54":^2PR8E2-XZB<_ M,HZ@/#XO85;^1;, M:W^\=B5M:L1/[L84,[Q&* K8#/U,LPN1/9%BBLJF M),>*K2MN09!%MF@F,B41T)O:U&TIQ<^(_N":W0'%$AZF[\B>'' ^(W>*+?6P MA#^&\7&<'SY!Q$*!*#>8FV.DCVEZJ4#>F;G*Y8E6" F&Y8Y_D8%,Y,)W8 -S MK)A9=UTC5B;>M857"*R2?,1?PG6^79^Q<[-"0\*&$NN&"+JODB3R;E.N" =O M<,V-.-3WA)L.A!I'87:P$4%(2M-O\)3G!F]V(8G!$ZJ8XX\84XWDN<78"N(S MV4D4*(NN\#BQ=7)E&#;R8#P,AZ$@)7_(!DN_$IU2:8(81-R(1_S'TO 5\_%; MSR?,LS4')R'3\L-:,B1VT\\9%O7NAW@X@27FXYMA#-SN# $DQQ+FT.4)5!SS M]$'!.,$R!@1AMPMD=56D/+_IV;UAAJ@^CL'BCVNEV[6'WS+X\ MJU P<%B5QK*#8A$,I'RDSZW\>'[-GYB4H7VV88:O>@YTV+,ON[V-OG\OSG:5 MXLKK@I/TFMO0,96Q]NSAV= >#"NT/#2EPNOR6]K#WKD]'.ZD''M7CK\"$]2E M62*\NAWLKBAP&T:0)RSJV8.S"_NLMX,2P9>HWKX]P/]LAJ?WQ9%"78T%P%DX MH=\6(?KBEPGSEK-FGM+%*E<_=5-#24S](;!^V[HA:'[C@00DS.^QK1@K>; S3U?&PE=CLRA1H9.- M$-ER\JB8"ER?[R2YBI#O+^Y2;XSE-;)8*U9@S53&--;?P(H,62? 11,T.+/: MR+$FWKW;0NAUAL-#*30H.H')189.,G47,9$@,+ MT\J)4;>@$&'IA7-OE&AX]8F\3 +=A[[ A)UYLIR2^,RQ7$!AZJ+JY,Q@'AH1 M,!F5FUX?N1/$THXE"+L![P:_U'6.0D8N;U3T7OBA #9T?W!5(]L'W6A@,7.H9G'!D3T* 5P$8CLLM3".CJ$"6R=A")JDFHZS.)JX;Q?ZR%?#% M_54L@0>6\PR3/"CUPH-6IYOQPMK+2)B_W[+@BN^5DJ]T_;#^\*-12:SG#P'L MU?M>G>)T(@ZC]%D.K=E8E8F(O7.B,"5)$ -_T3;FVJQ=UK7Q)F+I7([')'QS MU(?8+N&',1=_DO/DHEK$[U5O,5[.'$;&@- AN\KM<&%Y%"?6?T#_"7M4=9.: MJ+BNS0U'67!O6WM;%7B.3]^YM5&EA]&PE"1GQ1V9]*[;J M7H%5H_^,54CAQ+RYF67%AK&KV &MG@GFS'@AU[PAXQ*'H_Q6.&FEL=D1X@C2 M.=498HE>B%O'I]?$4]=-5 &88+0C-\W@_4B$)"M:NSU1+M"V/LHO^KXL18#8 M*8YYNT,P88_ ^]G>7#0FU2%A\_/E]P5,-B]^.<:YD\#[ ]:2AB$U2D[Q6Z(F M42T$N0XRZO=CJG$D4'L7:_D?2I>ZU#G-B:8S021P/,[@L.:-K%L,,I"* MDJ(C*DY^YT3^HXH,R _,,8P$18YM5:S!Q2$/6C]39RPY:=@+29#=DN"%0DY' MX/J(B)=%DP6J'B+ %+.C.&?8OP72F"]:W6X.C]=P M<"3A"5.Y7)SU3M]8WY V#E_[P>#@U&[0%M7%BHK%-KC6!-DJT>*%2-#&;8@! MI?>87:^(V(4L'N-,DF:A/'5Q*S4U4V2'%O.$:%51OPS752N&SKQG(EIB#ZMR M2 QF,A97"EK$ MX8#NBRF@%GQ7"T^G$)[E./KE9OKCL3%6L&82-;9H#U-O)3DR[_M5[,(WM OS.2_G M1E3AGF-DEZ077_ @Z/57![]^YHR(3SPB7H1OM'OG7M!4<+W<8AYIUO^'4J,2 M*%E&05I"V9>R#Q4M>=LY"^2BCHNY$'O7-5_>7 M*IMFK::IXF:X7YM5(Y[%60>75L<-1I'.Q.DBD7S]KE"[ZI\RMV=UA3Y:YDTYG1U:.(PH-(\Y+H=>0DAD&6O*=)8\'P3/A.^ MTO'Q&!UQ_RH!/ZBQ>@$16W+N6<$MY41F&?!WGF:,5]=\>2T)#4F=<+9UB2QX M%QO8>IA-2@21B+2U@/KU!'#G4QBTOZ!;L" MNY-7MGQ9*8#5<$+$Q8.5N70@K+:L\5#"65T)2#LP+ =_(UJ%8V.5X.(($J(( M5^30+\BCJ#7#\SUS'M5"D=T-='D0,LC;&"^R)0"9,=MP,66QG/MV003XR4"VR^@NRHT$5C3Q&$^$?>BR[<5 M_"'X0X$><#P*S-5>%]1:6Q^XEND">1QA+8FCBGC!+>8*\#!FX#V8MGO>A^2. M056>L$3#="S@77(5- )HDE8[E^BJ(,6HV5$"DB%)I-I%]A4/OBIJ MRU$^X6W49?7$U8 _X+C#D4<16M%D,![HK5%];*NB4PDXS/5?"DROD@($H(\J M:2X>0I&:=!4D3T:LAV2,15F)')1H%K!.A%&=*@7HT8KB0+T4\[5D3A"DCD9B M6U9-9MQ-GFRT@4\5C;>O?#$.H0$=)&(DS*4-YB5RS;L4I MF6(65$[;'Y7M9"L@/)X=W8X!4HJS#C<0 NA;!4[:I'4/0% M^#D.)PTG*M=2;VKZ_3N'7G./,W-_J%.D+Y$N+QVXV_0=#T*YP.__C[__P? MF)+[J_S5>\>+_H5'XK>J4%5_F79.^,M7=_*W5^^C<(8KO]7IPO\G(?_YLM7O MO/K[9@,L"DK[5LM"X2R2SC)Z E;'+ZR;@5=(/XFP*@,G)S%'")1; )&0/!): M<)+]/ICS/]/ %=T Y[A;B(C_,M,1&[]PYG3D INM&$P[FOOVM@X!8H+A5^%KX,8 M6"U[ZWOQE."KJ5\N)H3Y203!RT,8_<%&0*N/ G3=Y<)I'K!6V/)UF3L?$R6^ MWLSYG<[>"[01%B:J[L+H43R;Y]OLH0ED83\6^:)+QM?#PX(PT'^GG$.;'07_ MCE#G)PI)4D14\P@/ NS+91"(".B@4PKS8A>/_X&0%!VYXW'\)YL4'4/V$VQR M_.$E_-A3T89(%4"(VHT_P7I@40XJ^1]@KO^ A\\=O [TYK22A8UKNQZK_LH* M,R#FBTDC&&ZQY>-)P$#)GWH0]8"O>!11KI-P[@[BHS\%HX(7P#&*O(K^6>*. MIH'WGQ1;G&+6D9@H4P#V&10QR5)B@LX73\1(+KS%&)72M2*'D ;ZL[;U6?^[ M^)5HX93Z HTXXE CH2_QEF;NTE4-'&W $[JQ;!4T'U[\0&$6<3H3Z)R4SQ1U MZWHBN$&4I\+4K-*G.H \H3XPR-O( Q$>03I9K\#+> >\R]'_ M]0?MH6S.]U75/RJR:PQ0;T8?M.5 B$0%B'A*^T\:BC+WD<@I4[ M&K0)*L07ERO89F/>I?!ZFQD=AKCB=C/^?6J[]Y2V];*Q#6[#R!&0R<:7# >D=K4XO<4*>(&;RC=MR." -VCB#*Y::HI4\0LE'([=VOJ% MUO:]P#>KRM'IW/1(@[S"_^8L %0ZZJ:X:V$ MDKN=%*X<$$',7S+ZP-LG0V^F5GE;4SD;$<#I[^H-#W#=11'-5EI]:M'# ML_5&G22<5ZB%[YW-?QC"\!#6K4WD=V6_L'&47[AOK"V_95*]"&RSL M='!8QPR849YQ1_3TPML*!VLTH+F!L_<75$7-=1Y,\STFZ_1*PQ MR*P-/RK!1CCWG9$ ]9,X$1 0>XBL ). 0G@]+2M$9+68 M@)8R\AS"H_&]CP0PT7=AV3(SO6G:HORFA><>NI?D(BD"5G BO'>+&9:KIHYN MDY1F?XF7)X-EU6,&YX,D$<<+DZXDHIR?#\$>';KP$$@> /$U0+FT]<#&X@:C M1W@HEMN796T..A94MR9VR S%KP8.B[; 0 M;TFG2@DBK3Q#;::FN?P-3YBY Y55>)@ZX1OR-,;\>65BD\/;=^K9%V\.9Y/T M(RLVXVZ*[*1[MB>VDPTW)^^)\J34&HZ_)=W,Q3==_"NHK $^6%EE%:">&Y5) ME:V)P;X;V(?*3I0W;_IZ(6+GF^4'N54GHNIO-OV]1H9MR+"&86X,C^2\5X"? M4$+N4$"CD%N!QC*X7EX%==)=TMU; /%09?T;;]\0H$7A"RHZMNHX&)=%.!C/ M>?6F,%9VI?9F9VFW.[H:!C$W1,#$)1/H#U:9HV8XK/ ML;\<'= ZD"//>-VS\&4*Z88]'%@5U^ MU2FKNODK+1)"\6/L%!!ZFRG6NDU<J;E2] M[UN+]>/0YR;7GI6=:\@.FK$V8ST$$HO-E%A%#X)2HW:PL7L+!U?L MUZ#2P\V<6?=P=5!\?[ZF0>VLXF:GI1C-S#4SU\Q<,W/-S#7'A#J%6,U8F[$> M^ECWNA MCW4O@7U=6ZP/))NU[8VPCDFL9L*:"6LFK)FP9L)V?CQHTG O^A3:3%4S5J8)_=?S% M6@]OON,%ZY:4RTBF,(52*8E0^,MO!%G^X" 7K36:(EVS=1*XR:FU"!"9$%8]!, [ :C LDC M*$YC\.&/S! 3(-3_*$*>V S1''$^_/!F5/VK%](X=04!%7P43\,(V2 340G, M)(]@Q?2S\>(")!D$:X2'KT<>:I,(A_YNX__HA9,!B[>)S\#\-R0B(>[I&1). M_DE2.P3^A=,>S+#3+LV8,)W[0V]^)39XX2O34,+4S*R)" M1: PX&D])/^22X/I;)E4]5I_EX@(D(IY+IZLOQ>;Q!EZA5A!2EL&TTF#G$C' M03[;BYD9S%B_O#1@CX:](2*>E+9UY2.QP5V&:H%X>3UX=P+C=(A\G1FB:,=3 M/@#)T#VBD8*WX_#DHT&;H%GG3G!VABY3N0M6=I+"))LSE!4C52]2"R4%VR&N MP 5($/8'4G#U+D$^Q!@NL.TQ;14[ *.M $5!1F$F'2R=HZ+%6V4]RC4=VT45$[?]5LJ7A$?DRZ]*?U M?#'6&E(ME0$AP[;4L2&37KG>,FNYE&"8P)&&TF\0U\,IR2T?\G-O C94GM8= MK($J>F@U>-W>9@>Y%Q]:*-^GJYNW5__/FKC+6N3K,@MGQV]I]:[V7,_#?73O MX(0)!T''"]RH]E/0.S]^,]OP&.OCSYC&GKF9P[O(FBGO[$H43-X[AO %>3G#3QX?C[KHOP-U5.!G7U=OA1U_=(*F]CBL< M5@_=C*IDI [%:[W[3^K-Z7I-N"QK[,[#V$OJOT%6 #D_=$NKY?:X@?#L?1BY M\(DU=_ >'#;).R\6-Z"UGY/>"["[S3KQ?3FXDCX+]GO!'81E;@3_:EMQ.$D> ML%;'!P=(5[NJRN=I192_XWD%NKL MJKTCNY&^(+64\OQ*W<-%[^ZK:]8W3K.MF<;&RF"K_+D?F>-59T% MRTL7+__U=<6JK7RAYI<(2ZB3QR^^$R17P5B%ZC6K^!I0Q1?+2ANG$I04<01U M7\;87#DVVPKOG21O/-O*+_U+I] M;N9G0U<1PPW7B-1SD.MDJ>JVR59>6E=I$F[ \'8QQROLD";>#_SSP:VAX8&LH?[P^-?0AL>XOQVGZH)Z"EJ87O31=6)W M"B=8RYO-H_">X6S6/!COZ;9[\W?FXKZM_,'_>Q]2U>PFOW>QDZO\1KO;U.Y. M0X$J&_\^-O'-;# 'M!?V[&%GLS6]-1WF8'# )?#;W/5CPNM)9ZE/8&!C=QZY M(X\*4AEVC &[*K:3U\FG[R$::#8NXQTG7?MBN(9S6:;@=:DLCDROYQ=K]"Q5 MUFL-0H$EB.N79NGDZN:PK_+ 39<8EOBB.HA6A^K'BWX%L(RFF+2J.KMV9S/' MD&>4DZJ/#J%T\G];-PB[RKB2/N96(%:+9@BAJ)%74RY$\;$09?LB[;M^,@NN MG>P(7'M-'&T"PZYV(_DAL*[2.Y"5(#;M# SHV(OG8>R.);IH]C*5P4H=JJ>] M#<,_- KO3SW$,$U]:N3W(!(GW&@K9+AI?BH"^3)/"7BQSD^1-(Y_0JK&6R)?JM=P^/M>GSG_K=,_&'?D\]=PF M.@GQQ*,+,5U7*=W/E_U?"=S8+XQZ#;^^8LQK@W*S9AT 0ZME"2&/#/-5CJK! M?*UIP7]3X![I]S>5[E4JW0U]'5+)>[D67D1U7X-G6AL75<"SZ[)9+R$B_M:XD"M3!RL+]H^-] Z["W7D;ZY M>-\;17?=??A3$#M.+IVUNID<#-U \VMJ%#GL/O$0C#!<)Z9YLYGR]^Z MMW7#P[FP6M:O81117OA8\N!6G,[@H\=%+L];-52#P-,:.7,//0Y?^H:WOCC MQ#8)Y<66$XOL>=SDS@\7+*?^:=\F3_XR\^1;#)-KGOIM4N5'DBHO,F]R:5A4 MU:)*JC'$/V\VD, PM+SIY,A^9-C+>6S9S<3Z;0I&&=9U&D58AH0LPX(PV0_A MB\H6GC9E(P^^&1>Y)+&^A73 LLN JIB[O>==%VQ!<2]T)GI5]JJ-SL2NND!ZHOIOTFX-<>6R7S/+1[GA50)SYFMI9-A!G; MO2?9B0C'/=8:^T?2Y>CNYM8BTFUN/JM&U6=K=/G7/)2N'CC7?N?N70[JOA<\?Y!G%VMT MGA[OIJ!,%*$FWEBCYZ=QCMZ+G:QULFQ@$Y[0ZEIGVGJ")JRZ,@M@%'(YE^-7*L]U[@!",/ M'G\C&,E!&#B4SD+XIQA/ISG M?]Q@R0\\E1[&C\4JH#8^#N06]3XD"0D58Y&AAX"UB77O1%Z8QM;8@>.O)07] M9^IC)WZOSR#K3@0'9 \O<]TXL2+Z:N0@3>>=-8$CM#5HG_UL):'5[;8'/["@;01@)-%:'\$#*H">:6LD]UTJN6UY4N!;6/(?6N8SJ M4TI6B[X@LE[C)V#.F;_N<_#;?O F-?D6-HZ,XC[$<0HQWG&,[AO$GD=H_N]^ M8&0,T<,7"+MWPZ>W1JJEK)YP6U5\Y9K>7Y'A[D3:Y:N.IG3R_(PW[<]I$B<0 M,E* GU@F2RF&1!525-N#+-A4D1P];&"?P9@JM:35"]#A.8I]QDNS8U\3 .= M;&/[@FUHJ9?FZW?A4^M?5+5=G=1Q/SK(:=K+OE$_$_C69D*[=[??M MR]J2:&A)1\C#34<[.0VMUU:WMSH-KUV7^*EU,+CF&.#X>P MWYS N8/_?3JE5Y.%U1L,[8O:$@DWRZIP60U[FZV9W]<&5=9=HW8G5R0/Z[]! MG73ML^&Y/3A?-]#; *UYB%1G=WM'U_?BYETY'5?EY=G%A=[=:_;E- MS=;I*44W1W65;Y.=,P6F5Q>!M[VYXT=/W$EL*63;9)JF:_=Z _MBG>ZK)KW9 M[.,;W<=+@N%#R7@.!O9@G4KYG><[?::[:LZ3@XL--V'7]D#Y[I .E+W+"[O7 M7;=;< ,'ROJD9':V1^TCV7D0FU*EP^4JZ^SE'"_[W9[=Z6R$;W;/+9M/'FTJ M^83FR%GVW/6:[%OL*UN4 M_L%+L/]4WIA9-PX?@ 4F-DM#Z"7<*XTON M9,(TOJ(7]8SS>/C^41@$^&\@([T\3"/K*ZZ>6-V',ZGPS'FT;K'7Z_9W^#Z^ M99)&U-:IWLRR8+\NV,L\C>(4.[_@F_ _WMCS4WH-#T5_%W&C$B$"-O0Y7@## M06&HES(D^F36VXXYI-=>@L_N4?ML&H:H!,_R> L+")XG:B'@P>?VQ:"#(2];$_7O>4F< M-6W8P\$T.X9I4I^I^!+)D6T(]-1],/FK%$S$MR9HHX^87N%.4J(_=Q*R_#O\ MF?E00YPL4X.0"$:C-:$&3J*X/Y#;&%$TYBY!:?C4F!B[B!ALHT1DQRL-7-!V[A>8)W]-!ATK32F M\,CRG23!13,+QZX/D1;QMP=98F8K!BO%]G92;C"'^.J-[$-E,4P?T@'CQG9[ M&*YA)C2T^Q!>1WVJ^-UAOXUUVY$[@W6)KR'4D'.>I%^LL7?O@?[&UJ/G^D0J MW_F9F2B]^(_6!)N>,YW"^(UN^V+(\YAW;'K3 MRIY1J&.9=S0UU+:^@&!WJ3C:%V==$B0-5/V&GI1D"B:LY0*IXNK>'OYX[\62NQ3G%[;X4

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end XML 24 R31.htm IDEA: XBRL DOCUMENT v3.19.3
Summary of Significant Accounting Policies (Details) - USD ($)
$ in Thousands
Sep. 30, 2019
Dec. 31, 2018
Accounting Policies [Abstract]    
Raw materials $ 1,063 $ 1,111
Work in progress 3
Finished goods 223 154
Total inventory 1,289 1,265
Less: reserve for obsolete (4) (4)
Total net inventory $ 1,285 $ 1,261
XML 25 R39.htm IDEA: XBRL DOCUMENT v3.19.3
Property and Equipment (Details Narrative) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2019
Sep. 30, 2018
Aug. 31, 2019
May 31, 2019
Apr. 30, 2019
Dec. 31, 2018
Net book value $ 830   $ 830         $ 1,083
Loss on the disposal of fixed assets     (3) $ (15)        
Depreciation and amortization expense $ 101 $ 108 $ 314 $ 332        
Obsolete Computer Equipment [Member]                
Net book value         $ 2 $ 2 $ 2  
XML 26 R12.htm IDEA: XBRL DOCUMENT v3.19.3
Property and Equipment
9 Months Ended
Sep. 30, 2019
Property, Plant and Equipment [Abstract]  
Property and Equipment

Note 6 - Property and Equipment

 

Property and equipment, net consist of the following:

 

            September 30,     December 31,  
        Useful Life   2019     2018  
Research and development equipment       5 years   $ 1,582     $ 1,552  
Office and computer equipment   (1)   3 years     753       742  
Autos       5 years     54       54  
Furniture and fixtures       7 years     37       37  
Leasehold improvements       *     283       283  
              2,709       2,668  
Less accumulated depreciation and amortization             (1,879 )     (1,585 )
Total           $ 830     $ 1,083  

 

* Shorter of lease term or estimated useful life 

 

(1) In August 2019, the Company disposed of computer equipment with a net book value of $2 resulting in a loss on the disposal of fixed assets of less than $1. In April and May 2019, the Company disposed of obsolete computer equipment with a net book value of $2 resulting in a loss on disposal of fixed assets of $2.

 

Depreciation and amortization expense was approximately $101 and $108 for the three months ended September 30, 2019 and 2018, respectively, and $314 and $332 for the nine months ended September 30, 2019 and 2018, respectively.

XML 27 R16.htm IDEA: XBRL DOCUMENT v3.19.3
Stockholders' Deficit
9 Months Ended
Sep. 30, 2019
Equity [Abstract]  
Stockholders' Deficit

Note 10 - Stockholders' Deficit

 

Capital Stock

 

The Company was organized under the laws of the state of Nevada on July 27, 2004 and was subsequently reincorporated under the laws of the state of Delaware on November 10, 2015. In connection with the reincorporation, as approved by the stockholders, the Company changed its authorized capital stock to consist of (i) 100 million shares of common stock, $.001 par value, and (ii) 2 million shares of preferred stock, $0.001 par value, designated as Series A convertible preferred stock. In December 2015, the Company amended its Certificate of Incorporation to change its authorized capital stock to provide for 15 million authorized shares of preferred stock of which 7,515,000 was designated as Series B convertible preferred stock, par value $.001 per share.

 

Common Stock

 

The Company had 28,288,285 and 23,471,999 shares of common stock issued and outstanding as of September 30, 2019 and December 31, 2018, respectively. 

 

During the nine months ended September 30, 2019, the Company issued an aggregate of 4,816,286 shares of common stock as follows:

 

  an aggregate of 3,037,038 shares in connection with a public offering generating net proceeds to the Company of approximately $3.6 million, as further described below
  an aggregate of 1,610,210 shares for the exercise of outstanding warrants for gross proceeds of $1.8 million (see Note 9 — Common Stock Warrants and Common Stock Warrant Liability for further details)
  An aggregate of 105,474 shares for service as a result of the vesting of restricted stock units
  3,022 shares for the exercise of stock options
  21,962 shares for the cashless exercise of stock options and
  an aggregate of 38,580 shares to certain employees in net settlement of bonus compensation totaling $32.

 

Public Offering

 

On July 16, 2019, the Company issued 3,037,038 shares of common stock, including 696,296 shares to the Company's chief executive officer and 7,408 shares to an employee of the Company, in a public offering of shares of the Company's common stock at $1.35 per share, resulting in net proceeds of approximately $3.6 million after deducting certain fees due to the placement agent and other transaction expenses. In addition, the Company issued a warrant to purchase 166,667 shares of the Company's common stock to the placement agent at an exercise price of $1.6875 per share.

XML 28 R6.htm IDEA: XBRL DOCUMENT v3.19.3
CONDENSED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
CASH FLOWS FROM OPERATING ACTIVITIES    
Net loss $ (7,238) $ (9,278)
Adjustments to reconcile net loss to net cash used in operating activities:    
Gain on investments held to maturity (44)
Bad debts expense
Depreciation and amortization 314 332
Stock-based compensation 675 3,090
Loss on sale of equipment 3 15
Loss on early extinguishment of debt 10
Loss on remeasurement of common stock warrant liability 1
(Increase) decrease in current assets:    
Accounts receivable (16) (36)
Prepaid expenses 38 (166)
Inventory (24) (578)
Deposits 3 7
Increase (decrease) in current liabilities:    
Accounts payable 118 (185)
Accrued expenses 46 (66)
Deferred rent (11) (18)
Net cash used in operating activities (6,092) (6,916)
CASH FLOWS FROM INVESTING ACTIVITIES    
Proceeds received on sale of securities held to maturity 2,619
Proceeds received on sale of equipment 185
Purchase of property and equipment (64) (212)
Net cash provided by (used in) investing activities (64) 2,592
CASH FLOWS FROM FINANCING ACTIVITIES    
Proceeds from the issuance of common stock, net 3,631 5,132
Proceeds from the issuance of notes payable   9
Repayments of notes payable (184) (236)
Repayments of notes payable, related parties (12)
Repayments of capital lease obligations (50)
Proceeds from the exercise of warrants 1,789 2,213
Payment of employee withholding taxes related to share-based awards (55) (42)
Net cash provided by financing activities 5,181 7,014
NET CHANGE IN CASH (975) 2,690
CASH AT BEGINNING OF PERIOD 4,920 2,101
CASH AT END OF PERIOD 3,945 4,791
SUPPLEMENTAL INFORMATION:    
Interest paid 34 60
Income taxes paid
NON-CASH INVESTING AND FINANCING ACTIVITIES:    
Deemed dividend 333
Purchases of equipment under capital lease obligations 37
Common stock issued on accrued bonus $ 32
XML 29 R2.htm IDEA: XBRL DOCUMENT v3.19.3
CONDENSED BALANCE SHEETS (Unaudited) - USD ($)
$ in Thousands
Sep. 30, 2019
Dec. 31, 2018
Current assets:    
Cash $ 3,945 $ 4,920
Accounts receivable 155 139
Prepaid expenses 304 342
Inventory 1,285 1,261
Deposits 6 9
Total current assets 5,695 6,671
Right to use asset-operating leases 29
Property and equipment, net 830 1,083
Total assets 6,554 7,754
Current liabilities:    
Short-term debt 129 219
Accounts payable 291 173
Accrued expenses 785 771
Total current liabilities 1,205 1,163
Long-term debt, net 167 261
Operating lease liability 29
Common stock warrant liability
Deferred rent 5 16
Total liabilities 1,406 1,440
Commitments and contingencies (See note 12)
Stockholders' equity:    
Common stock, $0.001 par value, 100,000,000 shares authorized, 28,288,285 and 23,471,999 shares issued and outstanding at September 30, 2019 and December 31, 2018, respectively 28 24
Additional paid-in capital 98,196 92,128
Accumulated deficit (93,076) (85,838)
Total stockholders' equity 5,148 6,314
Total liabilities and stockholders' equity $ 6,554 $ 7,754
XML 30 R51.htm IDEA: XBRL DOCUMENT v3.19.3
Commitments and Contingencies (Details)
$ in Thousands
Sep. 30, 2019
USD ($)
Capital Leases  
2019 $ 24
2020 78
2021 63
2022 33
2023 3
Total minimum lease payments 201
Operating Lease  
2019 62
2020 24
2021
2022
2023
Total minimum lease payments 86
Less: amounts representing interest (6.39%, ranging from 10.48% to 11.56%) 26
Present value of minimum lease payments 175
Less: current installments under capital lease obligations 70
Total long-term portion $ 105
XML 31 R38.htm IDEA: XBRL DOCUMENT v3.19.3
Property and Equipment (Details) - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2019
Dec. 31, 2018
Property, Plant and Equipment, Gross $ 2,709 $ 2,668
Less accumulated depreciation and amortization (1,879) (1,585)
Total 830 1,083
Office and Computer Equipment [Member]    
Property, Plant and Equipment, Gross [1] $ 753 742
Property, Plant and Equipment, Useful Life [1] 3 years  
Research and Development Equipment [Member]    
Property, Plant and Equipment, Gross $ 1,582 1,552
Property, Plant and Equipment, Useful Life 5 years  
Furniture and Fixtures [Member]    
Property, Plant and Equipment, Gross $ 37 37
Property, Plant and Equipment, Useful Life 7 years  
Autos [Member]    
Property, Plant and Equipment, Gross $ 54 54
Property, Plant and Equipment, Useful Life 5 years  
Leasehold Improvements [Member]    
Property, Plant and Equipment, Gross [2] $ 283 $ 283
[1] In August 2019, the Company disposed of computer equipment with a net book value of $2 resulting in a loss on the disposal of fixed assets of less than $1. In April and May 2019, the Company disposed of obsolete computer equipment with a net book value of $2 resulting in a loss on disposal of fixed assets of $2.
[2] Shorter of lease term or estimated useful life
XML 32 R34.htm IDEA: XBRL DOCUMENT v3.19.3
Summary of Significant Accounting Policies (Details 3) - USD ($)
$ in Thousands
Sep. 30, 2019
Jan. 02, 2019
Dec. 31, 2018
Right to Use Asset - Long Term $ 29 $ 87
Lease Liability - Long Term $ (29) $ (87)
Adjustment Due to ASC 842 [Member]      
Right to Use Asset - Long Term     87
Lease Liability - Long Term     $ (87)
XML 33 R30.htm IDEA: XBRL DOCUMENT v3.19.3
Organization and Description of Business (Details Narrative) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2019
Sep. 30, 2019
Sep. 30, 2018
Dec. 31, 2017
Dec. 31, 2018
Organization, Consolidation and Presentation of Financial Statements [Abstract]          
Exercise price (in dollars per share) $ 1.6875 $ 1.6875      
Proceeds from issuance and sale of common stock, preferred stock, warrants exercise, convertible and other promissory notes   $ 67,200      
Proceeds from licensing fees   1,700      
Proceeds from product sales   500      
Accumulated deficit $ (93,076) (93,076)     $ (85,838)
Cash, cash equivalents and short-term investments 3,900 $ 3,900      
Common Stock Offering Warrants Issued   166,667    
Issuance of common stock upon exercise of warrants $ 5 $ 1,788 $ 2,214    
XML 34 R13.htm IDEA: XBRL DOCUMENT v3.19.3
Accrued Expenses
9 Months Ended
Sep. 30, 2019
Payables and Accruals [Abstract]  
Accrued Expenses

Note 7 - Accrued Expenses

 

Accrued expenses consist of the following:

 

    September 30,     December 31,  
    2019     2018  
Compensation and related benefits   $ 264     $ 479  
Accrued Litigation     507       269  
Board Compensation     9       23  
Other     5        
Total accrued expenses   $ 785     $ 771
XML 35 R17.htm IDEA: XBRL DOCUMENT v3.19.3
Stock-based Compensation
9 Months Ended
Sep. 30, 2019
Share-based Payment Arrangement [Abstract]  
Stock-based Compensation

Note 11 - Stock-based Compensation

 

On June 12, 2018, the Company's stockholders approved the 2018 Equity Incentive Plan (the "2018 Plan") to replace the Company's 2015 Equity Incentive Plan (the "2015 Plan"). The 2018 Plan authorizes the issuance of 1,000,000 shares of our common stock. In addition, up to 2,874,280 shares of our common stock reserved for issuance under the 2015 Plan became available for issuance under the 2018 Plan to the extent such shares were available for issuance under the 2015 Plan as of June 12, 2018 or cease to be subject to awards outstanding under the 2015 Plan, such as by expiration, cancellation, or forfeiture of such awards.

 

Stock options are generally issued with an exercise price equal to no less than fair value at the date of grant. Options granted under the 2018 Plan generally vest immediately, or ratably over a two- to 36-month period coinciding with their respective service periods; however, participants may exercise their options prior to vesting as provided by the 2018 Plan. Unvested shares issued for options exercised early may be subject to a repurchase by the Company if the participant terminates, at the original exercise price. Options under the 2018 Plan generally have a contractual term of five years. Certain stock option awards provide for accelerated vesting upon a change in control.

 

As of September 30, 2019, the Company had 632,936 shares of common stock available for issuance under the 2018 Plan.

 

The Company measures the fair value of stock options with service-based and performance-based vesting criteria to employees, directors and consultants on the date of grant using the Black-Scholes option pricing model. The fair value of equity instruments issued to non-employees is re-measured as the award vests. The Black-Scholes valuation model requires the Company to make certain estimates and assumptions, including assumptions related to the expected price volatility of the Company's stock, the period under which the options will be outstanding, the rate of return on risk-free investments, and the expected dividend yield for the Company's stock.

 

The weighted-average assumptions used in the Black-Scholes option-pricing model used to calculate the fair value of options granted during the nine months ended September 30, 2019 were as follows:

 

    Employee   Non-Employee
Expected volatility   76.4%-80.6 %   N/A
Expected dividend yield     N/A
Expected term (in years)   3.0-6.0   N/A
Risk-free interest rate   1.63% -2.48 %   N/A

 

The weighted average grant date fair value of options granted during the nine months ended September 30, 2019 was $1.29 per share, as per the table below.

 

Due to the Company's limited operating history and lack of company-specific historical or implied volatility, the expected volatility assumption was determined based on historical volatilities from traded options of biotech companies of comparable in size and stability, whose share prices are publicly available. The expected dividend assumption is based on the Company's history and expectation of dividend payouts. The Company has not paid and does not intend to pay dividends. The expected term of options granted to employees is calculated based on the mid-point between the vesting date and the end of the contractual term according to the simplified method as described in SEC Staff Accounting Bulletin 110 because the Company does not have sufficient historical exercise data to provide a reasonable basis upon which to estimate the expected term due to the limited period of time its awards have been outstanding. For non-employee options, the expected term of options granted is the contractual term of the options. The risk-free interest rate is determined by reference to the implied yields of U.S. Treasury securities with a remaining term equal to the expected term assumed at the time of grant.

 

The following table summarizes the stock option activity, for both equity plans, for the periods indicated as follows:

 

    Number of
Options
    Weighted
Average
Exercise
Price Per
Share
    Weighted
Average
Remaining
Contractual
Term
(years)
    Aggregate
Intrinsic
Value (1)
 
Outstanding at December 31, 2018     1,721,771     $ 1.57       4.0     $  
Granted     1,167,906     $ 1.29       4.9     $  
Exercised     (63,990 )   $ 0.65           $  
Forfeited     (59,500 )   $           $  
Expired     (18,510 )   $           $  
Outstanding at September 30, 2019     2,747,677     $ 1.40       3.9     $  
Exercisable at September 30, 2019     1,667,064     $ 1.55       2.8     $  

 

(1) The aggregate intrinsic value in the table was calculated based on the difference between the estimated fair market value of the Company's stock and the exercise price of the underlying options. The estimated stock values used in the calculation was $1.01 and $0.59 per share for the nine months ended September 30, 2019 and the year ended December 31, 2018, respectively.

 

Restricted Stock Units

 

The following table summarizes restricted stock unit activity for the nine months ended September 30, 2019:

 

    Number of
Units
    Weighted Average
Grant-Date Fair
Value Per Unit
 
Outstanding as of December 31, 2018     136,245     $ 0.98  
Granted     123,727     $ 1.51  
Vested     (142,507 )   $ 1.10  
Forfeited         $  
Outstanding as of September 30, 2019     117,465     $ 1.42  

  

The stock-based compensation expense was recorded as follows:

 

    Three Months Ended
September 30,
    Nine Months Ended
September 30,
 
    2019     2018     2019     2018  
                         
Research and development   $ 1     $ 29     $ 11     $ 87  
General and administrative     203       326       664       3,003  
Total stock-based compensation expense   $ 204     $ 355     $ 675     $ 3,090  

 

The allocation between research and development and selling, general and administrative expense was based on the department and services performed by the employee or non-employee.

 

At September 30, 2019, the total compensation cost related to restricted stock units and unvested options not yet recognized was $1,205, which will be recognized over a weighted average period of 36 months, assuming the employees and non-employees complete their service period required for vesting.

XML 36 R21.htm IDEA: XBRL DOCUMENT v3.19.3
Summary of Significant Accounting Policies (Tables)
9 Months Ended
Sep. 30, 2019
Accounting Policies [Abstract]  
Schedule of inventory

Components of inventory are:

 

    September 30,     December 31,  
    2019     2018  
Raw materials   $ 1,063     $ 1,111  
Work in progress     3        
Finished goods     223       154  
Total inventory     1,289       1,265  
Less:                
Reserve for obsolete     (4 )     (4 )
Total net inventory   $ 1,285     $ 1,261  
Schedule of employee stock-based compensation expense

The stock-based compensation expense recorded for the three and nine months ended September 30, 2019 and 2018,

 

is as follows:

 

    Three Months Ended
September 30,
    Nine Months Ended
September 30,
 
    2019     2018     2019     2018  
                         
Research and development   $ 1     $ 29     $ 11     $ 87  
General and administrative     203       326       661       3,003  
Total stock-based compensation expense   $ 204     $ 355     $ 675     $ 3,090
Schedule of outstanding potentially dilutive securities calculation of diluted loss per share attributable to common stockholders

The following table sets forth the outstanding potentially dilutive securities that have been excluded in the calculation of diluted loss per share attributable to common stockholders (in common stock equivalent shares):

 

    September 30,  
    2019     2018  
Common stock purchase warrants     9,783,278       11,714,940  
Restricted stock unit     117,465       172,912  
Common stock options     2,747,677       1,725,771  
Total     12,648,420       13,613,623  
Schedule of cumulative effect of the changes made to the Company's Consolidated Balance Sheet

The cumulative effect of the changes made to the Company's Consolidated Balance Sheet as of January 1, 2019 for the adoption of the new leasing standard was as follows:

 

    Balance @
December 31, 2018
    Adjustment Due
to ASC 842
    Balance @
January 1,
2019
 
Right to Use Asset - Long Term         $ 87     $ 87  
                         
Lease Liability – Long Term         $ (87 )   $ (87 )
XML 37 R25.htm IDEA: XBRL DOCUMENT v3.19.3
Accrued Expenses (Tables)
9 Months Ended
Sep. 30, 2019
Payables and Accruals [Abstract]  
Schedule of accrued expenses

Accrued expenses consist of the following:

 

    September 30,     December 31,  
    2019     2018  
Compensation and related benefits   $ 264     $ 479  
Accrued Litigation     507       269  
Board Compensation     9       23  
Other     5        
Total accrued expenses   $ 785     $ 771
XML 38 R29.htm IDEA: XBRL DOCUMENT v3.19.3
Commitments and Contingencies (Tables)
9 Months Ended
Sep. 30, 2019
Commitments and Contingencies Disclosure [Abstract]  
Schedule of the future minimum lease payments under non-cancellable operating lease and future minimum capital lease payments

The future minimum lease payments under our non-cancellable operating lease and our capital lease as of September 30, 2019 are as follows:

 

    Capital
Leases
    Operating
Lease
 
Years Ending December 31,            
2019     24       62  
2020     78       24  
2021     63        
2022     33        
2023     3          
Total minimum lease payments   $ 201     $ 86  

 

    Capital
Leases
 
       
Less: amounts representing interest (6.39%, ranging from 10.48% to 11.56%)   $ 26  
         
Present value of minimum lease payments     175  
         
Less: current installments under capital lease obligations     70  
         
Total long-term portion   $ 105  
XML 40 R48.htm IDEA: XBRL DOCUMENT v3.19.3
Stock-based Compensation (Details 2) - Restricted Stock Units [Member]
9 Months Ended
Sep. 30, 2019
$ / shares
shares
Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares [Roll Forward]  
Balance at beginning | shares 136,245
Granted | shares 123,727
Vested | shares (142,507)
Forfeited | shares
Balance at ending | shares 117,465
Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]  
Balance at beginning | $ / shares $ 0.98
Granted | $ / shares 1.51
Vested | $ / shares 1.10
Forfeited | $ / shares
Balance at ending | $ / shares $ 1.42
XML 41 R44.htm IDEA: XBRL DOCUMENT v3.19.3
Common Stock Warrants and Common Stock Warrant Liability (Details Narrative) - USD ($)
$ / shares in Units, $ in Thousands
1 Months Ended 3 Months Ended 9 Months Ended 12 Months Ended
Jul. 31, 2019
Sep. 13, 2018
Aug. 13, 2018
Jul. 24, 2018
Jun. 20, 2018
Nov. 21, 2017
Jun. 15, 2015
Jun. 30, 2018
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2019
Sep. 30, 2018
Dec. 31, 2018
Dec. 31, 2017
Warrants exercised                     1,298,210   (1,475,659)  
Common Stock Offering Warrants Issued                     166,667    
Number of warrant purchased                 1,610,210   1,610,210      
Exercise price (in dollars per share)                 $ 1.6875   $ 1.6875      
Share price (in dollars per share)                 $ 1.01   $ 1.01   $ 0.59  
Change in fair value of the derivative warrant liability                 $ 13 $ (3) $ 19    
Fair value adjustment of warrants                     1      
Stock compensation expense                     675 $ 3,090    
Deemed dividend                     333      
Unexercised warrants                     $ 3,181,841      
Public Offering [Member]                            
Number of warrant purchased           5,860,000                
Right Offering [Member]                            
Common Stock Offering Warrants Issued     5,357,052                      
Share price (in dollars per share)     $ 0.94                      
Fair value of common stock warrant     $ 3,600                      
Expected volatility rate   159.00%                        
Expected term   5 years                        
Expected dividend rate   0.00%                        
Risk free interest rate   2.77%                        
Number of share issued in transaction     5,357,052                      
Right Offering [Member] | Warrant [Member] | Maxim Partners LLC [Member]                            
Share price (in dollars per share)     $ 0.94                      
Fair value of common stock warrant     $ 169                      
Expected volatility rate     159.00%                      
Expected term     5 years                      
Expected dividend rate     0.00%                      
Risk free interest rate     2.77%                      
University of Arizona Common Stock Warrant [Member]                            
Exercise price (in dollars per share)                 $ 7.91   $ 7.91      
Warrant term                     5 years      
Description of method used                     Monte Carlo option pricing model      
Expected volatility rate                     77.70%      
Expected dividend rate                     0.00%      
Risk free interest rate                     1.93%      
Change in fair value of the derivative warrant liability                 $ 0   $ 0      
Derivative liability                 $ 1   $ 1      
University of Arizona Common Stock Warrant [Member] | License Agreement [Member]                            
Number of warrant purchased             15,000              
Exercise price (in dollars per share)             $ 7.50              
Change in fair value of the derivative warrant liability             $ 53              
Common Stock Warrant Issued to Underwriter of Common Stock Offering [Member]                            
Exercise price (in dollars per share)     $ 0.95 $ 1.47                    
Share price (in dollars per share)     $ 1.02 $ 1.38                    
Expected volatility rate     74.00% 72.40%                    
Expected term     4 years 3 months 4 years 3 months 29 days                    
Expected dividend rate     0.00% 0.00%                    
Risk free interest rate     2.75% 2.83%                    
Common Stock Warrant Issued to Underwriter of Common Stock Offering [Member] | H.C. Wainwright & Co [Member]                            
Number of warrant purchased 166,667                          
Exercise price (in dollars per share) $ 1.6875               $ 1.6875   $ 1.6875      
Warrant term 5 years                          
Share price (in dollars per share)                 $ 1   $ 1      
Fair value of common stock warrant                 $ 127   $ 127      
Expected volatility rate                     133.30%      
Expected term                     5 years      
Expected dividend rate                     0.00%      
Risk free interest rate                     2.07%      
Common Stock Warrants Issued To Participants in Offering of the Company's Common Stock [Member]                            
Common Stock Offering Warrants Issued         1,133,909                  
Number of warrant purchased         1,133,909 4,657,500     1,133,909   1,133,909      
Exercise price (in dollars per share)         $ 1.50 $ 1.50     $ 1.82   $ 1.82      
Warrant term           5 years                
Description of method used           Lattice model                
Share price (in dollars per share)           $ 1.34     $ 2.11   $ 2.11      
Fair value of common stock warrant           $ 661                
Expected volatility rate           73.80%   72.60%            
Expected term           5 years   5 years            
Expected dividend rate           0.00%   0.00%            
Risk free interest rate           1.87%   2.80%            
Proceeds from warrant exercises         $ 1,700     $ 1,700            
Stock compensation expense               1,700            
New Warrants November 8, 2017 [Member]                            
Number of warrant purchased         1,133,909       341,750   341,750      
Exercise price (in dollars per share)         $ 1.82                  
Proceeds from warrant exercises               $ 513            
XML 42 R40.htm IDEA: XBRL DOCUMENT v3.19.3
Accrued Expenses (Details) - USD ($)
$ in Thousands
Sep. 30, 2019
Dec. 31, 2018
Payables and Accruals [Abstract]    
Compensation and related benefits $ 264 $ 479
Accrued Litigation 507 269
Board Compensation 9 23
Other 5
Total accrued expenses $ 785 $ 771
XML 43 R53.htm IDEA: XBRL DOCUMENT v3.19.3
Subsequent Events (Details)
Nov. 01, 2019
shares
Subsequent Event [Member]  
Subsequent Events (Textual)  
Cashless exercise of vested common stock options 311
XML 44 R4.htm IDEA: XBRL DOCUMENT v3.19.3
CONDENSED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2019
Sep. 30, 2018
Revenue:        
Sales $ 36 $ 105 $ 79 $ 160
Cost of sales 25 114 58 153
Gross profit (loss) 11 (9) 21 7
Operating expenses:        
Research and development 432 476 1,359 1,746
Selling, general and administrative 2,173 2,013 5,908 7,506
Total operating expenses 2,605 2,489 7,267 9,252
Net operating loss (2,594) (2,498) (7,246) (9,245)
Other income (expense):        
Interest income 19 1 45 8
Interest expense (10) (16) (34) (60)
Other income (expense) 13 (3) 19
Total other income (expense) 9 (2) 8 (33)
Net loss and comprehensive loss (2,585) (2,500) (7,238) (9,278)
Deemed dividend-warrant price protection adjustment 333 333
Net loss attributable to common shareholders $ (2,585) $ (2,833) $ (7,238) $ (9,611)
Weighted average common shares outstanding - basic and fully diluted (in shares) 27,891,501 20,862,216 25,336,837 18,036,982
Net loss per common share - basic and fully diluted (in dollars per share) $ (0.09) $ (0.14) $ (0.29) $ (0.53)
XML 45 R8.htm IDEA: XBRL DOCUMENT v3.19.3
Summary of Significant Accounting Policies
9 Months Ended
Sep. 30, 2019
Accounting Policies [Abstract]  
Summary of Significant Accounting Policies

Note 2 - Summary of Significant Accounting Policies

 

Use of Estimates

 

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts and classification of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements and reported amounts of revenues and expenses during the reporting period. The significant estimates in the Company's financial statements include the valuation of preferred stock, common stock and related warrants, and other stock-based awards. Actual results could differ from such estimates.

 

Reclassifications

 

Certain prior year amounts have been reclassified to conform to the current period presentation. These reclassifications had no material impact on net earnings, financial position or cash flows.

 

Accounts Receivable

 

Accounts receivable consist primarily of trade receivables. The Company provides an allowance for doubtful trade receivables equal to the estimated uncollectible amounts. That estimate is based on historical collection experience, current economic and market conditions and a review of the current status of each customer's trade accounts receivable. The allowance for doubtful trade receivables was less than $1 at September 30, 2019 and at December 31, 2018.

 

Inventories

 

Inventories are stated at the lower of cost or market value, using the first-in, first-out convention. Inventories consist of raw materials, work in progress and finished goods.

 

Components of inventory are:

 

    September 30,     December 31,  
    2019     2018  
Raw materials   $ 1,063     $ 1,111  
Work in progress     3        
Finished goods     223       154  
Total inventory     1,289       1,265  
Less:                
Reserve for obsolete     (4 )     (4 )
Total net inventory   $ 1,285     $ 1,261  

 

Prepaid Expenses

 

Prepaid expenses consist primarily of payments made for director and officer insurance, director compensation, rent, legal and inventory purchase deposits and seminar fees to be expensed in the current year.

 

Property and Equipment

 

Property and equipment are stated at cost less accumulated depreciation. Equipment held under capital leases are stated at the present value of minimum lease payments less accumulated amortization.

 

Depreciation on property and equipment is computed using the straight-line method over the estimated useful lives of the respective assets. The cost of leasehold improvements is amortized over the life of the improvement or the term of the lease, whichever is shorter. Equipment held under capital leases is amortized over the shorter of the lease term or estimated useful life of the asset. The Company incurs repair and maintenance costs on its major equipment, which are expensed as incurred.

 

Impairment of Long-Lived Assets

 

Long-lived assets, such as property and equipment, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. If circumstances require long-lived assets or asset groups to be tested for possible impairment, the Company compares the undiscounted cash flows expected to be generated from the use of the asset or asset group to its carrying amount. If the carrying amount of the long-lived asset or asset group is not recoverable on an undiscounted cash flow basis, an impairment charge is recognized to the extent that the carrying amount exceeds its fair value. Fair value is determined through various valuation techniques, such as discounted cash flow models and the use of third-party independent appraisals. The Company has not recorded an impairment of long-lived assets since its inception.

 

Revenue Recognition

 

Effective January 1, 2018, the Company adopted ASC 606 — Revenue from Contracts with Customers. Under ASC 606, the Company recognizes revenue from the commercial sales of products, licensing agreements and contracts to perform pilot studies by applying the following steps: (1) identify the contract with a customer; (2) identify the performance obligations in the contract; (3) determine the transaction price; (4) allocate the transaction price to each performance obligation in the contract; and (5) recognize revenue when each performance obligation is satisfied. For the comparative periods, revenue has not been adjusted and continues to be reported under ASC 605 — Revenue Recognition. Under ASC 605, revenue is recognized when the following criteria are met: (1) persuasive evidence of an arrangement exists; (2) the performance of service has been rendered to a customer or delivery has occurred; (3) the amount of the fee to be paid by a customer is fixed and determinable; and (4) the collectability of the fee is reasonably assured. The performance obligations identified by the Company under Accounting Standards Codification ("ASC") Topic 606, Revenue From Contracts With Customers, are straightforward and similar to the unit of account and performance obligation determination under ASC Topic 605, Revenue Recognition. There was no impact on the Company's financial statements as a result of adopting ASC 606 for the three months or nine months ended September 30, 2019 and 2018, respectively.

 

The Company recognizes revenue when product leaves its dock at a fixed selling price on payment terms of 30 to 120 days from invoicing. The Company recognizes other revenue earned from pilot studies upon the performance of specific services under the respective service contract.

 

The Company derives revenue primarily from commercial sales of products.

 

Research and Development

 

Research and development costs are expensed as incurred. Research and development expenses primarily consist of salaries and benefits for research and development employees, stock-based compensation, consulting fees, lab supplies, costs incurred related to conducting scientific trials and field studies, and regulatory compliance costs. Also, included in research and development expenses is an allocation of facilities related costs, including depreciation of research and development equipment.

 

Stock-based Compensation

 

Employee stock-based awards, consisting of restricted stock units and stock options expected to be settled in shares of the Company's common stock, are recorded as equity awards. The grant date fair value of stock options is measured using the Black-Scholes option pricing model. The Company expenses the grant date fair value of its stock options on a straight-line basis over their respective vesting periods. Performance-based awards are expensed over the performance period when the related performance goals are probable of being achieved.

 

For equity instruments issued to non-employees, the stock-based consideration is measured using a fair value method. The measurement of the stock-based compensation is subject to re-measurement as the underlying equity instruments vest.

 

The stock-based compensation expense recorded for the three and nine months ended September 30, 2019 and 2018, 

is as follows:

 

    Three Months Ended
September 30,
    Nine Months Ended
September 30,
 
    2019     2018     2019     2018  
                         
Research and development   $ 1     $ 29     $ 11     $ 87  
General and administrative     203       326       661       3,003  
Total stock-based compensation expense   $ 204     $ 355     $ 675     $ 3,090  

 

See Note 11 for additional discussion on stock-based compensation.

 

Income Taxes

 

Company accounts for income taxes under the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements. Under this method, deferred tax assets and liabilities are determined based on the differences between the financial statement and tax bases of assets and liabilities and net operating loss carryforwards using enacted tax rates in effect for the year in which the differences are expected to reverse. The effect of a change in tax rates on deferred tax assets and liabilities is recognized in the period that includes the enactment date.

 

The Company records net deferred tax assets to the extent it believes these assets will more likely than not be realized. These deferred tax assets are subject to periodic assessments as to recoverability and if it is determined that it is more likely than not that the benefits will not be realized, valuation allowances are recorded which would increase the provision for income taxes. In making such determination, the Company considers all available positive and negative evidence, including future reversals of existing taxable temporary differences, projected future taxable income, tax planning strategies and recent financial operations. The Company currently maintains a full allowance against its deferred tax assets.

 

The Company applies a more-likely-than-not recognition threshold for all tax uncertainties. Only those benefits that have a greater than fifty percent likelihood of being sustained upon examination by the taxing authorities are recognized. Based on its evaluation, the Company has concluded there are no significant uncertain tax positions requiring recognition in its financial statements.

 

The Company recognizes interest and/or penalties related to uncertain tax positions in income tax expense. There are no uncertain tax positions as of September 30, 2019 or December 31, 2018 and as such, no interest or penalties were recorded in income tax expense.

 

Comprehensive Loss

 

Net loss and comprehensive loss were the same for all periods presented; therefore, a separate statement of comprehensive loss is not included in the accompanying financial statements.

 

Loss Per Share Attributable to Common Stockholders

 

Basic loss per share attributable to common stockholders is calculated by dividing the net loss attributable to common stockholders by the weighted average number of common shares outstanding during the period. Diluted loss per share attributable to common stockholders is computed by dividing the loss attributable to common stockholders by the weighted average number of common shares and potentially dilutive securities outstanding for the period determined using the treasury stock and if-converted methods. For purposes of the computation of diluted loss per share attributable to common stockholders, common stock purchase warrants, and common stock options are considered to be potentially dilutive securities but have been excluded from the calculation of diluted loss per share attributable to common stockholders because their effect would be anti-dilutive given the net loss reported for the three and nine months ended September 30, 2019 and 2018. Therefore, basic and diluted loss per share attributable to common stockholders are the same for each period presented.

 

The following table sets forth the outstanding potentially dilutive securities that have been excluded in the calculation of diluted loss per share attributable to common stockholders (in common stock equivalent shares):

 

    September 30,  
    2019     2018  
Common stock purchase warrants     9,783,278       11,714,940  
Restricted stock unit     117,465       172,912  
Common stock options     2,747,677       1,725,771  
Total     12,648,420       13,613,623  

 

Adoption of New Accounting Standards:

 

In May 2014, the FASB issued ASU 2014-09, Revenue from Contracts with Customers. Since ASU 2014-09 was issued, several additional ASUs have been issued to clarify various elements of the guidance. These standards provide guidance on recognizing revenue, including a five-step model to determine when revenue recognition is appropriate. The standard requires that an entity recognize revenue to depict the transfer of control of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. Effective January 1, 2018, the Company adopted ASU 2014-09, "Revenue from Contracts with Customers" using the modified retrospective method to all contracts that were not completed as of the date of adoption. The results of operations for reported periods after January 1, 2018 are presented under this amended guidance, while prior period amounts are reported in accordance with ASC 605 — Revenue Recognition. There was no material impact on our financial position, results of operations, or cash flows.

 

In January 2016, the FASB issued ASU 2016-01, Recognition and Measurement of Financial Assets and Financial Liabilities ("ASU 2016-01"). This standard affects the accounting for equity instruments, financial liabilities under the fair value option and the presentation and disclosure requirements of financial instruments. ASU 2016-01 is effective the first quarter of 2018. The Company has adopted the provisions of ASU 2016-01 on its financial statements. There was no material impact on our financial position, results of operations, or cash flows.

 

In February 2016, the FASB issued ASU 2016-02, Leases ("ASU 2016-02"). This standard amends various aspects of existing accounting guidance for leases, including the recognition of a right-of-use asset and a lease liability on the balance sheet for all leases with terms longer than 12 months. Leases will be classified as either finance or operating, with classification affecting the pattern of expense recognition in the income statement. This standard also introduces new disclosure requirements for leasing arrangements. ASU 2016-02 is effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years for public business entities. Early adoption was permitted, and the new standard had been adopted using a modified retrospective approach and provides for certain practical expedients.

 

On January 1, 2019, the Company adopted the new leasing standard and all related amendments. The Company elected the optional transition method provided by the FASB in ASU 2018-11, Leases (Topic 842): Targeted Improvements, and as a result, has not restated its condensed consolidated financial statements for prior periods presented. The Company has elected the practical expedients upon transition to retain the lease classification and initial direct costs for any leases that existed prior to adoption. The Company has also not reassessed whether any contracts entered into prior to adoption are leases.

 

ASU 2016-02 did not have a material impact on the Company's Condensed Consolidated Statements of Comprehensive Income. The cumulative effect of the changes made to the Company's Consolidated Balance Sheet as of January 1, 2019 for the adoption of the new leasing standard was as follows:

 

    Balance @
December 31, 2018
    Adjustment Due
to ASC 842
    Balance @
January 1,
2019
 
Right to Use Asset - Long Term         $ 87     $ 87  
                         
Lease Liability – Long Term         $ (87 )   $ (87 )

 

At September 30, 2019, the balance remaining in Right to Use Asset-Long Term and Lease Liability-Long Term was $29,000 and ($29,000) respectively.

 

The Company determines if an arrangement is a lease at lease inception. Operating lease right-of-use (ROU) assets and operating lease liabilities are recognized based on the present value of the future minimum lease payments over the lease term at commencement date. As most of the Company's lease contracts do not include an implicit rate, the Company uses its incremental borrowing rate based on information available at commencement date in determining the present value of future payments. The incremental borrowing rate is estimated to approximate the interest rate on a collateralized basis with similar terms and payments, and in economic environments where the leased asset is located. The operating lease ROU asset also includes any initial direct costs and lease payments made prior to lease commencement and excludes lease incentives incurred.

 

The Company's lease terms may include options to extend or terminate the lease when it is reasonably certain that we will exercise that option. Operating lease expense for minimum lease payments is recognized on a straight-line basis over the lease term. The Company has certain lease agreements that contain both lease and non-lease components, which it has elected to account for as a single lease component for all asset classes.

 

See Note 12, Commitments and Contingencies, for future minimum lease payments and maturities.

 

Accounting Standards Issued but Not Yet Adopted

 

In August 2018, the FASB issued authoritative guidance intended to address a customer's accounting for implementation costs incurred in a cloud computing arrangement that is a service contract. This guidance aligns the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software. The guidance also requires presentation of the capitalized implementation costs in the statement of financial position and in the statement of cash flows in the same line item that a prepayment for the fees of the associated hosting arrangement would be presented, and the expense related to the capitalized implementation costs to be presented in the same line item in the statement of operations as the fees associated with the hosting element (service) of the arrangement. This guidance is effective for annual periods beginning after December 15, 2019, including interim periods within those annual periods, with early adoption permitted. We are currently evaluating the potential impact on our financial position, results of operations and statement of cash flows upon adoption of this guidance. We do not expect this guidance to have a significant impact, or potential significant impact, to our unaudited condensed consolidated interim financial statements.

 

Other than the items noted above, there have been no new accounting pronouncements not yet effective or adopted in the current year that we believe have a significant impact, or potential significant impact, to our unaudited condensed consolidated interim financial statements.

XML 46 R19.htm IDEA: XBRL DOCUMENT v3.19.3
Subsequent Events
9 Months Ended
Sep. 30, 2019
Subsequent Events [Abstract]  
Subsequent Events

Note 13 - Subsequent Events

  

On November 1, 2019, the Company net issued 311 shares of common stock in satisfaction of a cashless exercise of vested common stock options.

 

The Company has evaluated subsequent events from the balance sheet date through November 14, 2019, the date at which the financial statements were issued, and determined that there were no other items that require adjustment to or disclosure in the financial statements.

XML 47 R11.htm IDEA: XBRL DOCUMENT v3.19.3
Prepaid Expenses
9 Months Ended
Sep. 30, 2019
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]  
Prepaid Expenses

Note 5 - Prepaid Expenses

 

Prepaid expenses consist of the following:

 

    September 30,     December 31,  
    2019     2018  
Director compensation   $ -     $ 100  
Director and officer insurance     161       121  
NASDAQ fees     14          
Legal retainer     25       25  
Marketing programs and conferences     54       53  
Professional services retainer     15       8  
Rent     -       19  
Equipment service deposits     2       3  
Foreign patent registration     22       -  
Engineering, software licenses and other     11       13  
Total prepaid expenses   $ 304     $ 342  
XML 48 R15.htm IDEA: XBRL DOCUMENT v3.19.3
Common Stock Warrants and Common Stock Warrant Liability
9 Months Ended
Sep. 30, 2019
Warrants and Rights Note Disclosure [Abstract]  
Common Stock Warrants and Common Stock Warrant Liability

Note 9 - Common Stock Warrants and Common Stock Warrant Liability

 

The table summarizes the common stock warrant activity as of September 30, 2019 as follows:

 

Common Stock Warrants   Number
of
Warrants
    Date
Issued
  Term   Exercise Price  
                     
Outstanding at December 31, 2017     6,431,785                  
                         
Warrants issued     1,133,909     June 2018   5 Years   $ 1.82  
Common Stock Offering Warrants Issued     5,357,052     August 2018   5 Years   $ 1.15 (1)
Common Stock Offering - Dealer Manager Warrants     267,853     August 2018   5 Years   $ 1.725  
Warrants exercised     (1,475,659 )                
Expired Warrants     (488,119 )                
Outstanding at December 31, 2018     11,226,821                  
Warrants issued     166,667     July 2019   5 Years   $ 1.6875  
Warrants Exercised     (1,298,210 )   August 2018       $ 1.15  
Warrants Exercised     (312,000 )   August 2018       $ 0.95  
Outstanding at September 30, 2019     9,783,278                  

 

  (1) The common stock warrants issued in November 2017 with an initial exercise price of $1.50 per share adjusted downward to $0.95 per share effective July 24, 2018 in connection with our Rights Offering, and may be subject to further downward adjustments, pursuant to antidilution price adjustment protection contained within those warrants.

 

On November 21, 2017, the Company issued a total of 4,657,500 detachable common stock warrants issued with the second public offering of 5,860,000 shares of its common stock at $1.00 per share. The common stock warrant is exercisable until five years from the date of grant. The common shares of the Company's stock and detachable warrants exist independently as separate securities. As such, the Company estimated the fair value of the common stock warrants, exercisable at $1.50 per share, to be $661 using a lattice model based on the following significant inputs: Common stock price of $1.00; comparable company volatility of 73.8%; remaining term 5 years; dividend yield of 0% and risk-free interest rate of 1.87. The initial exercise price of these warrants was $1.50 per share, which adjusted downward to $1.47 on July 24, 2018, the record date of the Right's Offering and downward to $0.95 per share on August 13, 2018, the date of the Rights Offering, pursuant to antidilution price adjustment protection contained within these warrants. Per guidance of ASC 260, the Company recorded a deemed dividend of $333 on the 3,181,841 unexercised warrants that contained this antidilution price adjustment protection provision and was calculated as the difference between the fair value of the warrants immediately prior to downward exercise price adjustment and immediately after the adjustment using a Black Scholes model based on the following significant inputs: On July 24, 2018: Common stock price of $1.38; comparable company volatility of 72.4%; remaining term 4.33 years; dividend yield of 0% and risk-free interest rate of 2.83. On August 13, 2018: Common stock price of $1.02; comparable company volatility of 74.0%; remaining term 4.25 years; dividend yield of 0% and risk-free interest rate of 2.75.

 

On June 20, 2018, the Company entered into an agreement with a holder of 1,133,909 of the November 2017 warrants to exercise its original warrant representing 1,133,909 shares of Common Stock for cash at the $1.50 exercise price for gross proceeds of $1.7 million and the Company issued to holder a new warrant to purchase 1,133,909 shares of Common Stock at an exercise price of $1.82 per share. The new warrant did not contain the antidilution price adjustment protection that was contained within the exercised warrants. In June 2018, the Company recorded stock compensation expense of $1.7 million representing the fair value of the of 1,133,909 inducement warrants issued. The Company estimated the fair value of the common stock warrants, exercisable at $1.82 per share, to be $1.7 million using a Black Scholes model based on the following significant inputs: Common stock price of $2.11; comparable company volatility of 72.6%; remaining term 5 years; dividend yield of 0% and risk-free interest rate of 2.8%. Also, in June 2018, an additional 341,750 of the November 8, 2017 warrants that were in the money at the time of exercise, were exercised for gross proceeds of $513.

 

On August 13, 2018, in connection with a Rights Offering of 5,357,052 shares of its common stock, the Company issued 5,357,052 warrants to purchase shares of its common stock at an exercise price of $1.15 per share. The Company estimated the fair value of the common stock warrants, exercisable at $1.15 per share, to be $3.6 million using a Monte Carlo model based on the following significant inputs: common stock price of $0.94; comparable company volatility of 159.0%; remaining term 5 years; dividend yield of 0% and risk-free interest rate of 2.77%.

 

In connection with the closing of the Rights Offering, the Company issued a warrant to purchase 267,853 shares of common stock to Maxim Partners LLC, an affiliate of the dealer-manager of the Rights Offering. The Company estimated the fair value of the common stock warrants, exercisable at $1.725 per share, to be $169 using a using a Monte Carlo model based on the following significant inputs: common stock price of $0.94; comparable company volatility of 159.0%; remaining term 5 years; dividend yield of 0% and risk-free interest rate of 2.77%.

 

Common Stock Warrant Issued to Underwriter of Common Stock Offering 

 

In July 2019, the Company issued to H.C. Wainwright & Co., as placement agent, a warrant to purchase 166,667 shares of common stock at an exercise price of $1.6875 per share as consideration for providing services in connection with a common stock offering in July 2019. The warrant was fully vested and exercisable on the date of issuance. The common stock warrant is exercisable until five years from the date of grant. The Company estimated the fair value of the common stock warrants, exercisable at $1.6875 per share, to be $127 using a lattice model based on the following significant inputs: Common stock price of $1.34; comparable company volatility of 133.3%; remaining term 5 years; dividend yield of 0% and risk-free interest rate of 2.07%.

 

University of Arizona Common Stock Warrant

 

In connection with the June 2015 amended and restated exclusive license agreement with the University of Arizona ("University"), the Company issued to the University a common stock warrant to purchase 15,000 shares of common stock at an exercise price of $7.50 per share. The warrant was fully vested and exercisable on the date of grant, and expires, if not exercised, five years from the date of grant. In the event of a "terminating change" of the Company, as defined in the warrant agreement, the warrant holder would be paid in cash the aggregate fair market value of the underlying shares immediately prior to the consummation of the terminating change event. Due to the cash settlement provision, the derivative warrant liability was recorded at fair value and is revalued at the end of each reporting period. The changes in fair value are reported in other income (expense) in the statements of operations and comprehensive loss. The estimated fair value of the derivative warrant liability was $53 at the date of grant.

 

The estimated fair value of the derivative warrant liability was $0 at September 30, 2019. As this derivative warrant liability is revalued at the end of each reporting period, the fair values as determined at the date of grant and subsequent periods was based on the following significant inputs using a Monte Carlo option pricing model: common stock price of $7.91; comparable company volatility of 77.7% of the underlying common stock; risk-free rates of 1.93%; and dividend yield of 0%; including the probability assessment of a terminating change event occurring. The change in fair value of the derivative warrant liability was ($0) and $0 for the three and nine months ended September 30, 2019. As such, no entry was recorded in other income (expense) in the accompanying statements of operations and comprehensive loss.

XML 49 R36.htm IDEA: XBRL DOCUMENT v3.19.3
Fair Value Measurements (Details) - Fair Value Measurements, Recurring [Member] - USD ($)
$ in Thousands
Sep. 30, 2019
Dec. 31, 2018
Financial Assets:    
Held-to-maturity Securities, Fair Value  
Total  
Financial Liabilities:    
Common stock warrant liability [1] $ 1
Total 1
Corporate Fixed Income Debt Securities [Member]    
Financial Assets:    
Held-to-maturity Securities, Fair Value  
Total  
Money Market Funds [Member]    
Financial Assets:    
Held-to-maturity Securities, Fair Value  
Total  
Fair Value Inputs, Level 1 [Member]    
Financial Assets:    
Held-to-maturity Securities, Fair Value  
Total   3
Financial Liabilities:    
Common stock warrant liability [1]
Total
Fair Value Inputs, Level 1 [Member] | Corporate Fixed Income Debt Securities [Member]    
Financial Assets:    
Held-to-maturity Securities, Fair Value  
Total  
Fair Value Inputs, Level 1 [Member] | Money Market Funds [Member]    
Financial Assets:    
Held-to-maturity Securities, Fair Value  
Total  
Fair Value Inputs, Level 2 [Member]    
Financial Assets:    
Held-to-maturity Securities, Fair Value  
Total  
Financial Liabilities:    
Common stock warrant liability [1]
Total
Fair Value Inputs, Level 2 [Member] | Corporate Fixed Income Debt Securities [Member]    
Financial Assets:    
Held-to-maturity Securities, Fair Value  
Total  
Fair Value Inputs, Level 2 [Member] | Money Market Funds [Member]    
Financial Assets:    
Held-to-maturity Securities, Fair Value  
Total  
Fair Value Inputs, Level 3 [Member]    
Financial Assets:    
Held-to-maturity Securities, Fair Value  
Total  
Financial Liabilities:    
Common stock warrant liability [1] 1
Total $ 1
Fair Value Inputs, Level 3 [Member] | Corporate Fixed Income Debt Securities [Member]    
Financial Assets:    
Held-to-maturity Securities, Fair Value  
Total  
Fair Value Inputs, Level 3 [Member] | Money Market Funds [Member]    
Financial Assets:    
Held-to-maturity Securities, Fair Value  
Total  
[1] There was no change (net) in the fair value of the common stock warrant for the three and nine months ended September 30, 2019. If there had been, it would have been recorded to other income (expense) and interest expense in the statements of operations and comprehensive loss.
XML 50 R32.htm IDEA: XBRL DOCUMENT v3.19.3
Summary of Significant Accounting Policies (Details 1) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2019
Sep. 30, 2018
Total stock-based compensation expense $ 204 $ 355 $ 675 $ 3,090
Research and Development Expense [Member]        
Total stock-based compensation expense 1 29 11 87
General and Administrative Expenses [Member]        
Total stock-based compensation expense $ 203 $ 326 $ 664 $ 3,003
XML 51 R23.htm IDEA: XBRL DOCUMENT v3.19.3
Prepaid Expenses (Tables)
9 Months Ended
Sep. 30, 2019
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]  
Schedule of prepaid expenses

Prepaid expenses consist of the following:

 

    September 30,     December 31,  
    2019     2018  
Director compensation   $ -     $ 100  
Director and officer insurance     161       121  
NASDAQ fees     14          
Legal retainer     25       25  
Marketing programs and conferences     54       53  
Professional services retainer     15       8  
Rent     -       19  
Equipment service deposits     2       3  
Foreign patent registration     22       -  
Engineering, software licenses and other     11       13  
Total prepaid expenses   $ 304     $ 342  
XML 52 R27.htm IDEA: XBRL DOCUMENT v3.19.3
Common Stock Warrants and Common Stock Warrant Liability (Tables)
9 Months Ended
Sep. 30, 2019
Warrants and Rights Note Disclosure [Abstract]  
Schedule of common stock warrant activity

The table summarizes the common stock warrant activity as of September 30, 2019 as follows:

 

Common Stock Warrants   Number
of
Warrants
    Date
Issued
  Term   Exercise Price  
                     
Outstanding at December 31, 2017     6,431,785                  
                         
Warrants issued     1,133,909     June 2018   5 Years   $ 1.82  
Common Stock Offering Warrants Issued     5,357,052     August 2018   5 Years   $ 1.15 (1)
Common Stock Offering - Dealer Manager Warrants     267,853     August 2018   5 Years   $ 1.725  
Warrants exercised     (1,475,659 )                
Expired Warrants     (488,119 )                
Outstanding at December 31, 2018     11,226,821                  
Warrants issued     166,667     July 2019   5 Years   $ 1.6875  
Warrants Exercised     (1,298,210 )   August 2018       $ 1.15  
Warrants Exercised     (312,000 )   August 2018       $ 0.95  
Outstanding at September 30, 2019     9,783,278                  

 

  (1) The common stock warrants issued in November 2017 with an initial exercise price of $1.50 per share adjusted downward to $0.95 per share effective July 24, 2018 in connection with our Rights Offering, and may be subject to further downward adjustments, pursuant to antidilution price adjustment protection contained within those warrants.
XML 53 FilingSummary.xml IDEA: XBRL DOCUMENT 3.19.3 html 169 359 1 true 54 0 false 5 false false R1.htm 00000001 - Document - Document and Entity Information Sheet http://senestech.com/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 00000002 - Statement - CONDENSED BALANCE SHEETS (Unaudited) Sheet http://senestech.com/role/BalanceSheets CONDENSED BALANCE SHEETS (Unaudited) Statements 2 false false R3.htm 00000003 - Statement - CONDENSED BALANCE SHEETS (Unaudited) (Parenthetical) Sheet http://senestech.com/role/CondensedBalanceSheetsParenthetical CONDENSED BALANCE SHEETS (Unaudited) (Parenthetical) Statements 3 false false R4.htm 00000004 - Statement - CONDENSED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (Unaudited) Sheet http://senestech.com/role/StatementsOfOperationsAndComprehensiveLoss CONDENSED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (Unaudited) Statements 4 false false R5.htm 00000005 - Statement - STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT) (Unaudited) Sheet http://senestech.com/role/StatementOfChangesInStockholdersEquityDeficit STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT) (Unaudited) Statements 5 false false R6.htm 00000006 - Statement - CONDENSED STATEMENTS OF CASH FLOWS (Unaudited) Sheet http://senestech.com/role/StatementsOfCashFlows CONDENSED STATEMENTS OF CASH FLOWS (Unaudited) Statements 6 false false R7.htm 00000007 - Disclosure - Organization and Description of Business Sheet http://senestech.com/role/OrganizationAndDescriptionOfBusiness Organization and Description of Business Notes 7 false false R8.htm 00000008 - Disclosure - Summary of Significant Accounting Policies Sheet http://senestech.com/role/SummaryOfSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 8 false false R9.htm 00000009 - Disclosure - Fair Value Measurements Sheet http://senestech.com/role/FairValueMeasurements Fair Value Measurements Notes 9 false false R10.htm 00000010 - Disclosure - Credit Risk Sheet http://senestech.com/role/CreditRisk Credit Risk Notes 10 false false R11.htm 00000011 - Disclosure - Prepaid Expenses Sheet http://senestech.com/role/PrepaidExpenses Prepaid Expenses Notes 11 false false R12.htm 00000012 - Disclosure - Property and Equipment Sheet http://senestech.com/role/PropertyAndEquipment Property and Equipment Notes 12 false false R13.htm 00000013 - Disclosure - Accrued Expenses Sheet http://senestech.com/role/AccruedExpenses Accrued Expenses Notes 13 false false R14.htm 00000014 - Disclosure - Borrowings Sheet http://senestech.com/role/Borrowings Borrowings Notes 14 false false R15.htm 00000015 - Disclosure - Common Stock Warrants and Common Stock Warrant Liability Sheet http://senestech.com/role/CommonStockWarrantsAndCommonStockWarrantLiability Common Stock Warrants and Common Stock Warrant Liability Notes 15 false false R16.htm 00000016 - Disclosure - Stockholders' Deficit Sheet http://senestech.com/role/StockholdersDeficit Stockholders' Deficit Notes 16 false false R17.htm 00000017 - Disclosure - Stock-based Compensation Sheet http://senestech.com/role/Stock-basedCompensation Stock-based Compensation Notes 17 false false R18.htm 00000018 - Disclosure - Commitments and Contingencies Sheet http://senestech.com/role/CommitmentsAndContingencies Commitments and Contingencies Notes 18 false false R19.htm 00000019 - Disclosure - Subsequent Events Sheet http://senestech.com/role/SubsequentEvents Subsequent Events Notes 19 false false R20.htm 00000020 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://senestech.com/role/SummaryOfSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) Policies http://senestech.com/role/SummaryOfSignificantAccountingPolicies 20 false false R21.htm 00000021 - Disclosure - Summary of Significant Accounting Policies (Tables) Sheet http://senestech.com/role/SummaryOfSignificantAccountingPoliciesTables Summary of Significant Accounting Policies (Tables) Tables http://senestech.com/role/SummaryOfSignificantAccountingPolicies 21 false false R22.htm 00000022 - Disclosure - Fair Value Measurements (Tables) Sheet http://senestech.com/role/FairValueMeasurementsTables Fair Value Measurements (Tables) Tables http://senestech.com/role/FairValueMeasurements 22 false false R23.htm 00000023 - Disclosure - Prepaid Expenses (Tables) Sheet http://senestech.com/role/PrepaidExpensesTables Prepaid Expenses (Tables) Tables http://senestech.com/role/PrepaidExpenses 23 false false R24.htm 00000024 - Disclosure - Property and Equipment (Tables) Sheet http://senestech.com/role/PropertyAndEquipmentTables Property and Equipment (Tables) Tables http://senestech.com/role/PropertyAndEquipment 24 false false R25.htm 00000025 - Disclosure - Accrued Expenses (Tables) Sheet http://senestech.com/role/AccruedExpensesTables Accrued Expenses (Tables) Tables http://senestech.com/role/AccruedExpenses 25 false false R26.htm 00000026 - Disclosure - Borrowings (Tables) Sheet http://senestech.com/role/BorrowingsTables Borrowings (Tables) Tables http://senestech.com/role/Borrowings 26 false false R27.htm 00000027 - Disclosure - Common Stock Warrants and Common Stock Warrant Liability (Tables) Sheet http://senestech.com/role/CommonStockWarrantsAndCommonStockWarrantLiabilityTables Common Stock Warrants and Common Stock Warrant Liability (Tables) Tables http://senestech.com/role/CommonStockWarrantsAndCommonStockWarrantLiability 27 false false R28.htm 00000028 - Disclosure - Stock-based Compensation (Tables) Sheet http://senestech.com/role/Stock-basedCompensationTables Stock-based Compensation (Tables) Tables http://senestech.com/role/Stock-basedCompensation 28 false false R29.htm 00000029 - Disclosure - Commitments and Contingencies (Tables) Sheet http://senestech.com/role/CommitmentsAndContingenciesTables Commitments and Contingencies (Tables) Tables http://senestech.com/role/CommitmentsAndContingencies 29 false false R30.htm 00000030 - Disclosure - Organization and Description of Business (Details Narrative) Sheet http://senestech.com/role/OrganizationAndDescriptionOfBusinessDetailsNarrative Organization and Description of Business (Details Narrative) Details http://senestech.com/role/OrganizationAndDescriptionOfBusiness 30 false false R31.htm 00000031 - Disclosure - Summary of Significant Accounting Policies (Details) Sheet http://senestech.com/role/SummaryOfSignificantAccountingPoliciesDetails Summary of Significant Accounting Policies (Details) Details http://senestech.com/role/SummaryOfSignificantAccountingPoliciesTables 31 false false R32.htm 00000032 - Disclosure - Summary of Significant Accounting Policies (Details 1) Sheet http://senestech.com/role/SummaryOfSignificantAccountingPoliciesDetails1 Summary of Significant Accounting Policies (Details 1) Details http://senestech.com/role/SummaryOfSignificantAccountingPoliciesTables 32 false false R33.htm 00000033 - Disclosure - Summary of Significant Accounting Policies (Details 2) Sheet http://senestech.com/role/SummaryOfSignificantAccountingPoliciesDetails2 Summary of Significant Accounting Policies (Details 2) Details http://senestech.com/role/SummaryOfSignificantAccountingPoliciesTables 33 false false R34.htm 00000034 - Disclosure - Summary of Significant Accounting Policies (Details 3) Sheet http://senestech.com/role/SummaryOfSignificantAccountingPoliciesDetails3 Summary of Significant Accounting Policies (Details 3) Details http://senestech.com/role/SummaryOfSignificantAccountingPoliciesTables 34 false false R35.htm 00000035 - Disclosure - Summary of Significant Accounting Policies (Details Narrative) Sheet http://senestech.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative Summary of Significant Accounting Policies (Details Narrative) Details http://senestech.com/role/SummaryOfSignificantAccountingPoliciesTables 35 false false R36.htm 00000036 - Disclosure - Fair Value Measurements (Details) Sheet http://senestech.com/role/FairValueMeasurementsDetails Fair Value Measurements (Details) Details http://senestech.com/role/FairValueMeasurementsTables 36 false false R37.htm 00000037 - Disclosure - Prepaid Expenses (Details) Sheet http://senestech.com/role/PrepaidExpensesDetails Prepaid Expenses (Details) Details http://senestech.com/role/PrepaidExpensesTables 37 false false R38.htm 00000038 - Disclosure - Property and Equipment (Details) Sheet http://senestech.com/role/PropertyAndEquipmentDetails Property and Equipment (Details) Details http://senestech.com/role/PropertyAndEquipmentTables 38 false false R39.htm 00000039 - Disclosure - Property and Equipment (Details Narrative) Sheet http://senestech.com/role/PropertyAndEquipmentDetailsNarrative Property and Equipment (Details Narrative) Details http://senestech.com/role/PropertyAndEquipmentTables 39 false false R40.htm 00000040 - Disclosure - Accrued Expenses (Details) Sheet http://senestech.com/role/AccruedExpensesDetails Accrued Expenses (Details) Details http://senestech.com/role/AccruedExpensesTables 40 false false R41.htm 00000041 - Disclosure - Borrowings (Details) Sheet http://senestech.com/role/BorrowingsDetails Borrowings (Details) Details http://senestech.com/role/BorrowingsTables 41 false false R42.htm 00000042 - Disclosure - Borrowings (Details Narrative) Sheet http://senestech.com/role/BorrowingsDetailsNarrative Borrowings (Details Narrative) Details http://senestech.com/role/BorrowingsTables 42 false false R43.htm 00000043 - Disclosure - Common Stock Warrants and Common Stock Warrant Liability (Details) Sheet http://senestech.com/role/CommonStockWarrantsAndCommonStockWarrantLiabilityDetails Common Stock Warrants and Common Stock Warrant Liability (Details) Details http://senestech.com/role/CommonStockWarrantsAndCommonStockWarrantLiabilityTables 43 false false R44.htm 00000044 - Disclosure - Common Stock Warrants and Common Stock Warrant Liability (Details Narrative) Sheet http://senestech.com/role/CommonStockWarrantsAndCommonStockWarrantLiabilityDetailsNarrative Common Stock Warrants and Common Stock Warrant Liability (Details Narrative) Details http://senestech.com/role/CommonStockWarrantsAndCommonStockWarrantLiabilityTables 44 false false R45.htm 00000045 - Disclosure - Stockholders' Deficit (Details Narrative) Sheet http://senestech.com/role/StockholdersDeficitDetailsNarrative Stockholders' Deficit (Details Narrative) Details http://senestech.com/role/StockholdersDeficit 45 false false R46.htm 00000046 - Disclosure - Stock-based Compensation (Details) Sheet http://senestech.com/role/Stock-basedCompensationDetails Stock-based Compensation (Details) Details http://senestech.com/role/Stock-basedCompensationTables 46 false false R47.htm 00000047 - Disclosure - Stock-based Compensation (Details 1) Sheet http://senestech.com/role/Stock-basedCompensationDetails1 Stock-based Compensation (Details 1) Details http://senestech.com/role/Stock-basedCompensationTables 47 false false R48.htm 00000048 - Disclosure - Stock-based Compensation (Details 2) Sheet http://senestech.com/role/Stock-basedCompensationDetails2 Stock-based Compensation (Details 2) Details http://senestech.com/role/Stock-basedCompensationTables 48 false false R49.htm 00000049 - Disclosure - Stock-based Compensation (Details 3) Sheet http://senestech.com/role/Stock-basedCompensationDetails3 Stock-based Compensation (Details 3) Details http://senestech.com/role/Stock-basedCompensationTables 49 false false R50.htm 00000050 - Disclosure - Stock-based Compensation (Details Narrative) Sheet http://senestech.com/role/Stock-basedCompensationDetailsNarrative Stock-based Compensation (Details Narrative) Details http://senestech.com/role/Stock-basedCompensationTables 50 false false R51.htm 00000051 - Disclosure - Commitments and Contingencies (Details) Sheet http://senestech.com/role/CommitmentsAndContingenciesDetails Commitments and Contingencies (Details) Details http://senestech.com/role/CommitmentsAndContingenciesTables 51 false false R52.htm 00000052 - Disclosure - Commitments and Contingencies (Details Narrative) Sheet http://senestech.com/role/CommitmentsAndContingenciesDetailsNarrative Commitments and Contingencies (Details Narrative) Details http://senestech.com/role/CommitmentsAndContingenciesTables 52 false false R53.htm 00000053 - Disclosure - Subsequent Events (Details) Sheet http://senestech.com/role/SubsequentEventsDetails Subsequent Events (Details) Details http://senestech.com/role/SubsequentEvents 53 false false All Reports Book All Reports snes-20190930.xml snes-20190930.xsd snes-20190930_cal.xml snes-20190930_def.xml snes-20190930_lab.xml snes-20190930_pre.xml http://fasb.org/us-gaap/2019-01-31 http://xbrl.sec.gov/dei/2019-01-31 http://fasb.org/srt/2019-01-31 true true XML 54 R46.htm IDEA: XBRL DOCUMENT v3.19.3
Stock-based Compensation (Details) - Employee [Member]
9 Months Ended
Sep. 30, 2019
Expected dividend yield
Minimum [Member]  
Expected volatility 76.40%
Expected term (in years) 3 years
Risk-free interest rate 1.63%
Maximum [Member]  
Expected volatility 80.60%
Expected term (in years) 6 years
Risk-free interest rate 2.48%
XML 55 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 56 R42.htm IDEA: XBRL DOCUMENT v3.19.3
Borrowings (Details Narrative)
9 Months Ended
Sep. 30, 2019
Capital Lease Obligations [Member]  
Description of borrowings expiration period Various dates through July 2023
Capital Lease Obligations [Member] | Maximum [Member]  
Interest rate on borrowings 11.60%
Capital Lease Obligations [Member] | Minimum [Member]  
Interest rate on borrowings 6.40%
Other Promissory Notes [Member]  
Description of borrowings expiration period Various dates through June 2022
Other Promissory Notes [Member] | Maximum [Member]  
Interest rate on borrowings 13.28%
Other Promissory Notes [Member] | Minimum [Member]  
Interest rate on borrowings 10.88%
XML 57 R22.htm IDEA: XBRL DOCUMENT v3.19.3
Fair Value Measurements (Tables)
9 Months Ended
Sep. 30, 2019
Fair Value Disclosures [Abstract]  
Schedule of fair value of financial instruments

The following table sets forth the Company's financial instruments that were measured at fair value on a recurring basis by level within the fair value hierarchy (in thousands):

 

    September 30, 2019  
    Level 1     Level 2     Level 3     Total  
Financial Liabilities:                        
Common stock warrant liability (1)   $     $     $ <1     $ <1  
Total   $     $     $ <1     $ <1  

 

    December 31, 2018  
    Level 1     Level 2     Level 3     Total  
Financial Assets:                        
Money market funds   $     $     $     $  
                                 
Corporate fixed income debt securities                        
                                 
Total   $     $     $     $  
Financial Liabilities:                                
Common stock warrant liability (1)   $     $     $     $  
Total   $     $     $     $  

  

  (1) There was no change (net) in the fair value of the common stock warrant for the three and nine months ended September 30, 2019. If there had been, it would have been recorded to other income (expense) and interest expense in the statements of operations and comprehensive loss.
XML 58 R26.htm IDEA: XBRL DOCUMENT v3.19.3
Borrowings (Tables)
9 Months Ended
Sep. 30, 2019
Debt Disclosure [Abstract]  
Schedule of capital lease obligations

A summary of the Company’s borrowings, including capital lease obligations, is as follows:

 

    September 30,     December 31,  
    2019     2018  
Short-term debt:            
Current portion of long-term debt     129       219  
Total short-term debt   $ 129     $ 219  
Long-term debt:                
Capital lease obligations   $ 175     $ 232  
Other promissory notes     121       248  
Total     296       480  
Less: current portion of long-term debt     (129 )     (219 )
Total long-term debt   $ 167     $ 261  
XML 59 R47.htm IDEA: XBRL DOCUMENT v3.19.3
Stock-based Compensation (Details 1)
9 Months Ended
Sep. 30, 2019
USD ($)
$ / shares
shares
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]  
Outstanding at beginning | shares 1,721,771
Granted | shares 1,167,906
Forfeited | shares (59,500)
Expired | shares (18,510)
Outstanding at ending | shares 2,747,677
Exercisable at ending | shares 1,667,064
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Roll Forward]  
Outstanding at beginning $ 1.57
Granted 1.29
Exercised 0.65
Forfeited
Expired
Outstanding at ending 1.4
Exercisable at ending $ 1.55
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Life [Roll Forward]  
Outstanding at beginning 4 years
Granted 4 years 10 months 24 days
Outstanding at ending 3 years 10 months 24 days
Exercisable at ending 2 years 9 months 18 days
Share-based Compensation Arrangement by Share-based Payment Award, Options, Aggregate Intrinsic Value [Roll Forward]  
Outstanding at beginning | $ [1]
Granted [1]
Outstanding at ending | $ [1]
Exercisable at ending | $ [1]
[1] The aggregate intrinsic value in the table was calculated based on the difference between the estimated fair market value of the Company's stock and the exercise price of the underlying options. The estimated stock values used in the calculation was $1.01 and $0.59 per share for the nine months ended September 30, 2019 and the year ended December 31, 2018, respectively.
XML 60 R43.htm IDEA: XBRL DOCUMENT v3.19.3
Common Stock Warrants and Common Stock Warrant Liability (Details) - $ / shares
9 Months Ended 12 Months Ended
Sep. 30, 2019
Dec. 31, 2018
Dec. 31, 2017
Outstanding at beginning 11,226,821 6,431,785 829,285
Warrants issued 166,667  
Warrants Exercised 1,298,210 (1,475,659)  
Warrants Exercised (312,000)    
Expired Warrants 9,783,278 (488,119)  
Date Issued 2019-07    
Date Issued 2018-08    
Date issued 2018-08    
Term 5 years    
Excercise price (in dollars per share) $ 0.95    
Exercise Price (in dollars per share) 1.15    
Exercise Price (in dollars per share) $ 1.6875    
Outstanding at ending 9,783,278 11,226,821 6,431,785
Warrants issued [Member]      
Warrants issued   1,133,909  
Date Issued   2018-06  
Term   5 years  
Exercise Price (in dollars per share)   $ 1.82  
Common Stock Offering Warrants Issued [Member]      
Warrants issued   5,357,052 4,657,500
Date Issued   2018-08 2017-11
Term   5 years 5 years
Exercise Price (in dollars per share) [1]   $ 1.15 $ 1.15
Common Stock Offering - Dealer Manager Warrants [Member]      
Warrants issued   267,853  
Date Issued   2018-08  
Term   5 years  
Exercise Price (in dollars per share)   $ 1.725  
Common Stock Offering Underwriter Warrants [Member]      
Warrants issued     945,000
Date Issued     2017-11
Term     5 years
Exercise Price (in dollars per share)     $ 1.50
[1] The common stock warrants issued in November 2017 with an initial exercise price of $1.50 per share adjusted downward to $0.95 per share effective July 24, 2018 in connection with our Rights Offering (as defined in Note 9 below), and may be subject to further downward adjustments, pursuant to antidilution price adjustment protection contained within those warrants.
XML 61 R52.htm IDEA: XBRL DOCUMENT v3.19.3
Commitments and Contingencies (Details Narrative)
$ in Thousands
9 Months Ended
Nov. 16, 2016
ft²
Sep. 30, 2019
USD ($)
Sep. 30, 2018
USD ($)
Jul. 31, 2019
ft²
Rent expense   $ 187 $ 183  
Lease commitments extended   P0Y24M    
Research and Development [Member]        
Area | ft² 1,954      
Area cancelled | ft²       1,000
Lease expiration date Nov. 15, 2018      
Lease notice period 30 days      
Office and Computer Equipment [Member]        
Accumulated amortization   $ 498    
Research and Development Equipment [Member]        
Accumulated amortization   $ 252    
XML 62 R9.htm IDEA: XBRL DOCUMENT v3.19.3
Fair Value Measurements
9 Months Ended
Sep. 30, 2019
Fair Value Disclosures [Abstract]  
Fair Value Measurements

Note 3 - Fair Value Measurements

 

The Company issued common stock warrants to purchase shares of common stock in June of 2015 (see Note 9 — Stock-based Compensation for more details) that contain a cash settlement provision resulting in a common stock warrant liability that is revalued at the end of each reporting period.

 

We value these warrant derivatives at fair value. The accounting guidance for fair value, among other things, establishes a consistent framework for measuring fair value and expands disclosure for each major asset and liability category measured at fair value on either a recurring or nonrecurring basis. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction between market participants at the reporting date. The framework for measuring fair value consists of a three-level valuation hierarchy that prioritizes the inputs to valuation techniques used to measure fair value based upon whether such inputs are observable or unobservable. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect market assumptions made by the reporting entity. The three-level hierarchy for the inputs to valuation techniques is briefly summarized as follows: 

 

Level 1—Inputs are unadjusted, quoted prices in active markets for identical assets or liabilities at the measurement date;

 

Level 2—Inputs are observable, unadjusted quoted prices in active markets for similar assets or liabilities, unadjusted quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the related assets or liabilities; and

 

Level 3—Unobservable inputs that are significant to the measurement of the fair value of the assets or liabilities that are supported by little or no market data.

 

An asset's or liability's fair value measurement level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement. Valuation techniques used need to maximize the use of observable inputs and minimize the use of unobservable inputs.

 

Assets and liabilities measured at fair value are based on one or more of the following three valuation techniques:

 

  A. Market approach: Prices and other relevant information generated by market transactions involving identical or comparable assets or liabilities.

 

  B. Cost approach: Amount that would be required to replace the service capacity of an asset (replacement cost).

 

  C. Income approach: Techniques to convert future amounts to a single present amount based upon market expectations, including present value techniques, option-pricing and excess earnings models.

 

The Company's common stock warrant liabilities are classified as Level 3 because there is limited activity or less transparency around the inputs to valuation.

 

Items Measured at Fair Value on a Recurring Basis 

 

The following table sets forth the Company's financial instruments that were measured at fair value on a recurring basis by level within the fair value hierarchy (in thousands):

 

    September 30, 2019  
    Level 1     Level 2     Level 3     Total  
Financial Liabilities:                        
Common stock warrant liability (1)   $     $     $ <1     $ <1  
Total   $     $     $ <1     $ <1  

 

    December 31, 2018  
    Level 1     Level 2     Level 3     Total  
Financial Assets:                        
Money market funds   $     $     $     $  
                                 
Corporate fixed income debt securities                        
                                 
Total   $     $     $     $  
Financial Liabilities:                                
Common stock warrant liability (1)   $     $     $     $  
Total   $     $     $     $  

  

  (1) There was no change (net) in the fair value of the common stock warrant for the three and nine months ended September 30, 2019. If there had been, it would have been recorded to other income (expense) and interest expense in the statements of operations and comprehensive loss.

 

Financial Instruments Not Carried at Fair Value

 

The carrying amounts of the Company's financial instruments, including accounts payable and accrued liabilities, approximate fair value due to their short maturities. The estimated fair value of the convertible notes and other notes, not recorded at fair value, are recorded at cost or amortized cost which was deemed to estimate fair value.

XML 63 R5.htm IDEA: XBRL DOCUMENT v3.19.3
STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT) (Unaudited) - USD ($)
$ in Thousands
Common Stock [Member]
Additional Paid-In Capital [Member]
Stock Subscription Payable [Member]
Accumulated Deficit [Member]
Total
Balance at beginning at Dec. 31, 2017 $ 16 $ 81,103   $ (73,597) $ 7,522
Balance at beginning (in shares) at Dec. 31, 2017 16,404,195        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock for services $ 1 34 $ (8)   27
Issuance of common stock for services (in shares) 174,481        
Issuance of common stock, sold for cash, net $ 5 5,127     5,132
Issuance of common stock, sold for cash, net (in shares) 5,357,052        
Stock-based compensation   3,062     3,062
Warrant antidilution price protection adjustment   333   (333) 333
Payments for employee withholding taxes related to share-based awards   (42)     (42)
Stock subscribed but not issued   (8) $ 8    
Issuance of common stock upon exercise of warrants $ 1 2,213     2,214
Issuance of common stock upon exercise of warrants (in shares) 1,475,659        
Issuance of common stock upon cashless exercise of stock options (in shares) 13,900        
Net loss       (9,278) (9,278)
Balance at ending at Sep. 30, 2018 $ 23 91,822   (83,208) 8,637
Balance at ending (in shares) at Sep. 30, 2018 23,425,287        
Balance at beginning at Jun. 30, 2018 $ 18 86,022   (80,375) 5,665
Balance at beginning (in shares) at Jun. 30, 2018 18,040,497        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock for services (in shares) 27,738        
Issuance of common stock, sold for cash, net $ 5 5,127     5,132
Issuance of common stock, sold for cash, net (in shares) 5,357,052        
Stock-based compensation   355     355
Warrant antidilution price protection adjustment   333   (333) 333
Payments for employee withholding taxes related to share-based awards   (15)     (15)
Net loss       (2,500) (2,500)
Balance at ending at Sep. 30, 2018 $ 23 91,822   (83,208) 8,637
Balance at ending (in shares) at Sep. 30, 2018 23,425,287        
Balance at beginning at Dec. 31, 2018 $ 24 92,128   (85,838) 6,314
Balance at beginning (in shares) at Dec. 31, 2018 23,471,999        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock for services   34     34
Issuance of common stock for services (in shares) 144,054        
Issuance of common stock, sold for cash, net $ 3 3,627     3,630
Issuance of common stock, sold for cash, net (in shares) 3,037,038        
Stock-based compensation   675     675
Warrant antidilution price protection adjustment        
Payments for employee withholding taxes related to share-based awards   (55)     (55)
Issuance of common stock upon exercise of warrants $ 1 1,787     1,788
Issuance of common stock upon exercise of warrants (in shares) 1,610,210        
Issuance of common stock upon cashless exercise of stock options (in shares) 24,984        
Net loss       (7,238) (7,238)
Balance at ending at Sep. 30, 2019 $ 28 98,196   (93,076) 5,148
Balance at ending (in shares) at Sep. 30, 2019 28,288,285        
Balance at beginning at Jun. 30, 2019 $ 25 94,391   (90,491) 3,925
Balance at beginning (in shares) at Jun. 30, 2019 25,227,475        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock, sold for cash, net $ 3 3,627     3,630
Issuance of common stock, sold for cash, net (in shares) 3,037,038        
Stock-based compensation   204     204
Warrant antidilution price protection adjustment        
Payments for employee withholding taxes related to share-based awards   (31)     (31)
Issuance of common stock upon exercise of warrants   5     5
Issuance of common stock upon exercise of warrants (in shares) 4,514        
Net loss       (2,585) (2,585)
Balance at ending at Sep. 30, 2019 $ 28 $ 98,196   $ (93,076) $ 5,148
Balance at ending (in shares) at Sep. 30, 2019 28,288,285        
XML 64 R1.htm IDEA: XBRL DOCUMENT v3.19.3
Document and Entity Information - shares
9 Months Ended
Sep. 30, 2019
Nov. 14, 2019
Document And Entity Information    
Entity Registrant Name SenesTech, Inc.  
Entity Central Index Key 0001680378  
Document Type 10-Q  
Document Period End Date Sep. 30, 2019  
Amendment Flag false  
Current Fiscal Year End Date --12-31  
Entity Reporting Status Current Yes  
Entity File Number 001-37941  
Entity Incorporation, State or Country Code DE  
Entity Filer Category Non-accelerated Filer  
Entity Interactive Data Current Yes  
Entity Small Business true  
Entity Emerging Growth Company true  
Entity Ex Transition Period true  
Entity Shell Company false  
Title of 12(b) Security Common Stock, $0.001 par value  
Trading Symbol SNES  
Security Exchange Name NASDAQ  
Entity Common Stock, Shares Outstanding   28,288,596
Document Fiscal Period Focus Q3  
Document Fiscal Year Focus 2019  
EXCEL 65 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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�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end XML 66 R10.htm IDEA: XBRL DOCUMENT v3.19.3
Credit Risk
9 Months Ended
Sep. 30, 2019
Risks and Uncertainties [Abstract]  
Credit Risk

Note 4 - Credit Risk

 

The Company is potentially subject to concentrations of credit risk in its accounts receivable. Credit risk with respect to receivables is limited due to the number of companies comprising the Company's customer base. Although the Company is directly affected by the financial condition of its customers, management does not believe significant credit risks exist at September 30, 2019 or December 31, 2018. The Company does not require collateral or other securities to support its accounts receivable.

XML 67 R14.htm IDEA: XBRL DOCUMENT v3.19.3
Borrowings
9 Months Ended
Sep. 30, 2019
Debt Disclosure [Abstract]  
Borrowings

Note 8 - Borrowings

 

A summary of the Company's borrowings, including capital lease obligations, is as follows:

 

    September 30,     December 31,  
    2019     2018  
Short-term debt:            
Current portion of long-term debt     129       219  
Total short-term debt   $ 129     $ 219  
Long-term debt:                
Capital lease obligations   $ 175     $ 232  
Other promissory notes     121       248  
Total     296       480  
Less: current portion of long-term debt     (129 )     (219 )
Total long-term debt   $ 167     $ 261  

 

Capital Lease Obligations 

 

Capital lease obligations are for computer and lab equipment leased through GreatAmerica Financial Services, Thermo Fisher Scientific, Navitas Credit Corp. and ENGS Commercial Finance Co. These capital leases expire at various dates through July 2023 and carry interest rates ranging from 6.4% to 11.6%.

 

Other Promissory Notes

 

Also included in the table above are three notes payable to Direct Capital, one note to M2 Financing and one note to Fidelity Capital, all for the financing of fixed assets. These notes expire at various dates through June 2022 and carry interest rates ranging from 10.88% to 13.28%.

XML 68 R18.htm IDEA: XBRL DOCUMENT v3.19.3
Commitments and Contingencies
9 Months Ended
Sep. 30, 2019
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies

Note 12 - Commitments and Contingencies

 

Legal Proceedings 

 

The Company may be subject to legal proceedings and claims arising from contracts or other matters from time to time in the ordinary course of business. Management is not aware of any pending or threatened litigation where the ultimate disposition or resolution could have a material adverse effect on its financial position, results of operations or liquidity.

 

On February 20, 2018, New Enterprises, Ltd. ("New Enterprises"), filed a lawsuit against the Company and Roth Capital Partners, LLC ("Roth") in the U.S. District Court for the District of Arizona (the "Court"). The complaint alleges nine counts against the Company, including that the Company: engaged in common law fraud and securities fraud to induce the chairman of New Enterprises into investing in the Company; failed to register New Enterprises' requested transfer; breached stock certificates and the lock-up contract; tortuously interfered with prospective business advantage; and was liable for conversion. New Enterprises is seeking monetary damages, including compensatory damages, punitive damages, and attorney's fees. On December 3, 2018, the Court issued its order granting the Company's and Roth's motions to dismiss all of New Enterprises' claims but gave them leave to file a motion to amend the complaint. On January 25, 2019, New Enterprises moved for leave to file an amended complaint, alleging similar claims against the Company and Roth, and the court granted that motion. On April 5, 2019, New Enterprises filed an amended complaint, alleging similar claims against the Company and Roth. The Company and Roth moved to dismiss the amended complaint, and on August 16, 2019, the Court issued its order denying the Company's and Roth's motions to dismiss. Roth has made a claim for indemnification to the Company based on contractual indemnification agreements, but to date the Company has not accepted Roth's indemnification demand.

 

On April 20, 2018, the Company's former Executive Vice President and Chief Operating Officer Andrew Altman filed a charge of employment discrimination with the Equal Employment Opportunity Commission (EEOC) against the Company. Mr. Altman claimed that he was terminated after he expressed opposition to an email that Cheryl Dyer, Chief Research Officer, had sent out to the management team, in which she criticized a Mormon newspaper. The Company filed a position statement on May 21, 2018. No substantive action has been taken since then, and the Company has not heard anything further either from the EEOC or Mr. Altman's attorneys.

 

Lease Commitments

 

The Company is obligated under capital leases for certain research and computer equipment that expire on various dates through July 2023. At September 30, 2019, the gross amount of office and computer equipment, and research equipment and the related accumulated amortization recorded under the capital leases was $498 and $252, respectively.

 

In February 2012, the Company entered into an operating lease for its corporate headquarters. The lease was due to expire in January 2015. In December 2013, the Company amended its lease to expand into the remaining area in the building and extended the term to December 31, 2019. In February 2014, the Company further amended the lease to expand into an adjacent building. The lease requires escalating rental payments over the lease term. Minimum rental payments under the operating lease are recognized on a straight-line basis over the term of the lease and accordingly, the Company records the difference between the cash rent payments and the recognition of rent expense as a deferred rent liability. The lease is guaranteed by the President of the Company. We are currently in discussions to extend the current lease.

 

On November 16, 2016, we leased an additional 1,954 square feet of research and development space, also in Flagstaff. This lease expired on November 15, 2018 but was extended for an additional 24 months, through November 2020. A subsequent amendment to the lease allows for the Company to cancel the lease at any time through the lease term with 30-day notice. In June 2019, the Company cancelled approximately 1,000 square feet of this leased space, and the fixed rental payment was reduced for the remaining term of the lease. The lease extension requires fixed rental payments over the lease term. Minimum rental payments under the operating lease are recognized on a straight-line basis over the term of the lease as expense, and accordingly, the Company recorded no deferred rent liability under this lease.

 

Total rent expense was $187 and $183 for the nine months ended September 30, 2019 and September 30, 2018, respectively. The future minimum lease payments under our non-cancellable operating lease and our capital lease as of September 30, 2019 are as follows:

 

    Capital
Leases
    Operating
Lease
 
Years Ending December 31,            
2019     24       62  
2020     78       24  
2021     63        
2022     33        
2023     3          
Total minimum lease payments   $ 201     $ 86  

 

    Capital
Leases
 
       
Less: amounts representing interest (6.39%, ranging from 10.48% to 11.56%)   $ 26  
         
Present value of minimum lease payments     175  
         
Less: current installments under capital lease obligations     70  
         
Total long-term portion   $ 105  
XML 69 R37.htm IDEA: XBRL DOCUMENT v3.19.3
Prepaid Expenses (Details) - USD ($)
$ in Thousands
Sep. 30, 2019
Dec. 31, 2018
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]    
Director compensation   $ 100
Director and officer insurance $ 161 121
NASDAQ fees 14
Legal retainer 25 25
Marketing programs and conferences 54 53
Professional services retainer 15 8
Rent   19
Equipment service deposits 2 3
Foreign patent registration 22  
Engineering, software licenses and other 11 13
Total prepaid expenses $ 304 $ 342
XML 70 R33.htm IDEA: XBRL DOCUMENT v3.19.3
Summary of Significant Accounting Policies (Details 2) - shares
9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Total 12,648,420 13,613,623
Common Stock Purchase Warrants [Member]    
Total 9,783,278 11,714,940
Restricted Stock Units [Member]    
Total 117,465 172,912
Common Stock Options [Member]    
Total 2,747,677 1,725,771